{"text": "Preincubation (30 min) of bovine tracheal smooth muscle with various concentrations (0.1, 1 and 10 microM) of fenoterol decreased isoprenaline-induced maximal relaxation (E(max)) of methacholine-contracted preparations in a concentration dependent fashion, indicating desensitization of the beta(2)-adrenoceptor.", "spo_list": [{"subject": "isoprenaline", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}]}
{"text": "Preincubation with 1 microM of the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) caused a small but significant decrease in isoprenaline-induced E(max), indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization.", "spo_list": [{"subject": "phorbol 12-myristate 13-acetate", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PKC", "object_type": "GENE"}, {"subject": "phorbol 12-myristate 13-acetate", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "protein kinase C", "object_type": "GENE"}, {"subject": "PMA", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "protein kinase C", "object_type": "GENE"}, {"subject": "PMA", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PKC", "object_type": "GENE"}, {"subject": "isoprenaline", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}, {"subject": "phorbol 12-myristate 13-acetate", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PKC", "object_type": "GENE"}, {"subject": "PMA", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PKC", "object_type": "GENE"}]}
{"text": "Moreover, the specific PKC-inhibitor 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl) maleimide (GF 109203X) markedly increased the potency and E(max) of isoprenaline for all conditions used, including control conditions, and the synergistic effects of PMA and fenoterol were completely prevented.", "spo_list": [{"subject": "2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl) maleimide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PKC", "object_type": "GENE"}, {"subject": "GF 109203X", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PKC", "object_type": "GENE"}]}
{"text": "Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.", "spo_list": [{"subject": "salsalate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "salsalate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "acetaminophen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "acetaminophen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "celecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "celecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "rofecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "rofecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Our results dissect the roles of HMGB1-associated proteins in DNA damage response: HMGB1 and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress, and PDIA3 has been found essential for H2AX phosphorylation (no gamma-H2AX accumulated after 24-72 hours of incubation with 1 micromol/L of cytarabine in PDIA3 knockdown cells).", "spo_list": [{"subject": "cytarabine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "p53", "object_type": "GENE"}]}
{"text": "This effect has been attributed to the antagonist effects of pindolol at the 5-HT(1A) receptor.", "spo_list": [{"subject": "pindolol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT(1A)", "object_type": "GENE"}]}
{"text": "In the present study, we compared the pharmacology of (+/-)pindolol, WAY-100635 (a 5-HT(1A) antagonist), GR127935 (a 5-HT(1B/1D) antagonist), and isamoltane (a 5-HT(1B) antagonist), when given acutely in combination with fluoxetine, using in vivo microdialysis in the frontal cortex of the freely moving rat.", "spo_list": [{"subject": "(+/-)pindolol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT(1A)", "object_type": "GENE"}, {"subject": "WAY-100635", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT(1A)", "object_type": "GENE"}, {"subject": "isamoltane", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT(1B)", "object_type": "GENE"}]}
{"text": "In addition, by comparing the combined administration of (+/-)pindolol with either WAY100635, GR127935 or isamoltane, we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the 5-HT(1B/D) receptor in addition to any activity it has at the presynaptic 5-HT(1A) receptor.", "spo_list": [{"subject": "(+/-)pindolol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT(1A)", "object_type": "GENE"}]}
{"text": "Previously, we reported that a primary heparin or heparan sulfate binding site resides in a distinct sequence in immunoglobulin (Ig)-like module II of the three modules of FGFR.", "spo_list": [{"subject": "sulfate", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "immunoglobulin (Ig)-like module II", "object_type": "GENE"}, {"subject": "sulfate", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "FGFR", "object_type": "GENE"}]}
{"text": "Ig module I and the C-terminus of Ig module III are dispensable for high-affinity binding of FGF-1, FGF-2, and FGF-7.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Ig module III", "object_type": "GENE"}]}
{"text": "Addition of a specific number of FGFR sequences to the C-terminus of Ig module II resulted in a gain in affinity for FGF-7.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Ig module II", "object_type": "GENE"}]}
{"text": "Several site-specific alterations in the C-terminus of full-length FGFR1IIIc, an isoform that otherwise absolutely rejects FGF-7, resulted in gain of FGF-7 binding.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "FGFR1IIIc", "object_type": "GENE"}]}
{"text": "These results suggest that a complex of Ig module II and heparan sulfate is the base common active core of the FGFR ectodomain and that flanking structural domains modify FGF affinity and determine specificity.", "spo_list": [{"subject": "sulfate", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Ig module II", "object_type": "GENE"}]}
{"text": "Pharmacokinetic and pharmacodynamic modeling of hedgehog inhibitor TAK-441 for the inhibition of Gli1 messenger RNA expression and antitumor efficacy in xenografted tumor model mice.", "spo_list": [{"subject": "TAK-441", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "hedgehog", "object_type": "GENE"}, {"subject": "TAK-441", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Gli1", "object_type": "GENE"}]}
{"text": "6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide (TAK-441) is a potent, selective hedgehog signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer.", "spo_list": [{"subject": "TAK-441", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "hedgehog", "object_type": "GENE"}, {"subject": "TAK-441", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Smo", "object_type": "GENE"}]}
{"text": "The IC50 values for Gli1 mRNA inhibition in the tumor and skin by TAK-441 were estimated to be 0.0457 and 0.113 μg/ml, respectively.", "spo_list": [{"subject": "TAK-441", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Gli1", "object_type": "GENE"}]}
{"text": "We show that the expression of PIM-1 is induced in response to estradiol in MCF-7 cells and that the induction is mediated by ERα-regulated enhancers located distally upstream from the gene.", "spo_list": [{"subject": "estradiol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PIM-1", "object_type": "GENE"}, {"subject": "estradiol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "ERα", "object_type": "GENE"}]}
{"text": "Esmolol, a unique cardioselective beta 1-adrenergic receptor blocker with a half-life of 9 minutes, can enable some patients with relative contraindications to beta blockers to nevertheless benefit from early beta-blocking therapy.", "spo_list": [{"subject": "Esmolol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "beta 1-adrenergic receptor", "object_type": "GENE"}]}
{"text": "Inhibition of the actions of ET-1 by salicylates is apparently competitive.", "spo_list": [{"subject": "salicylates", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ET-1", "object_type": "GENE"}]}
{"text": "Salicylates inhibit (125)I-ET-1 binding to recombinant rat ETA receptors.", "spo_list": [{"subject": "Salicylates", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ET-1", "object_type": "GENE"}, {"subject": "(125)I", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ET-1", "object_type": "GENE"}, {"subject": "Salicylates", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "rat ETA receptors", "object_type": "GENE"}]}
{"text": "Salicylic acid promotes dissociation of (125)I-ET-1 ETA receptor complexes both in the absence and the presence of unlabeled ET-1.", "spo_list": [{"subject": "(125)I", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ET-1", "object_type": "GENE"}, {"subject": "(125)I", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ETA receptor", "object_type": "GENE"}, {"subject": "Salicylic acid", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ET-1", "object_type": "GENE"}, {"subject": "Salicylic acid", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ETA receptor", "object_type": "GENE"}]}
{"text": "It has no influence on the rate of association of (125)I-ET-1 to ETA receptors.", "spo_list": [{"subject": "(125)I", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ET-1", "object_type": "GENE"}, {"subject": "(125)I", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ETA receptors", "object_type": "GENE"}]}
{"text": "Salicylates do not promote dissociation of (125)I-ET-1 ETB receptor complexes.", "spo_list": [{"subject": "(125)I", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ET-1", "object_type": "GENE"}, {"subject": "(125)I", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ETB receptor", "object_type": "GENE"}]}
{"text": "This process was reduced by a protonophore, carbonylcyanide p-trifluoromethoxyphenylhydrazone, and a typical monocarboxylate transporter (MCT) inhibitor, alpha-cyano-4-hydroxycinnamic acid, suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system.", "spo_list": [{"subject": "alpha-cyano-4-hydroxycinnamic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monocarboxylate transporter", "object_type": "GENE"}, {"subject": "alpha-cyano-4-hydroxycinnamic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MCT", "object_type": "GENE"}, {"subject": "nicotinate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "monocarboxylate transport system", "object_type": "GENE"}]}
{"text": "Because l-lactate reduced to 67% of the nicotinate uptake even at 10mM, it is unlikely that nicotinate uptake in rat astrocytes is mediated by MCT1 and/or MCT2.", "spo_list": [{"subject": "nicotinate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "MCT1", "object_type": "GENE"}, {"subject": "nicotinate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "MCT2", "object_type": "GENE"}]}
{"text": "These results provide biochemical evidence of a H(+)-coupled and saturable transport system, presumed to be a low-affinity monocarboxylate transporter MCT4 or other unknown H(+)-coupled monocarboxylate transport system, for nicotinate in rat cerebrocortical astrocytes.", "spo_list": [{"subject": "nicotinate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "H(+)-coupled monocarboxylate transport system", "object_type": "GENE"}, {"subject": "nicotinate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "low-affinity monocarboxylate transporter", "object_type": "GENE"}, {"subject": "nicotinate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "MCT4", "object_type": "GENE"}]}
{"text": "Potency switch between CHK1 and MK2: Discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.", "spo_list": [{"subject": "imidazo[1,2-c]pyrimidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "imidazo[1,2-a]pyrazine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "imidazo[1,2-a]pyrazine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CHK1", "object_type": "GENE"}, {"subject": "imidazo[1,2-c]pyrimidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MK2", "object_type": "GENE"}, {"subject": "imidazo[1,2-c]pyrimidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CHK1", "object_type": "GENE"}, {"subject": "imidazo[1,2-a]pyrazine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MK2", "object_type": "GENE"}]}
{"text": "PURPOSE: Testosterone-to-estradiol ratio levels in infertile men improve during treatment with the aromatase inhibitor, testolactone, and resulting changes in semen parameters.", "spo_list": [{"subject": "testolactone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "aromatase", "object_type": "GENE"}]}
{"text": "We evaluated the effect of anastrozole, a more selective aromatase inhibitor, on the hormonal and semen profiles of infertile men with abnormal baseline testosterone-to-estradiol ratios.", "spo_list": [{"subject": "anastrozole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "aromatase", "object_type": "GENE"}]}
{"text": "Increased IL-5 activity in the serum was inhibited by both pranlukast and MCI-826 by over 90%.", "spo_list": [{"subject": "pranlukast", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "IL-5", "object_type": "GENE"}, {"subject": "MCI-826", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "IL-5", "object_type": "GENE"}]}
{"text": "CONCLUSIONS: CysLTs produced after antigen provocation sequentially induced IL-5 production from some immune component cells via CysLT1 receptor activation.", "spo_list": [{"subject": "CysLTs", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "CysLT1", "object_type": "GENE"}]}
{"text": "Angiotensin AT1 receptor antagonist losartan and the defence reaction in the anaesthetised rat.", "spo_list": [{"subject": "losartan", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "Angiotensin AT1 receptor", "object_type": "GENE"}]}
{"text": "We investigated the effect of AT1 receptor blockade in the NTS on the response to stimulation of HDA in anaesthetised rats treated with the neuromuscular blocking agent pancuronium bromide.", "spo_list": [{"subject": "pancuronium bromide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AT1 receptor", "object_type": "GENE"}]}
{"text": "The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan.", "spo_list": [{"subject": "dimemorfan", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "sigma1 receptor", "object_type": "GENE"}, {"subject": "dextromethorphan", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "sigma1 receptor", "object_type": "GENE"}]}
{"text": "Dextromethorphan and dimemorfan are high-affinity ligands at sigma1 receptors.", "spo_list": [{"subject": "Dextromethorphan", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sigma1 receptors", "object_type": "GENE"}, {"subject": "dimemorfan", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sigma1 receptors", "object_type": "GENE"}]}
{"text": "Dimemorfan pre-treatment also attenuated the KA-induced increases in c-fos/c-jun expression, activator protein (AP)-1 DNA-binding activity, and loss of cells in the CA1 and CA3 fields of the hippocampus.", "spo_list": [{"subject": "KA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "c-fos", "object_type": "GENE"}, {"subject": "KA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "c-jun", "object_type": "GENE"}, {"subject": "KA", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "activator protein (AP)-1", "object_type": "GENE"}, {"subject": "Dimemorfan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "activator protein (AP)-1", "object_type": "GENE"}, {"subject": "Dimemorfan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "c-fos", "object_type": "GENE"}, {"subject": "Dimemorfan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "c-jun", "object_type": "GENE"}]}
{"text": "The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047, suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is, at least in part, related to sigma1 receptor-activated modulation of AP-1 transcription factors.", "spo_list": [{"subject": "BD 1047", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "sigma1 receptor", "object_type": "GENE"}]}
{"text": "Fragment-based design, synthesis, and biological evaluation of N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide derivatives as novel Mcl-1 inhibitors.", "spo_list": [{"subject": "N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Mcl-1", "object_type": "GENE"}]}
{"text": "We have previously reported a nanomolar inhibitor of antiapoptotic Mcl-1 protein, 3-thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile (S1).", "spo_list": [{"subject": "3-thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Mcl-1", "object_type": "GENE"}]}
{"text": "A novel potent compound, N-benzyl-5-(4-isopropylthiophenol)-2-hydroxyl nicotinamide (12c), which binds Mcl-1 with an IC(50) value of 54 nM was obtained.", "spo_list": [{"subject": "N-benzyl-5-(4-isopropylthiophenol)-2-hydroxyl nicotinamide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Mcl-1", "object_type": "GENE"}, {"subject": "N-benzyl-5-(4-isopropylthiophenol)-2-hydroxyl nicotinamide", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Mcl-1", "object_type": "GENE"}]}
{"text": "In vitro binding studies showed that both amoxapine and amitriptyline interact in the nanomolar range with 5-HT2 receptors labelled by [3H]ketanserin in cortical membranes.", "spo_list": [{"subject": "amoxapine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT2", "object_type": "GENE"}, {"subject": "amitriptyline", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT2", "object_type": "GENE"}, {"subject": "[3H]ketanserin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT2", "object_type": "GENE"}]}
{"text": "Interestingly, amoxapine binds with a good affinity (IC50 = 0.30 microM) to 5-HT3 receptors labelled by [3H]zacopride in cortical membranes.", "spo_list": [{"subject": "amoxapine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT3", "object_type": "GENE"}, {"subject": "[3H]zacopride", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT3", "object_type": "GENE"}]}
{"text": "Complementary experiments using the 5-HT3-dependent Bezold-Jarisch reflex confirmed that amoxapine really acts in vivo as a 5-HT3 antagonist (IC50 = 50 micrograms/kg i.v.), whereas amitriptyline is essentially inactive on 5-HT3 receptors.", "spo_list": [{"subject": "amoxapine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT3", "object_type": "GENE"}]}
{"text": "In this study, the activity of the delta-opioid receptor subtype-selective agonist, SB 227122, was investigated in a guinea pig model of citric acid-induced cough.", "spo_list": [{"subject": "SB 227122", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "delta-opioid receptor", "object_type": "GENE"}]}
{"text": "Parenteral administration of selective agonists of the delta-opioid receptor (SB 227122), mu-opioid receptor (codeine and hydrocodone), and kappa-opioid receptor (BRL 52974) produced dose-related inhibition of citric acid-induced cough with ED(50) values of 7.3, 5.2, 5.1, and 5.3 mg/kg, respectively.", "spo_list": [{"subject": "SB 227122", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "delta-opioid receptor", "object_type": "GENE"}, {"subject": "codeine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "mu-opioid receptor", "object_type": "GENE"}, {"subject": "hydrocodone", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "mu-opioid receptor", "object_type": "GENE"}, {"subject": "BRL 52974", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "kappa-opioid receptor", "object_type": "GENE"}]}
{"text": "The nonselective opioid receptor antagonist, naloxone (3 mg/kg, i.m.), attenuated the antitussive effects of codeine or SB 227122, indicating that the antitussive activity of both compounds is opioid receptor-mediated.", "spo_list": [{"subject": "naloxone", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "opioid receptor", "object_type": "GENE"}, {"subject": "codeine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "opioid receptor", "object_type": "GENE"}, {"subject": "SB 227122", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "opioid receptor", "object_type": "GENE"}, {"subject": "codeine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "opioid receptor", "object_type": "GENE"}, {"subject": "SB 227122", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "opioid receptor", "object_type": "GENE"}]}
{"text": "The delta-receptor antagonist, SB 244525 (10 mg/kg, i.p.), inhibited the antitussive effect of SB 227122 (20 mg/kg, i.p.).", "spo_list": [{"subject": "SB 244525", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "delta-receptor", "object_type": "GENE"}, {"subject": "SB 227122", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "delta-receptor", "object_type": "GENE"}]}
{"text": "In contrast, combined pretreatment with beta-funaltrexamine (mu-receptor antagonist; 20 mg/kg, s.c.) and norbinaltorphimine (kappa-receptor antagonist; 20 mg/kg, s.c.), at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists, respectively, was without effect on the antitussive response of SB 227122 (20 mg/kg, i.p.).", "spo_list": [{"subject": "beta-funaltrexamine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "mu-receptor", "object_type": "GENE"}, {"subject": "norbinaltorphimine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "kappa-receptor", "object_type": "GENE"}]}
{"text": "The sigma-receptor antagonist rimcazole (3 mg/kg, i.p.) inhibited the antitussive effect of dextromethorphan (30 mg/kg, i.p.), a sigma-receptor agonist, but not that of SB 227122.", "spo_list": [{"subject": "rimcazole", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "sigma-receptor", "object_type": "GENE"}, {"subject": "dextromethorphan", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "sigma-receptor", "object_type": "GENE"}]}
{"text": "These studies provide compelling evidence that the antitussive effects of SB 227122 in this guinea pig cough model are mediated by agonist activity at the delta-opioid receptor.", "spo_list": [{"subject": "SB 227122", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "delta-opioid receptor", "object_type": "GENE"}]}
{"text": "A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome.", "spo_list": [{"subject": "benzo[d]imidazole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NLRP3", "object_type": "GENE"}]}
{"text": "In addition, the disease activity index, histopathologic scores and myeloperoxidase activity were also significantly reduced by Fc11a-2 treatment.", "spo_list": [{"subject": "Fc11a-2", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "myeloperoxidase", "object_type": "GENE"}]}
{"text": "Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-α, IL-1β, IL-18, IL-17A and IFN-γ, were markedly suppressed by Fc11a-2.", "spo_list": [{"subject": "Fc11a-2", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF-α", "object_type": "GENE"}, {"subject": "Fc11a-2", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-1β", "object_type": "GENE"}, {"subject": "Fc11a-2", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-18", "object_type": "GENE"}, {"subject": "Fc11a-2", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-17A", "object_type": "GENE"}, {"subject": "Fc11a-2", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IFN-γ", "object_type": "GENE"}, {"subject": "Fc11a-2", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cytokines", "object_type": "GENE"}]}
{"text": "Furthermore, a decreased CD11c(+) macrophage infiltration in colons and inactivation of caspase-1 in peritoneal macrophages were detected in Fc11a-2-treated mice.", "spo_list": [{"subject": "Fc11a", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "caspase-1", "object_type": "GENE"}]}
{"text": "The mechanism of action of Fc11a-2 was related to the inhibition of the cleavage of pro-caspase-1, pro-IL-1β and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome.", "spo_list": [{"subject": "Fc11a-2", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "pro-caspase-1", "object_type": "GENE"}, {"subject": "Fc11a-2", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "pro-IL-1β", "object_type": "GENE"}, {"subject": "Fc11a-2", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "pro-IL-18", "object_type": "GENE"}, {"subject": "Fc11a-2", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NLRP3", "object_type": "GENE"}]}
{"text": "Taken together, our results demonstrate the ability of Fc11a-2 to inhibit NLRP3 inflammasome activation and its potential use in the treatment of inflammatory bowel diseases.", "spo_list": [{"subject": "Fc11a-2", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NLRP3", "object_type": "GENE"}]}
{"text": "As revealed by glucose oxidase (GOD) and radioimmunoassay (RIA), both dimethyldiguanide (DC, 0.6gkg(-1)d(-1)) and CPS (0.3, 0.6, 1.2gkg(-1)d(-1)) treatments significantly resulted in down-regulation of blood glucose and insulin levels in serum, while the levels of oxidative stress markers were markedly lowered through ELISA assay.", "spo_list": [{"subject": "dimethyldiguanide", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "insulin", "object_type": "GENE"}]}
{"text": "These findings demonstrate that cinnamon polyphenols can exert the hypoglycemic and hypolipidemic effects through the mechanisms that may be associated with repairing pancreatic beta cells in diabetic mice and improving its anti-oxidative capacity, as well as attenuating cytotoxicity via inhibition of iNOS, NF-κB activation.", "spo_list": [{"subject": "polyphenols", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "polyphenols", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NF-κB", "object_type": "GENE"}]}
{"text": "Involvement of COX-1 and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced prostaglandin E2 production by microglia.", "spo_list": [{"subject": "prostaglandin E2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-1", "object_type": "GENE"}, {"subject": "prostaglandin E2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "prostaglandin E synthases", "object_type": "GENE"}]}
{"text": "Furthermore, PS liposome-induced PGE2 production was significantly suppressed by indomethacin, a preferential COX-1 inhibitor, but not by NS-398, a selective COX-2 inhibitor.", "spo_list": [{"subject": "indomethacin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-1", "object_type": "GENE"}, {"subject": "NS-398", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "These observations strongly suggest that the up-regulation of terminal PGESs that are preferentially coupled with COX-1, especially mPGES-2, plays the pivotal role in PS liposome-induced PGE2 production by microglia.", "spo_list": [{"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PGESs", "object_type": "GENE"}, {"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-1", "object_type": "GENE"}, {"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "mPGES-2", "object_type": "GENE"}]}
{"text": "Consistent with the results of a computer analysis, the binding of R316C to triiodothyronine (T3) was significantly decreased to 38% that of the wild type.", "spo_list": [{"subject": "triiodothyronine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "R316C", "object_type": "GENE"}, {"subject": "T3", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "R316C", "object_type": "GENE"}]}
{"text": "Our findings suggest that R316C causes reduced association with and impaired release of NCoR, resulting in RTH predominantly at the pituitary level, and that slightly elevated serum TSH level with high dose of levothyroxine might be optimum for normal growth.", "spo_list": [{"subject": "levothyroxine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "TSH", "object_type": "GENE"}]}
{"text": "Phenserine, a derivative of physostigmine, was first described as an inhibitor of acetylcholinesterase (AChE) and was shown to improve cognition in various experimental paradigms in rodents and dogs.", "spo_list": [{"subject": "Phenserine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "acetylcholinesterase", "object_type": "GENE"}, {"subject": "physostigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "acetylcholinesterase", "object_type": "GENE"}, {"subject": "Phenserine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}, {"subject": "physostigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}]}
{"text": "Phenserine deserves attention for an additional quality of action: in addition to inhibiting AChE, it modulates the amount of beta-amyloid precursor protein (APP) in neuronal cell culture by reducing APP translation.", "spo_list": [{"subject": "Phenserine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}, {"subject": "Phenserine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "APP", "object_type": "GENE"}]}
{"text": "This effect probably involves interaction of phenserine with a regulatory element in the 5'-untranslated region of the APP gene that controls APP expression.", "spo_list": [{"subject": "phenserine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "APP", "object_type": "GENE"}]}
{"text": "Phenserine apparently reduces translational efficiency of APP mRNA into protein, a process that may involve an interaction with iron and/or an iron-responsive element.", "spo_list": [{"subject": "Phenserine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "APP", "object_type": "GENE"}]}
{"text": "As a consequence, phenserine reduces beta-amyloid peptide (Abeta) formation in vitro and in vivo.", "spo_list": [{"subject": "phenserine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "beta-amyloid", "object_type": "GENE"}, {"subject": "phenserine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Abeta", "object_type": "GENE"}]}
{"text": "Phenserine is also unique because of differing actions of its enantiomers: (-)-phenserine is the active enantiomer for inhibition of AChE, whereas (+)-phenserine ('posiphen') has weak activity as an AChE inhibitor and can be dosed much higher.", "spo_list": [{"subject": "(-)-phenserine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}, {"subject": "(+)-phenserine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}, {"subject": "posiphen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}]}
{"text": "The cellular prion protein PrP(C) consists of two domains--a flexible N-terminal domain, which participates in copper and zinc regulation, and a largely helical C-terminal domain that converts to β sheet in the course of prion disease.", "spo_list": [{"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "prion protein PrP(C)", "object_type": "GENE"}, {"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "prion protein PrP(C)", "object_type": "GENE"}]}
{"text": "Here, we identify a Zn²⁺-driven N-terminal to C-terminal tertiary interaction in PrP(C).", "spo_list": [{"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PrP(C)", "object_type": "GENE"}, {"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PrP(C)", "object_type": "GENE"}]}
{"text": "The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5- and 11.5-fold by Wy-14643 and 5,8,11,14-eicosatetraynoic acid (ETYA) each at 10 microM, respectively, whereas that of PPARalpha2, 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively.", "spo_list": [{"subject": "Wy-14643", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PPARalpha1", "object_type": "GENE"}, {"subject": "5,8,11,14-eicosatetraynoic acid", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PPARalpha1", "object_type": "GENE"}, {"subject": "ETYA", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PPARalpha1", "object_type": "GENE"}, {"subject": "Wy-14643", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PPARalpha2", "object_type": "GENE"}, {"subject": "5,8,11,14-eicosatetraynoic acid", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PPARalpha2", "object_type": "GENE"}, {"subject": "ETYA", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PPARalpha2", "object_type": "GENE"}, {"subject": "Wy-14643", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PPARalpha2", "object_type": "GENE"}, {"subject": "5,8,11,14-eicosatetraynoic acid", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PPARalpha2", "object_type": "GENE"}, {"subject": "ETYA", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PPARalpha2", "object_type": "GENE"}]}
{"text": "Furthermore, the activities of the two torafugu PPARalphas were enhanced 4.3- and 7.6-fold by arachidonic acid, 4.4- and 5.2-fold by docosahexaenoic acid, and 6.7- and 8.0-fold by eicosapentaenoic acid each at 50 microM, respectively.", "spo_list": [{"subject": "arachidonic acid", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "torafugu PPARalphas", "object_type": "GENE"}, {"subject": "docosahexaenoic acid", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "torafugu PPARalphas", "object_type": "GENE"}, {"subject": "eicosapentaenoic acid", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "torafugu PPARalphas", "object_type": "GENE"}]}
{"text": "Terbutaline (Bricanyl) and its prodrug Bambuterol (Bambec) are highly potent beta(2)-adrenoceptor agonists often used in asthma patients.", "spo_list": [{"subject": "Terbutaline", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}, {"subject": "Bricanyl", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}, {"subject": "Bambuterol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}, {"subject": "Bambec", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}]}
{"text": "Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers.", "spo_list": [{"subject": "D-amphetamine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "dopamine transporter", "object_type": "GENE"}, {"subject": "D-amphetamine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "SLC6A3", "object_type": "GENE"}]}
{"text": "N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine (SoRI-9804), N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine (SoRI-20040), and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine (SoRI-20041) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester (RTI-55) binding, slowed the dissociation rate of [(125)I]RTI-55 from the DAT, and partially inhibited [(3)H]dopamine uptake.", "spo_list": [{"subject": "[(125)I]RTI-55", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "[(3)H]dopamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "RTI-55", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "[(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "SoRI-9804", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "SoRI-20040", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "SoRI-20041", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}]}
{"text": "This mutation is the first described in exon 9 and impairs the last 27 amino acids of the hormone-binding domain.", "spo_list": [{"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "hormone-binding domain", "object_type": "GENE"}]}
{"text": "EROD activity induction in peripheral blood lymphocytes, liver and brain tissues of rats orally exposed to polycyclic aromatic hydrocarbons.", "spo_list": [{"subject": "polycyclic aromatic hydrocarbons", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "EROD", "object_type": "GENE"}]}
{"text": "Little is known in terms of multi-matrix cytochrome P450 activity induction under repeated oral exposure to planar halogenated and polycyclic aromatic hydrocarbons (PHH, PAH).", "spo_list": [{"subject": "halogenated and polycyclic aromatic hydrocarbons", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "cytochrome P450", "object_type": "GENE"}, {"subject": "PAH", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "cytochrome P450", "object_type": "GENE"}]}
{"text": "PDE5 is the predominant PDE in the corpus cavernosum, and cGMP is its primary substrate.", "spo_list": [{"subject": "cGMP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PDE5", "object_type": "GENE"}, {"subject": "cGMP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PDE", "object_type": "GENE"}]}
{"text": "Therefore, in men with ED, elevation of cGMP in corpus cavernosal tissue via selective inhibition of cGMP-specific PDE5 is a means of improving erectile function at minimal risk of adverse events.", "spo_list": [{"subject": "cGMP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE5", "object_type": "GENE"}]}
{"text": "This approach is validated by the clinical efficacy and safety of sildenafil, the pioneering drug for selective PDE5 inhibitor therapy for ED.", "spo_list": [{"subject": "sildenafil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE5", "object_type": "GENE"}]}
{"text": "Sildenafil exhibits inhibitory potency against PDE5 and a 10-fold lower dose-related inhibitory potency against rod outer segment PDE6, the predominant PDE in the phototransduction cascade in rods.", "spo_list": [{"subject": "Sildenafil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE5", "object_type": "GENE"}, {"subject": "Sildenafil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE6", "object_type": "GENE"}, {"subject": "Sildenafil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE", "object_type": "GENE"}]}
{"text": "As free sildenafil plasma concentrations approach concentrations sufficient to inhibit retinal PDE6, usually at higher therapeutic doses, transient, reversible visual adverse events can occur, albeit infrequently.", "spo_list": [{"subject": "sildenafil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE6", "object_type": "GENE"}]}
{"text": "Selective inhibition of PDE5 is a rational therapeutic approach in ED, as proved by the clinical success of sildenafil.", "spo_list": [{"subject": "sildenafil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE5", "object_type": "GENE"}]}
{"text": "We studied accumulation of lipid metabolites [triglycerides (TAGs), diglycerides (DAGs)] and ceramides in relation to insulin signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 μM).", "spo_list": [{"subject": "triglycerides", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PTP1B", "object_type": "GENE"}, {"subject": "TAGs", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PTP1B", "object_type": "GENE"}, {"subject": "diglycerides", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PTP1B", "object_type": "GENE"}, {"subject": "DAGs", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PTP1B", "object_type": "GENE"}, {"subject": "ceramides", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PTP1B", "object_type": "GENE"}]}
{"text": "Cells were also evaluated in the presence of wortmannin, an inhibitor of phosphatidylinositol 3-kinases and thus AKt (0-100 nM).", "spo_list": [{"subject": "wortmannin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "phosphatidylinositol 3-kinases", "object_type": "GENE"}, {"subject": "wortmannin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "AKt", "object_type": "GENE"}]}
{"text": "Unsaturated FFAs increased DAGs, TAGs and PTP1B expression significantly, but cells remained insulin sensitive as assessed by robust AKt and PTP1B phosphorylation at serine (Ser) 50, Ser 398 and tyrosine 152.", "spo_list": [{"subject": "serine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PTP1B", "object_type": "GENE"}, {"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PTP1B", "object_type": "GENE"}, {"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PTP1B", "object_type": "GENE"}, {"subject": "tyrosine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PTP1B", "object_type": "GENE"}]}
{"text": "Saturated palmitic and stearic acids increased ceramides, up-regulated PTP1B, and had AKt and PTP1B phosphorylation at Ser 50 impaired.", "spo_list": [{"subject": "palmitic and stearic acids", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "AKt", "object_type": "GENE"}, {"subject": "palmitic and stearic acids", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PTP1B", "object_type": "GENE"}, {"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PTP1B", "object_type": "GENE"}]}
{"text": "Only FFAs that increased ceramides caused impairment of AKt and PTP1B phosphorylation at Ser 50.", "spo_list": [{"subject": "ceramides", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "AKt", "object_type": "GENE"}, {"subject": "ceramides", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PTP1B", "object_type": "GENE"}, {"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PTP1B", "object_type": "GENE"}]}
{"text": "A clear relationship between PTP1B phosphorylation levels at Ser 50 and its negative effect on insulin signaling is shown.", "spo_list": [{"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PTP1B", "object_type": "GENE"}]}
{"text": "Design, Synthesis, and Pharmacological Characterization of Novel Endomorphin-1 Analogues as Extremely Potent μ-Opioid Agonists.", "spo_list": [{"subject": "Endomorphin-1", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "μ-Opioid", "object_type": "GENE"}]}
{"text": "Of the new compounds, Dmt(1)-(R)-βPro(2)-Trp(3)-(2-furyl)Map(4) (analogue 12) displayed the highest affinity toward MOR, in the picomolar range (Ki(μ) = 3.72 pM).", "spo_list": [{"subject": "Dmt", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "MOR", "object_type": "GENE"}, {"subject": "(R)-βPro", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "MOR", "object_type": "GENE"}, {"subject": "Trp", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "MOR", "object_type": "GENE"}, {"subject": "(2-furyl)Map", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "MOR", "object_type": "GENE"}]}
{"text": "Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine.", "spo_list": [{"subject": "alpha-difluoromethylornithine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mouse ornithine decarboxylase", "object_type": "GENE"}]}
{"text": "Mouse ornithine decarboxylase (ODC) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor, alpha-difluoromethylornithine (DFMO).", "spo_list": [{"subject": "pyridoxal 5'-phosphate", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Mouse ornithine decarboxylase", "object_type": "GENE"}, {"subject": "pyridoxal 5'-phosphate", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ODC", "object_type": "GENE"}, {"subject": "alpha-difluoromethylornithine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Mouse ornithine decarboxylase", "object_type": "GENE"}, {"subject": "DFMO", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Mouse ornithine decarboxylase", "object_type": "GENE"}, {"subject": "alpha-difluoromethylornithine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ODC", "object_type": "GENE"}, {"subject": "DFMO", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ODC", "object_type": "GENE"}]}
{"text": "The pyridoxal 5'-phosphate binding lysine in mouse ODC was identified as lysine 69 of the mouse sequence by reduction of the purified holoenzyme form with NaB[3H]4 followed by digestion of the carboxymethylated protein with endoproteinase Lys-C, radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing.", "spo_list": [{"subject": "lysine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "mouse ODC", "object_type": "GENE"}, {"subject": "lysine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "mouse ODC", "object_type": "GENE"}, {"subject": "pyridoxal 5'-phosphate", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "mouse ODC", "object_type": "GENE"}]}
{"text": "This lysine is contained in the sequence PFYAVKC, which is found in all known ODCs from eukaryotes.", "spo_list": [{"subject": "PFYAVKC", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "ODCs", "object_type": "GENE"}, {"subject": "lysine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "ODCs", "object_type": "GENE"}, {"subject": "lysine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PFYAVKC", "object_type": "GENE"}]}
{"text": "Using a similar procedure to analyze ODC labeled by reaction with [5-14C]DFMO, it was found that lysine 69 and cysteine 360 formed covalent adducts with the inhibitor.", "spo_list": [{"subject": "[5-14C]DFMO", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ODC", "object_type": "GENE"}, {"subject": "lysine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "ODC", "object_type": "GENE"}, {"subject": "cysteine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "ODC", "object_type": "GENE"}]}
{"text": "Cysteine 360, which was the major adduct accounting for about 90% of the total labeling, is contained within the sequence -WGPTCDGL(I)D-, which is present in all known eukaryote ODCs.", "spo_list": [{"subject": "Cysteine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "WGPTCDGL(I)D", "object_type": "GENE"}, {"subject": "Cysteine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "eukaryote ODCs", "object_type": "GENE"}, {"subject": "WGPTCDGL(I)D", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "eukaryote ODCs", "object_type": "GENE"}]}
{"text": "Extracellular Cbl (protein bound and free) and intracellular Cbl (protein bound and free) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin (CN-Cbl) bound to transcobalamin II (transcobalamin, TC).", "spo_list": [{"subject": "[57Co]cyanocobalamin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "transcobalamin II", "object_type": "GENE"}, {"subject": "CN-Cbl", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "transcobalamin II", "object_type": "GENE"}, {"subject": "[57Co]cyanocobalamin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "transcobalamin", "object_type": "GENE"}, {"subject": "CN-Cbl", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "transcobalamin", "object_type": "GENE"}, {"subject": "[57Co]cyanocobalamin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "TC", "object_type": "GENE"}, {"subject": "CN-Cbl", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "TC", "object_type": "GENE"}]}
{"text": "Intracellular protein-bound [57Co]Cbl fractionated with methionine synthase (MS) and methylmalonyl-CoA mutase (MU) activity.", "spo_list": [{"subject": "[57Co]Cbl", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "methionine synthase", "object_type": "GENE"}, {"subject": "[57Co]Cbl", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "MS", "object_type": "GENE"}, {"subject": "[57Co]Cbl", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "methylmalonyl-CoA mutase", "object_type": "GENE"}, {"subject": "[57Co]Cbl", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "MU", "object_type": "GENE"}]}
{"text": "Cells propagated in medium containing N5-methyltetrahydrofolate and homocysteine showed a substantial increase in MS activity which paralleled the increase in the intracellular concentration of Me-Cbl and the Cbl bound to the enzyme.", "spo_list": [{"subject": "homocysteine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "MS", "object_type": "GENE"}, {"subject": "N5-methyltetrahydrofolate", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "MS", "object_type": "GENE"}]}
{"text": "Binding and transactivation assays were used to compare affinities and transcriptional activities of adapalene and tretinoin for the nuclear transcription factors, retinoic acid receptors (RARs).", "spo_list": [{"subject": "adapalene", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "nuclear transcription factors", "object_type": "GENE"}, {"subject": "adapalene", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "retinoic acid receptors", "object_type": "GENE"}, {"subject": "adapalene", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "RARs", "object_type": "GENE"}, {"subject": "tretinoin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "nuclear transcription factors", "object_type": "GENE"}, {"subject": "tretinoin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "retinoic acid receptors", "object_type": "GENE"}, {"subject": "tretinoin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "RARs", "object_type": "GENE"}]}
{"text": "Additional neuroendocrine experiments in a parallel group of rats revealed a dose-related increase in plasma prolactin and ACTH levels after i.v. mCPP, pointing to a general state of arousal in these mCPP-treated animals.", "spo_list": [{"subject": "mCPP", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "plasma prolactin", "object_type": "GENE"}, {"subject": "mCPP", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ACTH", "object_type": "GENE"}]}
{"text": "These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin.", "spo_list": [{"subject": "ritanserin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT2A", "object_type": "GENE"}, {"subject": "ritanserin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT2C", "object_type": "GENE"}, {"subject": "pizotifen", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT2", "object_type": "GENE"}, {"subject": "pizotifen", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT1", "object_type": "GENE"}, {"subject": "methysergide", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT1", "object_type": "GENE"}, {"subject": "methysergide", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT2", "object_type": "GENE"}]}
{"text": "Various genes controlled by estrogen, including X-inactive-specific transcript, anterior gradient-2, trefoil factor-1, CRP-ductin, ghrelin, and small proline-rich protein-2A, were dramatically over-expressed.", "spo_list": [{"subject": "estrogen", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "X-inactive-specific transcript", "object_type": "GENE"}, {"subject": "estrogen", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "anterior gradient-2", "object_type": "GENE"}, {"subject": "estrogen", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "trefoil factor-1", "object_type": "GENE"}, {"subject": "estrogen", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CRP-ductin", "object_type": "GENE"}, {"subject": "estrogen", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ghrelin", "object_type": "GENE"}, {"subject": "estrogen", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "small proline-rich protein-2A", "object_type": "GENE"}]}
{"text": "Estrogen-regulated genes including cytokeratin 1-19 and Cyp2a4 were over-expressed, although Cyp3a25 was suppressed.", "spo_list": [{"subject": "Estrogen", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "cytokeratin 1-19", "object_type": "GENE"}, {"subject": "Estrogen", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Cyp2a4", "object_type": "GENE"}, {"subject": "Estrogen", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Cyp3a25", "object_type": "GENE"}]}
{"text": "Several genes involved with steroid metabolism also showed remarkable expression changes, including increased expression of 17beta-hydroxysteroid dehydrogenase-7 (HSD17beta7; involved in estradiol production) and decreased expression of HSD17beta5 (involved in testosterone production).", "spo_list": [{"subject": "estradiol", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "17beta-hydroxysteroid dehydrogenase-7", "object_type": "GENE"}, {"subject": "estradiol", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "HSD17beta7", "object_type": "GENE"}, {"subject": "testosterone", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "HSD17beta5", "object_type": "GENE"}]}
{"text": "The expression of key genes important in methionine metabolism, such as methionine adenosyltransferase-1a, betaine-homocysteine methyltransferase and thioether S-methyltransferase, were suppressed.", "spo_list": [{"subject": "methionine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "methionine adenosyltransferase-1a", "object_type": "GENE"}, {"subject": "methionine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "betaine-homocysteine methyltransferase", "object_type": "GENE"}, {"subject": "methionine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "thioether S-methyltransferase", "object_type": "GENE"}]}
{"text": "These compounds resulted from our efforts to merge the pharmacophores of selective factor Xa inhibitor rivaroxaban with a mimic of the Arg-Gly-Asp (RGD) sequence of fibrinogen to obtain designed multiple ligands with potential antithrombotic activity.", "spo_list": [{"subject": "rivaroxaban", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "factor Xa", "object_type": "GENE"}, {"subject": "Arg-Gly-Asp", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "fibrinogen", "object_type": "GENE"}]}
{"text": "Resulting from this study, a structurally novel class of submicromolar fibrinogen GPIIb/IIIa binding inhibitor bearing 1,2,4-oxadiazol-5(4H)-one moiety is also described.", "spo_list": [{"subject": "1,2,4-oxadiazol-5(4H)-one", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "GPIIb/IIIa", "object_type": "GENE"}]}
{"text": "Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors.", "spo_list": [{"subject": "galantamine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}]}
{"text": "This effect was reverted in the presence of atropine (ATR; 0.1 microM), which blocks the pre-synaptic muscarinic M2 receptor.", "spo_list": [{"subject": "atropine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "muscarinic M2 receptor", "object_type": "GENE"}, {"subject": "ATR", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "muscarinic M2 receptor", "object_type": "GENE"}]}
{"text": "After that, a wide range of concentrations of drugs, concomitantly with ATR (0.1 microM), was studied in the presence of haloperidol (HAL; 0.01 microM), a dopamine D2 antagonist.", "spo_list": [{"subject": "haloperidol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "dopamine D2", "object_type": "GENE"}, {"subject": "HAL", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "dopamine D2", "object_type": "GENE"}]}
{"text": "To test the role of nicotinic receptors in the drugs' effects on [3H]-ACh release, mecamylamine (MEC) 100 microM was used to block such receptors.", "spo_list": [{"subject": "mecamylamine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "nicotinic receptors", "object_type": "GENE"}, {"subject": "MEC", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "nicotinic receptors", "object_type": "GENE"}]}
{"text": "Interestingly, insulin treatment of αXBPKD cells reduced tyrosine phosphorylation of IRS-1 (pY(896)), and phosphorylation of Akt, while enhancing serine phosphorylation (pS(307)) of IRS-1.", "spo_list": [{"subject": "tyrosine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "IRS-1", "object_type": "GENE"}, {"subject": "serine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "IRS-1", "object_type": "GENE"}]}
{"text": "Investigation of bradykinin metabolism in human and rat plasma in the presence of the dual ACE/NEP inhibitors GW660511X and omapatrilat.", "spo_list": [{"subject": "GW660511X", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NEP", "object_type": "GENE"}, {"subject": "GW660511X", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NEP", "object_type": "GENE"}]}
{"text": "In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled BK (79/81 Br-Phe5) BrBK in the presence of two new dual ACE/NEP inhibitors (GW660511X and omapatrilat) currently under clinical trial.", "spo_list": [{"subject": "GW660511X", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}, {"subject": "GW660511X", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NEP", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NEP", "object_type": "GENE"}]}
{"text": "Unlike GW660511X, omapatrilat abolished the production of BrBK1-5 and BrBK1-7, suggesting a better ACE inhibition effect over GW660511X as no NEP activity was found.", "spo_list": [{"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "BrBK1-5", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "BrBK1-7", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}, {"subject": "GW660511X", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}]}
{"text": "In addition the production of BrBK1-8 was enhanced in the presence of these inhibitors with a greater accumulation being observed with omapatrilat.", "spo_list": [{"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "BrBK1-8", "object_type": "GENE"}]}
{"text": "The production of Br-Phe5 was reduced with GW660511X while no significant change was observed with omapatrilat after 4 h of incubation.", "spo_list": [{"subject": "GW660511X", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Br-Phe5", "object_type": "GENE"}]}
{"text": "GW660511X and omapatrilat reduced the production of BrBK1-5 and BrBK1-7 with more effect being observed with omapatrilat.", "spo_list": [{"subject": "GW660511X", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "BrBK1-5", "object_type": "GENE"}, {"subject": "GW660511X", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "BrBK1-7", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "BrBK1-5", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "BrBK1-7", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "BrBK1-5", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "BrBK1-7", "object_type": "GENE"}]}
{"text": "GW660511X and omapatrilat increased the production of both BrBK1-8 and Br-Phe5 but not that of BrBK4-8 and BrBK2-8.", "spo_list": [{"subject": "GW660511X", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "BrBK1-8", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "BrBK1-8", "object_type": "GENE"}, {"subject": "GW660511X", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Br-Phe5", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Br-Phe5", "object_type": "GENE"}]}
{"text": "This study shows that the potency of GW660511X in comparison with omapatrilat is more than 100-fold lower in human, but less than 10-fold lower in rat plasma, suggesting that rat may not be a suitable in vivo model for the evaluation of ACE/NEP inhibition in relation to effects in humans.", "spo_list": [{"subject": "GW660511X", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}, {"subject": "GW660511X", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NEP", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NEP", "object_type": "GENE"}]}
{"text": "Furthermore, MDZ caused mechanism-based inactivation of cytochrome P450 3A-dependent TRZ 1'-hydroxylation in mouse, rat and human intestinal microsomes with similar potencies.", "spo_list": [{"subject": "MDZ", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cytochrome P450 3A", "object_type": "GENE"}, {"subject": "TRZ", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytochrome P450 3A", "object_type": "GENE"}]}
{"text": "The porcine heart malate dehydrogenase (MDH) refolding assay revealed that compound 1l inhibited human Hsp60 chaperone activity (IC(50): 6.80 ± 0.25 μM) and this inhibition activity was higher than that of ETB (IC(50): 10.9 ± 0.63 μM).", "spo_list": [{"subject": "ETB", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "human Hsp60", "object_type": "GENE"}]}
{"text": "Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate beta-lyases to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.", "spo_list": [{"subject": "cysteine S-conjugates", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "beta-lyases", "object_type": "GENE"}, {"subject": "pyruvate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "beta-lyases", "object_type": "GENE"}, {"subject": "ammonia", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "beta-lyases", "object_type": "GENE"}, {"subject": "alpha-chloroenethiolate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "beta-lyases", "object_type": "GENE"}, {"subject": "DCVC", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "beta-lyases", "object_type": "GENE"}, {"subject": "alpha-difluoroalkylthiolate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "beta-lyases", "object_type": "GENE"}, {"subject": "TFEC", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "beta-lyases", "object_type": "GENE"}, {"subject": "lysine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "beta-lyases", "object_type": "GENE"}, {"subject": "epsilon-amino", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "beta-lyases", "object_type": "GENE"}]}
{"text": "The exception was bupropion, a dual norepinephrine transporter/dopamine transporter blocker, which tended to increase spontaneous locomotor activity.", "spo_list": [{"subject": "bupropion", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "norepinephrine transporter", "object_type": "GENE"}, {"subject": "bupropion", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dopamine transporter", "object_type": "GENE"}]}
{"text": "Coadministration of reboxetine and the dopamine transporter blocker GBR 12909 also increased spontaneous locomotor activity.", "spo_list": [{"subject": "GBR 12909", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dopamine transporter", "object_type": "GENE"}]}
{"text": "Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis.", "spo_list": [{"subject": "aprepitant", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "substance P receptor", "object_type": "GENE"}, {"subject": "melarsoprol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "substance P receptor", "object_type": "GENE"}]}
{"text": "In this study we investigated the effects of combination chemotherapy with melarsoprol and a humanised SP receptor antagonist aprepitant (EMEND) in this mouse model.", "spo_list": [{"subject": "aprepitant", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "humanised SP receptor", "object_type": "GENE"}, {"subject": "EMEND", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "humanised SP receptor", "object_type": "GENE"}]}
{"text": "Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.", "spo_list": [{"subject": "ATP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sulfonylurea receptor", "object_type": "GENE"}, {"subject": "MgADP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sulfonylurea receptor", "object_type": "GENE"}]}
{"text": "The ATP-sensitive potassium (KATP) channels in pancreatic beta cells are critical in the regulation of glucose-induced insulin secretion.", "spo_list": [{"subject": "glucose", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "insulin", "object_type": "GENE"}]}
{"text": "The KATP channel is a heterooligomeric complex of SUR1 subunits of the ATP-binding-cassette superfamily with two nucleotide-binding folds (NBF1 and NBF2) and the pore-forming Kir6.2 subunits.", "spo_list": [{"subject": "ATP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "nucleotide-binding folds", "object_type": "GENE"}, {"subject": "ATP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NBF1", "object_type": "GENE"}, {"subject": "ATP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NBF2", "object_type": "GENE"}]}
{"text": "Here, we report that MgATP and MgADP, but not the Mg salt of gamma-thio-ATP, stabilize the binding of prebound 8-azido-[alpha-32P]ATP to SUR1.", "spo_list": [{"subject": "8-azido-[alpha-32P]ATP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SUR1", "object_type": "GENE"}]}
{"text": "These results suggest that SUR1 binds 8-azido-ATP strongly at NBF1 and that MgADP, either by direct binding to NBF2 or by hydrolysis of bound MgATP at NBF2, stabilizes prebound 8-azido-ATP binding at NBF1.", "spo_list": [{"subject": "8-azido-ATP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SUR1", "object_type": "GENE"}, {"subject": "8-azido-ATP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NBF1", "object_type": "GENE"}, {"subject": "MgADP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NBF2", "object_type": "GENE"}, {"subject": "8-azido-ATP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NBF1", "object_type": "GENE"}, {"subject": "MgATP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NBF2", "object_type": "GENE"}]}
{"text": "The sulfonylurea glibenclamide caused release of prebound 8-azido-[alpha-32P]ATP from SUR1 in the presence of MgADP or MgATP in a concentration-dependent manner.", "spo_list": [{"subject": "sulfonylurea glibenclamide", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SUR1", "object_type": "GENE"}, {"subject": "8-azido-[alpha-32P]ATP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SUR1", "object_type": "GENE"}]}
{"text": "This direct biochemical evidence of cooperative interaction in nucleotide binding of the two NBFs of SUR1 suggests that glibenclamide both blocks this cooperative binding of ATP and MgADP and, in cooperation with the MgADP bound at NBF2, causes ATP to be released from NBF1.", "spo_list": [{"subject": "nucleotide", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NBFs", "object_type": "GENE"}, {"subject": "nucleotide", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SUR1", "object_type": "GENE"}, {"subject": "glibenclamide", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NBF2", "object_type": "GENE"}, {"subject": "glibenclamide", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NBF1", "object_type": "GENE"}, {"subject": "ATP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NBF2", "object_type": "GENE"}, {"subject": "MgADP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NBF2", "object_type": "GENE"}, {"subject": "MgADP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NBF2", "object_type": "GENE"}]}
{"text": "Cycloxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2) has been shown to be important in esophageal tumorigenesis.", "spo_list": [{"subject": "prostaglandin E2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Cycloxygenase-2", "object_type": "GENE"}, {"subject": "prostaglandin E2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-2", "object_type": "GENE"}, {"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Cycloxygenase-2", "object_type": "GENE"}, {"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-2", "object_type": "GENE"}]}
{"text": "We have shown that COX-2 mediates acid-induced PGE2 production.", "spo_list": [{"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-2", "object_type": "GENE"}]}
{"text": "We conclude that mPGES1 mediates acid-induced increase in PGE2 production and cell proliferation.", "spo_list": [{"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "mPGES1", "object_type": "GENE"}]}
{"text": "Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5.", "spo_list": [{"subject": "arylhydroxylamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytochrome b5", "object_type": "GENE"}, {"subject": "arylhydroxylamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human NADH cytochrome b5 reductase", "object_type": "GENE"}]}
{"text": "On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs, we hypothesized that the reductive detoxification of arylhydroxylamine carcinogens was catalyzed by NADH cytochrome b5 reductase (b5R) and cytochrome b5 (cyt b5).", "spo_list": [{"subject": "arylhydroxylamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NADH cytochrome b5 reductase", "object_type": "GENE"}, {"subject": "arylhydroxylamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "b5R", "object_type": "GENE"}, {"subject": "arylhydroxylamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytochrome b5", "object_type": "GENE"}, {"subject": "arylhydroxylamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cyt b5", "object_type": "GENE"}]}
{"text": "We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.", "spo_list": [{"subject": "hydroxylamines", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human b5R", "object_type": "GENE"}, {"subject": "hydroxylamines", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cyt b5", "object_type": "GENE"}, {"subject": "aromatic amine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human b5R", "object_type": "GENE"}, {"subject": "aromatic amine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cyt b5", "object_type": "GENE"}, {"subject": "4-aminobiphenyl", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human b5R", "object_type": "GENE"}, {"subject": "4-aminobiphenyl", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cyt b5", "object_type": "GENE"}, {"subject": "4-ABP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human b5R", "object_type": "GENE"}, {"subject": "4-ABP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cyt b5", "object_type": "GENE"}, {"subject": "heterocyclic amine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human b5R", "object_type": "GENE"}, {"subject": "heterocyclic amine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cyt b5", "object_type": "GENE"}, {"subject": "2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human b5R", "object_type": "GENE"}, {"subject": "2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cyt b5", "object_type": "GENE"}, {"subject": "PhIP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human b5R", "object_type": "GENE"}, {"subject": "PhIP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cyt b5", "object_type": "GENE"}]}
{"text": "Polyclonal antisera to either b5R or cyt b5 significantly inhibited N-hydroxy-4-aminobiphenyl (NHOH-4-ABP) reduction by 95 and 89%, respectively, and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both NHOH-4-ABP and N-hydroxy-PhIP (NHOH-PhIP).", "spo_list": [{"subject": "N-hydroxy-4-aminobiphenyl", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "b5R", "object_type": "GENE"}, {"subject": "N-hydroxy-4-aminobiphenyl", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cyt b5", "object_type": "GENE"}, {"subject": "NHOH-4-ABP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "b5R", "object_type": "GENE"}, {"subject": "NHOH-4-ABP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cyt b5", "object_type": "GENE"}]}
{"text": "Jaceosidin, isolated from dietary mugwort (Artemisia princeps), induces G2/M cell cycle arrest by inactivating cdc25C-cdc2 via ATM-Chk1/2 activation.", "spo_list": [{"subject": "Jaceosidin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cdc25C", "object_type": "GENE"}, {"subject": "Jaceosidin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cdc2", "object_type": "GENE"}, {"subject": "Jaceosidin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "ATM", "object_type": "GENE"}]}
{"text": "Additional mechanistic studies revealed that jaceosidin treatment resulted in an increase in phosphorylation of Cdc25C and ATM-Chk1/2.", "spo_list": [{"subject": "jaceosidin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Cdc25C", "object_type": "GENE"}, {"subject": "jaceosidin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "ATM", "object_type": "GENE"}]}
{"text": "Moreover, jaceosidin treatment resulted in phosphorylation of ERK, and pretreatment with the ERK inhibitor, PD98059, attenuated cell growth inhibition by jaceosidin.", "spo_list": [{"subject": "PD98059", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ERK", "object_type": "GENE"}]}
{"text": "These data suggest that jaceosidin, isolated from Japanese mugwort, modulates the ERK/ATM/Chk1/2 pathway, leading to inactivation of the Cdc2-cyclin B1 complex, followed by G2/M cell cycle arrest in endometrial cancer cells.", "spo_list": [{"subject": "jaceosidin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Cdc2", "object_type": "GENE"}, {"subject": "jaceosidin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclin B1", "object_type": "GENE"}]}
{"text": "However, chronic treatment of cLH rats with MPEP did not reverse learned helplessness, indicating that the enhanced mGlu5 receptor function is not the only player in the behavioral phenotype of this genetic model of depression.", "spo_list": [{"subject": "MPEP", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "mGlu5 receptor", "object_type": "GENE"}]}
{"text": "However, other alpha(1)-adrenoceptor antagonists (tamsulosin, WB4101 and corynanthine) did not inhibit the binding at a range of concentrations that generally exhibit alpha(1)-adrenoceptor antagonism, and noradrenaline, rauwolscine and propranolol were without effect on the [(3)H]prazosin binding.", "spo_list": [{"subject": "tamsulosin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1)-adrenoceptor", "object_type": "GENE"}, {"subject": "WB4101", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1)-adrenoceptor", "object_type": "GENE"}, {"subject": "corynanthine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1)-adrenoceptor", "object_type": "GENE"}]}
{"text": "On the other hand, ligands for the renal Na(+)-transporter (amiloride and triamterene) and for imidazoline recognition sites (guanabenz, guanfacine and agmatine) displaced the binding of [(3)H]prazosin to phentolamine-insensitive sites at micromolar concentrations.", "spo_list": [{"subject": "amiloride", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Na(+)-transporter", "object_type": "GENE"}, {"subject": "triamterene", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Na(+)-transporter", "object_type": "GENE"}]}
{"text": "Nox4 oxidase activity is thought to be constitutive and regulated at the transcriptional level; however, we challenge this point of view and suggest that specific quinone derivatives could modulate this activity.", "spo_list": [{"subject": "quinone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Nox4", "object_type": "GENE"}, {"subject": "quinone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "oxidase", "object_type": "GENE"}, {"subject": "quinone", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Nox4", "object_type": "GENE"}, {"subject": "quinone", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "oxidase", "object_type": "GENE"}]}
{"text": "In fact, we demonstrated a significant stimulation of Nox4 activity by 4 quinone derivatives (AA-861, tBuBHQ, tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-REx™, and chondrocyte cell lines.", "spo_list": [{"subject": "quinone", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Nox4", "object_type": "GENE"}, {"subject": "AA-861", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Nox4", "object_type": "GENE"}, {"subject": "tBuBHQ", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Nox4", "object_type": "GENE"}, {"subject": "tBuBQ", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Nox4", "object_type": "GENE"}, {"subject": "duroquinone", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Nox4", "object_type": "GENE"}]}
{"text": "Interestingly, Nox4 activity is also stimulated by reducing agents that possibly act by reducing the disulfide bridge (Cys226, Cys270) located in the extracellular E-loop of Nox4.", "spo_list": [{"subject": "Cys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Nox4", "object_type": "GENE"}, {"subject": "Cys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Nox4", "object_type": "GENE"}]}
{"text": "Such model of Nox4 activity regulation could provide new insight into the understanding of the molecular mechanism of the electron transfer through the enzyme, i.e., its potential redox regulation, and could also define new therapeutic targets in diseases in which quinones and Nox4 are implicated.", "spo_list": [{"subject": "quinones", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Nox4", "object_type": "GENE"}]}
{"text": "Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.", "spo_list": [{"subject": "XL184", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase", "object_type": "GENE"}, {"subject": "Cabozantinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase", "object_type": "GENE"}]}
{"text": "PURPOSE: XL184 (cabozantinib) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.", "spo_list": [{"subject": "XL184", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MET", "object_type": "GENE"}, {"subject": "cabozantinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MET", "object_type": "GENE"}, {"subject": "XL184", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "vascular endothelial growth factor receptor 2", "object_type": "GENE"}, {"subject": "XL184", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGFR2", "object_type": "GENE"}, {"subject": "XL184", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "RET", "object_type": "GENE"}, {"subject": "cabozantinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "vascular endothelial growth factor receptor 2", "object_type": "GENE"}, {"subject": "cabozantinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGFR2", "object_type": "GENE"}, {"subject": "cabozantinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "RET", "object_type": "GENE"}]}
{"text": "Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism.", "spo_list": [{"subject": "Prostacyclin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "tissue factor", "object_type": "GENE"}]}
{"text": "The present studies were undertaken to determine whether stable analogues of prostacyclin, a potent endothelium-derived platelet inhibitor and vasodilator, could inhibit tissue factor expression by human monocytic cells.", "spo_list": [{"subject": "prostacyclin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "tissue factor", "object_type": "GENE"}]}
{"text": "Preincubation for 30 minutes with iloprost, ciprostene, and carbacyclin led to a dose-dependent inhibition of tissue factor expression induced by all three challenging agents.", "spo_list": [{"subject": "iloprost", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "tissue factor", "object_type": "GENE"}, {"subject": "ciprostene", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "tissue factor", "object_type": "GENE"}, {"subject": "carbacyclin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "tissue factor", "object_type": "GENE"}]}
{"text": "Iloprost was the most potent: 50% inhibition occurred at 5 nM, a concentration close to the reported dissociation constant for iloprost binding to the platelet prostacyclin receptor.", "spo_list": [{"subject": "iloprost", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "prostacyclin receptor", "object_type": "GENE"}, {"subject": "prostacyclin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "prostacyclin receptor", "object_type": "GENE"}]}
{"text": "This effect was potentiated by isobutylmethylxanthine, an inhibitor of phosphodiesterase.", "spo_list": [{"subject": "isobutylmethylxanthine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "phosphodiesterase", "object_type": "GENE"}]}
{"text": "The inhibitory effects of iloprost on tissue factor expression were also potentiated by isobutylmethylxanthine and mimicked by forskolin and dibutyryl cyclic AMP but not dibutyryl cyclic GMP.", "spo_list": [{"subject": "isobutylmethylxanthine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tissue factor", "object_type": "GENE"}, {"subject": "forskolin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tissue factor", "object_type": "GENE"}, {"subject": "ibutyryl cyclic AMP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tissue factor", "object_type": "GENE"}]}
{"text": "These results suggest that prostacyclin may play a role in downregulating tissue factor expression in monocytes, at least in part via elevation of intracellular levels of cyclic AMP.", "spo_list": [{"subject": "prostacyclin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "tissue factor", "object_type": "GENE"}]}
{"text": "Synthesis and in-silico studies of some diaryltriazole derivatives as potential cyclooxygenase inhibitors.", "spo_list": [{"subject": "diaryltriazole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase", "object_type": "GENE"}]}
{"text": "The tyrosine kinase inhibitor ZD1839 (\"Iressa\") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells.", "spo_list": [{"subject": "ZD1839", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase", "object_type": "GENE"}, {"subject": "ZD1839", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HER2", "object_type": "GENE"}, {"subject": "Iressa", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HER2", "object_type": "GENE"}, {"subject": "Iressa", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase", "object_type": "GENE"}, {"subject": "Iressa", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HER2", "object_type": "GENE"}, {"subject": "tyrosine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "tyrosine kinase", "object_type": "GENE"}]}
{"text": "ZD1839 (\"Iressa\"), a quinazoline tyrosine kinase inhibitor selective for the EGFR, has shown good activity in preclinical studies and in the early phase of clinical trials.", "spo_list": [{"subject": "ZD1839", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase", "object_type": "GENE"}, {"subject": "ZD1839", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EGFR", "object_type": "GENE"}, {"subject": "Iressa", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase", "object_type": "GENE"}, {"subject": "Iressa", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EGFR", "object_type": "GENE"}, {"subject": "quinazoline tyrosine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "tyrosine kinase", "object_type": "GENE"}]}
{"text": "Growth inhibition of these tumor cell lines was associated with the dephosphorylation of EGFR, HER2, and HER3, accompanied by the loss of association of HER3 with phosphatidylinositol 3-kinase, and down-regulation of Akt activity.", "spo_list": [{"subject": "phosphatidylinositol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "phosphatidylinositol 3-kinase", "object_type": "GENE"}]}
{"text": "These studies suggest that HER2-overexpressing tumors are particularly susceptible to the inhibition of HER family tyrosine kinase signaling and suggest novel strategies to treat these particularly aggressive tumors.", "spo_list": [{"subject": "tyrosine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "tyrosine kinase", "object_type": "GENE"}]}
{"text": "Drug-protein interactions: isolation and characterization of covalent adducts of phenoxybenzamine and calmodulin.", "spo_list": [{"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}]}
{"text": "Phenoxybenzamine, an alpha-adrenergic antagonist containing a (chloroethyl)amine group, labels calmodulin in the presence of calcium.", "spo_list": [{"subject": "Phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}, {"subject": "(chloroethyl)amine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}]}
{"text": "Adducts of calmodulin and phenoxybenzamine were separated by high-performance liquid chromatography into four major fractions: two containing 0.6 and 1.2 mol of drug per mol of protein and two different fractions each containing 2.0 mol/mol.", "spo_list": [{"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}]}
{"text": "Each adduct had a reduced ability to activate cyclic nucleotide phosphodiesterase and myosin light chain kinase, and the chlorpromazine binding capacities of the phenoxybenzamine-calmodulin adducts were diminished to the extent of phenoxybenzamine incorporation into each adduct.", "spo_list": [{"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}, {"subject": "chlorpromazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}]}
{"text": "Isolation and characterization of labeled peptides from phenoxybenzamine-modified calmodulins indicated that peptides encompassing residues 38-75, 107-126, and 127-148 contained phenoxybenzamine label.", "spo_list": [{"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulins", "object_type": "GENE"}, {"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulins", "object_type": "GENE"}]}
{"text": "Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].", "spo_list": [{"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "neutral amino acid transporters", "object_type": "GENE"}, {"subject": "glutamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "neutral amino acid transporters", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "neutral amino acid transporters", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "solute carrier 1", "object_type": "GENE"}, {"subject": "glutamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "solute carrier 1", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "solute carrier 1", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SLC1", "object_type": "GENE"}, {"subject": "glutamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SLC1", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SLC1", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "alanine serine cysteine transporter 1", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ASCT1", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ASCT2", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SLC38", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "sodium-coupled neutral amino acid transporter 1", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT1", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT2", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT4", "object_type": "GENE"}, {"subject": "glutamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "alanine serine cysteine transporter 1", "object_type": "GENE"}, {"subject": "glutamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ASCT1", "object_type": "GENE"}, {"subject": "glutamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ASCT2", "object_type": "GENE"}, {"subject": "glutamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SLC38", "object_type": "GENE"}, {"subject": "glutamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "sodium-coupled neutral amino acid transporter 1", "object_type": "GENE"}, {"subject": "glutamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT1", "object_type": "GENE"}, {"subject": "glutamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT2", "object_type": "GENE"}, {"subject": "glutamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT4", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "alanine serine cysteine transporter 1", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ASCT1", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ASCT2", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "sodium-coupled neutral amino acid transporter 1", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT1", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT2", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT4", "object_type": "GENE"}]}
{"text": "Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and SNAT2.", "spo_list": [{"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ASCT2", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT1", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT2", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ASCT2", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT2", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT1", "object_type": "GENE"}, {"subject": "4-methoxy-7-nitroindolinyl", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ASCT2", "object_type": "GENE"}, {"subject": "MNI", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ASCT2", "object_type": "GENE"}, {"subject": "4-methoxy-7-nitroindolinyl", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT2", "object_type": "GENE"}, {"subject": "MNI", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT2", "object_type": "GENE"}, {"subject": "4-methoxy-7-nitroindolinyl", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT1", "object_type": "GENE"}, {"subject": "MNI", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SNAT1", "object_type": "GENE"}]}
{"text": "Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.", "spo_list": [{"subject": "imiquimod", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "TLR7", "object_type": "GENE"}, {"subject": "imiquimod", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "TLR8", "object_type": "GENE"}, {"subject": "imiquimod", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "TLR7", "object_type": "GENE"}]}
{"text": "Both porcine TLR7 and TLR8 proteins were expressed in cell lines and were N-glycosylated.", "spo_list": [{"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "porcine TLR7", "object_type": "GENE"}, {"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TLR8", "object_type": "GENE"}]}
{"text": "Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.", "spo_list": [{"subject": "imidazoquinoline", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "porcine TLR7", "object_type": "GENE"}, {"subject": "imiquimod", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "porcine TLR7", "object_type": "GENE"}, {"subject": "gardiquimod", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "porcine TLR7", "object_type": "GENE"}, {"subject": "imidazoquinoline", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "TLR8", "object_type": "GENE"}, {"subject": "imiquimod", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "TLR8", "object_type": "GENE"}, {"subject": "gardiquimod", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "TLR8", "object_type": "GENE"}, {"subject": "imidazoquinoline", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "human TLR7", "object_type": "GENE"}, {"subject": "imiquimod", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "human TLR7", "object_type": "GENE"}, {"subject": "gardiquimod", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "human TLR7", "object_type": "GENE"}, {"subject": "imidazoquinoline", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "porcine TLR7", "object_type": "GENE"}, {"subject": "imiquimod", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "porcine TLR7", "object_type": "GENE"}, {"subject": "gardiquimod", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "porcine TLR7", "object_type": "GENE"}, {"subject": "imidazoquinoline", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "TLR8", "object_type": "GENE"}, {"subject": "imiquimod", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "TLR8", "object_type": "GENE"}, {"subject": "gardiquimod", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "TLR8", "object_type": "GENE"}, {"subject": "imidazoquinoline", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human TLR7", "object_type": "GENE"}, {"subject": "imiquimod", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human TLR7", "object_type": "GENE"}, {"subject": "gardiquimod", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human TLR7", "object_type": "GENE"}, {"subject": "imidazoquinoline", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "TLR8", "object_type": "GENE"}, {"subject": "imiquimod", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "TLR8", "object_type": "GENE"}, {"subject": "gardiquimod", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "TLR8", "object_type": "GENE"}]}
{"text": "Moreover, activation of transfected cells and porcine PBMC by TLR7 ligands was inhibited by bafilomycin A(1) indicating the requirement of endosomal/lysosomal acidification for activation of the receptors.", "spo_list": [{"subject": "bafilomycin A(1)", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TLR7", "object_type": "GENE"}]}
{"text": "An experimental strategy based on solution viscosity perturbation allowed us to study the energetics of amide-substrates, p-aminobenzamidine (p-ABZ) and proflavin binding to the catalytic site of two proteolyzed forms of alpha-thrombin, i.e. zeta- and gamma T-thrombin.", "spo_list": [{"subject": "p-aminobenzamidine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha-thrombin", "object_type": "GENE"}, {"subject": "p-ABZ", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha-thrombin", "object_type": "GENE"}, {"subject": "proflavin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha-thrombin", "object_type": "GENE"}]}
{"text": "A phenomenological analysis of thermodynamic data showed that the amide substrates and p-ABZ interactions with zeta-thrombin were respectively, associated with a chemical compensation (i.e. the linear relationship between entropy and enthalpy of binding) and a hydrophobic phenomenon (i.e. a change in the standard heat capacity).", "spo_list": [{"subject": "p-ABZ", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "zeta-thrombin", "object_type": "GENE"}]}
{"text": "In conclusion, these data demonstrate that: (1) the Leu144-Gly150 loop and the FRS are both involved in the conformational transition linked to the binding of p-aminobenzamidine to the thrombin active site; (2) the extent of thrombin's capacity to undergo conformational transitions in alpha-, zeta- and gamma T forms is positively correlated to the free energy of activation for hydrolysis of macromolecular substrates interacting with both the catalytic domain and the FRS.", "spo_list": [{"subject": "p-aminobenzamidine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "thrombin", "object_type": "GENE"}]}
{"text": "Degenerate oligonucleotides corresponding to conserved amino acids from transmembrane domains III, V, and VI of known receptors [5-HT1A, 5-HT1C, and 5-HT2; 5-HT is serotonin (5-hydroxytryptamine)] were used as primers for the sequential reactions.", "spo_list": [{"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "5-HT1A", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "5-HT1C", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "5-HT2", "object_type": "GENE"}]}
{"text": "Within the conserved transmembrane domains, the sequences exhibit approximately 52%, 59%, 65%, and 68% amino acid identity with the known rat 5-HT1A, rat 5-HT1B, rat 5-HT1D, and human 5-HT1E receptors, respectively.", "spo_list": [{"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "rat 5-HT1A", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "rat 5-HT1B", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "rat 5-HT1D", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "human 5-HT1E", "object_type": "GENE"}]}
{"text": "The specific binding is displaced by the selective 5-HT1D agonist sumatriptan but not by the mixed 5-HT1A/1D agonist 5-carboxyamidotryptamine.", "spo_list": [{"subject": "sumatriptan", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT1D", "object_type": "GENE"}]}
{"text": "HeLa cells transfected with the MR77 gene exhibited inhibition of adenylate cyclase in response to serotonin.", "spo_list": [{"subject": "serotonin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "adenylate cyclase", "object_type": "GENE"}]}
{"text": "Stereospecific inhibition of monoamine uptake transporters by meta-hydroxyephedrine isomers.", "spo_list": [{"subject": "meta-hydroxyephedrine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine uptake transporters", "object_type": "GENE"}]}
{"text": "To extend structure-activity analyses of binding sites within monoamine transporters and to determine which stereoisomer displayed the best selectivity for PET imaging applications, we tested the HED compounds for their abilities to inhibit [(3)H]neurotransmitter uptake into platelets, transfected cells, and chromaffin vesicles.", "spo_list": [{"subject": "HED", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine transporters", "object_type": "GENE"}]}
{"text": "We hypothesized that the HED compounds would be most potent at the norepinephrine transporter (NET) compared to the serotonin or dopamine transporters and that the 1R diastereomers would be more effective than 1S diastereomers.", "spo_list": [{"subject": "HED", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "norepinephrine transporter", "object_type": "GENE"}, {"subject": "HED", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NET", "object_type": "GENE"}]}
{"text": "Here we show that fisetin rapidly increases the levels of both Nrf2 and ATF4 as well as Nrf2- and ATF4-dependent gene transcription via distinct mechanisms.", "spo_list": [{"subject": "fisetin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Nrf2", "object_type": "GENE"}, {"subject": "fisetin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ATF4", "object_type": "GENE"}, {"subject": "fisetin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Nrf2", "object_type": "GENE"}, {"subject": "fisetin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ATF4", "object_type": "GENE"}]}
{"text": "Although fisetin greatly increases the stability of both Nrf2 and ATF4, only the effect on ATF4 is dependent on protein kinase activity.", "spo_list": [{"subject": "fisetin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Nrf2", "object_type": "GENE"}, {"subject": "fisetin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ATF4", "object_type": "GENE"}]}
{"text": "Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.", "spo_list": [{"subject": "sulforaphane", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "NRF2", "object_type": "GENE"}, {"subject": "sulforaphane", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "NRF2", "object_type": "GENE"}, {"subject": "tert-butylhydroquinone", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "NRF2", "object_type": "GENE"}, {"subject": "tert-butylhydroquinone", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "NRF2", "object_type": "GENE"}, {"subject": "cinnamic aldehyde", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "NRF2", "object_type": "GENE"}, {"subject": "cinnamic aldehyde", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "NRF2", "object_type": "GENE"}, {"subject": "hydrogen peroxide", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "NRF2", "object_type": "GENE"}, {"subject": "hydrogen peroxide", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "NRF2", "object_type": "GENE"}, {"subject": "sulforaphane", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "aldo-keto reductase (AKR) 1C1", "object_type": "GENE"}, {"subject": "tert-butylhydroquinone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "aldo-keto reductase (AKR) 1C1", "object_type": "GENE"}, {"subject": "cinnamic aldehyde", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "aldo-keto reductase (AKR) 1C1", "object_type": "GENE"}, {"subject": "hydrogen peroxide", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "aldo-keto reductase (AKR) 1C1", "object_type": "GENE"}]}
{"text": "The treatment of U937 cells with NRF2 inducers including sulforaphane effectively elevated the expression of AKR1B1, 1B10, 1C1, 1C2, and 1C3.", "spo_list": [{"subject": "sulforaphane", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "NRF2", "object_type": "GENE"}, {"subject": "sulforaphane", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "AKR1B1, 1B10, 1C1, 1C2, and 1C3", "object_type": "GENE"}]}
{"text": "Whereas, the levels of both the basal and sulforaphane-inducible expression of AKR1C1 were significantly reduced in NRF2-silenced stable U937 cells compared to the control cells.", "spo_list": [{"subject": "sulforaphane", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "AKR1C1", "object_type": "GENE"}]}
{"text": "OBJECTIVES: The hypothesis of the present study was that differences among dopamine transporter (DAT) ligands in potency and effectiveness as a positive reinforcers were related to potency and effectiveness as DA uptake inhibitors.", "spo_list": [{"subject": "DA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "dopamine transporter", "object_type": "GENE"}, {"subject": "DA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DAT", "object_type": "GENE"}]}
{"text": "Accordingly, self-administration of a group of local anesthetics that are DAT ligands was compared to their effects as DA uptake blockers in vitro in brain tissue.", "spo_list": [{"subject": "DA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DAT", "object_type": "GENE"}]}
{"text": "BACKGROUND: To assess the sensitivity of biochemical, physiological, and pharmacological markers of peripheral norepinephrine (NE) transporter (NET) function, we chronically antagonized NET by a range of doses of duloxetine [(+)-N-methyl-3-(1-naphthalenyloxy)-2 thiophenepropanamine], which blocks the NE reuptake process.", "spo_list": [{"subject": "duloxetine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "NET", "object_type": "GENE"}, {"subject": "(+)-N-methyl-3-(1-naphthalenyloxy)-2 thiophenepropanamine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "NET", "object_type": "GENE"}, {"subject": "NE", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NET", "object_type": "GENE"}]}
{"text": "Plasma from duloxetine-treated subjects (ex vivo effect) dose-dependently decreased radioligand binding to human NET (maximum inhibition was 60%) (P=0.02).", "spo_list": [{"subject": "duloxetine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human NET", "object_type": "GENE"}]}
{"text": "We report herein the location of the binding site for the inhaled anesthetic halothane at the amino acid residue level of resolution in the ligand binding cavity in a prototypical G protein-coupled receptor, bovine rhodopsin.", "spo_list": [{"subject": "halothane", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "bovine rhodopsin", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "G protein-coupled receptor", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "bovine rhodopsin", "object_type": "GENE"}]}
{"text": "Radiosequence analysis of [(14)C]halothane-labeled rhodopsin revealed that halothane contacts an amino acid residue (Trp265) lining the ligand binding cavity in the transmembrane core of the receptor.", "spo_list": [{"subject": "[(14)C]halothane", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "rhodopsin", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "rhodopsin", "object_type": "GENE"}]}
{"text": "[N-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide] (SR 141716A), a selective cannabinoid CB1 receptor antagonist, injected into the paraventricular nucleus of the hypothalamus (PVN) of male rats, induces penile erection.", "spo_list": [{"subject": "N-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "cannabinoid CB1 receptor", "object_type": "GENE"}, {"subject": "SR 141716A", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "cannabinoid CB1 receptor", "object_type": "GENE"}]}
{"text": "Autoradiography studies with [(3)H](-)-CP 55,940 show that chronic treatment with SR 141716A for 15 days twice daily (1 mg/kg i.p.) significantly increases the density of CB1 receptors in the PVN.", "spo_list": [{"subject": "[(3)H](-)-CP 55,940", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "CB1 receptors", "object_type": "GENE"}]}
{"text": "The present findings confirm that PVN CB1 receptors, localized mainly in GABAergic synapses that control in an inhibitory fashion excitatory synapses, exert an inhibitory control on penile erection, demonstrating for the first time that chronic blockade of CB1 receptors by SR 141716A increases the density of these receptors in the PVN.", "spo_list": [{"subject": "SR 141716A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CB1 receptors", "object_type": "GENE"}]}
{"text": "Intravenous arginine significantly increased the acute glucagon response (129 +/- 12 vs 36 +/- 6 ng/l in controls; p < 0.01), notably without affecting plasma glucose.", "spo_list": [{"subject": "arginine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "glucagon", "object_type": "GENE"}]}
{"text": "Isolated islets displayed improved glucose-stimulated insulin secretion after GRA treatment (0.061 +/- 0.007 vs 0.030 +/- 0.004 pmol islet(-1) h(-1) at 16.7 mmol/l glucose; p < 0.001), without affecting islet glucose oxidation.", "spo_list": [{"subject": "glucose", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "insulin", "object_type": "GENE"}]}
{"text": "Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.", "spo_list": [{"subject": "captopril", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}, {"subject": "enalapril", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}, {"subject": "sulfhydryl", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}]}
{"text": "We compared the effects of Captopril (an ACE inhibitor with -SH group), enalapril (an ACE-inhibitor without -SH group), N-acetylcysteine (only -SH group not ACE inhibitor) on endothelial dysfunction injured by methionine-induced hyperhomocysteinemia (HHcy) in rats.", "spo_list": [{"subject": "Captopril", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}, {"subject": "enalapril", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}, {"subject": "SH", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}]}
{"text": "It was found that a single intragastric gavage by L-methionine resulted in inhibition of endothelium-dependent relaxation, markedly increased the serum level of malondialdehyde and decreased the activity of PON1 and SOD, similarly decreased the level of NO in the serum; but had no effects on endothelium-independent relaxation and angiotensin-converting enzyme activity compared with the control group.", "spo_list": [{"subject": "L-methionine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PON1", "object_type": "GENE"}, {"subject": "L-methionine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "SOD", "object_type": "GENE"}]}
{"text": "Given the treatment with three doses of Captopril (15 approximately 45 mg/kg) markedly attenuated inhibition of vasodilator responses to ACh, and eliminated the increased level of malondialdehyde, the decreased level of NO, activity of PON1 and SOD in serum by single intragastric gavaged L-methionine.", "spo_list": [{"subject": "Captopril", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PON1", "object_type": "GENE"}, {"subject": "Captopril", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "SOD", "object_type": "GENE"}]}
{"text": "These results suggested that Captopril can protect the vascular endothelium against the damages induced by L-methionine in rats, and the beneficial effects of Captopril may be related to attenuating the decrease in PON1 activity and NO levels.", "spo_list": [{"subject": "Captopril", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PON1", "object_type": "GENE"}, {"subject": "L-methionine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PON1", "object_type": "GENE"}]}
{"text": "Both apo-lycopenoic acids also decreased CSE-induced ROS production, 8-OHdG formation and reduced the increase in NOX-4 and COX-2 expressions caused by CSE.", "spo_list": [{"subject": "apo-lycopenoic acids", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "NOX-4", "object_type": "GENE"}, {"subject": "apo-lycopenoic acids", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Studies on an (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor antagonist IKM-159: asymmetric synthesis, neuroactivity, and structural characterization.", "spo_list": [{"subject": "IKM-159", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "(AMPA) receptor", "object_type": "GENE"}]}
{"text": "IKM-159 was developed and identified as a member of a new class of heterotricyclic glutamate analogues that act as AMPA receptor-selective antagonists.", "spo_list": [{"subject": "IKM-159", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "AMPA receptor", "object_type": "GENE"}, {"subject": "glutamate", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "AMPA receptor", "object_type": "GENE"}]}
{"text": "Racemic IKM-159 was crystallized with the ligand-binding domain of GluA2, and the structure revealed a complex containing (2R)-IKM-159 at the glutamate binding site.", "spo_list": [{"subject": "Racemic IKM-159", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "GluA2", "object_type": "GENE"}, {"subject": "(2R)-IKM-159", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "GluA2", "object_type": "GENE"}]}
{"text": "(2R)-IKM-159 locks the GluA2 in an open form, consistent with a pharmacological action as competitive antagonist of AMPA receptors.", "spo_list": [{"subject": "(2R)-IKM-159", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "GluA2", "object_type": "GENE"}, {"subject": "(2R)-IKM-159", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "AMPA receptors", "object_type": "GENE"}]}
{"text": "Also, vinblastine enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaBα (IκBα) kinase, and inositol requiring enzyme 1α.", "spo_list": [{"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Ras homologous protein A", "object_type": "GENE"}, {"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "apoptosis signal-regulating kinase 1", "object_type": "GENE"}, {"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "c-jun-N-terminal kinase", "object_type": "GENE"}, {"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "p38", "object_type": "GENE"}, {"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "inhibitor of kappaBα", "object_type": "GENE"}, {"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "IκBα", "object_type": "GENE"}, {"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "kinase", "object_type": "GENE"}, {"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "inositol requiring enzyme 1α", "object_type": "GENE"}]}
{"text": "In addition, vinblastine induces the DNA-binding activities of the transcription factor NF-κB, HSF1, AP-1, and ATF-2, together with the expression of HSP70 and Bax proteins.", "spo_list": [{"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "NF-κB", "object_type": "GENE"}, {"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "HSP70", "object_type": "GENE"}, {"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Bax", "object_type": "GENE"}, {"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "HSF1", "object_type": "GENE"}, {"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "AP-1", "object_type": "GENE"}, {"subject": "vinblastine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "ATF-2", "object_type": "GENE"}]}
{"text": "Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.", "spo_list": [{"subject": "Telmisartan", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "peroxisome proliferator-activated receptor gamma", "object_type": "GENE"}]}
{"text": "OBJECTIVE: Telmisartan, an angiotensin II type 1 receptor (AT1R) antagonist, was found to have a unique property: it is a partial agonist of peroxisome proliferator-activated receptor gamma (PPARgamma).", "spo_list": [{"subject": "Telmisartan", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "angiotensin II type 1 receptor", "object_type": "GENE"}, {"subject": "Telmisartan", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "AT1R", "object_type": "GENE"}, {"subject": "Telmisartan", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "peroxisome proliferator-activated receptor gamma", "object_type": "GENE"}, {"subject": "Telmisartan", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "PPARgamma", "object_type": "GENE"}]}
{"text": "RESULTS: Telmisartan decreased the expression of AT1R at the mRNA and protein levels in a dose- and time-dependent manner.", "spo_list": [{"subject": "Telmisartan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "AT1R", "object_type": "GENE"}]}
{"text": "Decreased AT1R promoter activity with unchanged mRNA stability suggested that telmisartan suppressed AT1R gene expression at the transcriptional level.", "spo_list": [{"subject": "telmisartan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "AT1R", "object_type": "GENE"}]}
{"text": "However, the expression of AT1R was not suppressed by other AT1R antagonists such as candesartan or olmesartan.", "spo_list": [{"subject": "candesartan", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "AT1R", "object_type": "GENE"}, {"subject": "olmesartan", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "AT1R", "object_type": "GENE"}]}
{"text": "Since the suppression of AT1R expression was prevented by pretreatment with GW9662, a PPARgamma antagonist, PPARgamma should have participated in the process.", "spo_list": [{"subject": "GW9662", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "AT1R", "object_type": "GENE"}, {"subject": "GW9662", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "PPARgamma", "object_type": "GENE"}]}
{"text": "The deletion and mutation analysis of the AT1R gene promoter indicated that a GC box located in the proximal promoter region is responsible for the telmisartan-induced downregulation.", "spo_list": [{"subject": "telmisartan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "GC box", "object_type": "GENE"}, {"subject": "telmisartan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "AT1R", "object_type": "GENE"}]}
{"text": "CONCLUSION: Our data provides a novel insight into an effect of telmisartan: telmisartan inhibits AT1R gene expression through PPARgamma activation.", "spo_list": [{"subject": "telmisartan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "AT1R", "object_type": "GENE"}, {"subject": "telmisartan", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PPARgamma", "object_type": "GENE"}]}
{"text": "Antiarrhythmic effects of (-)-epicatechin-3-gallate, a novel sodium channel agonist in cultured neonatal rat ventricular myocytes.", "spo_list": [{"subject": "(-)-epicatechin-3-gallate", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "sodium channel", "object_type": "GENE"}]}
{"text": "Yohimbine is a potent and selective alpha2- versus alpha1-adrenoceptor antagonist.", "spo_list": [{"subject": "Yohimbine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha2- versus alpha1-adrenoceptor", "object_type": "GENE"}]}
{"text": "Each dimeric analog showed higher affinities for alpha2A- and alpha2C-adrenoceptor versus the alpha2B-adrenoceptor; and yohimbine dimers with spacers of n = 2, 3, 4, 18, and 24 exhibited selectivity for the alpha2C-adrenoceptor.", "spo_list": [{"subject": "yohimbine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha2C-adrenoceptor", "object_type": "GENE"}]}
{"text": "The yohimbine dimers n = 3 and n = 24 showed the highest potency and selectivity (32- and 82-fold. respectively) for the alpha2C-adrenoceptor in receptor binding and in functional studies (42- and 29-fold, respectively) measuring cAMP changes using a cell-based luciferase reporter gene assay.", "spo_list": [{"subject": "yohimbine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha2C-adrenoceptor", "object_type": "GENE"}]}
{"text": "n-3 and n-6 polyunsaturated fatty acids induce the expression of COX-2 via PPARgamma activation in human keratinocyte HaCaT cells.", "spo_list": [{"subject": "n-3 and n-6 polyunsaturated fatty acids", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "n-3 and n-6 polyunsaturated fatty acids", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PPARgamma", "object_type": "GENE"}]}
{"text": "We demonstrate that only treatment of HaCaT with GLA and EPA or a PPARgamma ligand (roziglitazone), induced COX-2 expression (protein and mRNA).", "spo_list": [{"subject": "roziglitazone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PPARgamma", "object_type": "GENE"}, {"subject": "GLA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "EPA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "roziglitazone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Moreover stimulation of COX-2 promoter activity was increased by those PUFAs or rosiglitazone.", "spo_list": [{"subject": "PUFAs", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "COX-2 promoter", "object_type": "GENE"}, {"subject": "rosiglitazone", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "COX-2 promoter", "object_type": "GENE"}]}
{"text": "The inhibitory effects of GW9662 and T0070907 (PPARgamma antagonists), on COX-2 expression and on stimulation of COX-2 promoter activity by EPA and GLA suggest that PPARgamma is implicated in COX-2 induction.", "spo_list": [{"subject": "GW9662", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "PPARgamma", "object_type": "GENE"}, {"subject": "T0070907", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "PPARgamma", "object_type": "GENE"}]}
{"text": "Finally, PLA2 inhibitor methyl arachidonyl fluorophosphonate blocked the PUFA effects on COX-2 induction, promoter activity and arachidonic acid mobilization suggesting involvement of AA metabolites in PPAR activation.", "spo_list": [{"subject": "arachidonyl fluorophosphonate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PLA2", "object_type": "GENE"}, {"subject": "arachidonyl fluorophosphonate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "AA", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PPAR", "object_type": "GENE"}]}
{"text": "These findings demonstrate that n-3 and n-6 PUFA increased PPARgamma activity is necessary for the COX-2 induction in HaCaT human keratinocyte cells.", "spo_list": [{"subject": "n-3 and n-6 PUFA", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PPARgamma", "object_type": "GENE"}, {"subject": "n-3 and n-6 PUFA", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Given the anti-inflammatory properties of EPA, we suggest that induction of COX-2 in keratinocytes may be important in the anti-inflammatory and protective mechanism of action of PUFAs n-3 or n-6.", "spo_list": [{"subject": "PUFAs n-3", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Compared with normally-fed counterparts, PM-CP rats exhibited higher glutathione S-transferase, aminopeptidase N and cysteine S-conjugate beta-lyase (CCBL) and lower gamma-glutamyltransferase activities, PM-FU rats exhibited decreased dihydropyrimidine dehydrogenase and cytochrome P450 1A1/2 activities and PM-MMC rats showed higher quinone reductase and depleted xanthine oxidase activities.", "spo_list": [{"subject": "MMC", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "quinone reductase", "object_type": "GENE"}, {"subject": "MMC", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "xanthine oxidase", "object_type": "GENE"}]}
{"text": "Conclusively, protein malnutrition alters CP, FU and MMC metabolism in rat stomach by enhancing CCBL pathway for CP activation, delaying FU elimination and activating two-electron reduction of MMC, potentiating their gastrotoxicity.", "spo_list": [{"subject": "MMC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CCBL", "object_type": "GENE"}]}
{"text": "The concomitantly administered effects of rifampicin on other drugs can result in their altered metabolism or transportation that are metabolised by cytochromes P450 or transported by p-glycoprotein in the gastrointestinal tract and liver.", "spo_list": [{"subject": "rifampicin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "p-glycoprotein", "object_type": "GENE"}, {"subject": "rifampicin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytochromes P450", "object_type": "GENE"}]}
{"text": "In general, rifampicin can act on a pattern: rifampicin activates the nuclear pregnane X receptor that in turn affects cytochromes P450, glucuronosyltransferases and p-glycoprotein activities.", "spo_list": [{"subject": "rifampicin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "nuclear pregnane X receptor", "object_type": "GENE"}, {"subject": "rifampicin", "subject_type": "CHEMICAL", "predicate": "AGONIST-ACTIVATOR", "object": "nuclear pregnane X receptor", "object_type": "GENE"}]}
{"text": "Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.", "spo_list": [{"subject": "Curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-27", "object_type": "GENE"}, {"subject": "Curcumin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TLR4", "object_type": "GENE"}, {"subject": "Curcumin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NF-κB", "object_type": "GENE"}]}
{"text": "This study explored whether curcumin improves colonic inflammation in a rat colitis model through inhibition of the TLR4/NF-κB signaling pathway and IL-27 expression.", "spo_list": [{"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NF-κB", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TLR4", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-27", "object_type": "GENE"}]}
{"text": "Compared with the untreated colitis group, the curcumin-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-κB mRNA, IL-27 mRNA, TLR4 protein, NF-κB p65 protein, and IL-27 p28 protein (p < 0.05).", "spo_list": [{"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "myeloperoxidase", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "NF-κB", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-27", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TLR4", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "NF-κB", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "p65", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-27", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "p28", "object_type": "GENE"}]}
{"text": "There was no significant difference in TLR4, NF-κB, and IL-27 mRNA and proteins between curcumin-treated and sulfasalazine-treated groups.", "spo_list": [{"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TLR4", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "NF-κB", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-27", "object_type": "GENE"}, {"subject": "sulfasalazine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TLR4", "object_type": "GENE"}, {"subject": "sulfasalazine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "NF-κB", "object_type": "GENE"}, {"subject": "sulfasalazine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-27", "object_type": "GENE"}]}
{"text": "The anti-inflammatory actions of curcumin on colitis may involve inhibition of the TLR4/NF-κB signaling pathway and of IL-27 expression.", "spo_list": [{"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TLR4", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NF-κB", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-27", "object_type": "GENE"}]}
{"text": "Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.", "spo_list": [{"subject": "Licofelone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase", "object_type": "GENE"}, {"subject": "Licofelone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-lipoxygenase", "object_type": "GENE"}]}
{"text": "Licofelone, a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase (COX) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to cycloxygenase-1 blockade-mediated antithrombotic effect and a better gastrointestinal tolerability.", "spo_list": [{"subject": "Licofelone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cycloxygenase-1", "object_type": "GENE"}, {"subject": "Licofelone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-lipoxygenase", "object_type": "GENE"}, {"subject": "Licofelone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "LOX", "object_type": "GENE"}, {"subject": "Licofelone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase", "object_type": "GENE"}, {"subject": "Licofelone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX", "object_type": "GENE"}]}
{"text": "We examined the anti-inflammatory effect of licofelone on atherosclerotic lesions as well as in isolated neutrophils from whole blood of rabbits compared with a selective inhibitor of COX-2, rofecoxib.", "spo_list": [{"subject": "rofecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Licofelone reduced intima/media ratio in injured arteries, the macrophages infiltration in the neointimal area, monocyte chemoattractant protein-1 (MCP-1) gene expression, and the activation of nuclear factor-kappaB in rabbit atheroma.", "spo_list": [{"subject": "Licofelone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "monocyte chemoattractant protein-1", "object_type": "GENE"}, {"subject": "Licofelone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "MCP-1", "object_type": "GENE"}, {"subject": "Licofelone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "nuclear factor-kappaB", "object_type": "GENE"}]}
{"text": "Moreover, licofelone inhibited COX-2 and 5-LOX protein expression in vascular lesions.", "spo_list": [{"subject": "licofelone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "licofelone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "5-LOX", "object_type": "GENE"}]}
{"text": "Rofecoxib only diminished COX-2 protein expression and MCP-1 gene expression in vascular atheroma.", "spo_list": [{"subject": "Rofecoxib", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "Rofecoxib", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "MCP-1", "object_type": "GENE"}]}
{"text": "Licofelone almost abolished 5-LOX activity by inhibiting leukotriene B4 generation in rabbit neutrophils and prevented platelet thromboxane B2 production from whole blood.", "spo_list": [{"subject": "Licofelone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-LOX", "object_type": "GENE"}, {"subject": "leukotriene B4", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "5-LOX", "object_type": "GENE"}, {"subject": "thromboxane B2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "5-LOX", "object_type": "GENE"}]}
{"text": "KIEs were measured on the arsenolysis of 5'-methylthioadenosine (MTA) catalyzed by MTAP and were corrected for the forward commitment to catalysis.", "spo_list": [{"subject": "5'-methylthioadenosine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "MTAP", "object_type": "GENE"}, {"subject": "MTA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "MTAP", "object_type": "GENE"}]}
{"text": "However, in the presence of 100 mM Na+, which is required for opiate inhibition of adenylate cyclase activity, analysis of competition binding data revealed three sites: the first, consisting of 17.5% of total receptor population has a Kd = 0.38 +/- 0.18 nM; the second, 50.6% of the population, has a Kd = 6.8 +/- 2.2 nM; and the third, 31.9% of the population, has a Kd of 410 +/- 110 nM.", "spo_list": [{"subject": "Na+", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "adenylate cyclase", "object_type": "GENE"}]}
{"text": "Multiple affinity states of opiate receptor can be demonstrated further by Scatchard analysis of saturation binding studies with [3H]DADLE.", "spo_list": [{"subject": "[3H]DADLE", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "opiate receptor", "object_type": "GENE"}]}
{"text": "Jaspamide also inhibited other channels including Cav1.2, Cav3.2, and HCN2; however, the Kv11.1 (hERG) channel was minimally affected.", "spo_list": [{"subject": "Jaspamide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Cav1.2", "object_type": "GENE"}, {"subject": "Jaspamide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Cav3.2", "object_type": "GENE"}, {"subject": "Jaspamide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HCN2", "object_type": "GENE"}]}
{"text": "2. Troglitazone inhibited the antigen-induced production of LTB(4), C(4) and E(4) and the potency of the inhibition was comparable to that of zileuton, a specific inhibitor of 5-lipoxygenase (5-LOX) and a clinically used anti-asthmatic drug.", "spo_list": [{"subject": "zileuton", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-lipoxygenase", "object_type": "GENE"}, {"subject": "zileuton", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-LOX", "object_type": "GENE"}]}
{"text": "3. Troglitazone inhibited LTB(4) production by the supernatant fraction of RBL-2H3 cell lysate with similar potency to zileuton, suggesting that troglitazone inhibits LT production by direct inhibition of 5-LOX activity.", "spo_list": [{"subject": "zileuton", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-LOX", "object_type": "GENE"}, {"subject": "troglitazone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-LOX", "object_type": "GENE"}]}
{"text": "5. These findings suggest that troglitazone inhibits antigen-induced LT production in the IgE-sensitized RBL-2H3 cells and A23187-stimulated rat peritoneal neutrophils by direct inhibition of 5-LOX activity.", "spo_list": [{"subject": "troglitazone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-LOX", "object_type": "GENE"}]}
{"text": "Orlistat has been the most used anti-obesity drug and the mechanism of its action is to reduce lipid absorption by inhibiting gastrointestinal lipases.", "spo_list": [{"subject": "Orlistat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "lipases", "object_type": "GENE"}]}
{"text": "This study was designed to test the hypothesis that orlistat inhibits CESs with higher potency toward CES1 than CES2, a carboxylesterase with little lipase activity.", "spo_list": [{"subject": "orlistat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CESs", "object_type": "GENE"}, {"subject": "orlistat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CES1", "object_type": "GENE"}, {"subject": "orlistat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CES2", "object_type": "GENE"}, {"subject": "orlistat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "carboxylesterase", "object_type": "GENE"}, {"subject": "orlistat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "lipase", "object_type": "GENE"}]}
{"text": "Contrary to the hypothesis, orlistat at 1 nM inhibited CES2 activity by 75% but no inhibition on CES1, placing CES2 one of the most sensitive targets of orlistat.", "spo_list": [{"subject": "orlistat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CES2", "object_type": "GENE"}, {"subject": "orlistat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CES2", "object_type": "GENE"}]}
{"text": "Inhibition of this carboxylesterase probably presents a major source for altered therapeutic activity of these medicines if co-administered with orlistat.", "spo_list": [{"subject": "orlistat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "carboxylesterase", "object_type": "GENE"}]}
{"text": "A major part of this processing requires endoproteolytic cleavage at specific pairs of basic amino acid residues, an event necessary for the maturation of a variety of important biologically active proteins, such as insulin and nerve growth factor.", "spo_list": [{"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "insulin", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "nerve growth factor", "object_type": "GENE"}]}
{"text": "Furthermore, experiments showed that treatment with DEC results in a reduction in the amount of COX-1 protein in peritoneal exudate cells.", "spo_list": [{"subject": "DEC", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "COX-1", "object_type": "GENE"}]}
{"text": "During embryogenesis, lratb is expressed in mostly non-overlapping domains opposite to retinal dehydrogenase 2 (raldh2), the key enzyme for retinoic acid synthesis.", "spo_list": [{"subject": "retinoic acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "raldh2", "object_type": "GENE"}, {"subject": "retinoic acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "retinal dehydrogenase 2", "object_type": "GENE"}]}
{"text": "Blocking retinyl ester formation by a targeted knock down of Lratb results in significantly increased retinoic acid levels, which lead to severe embryonic patterning defects.", "spo_list": [{"subject": "retinyl ester", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Lratb", "object_type": "GENE"}]}
{"text": "Antitumor activity of sorafenib in FLT3-driven leukemic cells.", "spo_list": [{"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}]}
{"text": "We show that sorafenib (BAY 43-9006, Nexavar) potently inhibits FLT3 enzymatic and signaling activities.", "spo_list": [{"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}, {"subject": "BAY 43-9006", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}, {"subject": "Nexavar", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}]}
{"text": "In HEK293 cells stably transfected with FLT3-WT or FLT3-ITD, sorafenib blocked basal and ligand dependent FLT3-mediated tyrosine autophosphorylation as well as extracellular signal-regulated kinase1/2 and Stat5 phosphorylation.", "spo_list": [{"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "extracellular signal-regulated kinase1/2", "object_type": "GENE"}, {"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Stat5", "object_type": "GENE"}, {"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}]}
{"text": "In leukemia cell lines MV4-11 and EOL-1, sorafenib treatment resulted in decreased cell proliferation and inhibition of FLT3 signaling.", "spo_list": [{"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}]}
{"text": "The growth of the FLT3-independent RS4-11 cell line was only weakly inhibited by sorafenib.", "spo_list": [{"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}]}
{"text": "The demonstration that sorafenib exhibits potent target inhibition and efficacy in FLT3-driven models suggests that this compound may have a therapeutic benefit for patients with FLT3-driven leukemias.", "spo_list": [{"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}, {"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}]}
{"text": "RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than COX-1.", "spo_list": [{"subject": "NS398", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "NS398", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-1", "object_type": "GENE"}, {"subject": "carprofen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "carprofen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-1", "object_type": "GENE"}, {"subject": "tolfenamic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "tolfenamic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-1", "object_type": "GENE"}, {"subject": "nimesulide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "nimesulide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-1", "object_type": "GENE"}, {"subject": "etodolac", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "etodolac", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-1", "object_type": "GENE"}]}
{"text": "CONCLUSIONS AND CLINICAL RELEVANCE: Canine COX-2 was selectively inhibited by etodolac, nimesulide, and NS398; tolfenamic acid and carprofen also appeared to be preferential COX-2 inhibitors in dogs.", "spo_list": [{"subject": "etodolac", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Canine COX-2", "object_type": "GENE"}, {"subject": "nimesulide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Canine COX-2", "object_type": "GENE"}, {"subject": "NS398", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Canine COX-2", "object_type": "GENE"}, {"subject": "tolfenamic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "carprofen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "In eukaryotes, the most prominent Mo-enzymes are (1) sulfite oxidase, which catalyzes the final step in the degradation of sulfur-containing amino acids and is involved in detoxifying excess sulfite, (2) xanthine dehydrogenase, which is involved in purine catabolism and reactive oxygen production, (3) aldehyde oxidase, which oxidizes a variety of aldehydes and is essential for the biosynthesis of the phytohormone abscisic acid, and in autotrophic organisms also (4) nitrate reductase, which catalyzes the key step in inorganic nitrogen assimilation.", "spo_list": [{"subject": "sulfur", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "sulfite oxidase", "object_type": "GENE"}]}
{"text": "As determined by Western and Northern blot analyses, 5 alpha-NET inhibited the P4-induced UG gene expression in a dose-dependent manner.", "spo_list": [{"subject": "5 alpha-NET", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "UG", "object_type": "GENE"}]}
{"text": "The estrogenic agent 3 beta,5 alpha-NET and estradiol at a dose of 1.0 mg also inhibited the UG gene expression induced by P4.", "spo_list": [{"subject": "3 beta,5 alpha-NET", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "UG", "object_type": "GENE"}, {"subject": "estradiol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "UG", "object_type": "GENE"}]}
{"text": "Both 5 alpha-NET and 3 beta,5 alpha-NET blocked the PR down-regulation induced by P4 as assessed by Western and Northern blot methods.", "spo_list": [{"subject": "5 alpha-NET", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PR", "object_type": "GENE"}, {"subject": "3 beta,5 alpha-NET", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PR", "object_type": "GENE"}]}
{"text": "The inhibition of UG synthesis and PR down-regulation by 5 alpha-NET and 3 beta,5 alpha-NET indicates that these NET metabolites possess antiprogestational properties.", "spo_list": [{"subject": "5 alpha-NET", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PR", "object_type": "GENE"}, {"subject": "3 beta,5 alpha-NET", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "PR", "object_type": "GENE"}, {"subject": "NET", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "PR", "object_type": "GENE"}, {"subject": "5 alpha-NET", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "UG", "object_type": "GENE"}, {"subject": "3 beta,5 alpha-NET", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "UG", "object_type": "GENE"}, {"subject": "NET", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "UG", "object_type": "GENE"}]}
{"text": "Pretreatment with lysosomal enzyme inhibitors [(2S, 3S)trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester or chloroquine] or proteasome inhibitors (proteasome inhibitor I, MG-132, or lactacystin) decreased the extent of U50,488H-induced down-regulation.", "spo_list": [{"subject": "MG-132", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "proteasome", "object_type": "GENE"}, {"subject": "lactacystin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "proteasome", "object_type": "GENE"}]}
{"text": "Effects of some mono- and bisquaternary ammonium compounds on the reactivatability of soman-inhibited human acetylcholinesterase in vitro.", "spo_list": [{"subject": "soman", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "human acetylcholinesterase", "object_type": "GENE"}]}
{"text": "Acetylcholinesterase (AChE) inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.", "spo_list": [{"subject": "organophosphate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}, {"subject": "organophosphate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Acetylcholinesterase", "object_type": "GENE"}, {"subject": "soman", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}, {"subject": "soman", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Acetylcholinesterase", "object_type": "GENE"}, {"subject": "1,2,2-trimethyl-propylmethylphosphonofluoridate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}, {"subject": "1,2,2-trimethyl-propylmethylphosphonofluoridate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Acetylcholinesterase", "object_type": "GENE"}, {"subject": "oximes", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "AChE", "object_type": "GENE"}, {"subject": "oximes", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Acetylcholinesterase", "object_type": "GENE"}]}
{"text": "The effect of the four mono- and bisquaternary ammonium compounds tetramethylammonium (TMA), hexamethonium, decamethonium and suxamethonium on the reactivatability of soman-inhibited, solubilized AChE from human erythrocytes was investigated in vitro.", "spo_list": [{"subject": "soman", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}]}
{"text": "If the effectors were added after 5 min of aging they increased the activity of soman-inhibited AChE, but to a considerably smaller extent than HI 6.", "spo_list": [{"subject": "soman", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}]}
{"text": "Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs.", "spo_list": [{"subject": "IMG", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "thrombin", "object_type": "GENE"}, {"subject": "IMG", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FXa", "object_type": "GENE"}, {"subject": "hyperoside", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "thrombin", "object_type": "GENE"}, {"subject": "hyperoside", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FXa", "object_type": "GENE"}, {"subject": "IMG", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "thrombin", "object_type": "GENE"}, {"subject": "IMG", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "FXa", "object_type": "GENE"}, {"subject": "hyperoside", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "thrombin", "object_type": "GENE"}, {"subject": "hyperoside", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "FXa", "object_type": "GENE"}]}
{"text": "In addition, treatment with IMG and hyperoside resulted in inhibition of TNF-α-induced production of PAI-1, and treatment with IMG resulted in significant reduction of the PAI-1 to t-PA ratio.", "spo_list": [{"subject": "IMG", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "PAI-1", "object_type": "GENE"}, {"subject": "hyperoside", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "PAI-1", "object_type": "GENE"}, {"subject": "IMG", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "PAI-1", "object_type": "GENE"}, {"subject": "IMG", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "t-PA", "object_type": "GENE"}, {"subject": "IMG", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TNF-α", "object_type": "GENE"}, {"subject": "hyperoside", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TNF-α", "object_type": "GENE"}]}
{"text": "The most successful example of kinase blockers is Imatinib (Imatinib mesylate, Gleevec, STI571), the inhibitor of Bcr/Abl oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia.", "spo_list": [{"subject": "Imatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "Imatinib mesylate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "Gleevec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "Imatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Bcr", "object_type": "GENE"}, {"subject": "Imatinib mesylate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Bcr", "object_type": "GENE"}, {"subject": "Gleevec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Bcr", "object_type": "GENE"}, {"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Bcr", "object_type": "GENE"}, {"subject": "Imatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Abl", "object_type": "GENE"}, {"subject": "Imatinib mesylate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Abl", "object_type": "GENE"}, {"subject": "Gleevec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Abl", "object_type": "GENE"}, {"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Abl", "object_type": "GENE"}]}
{"text": "Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.", "spo_list": [{"subject": "Dasatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ABL", "object_type": "GENE"}, {"subject": "BMS-354825", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ABL", "object_type": "GENE"}, {"subject": "Dasatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "non-receptor cytoplasmic kinase", "object_type": "GENE"}, {"subject": "Gefitinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGF receptor", "object_type": "GENE"}, {"subject": "Gefitinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "Iressa", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGF receptor", "object_type": "GENE"}, {"subject": "Iressa", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "Erlotinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGF receptor", "object_type": "GENE"}, {"subject": "Erlotinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "OSI-774", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGF receptor", "object_type": "GENE"}, {"subject": "OSI-774", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "Tarceva", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGF receptor", "object_type": "GENE"}, {"subject": "Tarceva", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "Sunitinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGF receptor", "object_type": "GENE"}, {"subject": "Sunitinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "SU 11248", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGF receptor", "object_type": "GENE"}, {"subject": "SU 11248", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "Sutent", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGF receptor", "object_type": "GENE"}, {"subject": "Sutent", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "AMN107", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "c-KIT", "object_type": "GENE"}, {"subject": "Nilotinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "c-KIT", "object_type": "GENE"}, {"subject": "INNO-406", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "c-KIT", "object_type": "GENE"}, {"subject": "NS-187", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "c-KIT", "object_type": "GENE"}]}
{"text": "The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).", "spo_list": [{"subject": "Lapatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "Lapatinib ditosylate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "Tykerb", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "GW-572016", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "Canertinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "CI-1033", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "Zactima", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "ZD6474", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "Vatalanib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "PTK787", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "ZK 222584", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "Sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "Bay 43-9006", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "Nexavar", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "Leflunomide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "SU101", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}, {"subject": "Arava", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TK", "object_type": "GENE"}]}
{"text": "Molecular docking studies were performed with Human Serum Albumin (HSA: PDB 1E78), showing binding pattern with amino acid residues Arg218, Arg222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.", "spo_list": [{"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Human Serum Albumin", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HSA", "object_type": "GENE"}, {"subject": "Arg", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Human Serum Albumin", "object_type": "GENE"}, {"subject": "Arg", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HSA", "object_type": "GENE"}, {"subject": "Arg", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Human Serum Albumin", "object_type": "GENE"}, {"subject": "Arg", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HSA", "object_type": "GENE"}, {"subject": "Lys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Human Serum Albumin", "object_type": "GENE"}, {"subject": "Lys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HSA", "object_type": "GENE"}]}
{"text": "The present study examined the effect of antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), on VMAT2 activity by measuring adenosine triphosphate-dependent [(3)H]dopamine uptake into synaptic vesicles prepared from rat striatum.", "spo_list": [{"subject": "[(3)H]dopamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "VMAT2", "object_type": "GENE"}]}
{"text": "Moreover, kinetic analysis revealed that inhibition by reserpine, a typical VMAT2 inhibitor, was uncompetitive, decreasing maximum velocity and affinity for dopamine.", "spo_list": [{"subject": "reserpine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VMAT2", "object_type": "GENE"}, {"subject": "dopamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "VMAT2", "object_type": "GENE"}]}
{"text": "These results suggest that fluoxetine inhibited the activity of VMAT2 by a mechanism different from that of reserpine and did not directly interact with the active site of VMAT2.", "spo_list": [{"subject": "fluoxetine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VMAT2", "object_type": "GENE"}, {"subject": "reserpine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VMAT2", "object_type": "GENE"}, {"subject": "fluoxetine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VMAT2", "object_type": "GENE"}]}
{"text": "Also, reactive astrogliosis takes part of the early responses to the insult with (PhTe)(2), evidenced by upregulated GFAP in Western blot, PCR and immunofluorescence analysis.", "spo_list": [{"subject": "(PhTe)(2)", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "GFAP", "object_type": "GENE"}]}
{"text": "Six days after (PhTe)(2) injection we found persistent astrogliosis, increased propidium iodide (PI) positive cells in NeuN positive population evidenced by flow cytometry and reduced immunofluorescence for NeuN, suggesting that the in vivo exposure to (PhTe)(2) progressed to neuronal death.", "spo_list": [{"subject": "(PhTe)(2)", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "NeuN", "object_type": "GENE"}]}
{"text": "Neurodegeneration was related with decreased [(3)H]glutamate uptake and decreased Akt immunoreactivity, however phospho-GSK-3-β (Ser9) was not altered in (PhTe)(2) injected rat.", "spo_list": [{"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "phospho-GSK-3-β", "object_type": "GENE"}, {"subject": "(PhTe)(2)", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Akt", "object_type": "GENE"}]}
{"text": "Therefore, the present results show that the earlier cerebellar responses to (PhTe)(2) include disruption of cytoskeletal homeostasis that could be related with MAPK and PKA activation and reactive astrogliosis.", "spo_list": [{"subject": "(PhTe)(2)", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "MAPK", "object_type": "GENE"}, {"subject": "(PhTe)(2)", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PKA", "object_type": "GENE"}]}
{"text": "In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor.", "spo_list": [{"subject": "naltrindole", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "κ-opioid receptor", "object_type": "GENE"}]}
{"text": "Opioid receptor binding affinity and activity were assessed using [(3)H]-diprenorphine binding, guanosine-5'-O-(3-[35S]-thio) triphosphate ([(35)S]-GTPγS) binding and isolated guinea-pig ileum.", "spo_list": [{"subject": "[(3)H]-diprenorphine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Opioid receptor", "object_type": "GENE"}, {"subject": "guanosine-5'-O-(3-[35S]-thio) triphosphate", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Opioid receptor", "object_type": "GENE"}, {"subject": "[(35)S]-GTPγS", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Opioid receptor", "object_type": "GENE"}]}
{"text": "Both 5'-AMN and 5'-MABN had high affinity for κ-receptors (K (i) 1.36 ± 0.98 and 0.27 ± 0.08, respectively) and were revealed as potent κ-antagonists (pA(2) 7.43 and 8.18, respectively) and μ-receptor antagonists (pA(2) 7.62 and 7.85, respectively) in the ileum.", "spo_list": [{"subject": "5'-AMN", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "κ-receptors", "object_type": "GENE"}, {"subject": "5'-MABN", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "κ-receptors", "object_type": "GENE"}, {"subject": "5'-AMN", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "μ-receptor", "object_type": "GENE"}, {"subject": "5'-MABN", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "μ-receptor", "object_type": "GENE"}]}
{"text": "It has been claimed that hCTR1, the human high affinity copper transporter, is the major entry pathway for cDDP and related drugs via a mechanism that mimics copper.", "spo_list": [{"subject": "cDDP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human high affinity copper transporter", "object_type": "GENE"}, {"subject": "cDDP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "hCTR1", "object_type": "GENE"}]}
{"text": "We confirm the correlation between higher hCTR1 levels and higher Pt-drug uptake in tumor cells sensitive to the drug.", "spo_list": [{"subject": "Pt", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "hCTR1", "object_type": "GENE"}]}
{"text": "We investigated the involvement of the farnesoid X receptor (FXR), a nuclear receptor for bile acids, in the chenodeoxycholic acid (CDCA)-induced expression of Cdx2 and MUC2 in normal rat gastric epithelial cells (RGM-1 cells).", "spo_list": [{"subject": "CDCA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Cdx2", "object_type": "GENE"}, {"subject": "chenodeoxycholic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Cdx2", "object_type": "GENE"}, {"subject": "chenodeoxycholic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "MUC2", "object_type": "GENE"}, {"subject": "CDCA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "MUC2", "object_type": "GENE"}]}
{"text": "RGM-1 cells were treated with CDCA or GW4064, an FXR agonist, in the presence or absence of guggulsterone, an FXR antagonist.", "spo_list": [{"subject": "GW4064", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "FXR", "object_type": "GENE"}, {"subject": "guggulsterone", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "FXR", "object_type": "GENE"}, {"subject": "CDCA", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "FXR", "object_type": "GENE"}]}
{"text": "CDCA induced dose-dependent expression of Cdx2 and MUC2 at both the mRNA and protein levels.", "spo_list": [{"subject": "CDCA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Cdx2", "object_type": "GENE"}, {"subject": "CDCA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "MUC2", "object_type": "GENE"}]}
{"text": "The maximum stimulation of Cdx2 and MUC2 mRNA induced by CDCA was observed at 3 h and by 6 h, respectively.", "spo_list": [{"subject": "CDCA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Cdx2", "object_type": "GENE"}, {"subject": "CDCA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "MUC2", "object_type": "GENE"}]}
{"text": "The effects of CDCA and GW4064 on expression of Cdx2 and MUC2 were abolished by guggulsterone.", "spo_list": [{"subject": "guggulsterone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Cdx2", "object_type": "GENE"}, {"subject": "guggulsterone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "MUC2", "object_type": "GENE"}]}
{"text": "A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression.", "spo_list": [{"subject": "theophylline", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "histone deacetylase", "object_type": "GENE"}]}
{"text": "We show both in vitro and in vivo that low-dose theophylline enhances HDAC activity in epithelial cells and macrophages.", "spo_list": [{"subject": "theophylline", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "HDAC", "object_type": "GENE"}]}
{"text": "Thus we have shown that low-dose theophylline exerts an anti-asthma effect through increasing activation of HDAC which is subsequently recruited by corticosteroids to suppress inflammatory genes.", "spo_list": [{"subject": "theophylline", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "HDAC", "object_type": "GENE"}]}
{"text": "Drug-drug interactions are dependent on statins' pharmacokinetic profile: simvastatin, lovastatin and atorvastatin are metabolized through cytochrome P450 (CYP) 3A, while the metabolism of the other statins is independent of this CYP.", "spo_list": [{"subject": "simvastatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytochrome P450 (CYP) 3A", "object_type": "GENE"}, {"subject": "lovastatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytochrome P450 (CYP) 3A", "object_type": "GENE"}, {"subject": "atorvastatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytochrome P450 (CYP) 3A", "object_type": "GENE"}]}
{"text": "All HIV PIs except nelfinavir are coadministered with a low dose of ritonavir, a potent CYP3A inhibitor to improve their pharmacokinetic properties.", "spo_list": [{"subject": "ritonavir", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP3A", "object_type": "GENE"}]}
{"text": "The HCV-PIs boceprevir and telaprevir are both, to different extents, inhibitors of CYP3A.", "spo_list": [{"subject": "boceprevir", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP3A", "object_type": "GENE"}, {"subject": "telaprevir", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP3A", "object_type": "GENE"}]}
{"text": "Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drug-drug interaction with potent CYP3A inhibitors such as ritonavir- or cobicistat-boosted HIV-PI or the hepatitis C virus (HCV) PI, telaprevir or boceprevir, and therefore their coadministration is contraindicated.", "spo_list": [{"subject": "Simvastatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A", "object_type": "GENE"}, {"subject": "lovastatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A", "object_type": "GENE"}, {"subject": "ritonavir", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP3A", "object_type": "GENE"}, {"subject": "cobicistat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP3A", "object_type": "GENE"}, {"subject": "telaprevir", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP3A", "object_type": "GENE"}, {"subject": "boceprevir", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP3A", "object_type": "GENE"}]}
{"text": "Atorvastatin is also a CYP3A substrate, but less potent drug-drug interactions have been reported with CYP3A inhibitors.", "spo_list": [{"subject": "Atorvastatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A", "object_type": "GENE"}]}
{"text": "Effects of inhibition of urokinase-type plasminogen activator (u-PA) by amiloride in the cornea and tear fluid of eyes irradiated with UVB.", "spo_list": [{"subject": "amiloride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "urokinase-type plasminogen activator", "object_type": "GENE"}, {"subject": "amiloride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "u-PA", "object_type": "GENE"}]}
{"text": "The purpose of the present study was to test our hypothesis that amiloride, a specific u-PA inhibitor, effectively decreases u-PA activity in cornea as well as in tear fluid and favourably affects corneal healing.", "spo_list": [{"subject": "amiloride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "u-PA", "object_type": "GENE"}, {"subject": "amiloride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "u-PA", "object_type": "GENE"}]}
{"text": "Therefore, comparative histochemical and biochemical studies of u-PA and the effects of amiloride were performed on rabbit corneas and tear fluid using the sensitive fluorogenic substrate Z-Gly-Gly-Arg-7-amino-4-trifluoromethylcoumarin.", "spo_list": [{"subject": "Z-Gly-Gly-Arg-7-amino-4-trifluoromethylcoumarin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "u-PA", "object_type": "GENE"}]}
{"text": "When amiloride was dropped on the eye surface on the first day of irradiation and subsequently daily until the end of the experiment, u-PA activity in both cornea and tear fluid was strongly inhibited.", "spo_list": [{"subject": "amiloride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "u-PA", "object_type": "GENE"}]}
{"text": "In conclusion, early application of amiloride inhibited u-PA activity in UVB-irradiated corneas as well as in tear fluid and diminished the development of corneal pathology.", "spo_list": [{"subject": "amiloride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "u-PA", "object_type": "GENE"}]}
{"text": "Carbonic anhydrase (CA) is a zinc enzyme that catalyses the reversible hydration reaction of CO2 and plays a major role in the acid-base balance.", "spo_list": [{"subject": "CO2", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE_PRODUCT-OF", "object": "Carbonic anhydrase", "object_type": "GENE"}, {"subject": "CO2", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE_PRODUCT-OF", "object": "CA", "object_type": "GENE"}]}
{"text": "The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPβS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.", "spo_list": [{"subject": "okadaic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "phosphatase", "object_type": "GENE"}, {"subject": "lavendustin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase", "object_type": "GENE"}, {"subject": "1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mGlu1", "object_type": "GENE"}, {"subject": "1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KARs", "object_type": "GENE"}, {"subject": "BAPTA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KARs", "object_type": "GENE"}, {"subject": "BAPTA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mGlu1", "object_type": "GENE"}, {"subject": "okadaic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KARs", "object_type": "GENE"}, {"subject": "okadaic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mGlu1", "object_type": "GENE"}, {"subject": "lavendustin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KARs", "object_type": "GENE"}, {"subject": "lavendustin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mGlu1", "object_type": "GENE"}, {"subject": "phorbol 12-myristate,13-acetate", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PKC", "object_type": "GENE"}, {"subject": "phorbol 12-myristate,13-acetate", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "GluK2", "object_type": "GENE"}, {"subject": "phorbol 12-myristate,13-acetate", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "GluK5", "object_type": "GENE"}]}
{"text": "Using site-directed mutagenesis, we identified three serines (Ser833, Ser836, and Ser840) within the membrane proximal region of the GluK5 C-terminal domain that, in combination, are required for mGlu1-mediated potentiation of KARs.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "GluK5", "object_type": "GENE"}, {"subject": "serines", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "GluK5", "object_type": "GENE"}, {"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "GluK5", "object_type": "GENE"}, {"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "GluK5", "object_type": "GENE"}, {"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "GluK5", "object_type": "GENE"}]}
{"text": "To determine whether these responses were common to other amphetamines of abuse, effects of methylenedioxymethamphetamine (MDMA) on the plasmalemmal DA transporter (DAT) and vesicular monoamine transporter-2 (VMAT-2) were assessed.", "spo_list": [{"subject": "monoamine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "vesicular monoamine transporter-2", "object_type": "GENE"}]}
{"text": "Also in contrast to effects of multiple METH injections, 1) MDMA caused little or no decrease in binding of the DAT ligand WIN35428, and 2) neither prevention of hyperthermia nor prior depletion of DA prevented the MDMA-induced reduction in plasmalemmal DA transport.", "spo_list": [{"subject": "WIN35428", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "DA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DAT", "object_type": "GENE"}, {"subject": "DA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DAT", "object_type": "GENE"}]}
{"text": "In addition to affecting DAT function, MDMA rapidly decreased vesicular DA transport as assessed in striatal vesicles prepared from treated rats.", "spo_list": [{"subject": "DA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DAT", "object_type": "GENE"}]}
{"text": "GHRP-6 is a growth hormone secretagogue that also enhances tissue viability in different organs.", "spo_list": [{"subject": "GHRP-6", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "growth hormone", "object_type": "GENE"}]}
{"text": "Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain.", "spo_list": [{"subject": "[3H]SR 142948A", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "neurotensin receptor", "object_type": "GENE"}]}
{"text": "The present study describes the characterization of the binding properties and autoradiographic distribution of a new nonpeptide antagonist of neurotensin receptors, [3H]SR 142948A (2-[[5-(2,6-dimethoxyphenyl)-1-(4-(N-(3-dimethylaminopropyl)-N-methyl carbamoyl)-2-isopropylphenyl)-1H-pyrazole-3-carbonyl]-amino]-ad amantane-2-carboxylic acid, hydrochloride), in the rat brain.", "spo_list": [{"subject": "[3H]SR 142948A", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "neurotensin receptors", "object_type": "GENE"}, {"subject": "2-[[5-(2,6-dimethoxyphenyl)-1-(4-(N-(3-dimethylaminopropyl)-N-methyl carbamoyl)-2-isopropylphenyl)-1H-pyrazole-3-carbonyl]-amino]-ad amantane-2-carboxylic acid, hydrochloride", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "neurotensin receptors", "object_type": "GENE"}]}
{"text": "Saturation and competition studies in the presence or absence of the histamine H1 receptor antagonist, levocabastine, revealed that [3H]SR 142948A bound with similar affinities to both the levocabastine-insensitive neurotensin NT1 receptors (20% of the total binding population) and the recently cloned levocabastine-sensitive neurotensin NT2 receptors (80% of the receptors) (Kd = 6.8 and 4.8 nM, respectively).", "spo_list": [{"subject": "[3H]SR 142948A", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "neurotensin NT1 receptors", "object_type": "GENE"}, {"subject": "[3H]SR 142948A", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "neurotensin NT2 receptors", "object_type": "GENE"}, {"subject": "levocabastine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "histamine H1 receptor", "object_type": "GENE"}]}
{"text": "In conclusion, these findings indicate that [3H]SR 142948A is a new potent antagonist radioligand which recognizes with high affinity both neurotensin NT1 and NT2 receptors and represents thus an excellent tool to study neurotensin receptors in the rat brain.", "spo_list": [{"subject": "[3H]SR 142948A", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "neurotensin NT1", "object_type": "GENE"}, {"subject": "[3H]SR 142948A", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NT2 receptors", "object_type": "GENE"}, {"subject": "[3H]SR 142948A", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "neurotensin NT1", "object_type": "GENE"}, {"subject": "[3H]SR 142948A", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "NT2 receptors", "object_type": "GENE"}]}
{"text": "Orlistat is a new inhibitor of pancreatic lipase enzyme.", "spo_list": [{"subject": "Orlistat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "pancreatic lipase", "object_type": "GENE"}]}
{"text": "In the long term, orlistat has been shown to be more effective than placebo in reducing body weight and serum total and low-density lipoprotein cholesterol levels.", "spo_list": [{"subject": "orlistat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "low-density lipoprotein", "object_type": "GENE"}]}
{"text": "Acetylcholinesterase (AChE) predominates in the healthy brain, with butyrylcholinesterase (BuChE) considered to play a minor role in regulating brain acetylcholine (ACh) levels.", "spo_list": [{"subject": "acetylcholine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Acetylcholinesterase", "object_type": "GENE"}, {"subject": "acetylcholine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "AChE", "object_type": "GENE"}, {"subject": "acetylcholine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "butyrylcholinesterase", "object_type": "GENE"}, {"subject": "acetylcholine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "BuChE", "object_type": "GENE"}, {"subject": "ACh", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Acetylcholinesterase", "object_type": "GENE"}, {"subject": "ACh", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "AChE", "object_type": "GENE"}, {"subject": "ACh", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "butyrylcholinesterase", "object_type": "GENE"}, {"subject": "ACh", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "BuChE", "object_type": "GENE"}]}
{"text": "Experimental evidence from the use of agents with enhanced selectivity for BuChE (cymserine analogues, MF-8622) and the dual inhibitor of both AChE and BuChE, rivastigmine, indicates potential therapeutic benefits of inhibiting both AChE and BuChE in AD and related dementias.", "spo_list": [{"subject": "rivastigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}, {"subject": "rivastigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BuChE", "object_type": "GENE"}, {"subject": "rivastigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}, {"subject": "rivastigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BuChE", "object_type": "GENE"}]}
{"text": "The development of specific BuChE inhibitors and further experience with the dual enzyme inhibitor rivastigmine will improve understanding of the aetiology of AD and should lead to a wider variety of potent treatment options.", "spo_list": [{"subject": "rivastigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BuChE", "object_type": "GENE"}]}
{"text": "Amino acid residues at the N- and C-termini are essential for the folding of active human butyrylcholinesterase polypeptide.", "spo_list": [{"subject": "Amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "human butyrylcholinesterase", "object_type": "GENE"}]}
{"text": "Human serum butyrylcholinesterase (HuBChE) is currently the most suitable bioscavenger for the prophylaxis of highly toxic organophosphate (OP) nerve agents.", "spo_list": [{"subject": "organophosphate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "HuBChE", "object_type": "GENE"}, {"subject": "organophosphate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Human serum butyrylcholinesterase", "object_type": "GENE"}]}
{"text": "Studies have indicated that the three-dimensional structure and the domains of HuBChE (acyl pocket, lip of the active center gorge, and the anionic substrate-binding domain) that are critical for the binding of substrate are also essential for the selectivity and binding of inhibitors including OPs.", "spo_list": [{"subject": "acyl", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HuBChE", "object_type": "GENE"}]}
{"text": "The selective GluR5 kainate receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the GluR5 kainate receptor antagonist LY293558.", "spo_list": [{"subject": "LY293558", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "kainate receptor", "object_type": "GENE"}, {"subject": "LY293558", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "GluR5", "object_type": "GENE"}]}
{"text": "However, topiramate at low concentrations causes slow inhibition of GluR5 kainate receptor-mediated synaptic currents in the basolateral amygdala, indicating that it may protect against seizures, at least in part, through suppression of GluR5 kainate receptor responses.", "spo_list": [{"subject": "topiramate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "GluR5", "object_type": "GENE"}, {"subject": "topiramate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kainate receptor", "object_type": "GENE"}, {"subject": "topiramate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "GluR5", "object_type": "GENE"}, {"subject": "topiramate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kainate receptor", "object_type": "GENE"}]}
{"text": "In four (10 %) patients the peak ACTH-stimulated cortisol values were lower than 18 μg/dL.", "spo_list": [{"subject": "cortisol", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ACTH", "object_type": "GENE"}]}
{"text": "ACTH-stimulated peak cortisol, delta cortisol, and delta DHEA-S levels are decreased during hyperthyroidism, probably due to increased turnover.", "spo_list": [{"subject": "cortisol", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ACTH", "object_type": "GENE"}, {"subject": "delta cortisol", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ACTH", "object_type": "GENE"}, {"subject": "delta DHEA", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ACTH", "object_type": "GENE"}]}
{"text": "OBJECTIVES: The alkaloid galantamine (GAL), which exhibits a combined anticholinesterase and direct parasympathomimetic mechanism of action, is employed in conjunction with therapeutic interventions in the stimulation of central cholinergic transfer in cognitive diseases.", "spo_list": [{"subject": "galantamine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "anticholinesterase", "object_type": "GENE"}, {"subject": "GAL", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "anticholinesterase", "object_type": "GENE"}]}
{"text": "RESULTS: Following administration of the highest of the GAL doses used (2.5; 5; 10 mg/kg i.m.), AChE activity decreased mainly in the frontal cortex, hippocampus and hypophysis.", "spo_list": [{"subject": "GAL", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}]}
{"text": "In the interaction of GAL and CAR, AChE inhibition was stronger but without any statistical significance.", "spo_list": [{"subject": "GAL", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}]}
{"text": "A novel membrane sensor for histamine H1-receptor antagonist \"fexofenadine\".", "spo_list": [{"subject": "fexofenadine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "histamine H1-receptor", "object_type": "GENE"}]}
{"text": "Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells.", "spo_list": [{"subject": "17864", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "multikinase", "object_type": "GENE"}]}
{"text": "Glutaraldehyde crosslinked albumin nanoparticles with a size of approximately 100nm were loaded with the multikinase inhibitor 17864-L(x)-a platinum-bound sunitinib analogue-which couples the drug to methionine residues of albumin and is released in a reductive environment.", "spo_list": [{"subject": "Glutaraldehyde", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "albumin", "object_type": "GENE"}, {"subject": "methionine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "albumin", "object_type": "GENE"}, {"subject": "17864", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "multikinase", "object_type": "GENE"}]}
{"text": "Albumin nanoparticles were surface-coated with bifunctional polyethylene glycol 3500 (PEG) and a nanobody-the single variable domain of an antibody-(Ega1) against the epidermal growth factor receptor (EGFR).", "spo_list": [{"subject": "polyethylene glycol", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Albumin", "object_type": "GENE"}, {"subject": "PEG", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Albumin", "object_type": "GENE"}]}
{"text": "The nucleotide sequence of HmTx contains 649 bp, and the mature protein is predicted to have 131 amino acid residues-104 of which make up the large subunit, and 27 of which make up the small subunit.", "spo_list": [{"subject": "nucleotide", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HmTx", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HmTx", "object_type": "GENE"}]}
{"text": "The 3D-structure of HmTx consists of three conserved alpha-helices: h1 (Lys24-His34), h2 (Cys59-Asp71), and h3 (Ala80-Phe89).", "spo_list": [{"subject": "Lys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HmTx", "object_type": "GENE"}, {"subject": "His", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HmTx", "object_type": "GENE"}, {"subject": "Cys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HmTx", "object_type": "GENE"}, {"subject": "Asp", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HmTx", "object_type": "GENE"}, {"subject": "Ala", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HmTx", "object_type": "GENE"}, {"subject": "Phe", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HmTx", "object_type": "GENE"}]}
{"text": "Irbesartan is a long-acting angiotensin II antagonist acting specifically at the level of the Type 1-receptor subtype (AT1-receptor).", "spo_list": [{"subject": "Irbesartan", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "angiotensin II", "object_type": "GENE"}]}
{"text": "Irbesartan may have antiatherosclerotic properties beyond those expected from blood pressure lowering per se: this AT1-blocker decreases the vascular oxidative stress and prevents the procoagulant as well as the pro-inflammatory effects of angiotensin II.", "spo_list": [{"subject": "Irbesartan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AT1", "object_type": "GENE"}]}
{"text": "The functional protein contains 1160 amino acids with a large central mucin domain, three consensus sites for glycosaminoglycan attachment, two epidermal growth factor-like repeats, a putative hyaluronan-binding motif, and a potential transmembrane domain near the C-terminal.", "spo_list": [{"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "mucin domain", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "hyaluronan-binding motif", "object_type": "GENE"}, {"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "mucin domain", "object_type": "GENE"}, {"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "hyaluronan-binding motif", "object_type": "GENE"}]}
{"text": "Removal of N- and O-linked oligosaccharides reduces the M(r) to approximately 160,000, suggesting that approximately 60% of the mass of SPACRCAN is carbohydrate.", "spo_list": [{"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "SPACRCAN", "object_type": "GENE"}, {"subject": "O", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "SPACRCAN", "object_type": "GENE"}]}
{"text": "Anti-diabetic Activity of Swertiamarin is due to an Active Metabolite, Gentianine, that Upregulates PPAR-γ Gene Expression in 3T3-L1 cells.", "spo_list": [{"subject": "Gentianine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PPAR-γ", "object_type": "GENE"}]}
{"text": "Swertiamarin treatment had no significant effect on adipogenesis, or the mRNA expression of PPAR-γ and GLUT-4; however, there was a significant increase in the mRNA expression of adiponectin.", "spo_list": [{"subject": "Swertiamarin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "adiponectin", "object_type": "GENE"}]}
{"text": "On the other hand, treatment with gentianine significantly increased adipogenesis, which was associated with a significant increase in the mRNA expression of PPAR-γ, GLUT-4 and adiponectin.", "spo_list": [{"subject": "gentianine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PPAR-γ", "object_type": "GENE"}, {"subject": "gentianine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "GLUT-4", "object_type": "GENE"}, {"subject": "gentianine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "adiponectin", "object_type": "GENE"}]}
{"text": "As predicted, TES enhanced the production of both peroxynitrite precursors (i.e., superoxide and nitic oxide), and xanthine oxidase was identified as the likely source of TES-stimulated superoxide production.", "spo_list": [{"subject": "TES", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "xanthine oxidase", "object_type": "GENE"}, {"subject": "superoxide", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "xanthine oxidase", "object_type": "GENE"}]}
{"text": "Functional and biochemical studies indicated that TES signaling involved activity of the phosphoinositide 3 (PI3) kinase-protein kinase B (Akt) cascade initiated by activation of the androgen receptor and culminated in enhanced production of cGMP and microvascular vasodilation.", "spo_list": [{"subject": "TES", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "androgen receptor", "object_type": "GENE"}]}
{"text": "These findings, derived from a variety of analytical and functional approaches, provide evidence for a novel nongenomic signaling mechanism for androgen action in the microvasculature: TES-stimulated vasodilation mediated primarily by peroxynitrite formed from xanthine oxidase-generated superoxide and NO. This response was associated with activation of the PI3 kinase-Akt signaling cascade initiated by activation of the androgen receptor.", "spo_list": [{"subject": "peroxynitrite", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "xanthine oxidase", "object_type": "GENE"}, {"subject": "superoxide", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "xanthine oxidase", "object_type": "GENE"}, {"subject": "NO", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "xanthine oxidase", "object_type": "GENE"}]}
{"text": "The affinities of dfbp and dfbp-o for the regulatory domain of cTnC were measured in the absence and presence of cTnI by NMR spectroscopy, and dfbp-o was found to bind more strongly than dfbp.", "spo_list": [{"subject": "dfbp", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cTnC", "object_type": "GENE"}, {"subject": "dfbp-o", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cTnC", "object_type": "GENE"}, {"subject": "dfbp-o", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cTnC", "object_type": "GENE"}, {"subject": "dfbp", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cTnC", "object_type": "GENE"}]}
{"text": "Dfbp-o also increased the affinity of cTnI for cTnC.", "spo_list": [{"subject": "Dfbp-o", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cTnI", "object_type": "GENE"}, {"subject": "Dfbp-o", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cTnC", "object_type": "GENE"}]}
{"text": "The high resolution NMR solution structure of the cTnC-cTnI-dfbp-o ternary complex showed that dfbp-o bound at the hydrophobic interface formed by cTnC and cTnI making critical interactions with residues such as Arg147 of cTnI.", "spo_list": [{"subject": "dfbp-o", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cTnI", "object_type": "GENE"}, {"subject": "dfbp-o", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cTnC", "object_type": "GENE"}, {"subject": "dfbp-o", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cTnC", "object_type": "GENE"}, {"subject": "dfbp-o", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cTnI", "object_type": "GENE"}, {"subject": "dfbp-o", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cTnI", "object_type": "GENE"}]}
{"text": "In the absence of cTnI, docking localized dfbp-o to the same position in the hydrophobic groove of cTnC.", "spo_list": [{"subject": "dfbp-o", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cTnC", "object_type": "GENE"}]}
{"text": "The structural and functional data reveal that the levosimendan class of Ca(2+)-sensitizers work by binding to the regulatory domain of cTnC and stabilizing the pivotal cTnC-cTnI regulatory unit via a network of hydrophobic and electrostatic interactions, in contrast to the destabilizing effects of antagonists such as W7 at the same interface.", "spo_list": [{"subject": "levosimendan", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cTnC", "object_type": "GENE"}]}
{"text": "Sorafenib and sunitinib are synthetic, orally active agents shown to directly inhibit vascular endothelial growth factor receptors -2 and -3 (VEGFR-2, VEGFR-3) and platelet-derived growth factor receptor beta (PDGFR-beta), while temsirolimus is an mTOR inhibitor.", "spo_list": [{"subject": "Sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGFR-2", "object_type": "GENE"}, {"subject": "sunitinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGFR-2", "object_type": "GENE"}, {"subject": "Sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGFR-3", "object_type": "GENE"}, {"subject": "sunitinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGFR-3", "object_type": "GENE"}, {"subject": "Sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "platelet-derived growth factor receptor beta", "object_type": "GENE"}, {"subject": "sunitinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "platelet-derived growth factor receptor beta", "object_type": "GENE"}, {"subject": "Sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFR-beta", "object_type": "GENE"}, {"subject": "sunitinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFR-beta", "object_type": "GENE"}, {"subject": "temsirolimus", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mTOR", "object_type": "GENE"}]}
{"text": "The turnover of SERT was determined from the rate of recovery of binding after administration of RTI-76, an irreversible inhibitor of ligand binding.", "spo_list": [{"subject": "RTI-76", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "SERT", "object_type": "GENE"}]}
{"text": "In preliminary studies, in vitro incubation of rat cerebral cortex with RTI-76 produced a wash and temperature resistant inhibition of SERT binding densities (Bmax).", "spo_list": [{"subject": "RTI-76", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "SERT", "object_type": "GENE"}]}
{"text": "Citalopram protected against the RTI-76-induced inhibition of SERT binding.", "spo_list": [{"subject": "RTI-76", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "SERT", "object_type": "GENE"}, {"subject": "Citalopram", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SERT", "object_type": "GENE"}]}
{"text": "Following 6 h of in vivo intracerebroventricular injections of 100 nmol of RTI-76, there was a dose- and time-dependent reduction (- 60%) of SERT binding in hippocampus and striatum, without a change in the Kd.", "spo_list": [{"subject": "RTI-76", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SERT", "object_type": "GENE"}]}
{"text": "The decrease and recovery of [3H]-5-HT uptake correlated highly (r = 0.93) with the recovery of SERT binding.", "spo_list": [{"subject": "[3H]-5-HT", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SERT", "object_type": "GENE"}]}
{"text": "Using [(3)H]glucosamine-labeled gastric mucosal cells, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on mucin secretion was inhibited by EGFR kinase inhibitor, PD153035, as well as wortmannin, a specific inhibitor of PI3K.", "spo_list": [{"subject": "PD153035", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EGFR", "object_type": "GENE"}, {"subject": "PD153035", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "wortmannin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PI3K", "object_type": "GENE"}, {"subject": "PD153035", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "mucin", "object_type": "GENE"}, {"subject": "wortmannin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "mucin", "object_type": "GENE"}]}
{"text": "Both inhibitors, moreover, blunted the mucin secretory responses to beta-adrenergic agonist-generated second messenger, cAMP as well as adenylate cyclase activator, forskolin.", "spo_list": [{"subject": "forskolin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "adenylate cyclase", "object_type": "GENE"}, {"subject": "cAMP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "adenylate cyclase", "object_type": "GENE"}, {"subject": "forskolin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "mucin", "object_type": "GENE"}]}
{"text": "The gastric mucin secretory responses to isoproterenol, furthermore, were inhibited by PP2, a selective inhibitor of tyrosine kinase Src responsible for ligand-independent EGFR autophosphorylation, but not by ERK inhibitor, PD98059.", "spo_list": [{"subject": "PP2", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "gastric mucin", "object_type": "GENE"}, {"subject": "PP2", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase", "object_type": "GENE"}, {"subject": "PP2", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Src", "object_type": "GENE"}, {"subject": "PP2", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "EGFR", "object_type": "GENE"}, {"subject": "PD98059", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ERK", "object_type": "GENE"}]}
{"text": "The inhibition of ERK, moreover, did not cause attenuation in mucin secretion in response to cAMP and forskolin.", "spo_list": [{"subject": "cAMP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ERK", "object_type": "GENE"}, {"subject": "forskolin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ERK", "object_type": "GENE"}]}
{"text": "Cotreatments of 5, 10 and 20 µg/mL concentrations of MEP with aflatoxin B(1) decreased the frequencies of SCE and the malondialdehyde level and increased amount of superoxide dismutase, glutathione and glutathione peroxidase which were decreased by aflatoxin.", "spo_list": [{"subject": "aflatoxin B(1)", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "superoxide dismutase", "object_type": "GENE"}, {"subject": "aflatoxin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "glutathione peroxidase", "object_type": "GENE"}]}
{"text": "Statins are inhibitors of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-limiting step in cholesterol biosynthesis.", "spo_list": [{"subject": "cholesterol", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "3-hydroxy-3-methylglutaryl coenzyme A reductase", "object_type": "GENE"}]}
{"text": "We found that atorvastatin withdrawal decreased levels of nitric oxide and mitochondrial superoxide dismutase activity, whereas increased NADPH oxidase activity and immunoreactivity for the protein nitration marker 3-nitrotyrosine in the cerebral cortex.", "spo_list": [{"subject": "3-nitrotyrosine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "NADPH oxidase", "object_type": "GENE"}]}
{"text": "The progress of the enzymatic reaction of the hydrolysis of acetylthiocholine at pH 8 in the presence of AChE and the inhibitor studied is determined by measuring at 230 nm the peak area of the reaction product thiocholine (TCh).", "spo_list": [{"subject": "acetylthiocholine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "AChE", "object_type": "GENE"}]}
{"text": "These polyphenols, but not GvEx, showed a certain level of inhibition of human-cDNA-expressed CYPs.", "spo_list": [{"subject": "polyphenols", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYPs", "object_type": "GENE"}]}
{"text": "Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: Structure-activity relationships (SAR) of the C3-phenyl moiety.", "spo_list": [{"subject": "1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HIV capsid", "object_type": "GENE"}, {"subject": "phenyl", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HIV capsid", "object_type": "GENE"}]}
{"text": "Detailed structure-activity relationships of the C3-phenyl moiety that allow for the optimization of antiviral potency of a series of 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione inhibitors of HIV capsid (CA) assembly are described.", "spo_list": [{"subject": "1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HIV capsid", "object_type": "GENE"}, {"subject": "1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}]}
{"text": "Mifepriston'e blocks glucocorticoid receptor activation without modifying cortisol synthesis.", "spo_list": [{"subject": "Mifepriston'e", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "glucocorticoid receptor", "object_type": "GENE"}]}
{"text": "We have examined the effectiveness of two novel Chk1 selective inhibitors, AR323 and AR678, in a panel of melanoma cell lines and normal cell types.", "spo_list": [{"subject": "AR323", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Chk1", "object_type": "GENE"}, {"subject": "AR678", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Chk1", "object_type": "GENE"}]}
{"text": "CONCLUSIONS: Total vitamin B6 is abnormally high in autism, consistent with previous reports of an impaired pyridoxal kinase for the conversion of pyridoxine and pyridoxal to PLP.", "spo_list": [{"subject": "pyridoxine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "pyridoxal kinase", "object_type": "GENE"}, {"subject": "pyridoxal", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "pyridoxal kinase", "object_type": "GENE"}, {"subject": "PLP", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "pyridoxal kinase", "object_type": "GENE"}]}
{"text": "[-]-Huperzine A ([-]-Hup A), is a naturally occurring potent reversible AChE inhibitor that penetrates the blood-brain barrier.", "spo_list": [{"subject": "[-]-Huperzine A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}, {"subject": "[-]-Hup A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}]}
{"text": "The synthetic stereoisomer, [+]-Hup A, is less toxic due to poor AChE inhibition and is suitable for both pre-/post-exposure treatments of nerve agent toxicity.", "spo_list": [{"subject": "[+]-Hup A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}]}
{"text": "Under NaCl and sorbitol stresses, catalase (CAT) activity in wnk8 mutant was 1.92- and 3.7-times of that in Col-0, respectively.", "spo_list": [{"subject": "NaCl", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "catalase", "object_type": "GENE"}, {"subject": "NaCl", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "CAT", "object_type": "GENE"}, {"subject": "sorbitol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "catalase", "object_type": "GENE"}, {"subject": "sorbitol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "CAT", "object_type": "GENE"}]}
{"text": "Preclinical efficacy of emedastine, a potent, selective histamine H1 antagonist for topical ocular use.", "spo_list": [{"subject": "emedastine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "histamine H1", "object_type": "GENE"}]}
{"text": "In arginase, two cysteines at the C terminus of the protein are crucial for its epiarginase function but not for its catalytic activity and trimeric structure.", "spo_list": [{"subject": "cysteines", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "arginase", "object_type": "GENE"}, {"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "arginase", "object_type": "GENE"}]}
{"text": "In OTCase, mutations of putative ornithine binding residues, Asp-182, Asn-184, Asn-185, Cys-289, and Glu-256 greatly reduced the affinity for ornithine and impaired the interaction with arginase.", "spo_list": [{"subject": "ornithine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "OTCase", "object_type": "GENE"}, {"subject": "Asp", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OTCase", "object_type": "GENE"}, {"subject": "Asn", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OTCase", "object_type": "GENE"}, {"subject": "Asn", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OTCase", "object_type": "GENE"}, {"subject": "Cys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OTCase", "object_type": "GENE"}, {"subject": "Glu", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OTCase", "object_type": "GENE"}, {"subject": "ornithine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "OTCase", "object_type": "GENE"}]}
{"text": "The four lysine residues located in the SMG loop, Lys-260, Lys-263, Lys-265, and Lys-268, also play an important role in mediating the sensitivity of OTCase to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.", "spo_list": [{"subject": "Lys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OTCase", "object_type": "GENE"}, {"subject": "Lys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OTCase", "object_type": "GENE"}, {"subject": "Lys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OTCase", "object_type": "GENE"}, {"subject": "Lys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OTCase", "object_type": "GENE"}, {"subject": "lysine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OTCase", "object_type": "GENE"}, {"subject": "ornithine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "OTCase", "object_type": "GENE"}]}
{"text": "Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 2.", "spo_list": [{"subject": "pyripyropene A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "acyl-CoA:cholesterol acyltransferase 2", "object_type": "GENE"}, {"subject": "pyripyropene A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACAT2", "object_type": "GENE"}]}
{"text": "Progestin activation of Src/MAPK occurred outside the nucleus with the B isoform of PR that was distributed between the cytoplasm and nucleus, but not with PR-A that was predominantly nuclear.", "spo_list": [{"subject": "Progestin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Src", "object_type": "GENE"}, {"subject": "Progestin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "MAPK", "object_type": "GENE"}]}
{"text": "Progestin induction of the cyclin D1 gene, which lacks a progesterone response element, was dependent on PR activation of the Src/MAPK pathway, whereas induction of the Sgk (serum and glucocorticoid regulated kinase) gene that contains a functional progesterone response element was unaffected by mutations that interfere with PR activation of Src.", "spo_list": [{"subject": "Progestin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PR", "object_type": "GENE"}, {"subject": "Progestin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "MAPK", "object_type": "GENE"}, {"subject": "Progestin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Src", "object_type": "GENE"}]}
{"text": "These results highlight the importance of PR activation of the Src/MAPK signaling pathway for progesterone-induced transcription of select target genes and cell cycle progression.", "spo_list": [{"subject": "progesterone", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PR", "object_type": "GENE"}, {"subject": "progesterone", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "MAPK", "object_type": "GENE"}, {"subject": "progesterone", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Src", "object_type": "GENE"}]}
{"text": "5-HT3 receptor antagonism with alosetron reduced responses to 5-HT in controls but not during inflammation.", "spo_list": [{"subject": "alosetron", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT3 receptor", "object_type": "GENE"}]}
{"text": "In vitro studies demonstrated that the retinoid X receptor (RXR) retinoid, bexarotene, at biologically relevant concentrations of 10(-6) M to 10(-8) M, upregulated both the p55 and p75 subunits of the IL-2R and enhanced 5- to 10-fold the susceptibility of T-cell leukemia cells to denileukin diftitox.", "spo_list": [{"subject": "bexarotene", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "p55", "object_type": "GENE"}, {"subject": "bexarotene", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "p75", "object_type": "GENE"}]}
{"text": "Our results demonstrate that the combination of denileukin diftitox and bexarotene is well tolerated and that even low doses (150 mg/day) of bexarotene are capable of in vivo upregulation of CD25 expression on circulating leukemia cells.", "spo_list": [{"subject": "bexarotene", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CD25", "object_type": "GENE"}]}
{"text": "Sepracor in the US is developing arformoterol [R,R-formoterol], a single isomer form of the beta(2)-adrenoceptor agonist formoterol [eformoterol].", "spo_list": [{"subject": "formoterol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}, {"subject": "eformoterol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}]}
{"text": "The selective betaAR agonist isoproterenol caused an enhancement of hippocampal CA3 network activity, as measured by an increase in frequency of spontaneous burst discharges recorded in the CA3 region.", "spo_list": [{"subject": "isoproterenol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "betaAR", "object_type": "GENE"}]}
{"text": "The selective beta1AR antagonists atenolol and metoprolol blocked isoproterenol-induced enhancement, with apparent K(b) values of 85 +/- 36 and 3.9 +/- 1.7 nM, respectively.", "spo_list": [{"subject": "atenolol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "beta1AR", "object_type": "GENE"}, {"subject": "metoprolol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "beta1AR", "object_type": "GENE"}, {"subject": "isoproterenol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta1AR", "object_type": "GENE"}]}
{"text": "In contrast, the selective beta2AR antagonists ICI-118,551 and butoxamine inhibited isoproterenol-mediated enhancement with apparent low affinities (K(b) of 222 +/- 61 and 9268 +/- 512 nM, respectively).", "spo_list": [{"subject": "ICI-118,551", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "beta2AR", "object_type": "GENE"}, {"subject": "butoxamine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "beta2AR", "object_type": "GENE"}, {"subject": "isoproterenol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta2AR", "object_type": "GENE"}]}
{"text": "Together, this pharmacological profile of subtype-selective betaAR antagonists indicates that in this model, beta1AR activation is responsible for the enhanced hippocampal CA3 network activity initiated by isoproterenol.", "spo_list": [{"subject": "isoproterenol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta1AR", "object_type": "GENE"}]}
{"text": "The keto and phenolic -OH are major factors that are prominently involved in interaction with COX-2 active site.", "spo_list": [{"subject": "keto", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "phenolic", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "OH", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Oral lorcaserin (BELVIQ(®)), a selective serotonin 5-HT2C receptor agonist, is indicated in the US as an adjunct to diet and exercise in the chronic weight management of obese adults, or overweight adults with at least one weight-related comorbidity (e.g. dyslipidaemia, hypertension, type 2 diabetes).", "spo_list": [{"subject": "lorcaserin", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT2C", "object_type": "GENE"}, {"subject": "BELVIQ", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT2C", "object_type": "GENE"}]}
{"text": "Cloning, Characterization, and Sulfonamide and Thiol Inhibition Studies of an α-Carbonic Anhydrase from Trypanosoma cruzi, the Causative Agent of Chagas Disease.", "spo_list": [{"subject": "Sulfonamide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "α-Carbonic Anhydrase", "object_type": "GENE"}, {"subject": "Thiol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "α-Carbonic Anhydrase", "object_type": "GENE"}]}
{"text": "The enzyme (TcCA) has a very high catalytic activity for the CO(2) hydration reaction, being similar kinetically to the human (h) isoform hCA II, although it is devoid of the His64 proton shuttle.", "spo_list": [{"subject": "CO(2)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "TcCA", "object_type": "GENE"}, {"subject": "CO(2)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "hCA II", "object_type": "GENE"}, {"subject": "His", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "hCA II", "object_type": "GENE"}]}
{"text": "A large number of aromatic/heterocyclic sulfonamides and some 5-mercapto-1,3,4-thiadiazoles were investigated as TcCA inhibitors.", "spo_list": [{"subject": "aromatic/heterocyclic sulfonamides", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TcCA", "object_type": "GENE"}, {"subject": "5-mercapto-1,3,4-thiadiazoles", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TcCA", "object_type": "GENE"}]}
{"text": "Effect of fenoterol-induced constitutive beta(2)-adrenoceptor activity on contractile receptor function in airway smooth muscle.", "spo_list": [{"subject": "fenoterol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}]}
{"text": "In the present study, we investigated the effect of fenoterol-induced constitutive beta(2)-adrenoceptor activity on muscarinic receptor agonist- and histamine-induced bovine tracheal smooth muscle contractions.", "spo_list": [{"subject": "fenoterol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}]}
{"text": "Bovine tracheal smooth muscle strips were incubated with 10 microM fenoterol or vehicle for various periods of time (5, 30 min, 18 h) at 37 degrees C. After extensive washout (3 h, 37 degrees C), isometric contractions were measured to the full muscarinic receptor agonist methacholine, the partial muscarinic receptor agonist 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium (McN-A-343) and histamine.", "spo_list": [{"subject": "methacholine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "muscarinic receptor", "object_type": "GENE"}, {"subject": "4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "muscarinic receptor", "object_type": "GENE"}, {"subject": "histamine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "muscarinic receptor", "object_type": "GENE"}]}
{"text": "In conclusion, fenoterol-induced constitutive beta(2)-adrenoceptor activity reduces muscarinic receptor agonist- and histamine-induced contractions of bovine tracheal smooth muscle, which can be reversed by the inverse agonist timolol.", "spo_list": [{"subject": "fenoterol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}, {"subject": "timolol", "subject_type": "CHEMICAL", "predicate": "AGONIST-INHIBITOR", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}]}
{"text": "Intestinal and hepatic first-pass extraction of the 11β-HSD1 inhibitor AMG 221 in rats with chronic vascular catheters.", "spo_list": [{"subject": "AMG 221", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "11β-HSD1", "object_type": "GENE"}]}
{"text": "A catheterized rat model was used to define the intestinal and hepatic components of oral bioavailability for an 11β-HSD1 inhibitor, AMG 221.", "spo_list": [{"subject": "AMG 221", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "11β-HSD1", "object_type": "GENE"}]}
{"text": "In the present study we tested whether propranolol, a β-receptor antagonist commonly used as antihypertensive drug, could ameliorate the cognitive impairments and increases in AD-related markers shown by the senescence-accelerated mouse prone-8 (SAMP8).", "spo_list": [{"subject": "propranolol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "β-receptor", "object_type": "GENE"}]}
{"text": "Cat-1, the transporter for the essential amino acids, arginine and lysine, is one of the up-regulated genes.", "spo_list": [{"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Cat-1", "object_type": "GENE"}, {"subject": "arginine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Cat-1", "object_type": "GENE"}, {"subject": "lysine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Cat-1", "object_type": "GENE"}]}
{"text": "We begin by capturing RISC using a complementary 2'-O-methyl oligonucleotide tethered to beads.", "spo_list": [{"subject": "2'-O-methyl", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "RISC", "object_type": "GENE"}]}
{"text": "All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as cyclooxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2) inhibitory activity of murine macrophage RAW 264.7 cell line.", "spo_list": [{"subject": "prostaglandin E2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "prostaglandin E2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-2", "object_type": "GENE"}, {"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-2", "object_type": "GENE"}]}
{"text": "For example, clozapine revealed a radioligand-independent value of 1.6 nM at the dopamine D4 receptor, agreeing with the value directly measured with [3H]-clozapine at D4.", "spo_list": [{"subject": "clozapine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D4 receptor", "object_type": "GENE"}, {"subject": "[3H]-clozapine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D4", "object_type": "GENE"}]}
{"text": "However, because clozapine competes with endogenous dopamine, the in vivo concentration of clozapine (to occupy dopamine D4 receptors) can be derived to be about 13 nM, agreeing with the value of 12 to 20 nM in the plasma water or spinal fluid observed in treated patients.", "spo_list": [{"subject": "clozapine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D4 receptors", "object_type": "GENE"}, {"subject": "dopamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D4 receptors", "object_type": "GENE"}, {"subject": "clozapine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D4 receptors", "object_type": "GENE"}]}
{"text": "The atypical neuroleptics remoxipride, clozapine, perlapine, seroquel, and melperone had low affinity for the dopamine D2 receptor (radioligand-independent dissociation constants of 30 to 90 nM).", "spo_list": [{"subject": "remoxipride", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D2 receptor", "object_type": "GENE"}, {"subject": "clozapine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D2 receptor", "object_type": "GENE"}, {"subject": "perlapine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D2 receptor", "object_type": "GENE"}, {"subject": "seroquel", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D2 receptor", "object_type": "GENE"}, {"subject": "melperone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D2 receptor", "object_type": "GENE"}]}
{"text": "Most typical neuroleptics have radioligand-independent values of 0.3 to 5 nM at dopamine D2 receptors, making them more resistant to displacement by endogenous dopamine.", "spo_list": [{"subject": "dopamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D2 receptors", "object_type": "GENE"}]}
{"text": "Flutamide, an effective competitive inhibitor of the androgen receptor used orally for palliative treatment of prostatic carcinoma and regulation of prostatic hyperplasia was evaluated for its genotoxic effects in the intact rat and in primary cultures of human hepatocytes.", "spo_list": [{"subject": "Flutamide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "androgen receptor", "object_type": "GENE"}]}
{"text": "In the liver of rats given flutamide as initiating agent at the dose of 500 mg/kg/week for 6 successive weeks, gamma-glutamyltraspeptidase-positive foci were detected only in 3 of 10 rats.", "spo_list": [{"subject": "flutamide", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "gamma-glutamyltraspeptidase", "object_type": "GENE"}]}
{"text": "This 40 kDa PEG-conjugated IFNalpha(2a) ((40)PEG-IFNalpha(2a)) is obtained by the covalent binding of one 40 kDa branched PEG-polymer to a lysine side-chain of IFNalpha(2a).", "spo_list": [{"subject": "PEG", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "IFNalpha(2a)", "object_type": "GENE"}, {"subject": "lysine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "IFNalpha(2a)", "object_type": "GENE"}]}
{"text": "Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. beta(2)-Adrenoceptor agonists provide a potential therapy for muscle wasting and weakness, but their use may be limited by adverse effects on the heart, mediated in part, by beta(1)-adrenoceptor activation.", "spo_list": [{"subject": "formoterol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta2-adrenoceptor", "object_type": "GENE"}, {"subject": "salmeterol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta2-adrenoceptor", "object_type": "GENE"}]}
{"text": "Two beta(2)-agonists, formoterol and salmeterol, are approved for treating asthma and have an extended duration of action and increased safety, associated with greater beta(2)-adrenoceptor selectivity.", "spo_list": [{"subject": "formoterol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}, {"subject": "salmeterol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}]}
{"text": "The CYP3A4 activity could be induced 2-fold by rifampicin, whereas CYP2C9 activity remained equally high.", "spo_list": [{"subject": "rifampicin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "CYP3A4", "object_type": "GENE"}, {"subject": "rifampicin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "CYP2C9", "object_type": "GENE"}]}
{"text": "Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites.", "spo_list": [{"subject": "phenothiazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptor", "object_type": "GENE"}]}
{"text": "In vitro binding affinities of chlorpromazine, fluphenazine, levomepromazine, perphenazine and some of their metabolites for dopamine D2 receptors, alpha 1- and alpha 2 adrenoceptors in rat brain were previously reported from our laboratories.", "spo_list": [{"subject": "chlorpromazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D2 receptors", "object_type": "GENE"}, {"subject": "fluphenazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D2 receptors", "object_type": "GENE"}, {"subject": "levomepromazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D2 receptors", "object_type": "GENE"}, {"subject": "perphenazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D2 receptors", "object_type": "GENE"}]}
{"text": "The present study reports the in vitro binding affinities of the same compounds for muscarinic cholinergic receptors and for histamine H1 receptors in rat brain, using 3H-quinuclidinyl benzilate and 3H-mepyramine as radioligands.", "spo_list": [{"subject": "3H-quinuclidinyl benzilate", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "muscarinic cholinergic receptors", "object_type": "GENE"}, {"subject": "3H-mepyramine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "muscarinic cholinergic receptors", "object_type": "GENE"}, {"subject": "3H-quinuclidinyl benzilate", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptors", "object_type": "GENE"}, {"subject": "3H-mepyramine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptors", "object_type": "GENE"}]}
{"text": "Chlorpromazine, levomepromazine, and their metabolites had 5-30 times higher binding affinities for muscarinic cholinergic receptors than fluphenazine, perphenazine and their metabolites.", "spo_list": [{"subject": "Chlorpromazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "muscarinic cholinergic receptors", "object_type": "GENE"}, {"subject": "levomepromazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "muscarinic cholinergic receptors", "object_type": "GENE"}, {"subject": "fluphenazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "muscarinic cholinergic receptors", "object_type": "GENE"}, {"subject": "perphenazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "muscarinic cholinergic receptors", "object_type": "GENE"}]}
{"text": "Levomepromazine was the most potent and fluphenazine the least potent of the four drugs in histamine H1 receptor binding.", "spo_list": [{"subject": "Levomepromazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptor", "object_type": "GENE"}, {"subject": "fluphenazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptor", "object_type": "GENE"}]}
{"text": "7-Hydroxy levomepromazine, 3-hydroxy levomepromazine and 7-hydroxy fluphenazine had only 10% of the potency of the parent drug in histamine H1 receptor binding, while the 7-hydroxy-metabolites of chlorpromazine and perphenazine had about 75% of the potency of the parent drug in this binding system.", "spo_list": [{"subject": "7-Hydroxy levomepromazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptor", "object_type": "GENE"}, {"subject": "3-hydroxy levomepromazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptor", "object_type": "GENE"}, {"subject": "7-hydroxy fluphenazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptor", "object_type": "GENE"}, {"subject": "7-hydroxy", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptor", "object_type": "GENE"}, {"subject": "chlorpromazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptor", "object_type": "GENE"}, {"subject": "perphenazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptor", "object_type": "GENE"}]}
{"text": "Their histamine H1 receptor binding affinities indicate that metabolites may contribute to the sedative effects of chlorpromazine and levomepromazine.", "spo_list": [{"subject": "chlorpromazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptor", "object_type": "GENE"}, {"subject": "levomepromazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptor", "object_type": "GENE"}]}
{"text": "Auranofin, an antirheumatic gold compound, is an inhibitor of selenocysteine enzymes, such as thioredoxin reductase and glutathione peroxidase.", "spo_list": [{"subject": "Auranofin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "selenocysteine enzymes", "object_type": "GENE"}, {"subject": "Auranofin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "thioredoxin reductase", "object_type": "GENE"}, {"subject": "Auranofin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "glutathione peroxidase", "object_type": "GENE"}]}
{"text": "There was significantly less thioredoxin reductase activity in rat liver extracts, whereas the level of glutathione activity remained unchanged, demonstrating that the dose of auranofin used was able to selectively inhibit one of these enzyme systems.", "spo_list": [{"subject": "auranofin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "thioredoxin reductase", "object_type": "GENE"}]}
{"text": "Synthesis of a DOTA (Gd(3+))-conjugate of proton-pump inhibitor pantoprazole for gastric wall imaging studies.", "spo_list": [{"subject": "pantoprazole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "proton-pump", "object_type": "GENE"}, {"subject": "DOTA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "proton-pump", "object_type": "GENE"}, {"subject": "Gd(3+)", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "proton-pump", "object_type": "GENE"}]}
{"text": "To overcome this limitation, we de novo synthesized a conjugate that covalently combines a Gd-based MRI contrast agent, encaged with a chelating agent (DOTA), with pantoprazole, which is a widely used proton pump inhibitor that binds to proton pumps in the stomach and colon.", "spo_list": [{"subject": "Gd", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "proton pump", "object_type": "GENE"}, {"subject": "DOTA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "proton pump", "object_type": "GENE"}, {"subject": "pantoprazole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "proton pump", "object_type": "GENE"}, {"subject": "Gd", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "proton pumps", "object_type": "GENE"}, {"subject": "DOTA", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "proton pumps", "object_type": "GENE"}, {"subject": "pantoprazole", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "proton pumps", "object_type": "GENE"}]}
{"text": "Tacrine, the first of the cholinesterase inhibitors to undergo extensive trials for this purpose, was associated with significant adverse effects including hepatotoxicity.", "spo_list": [{"subject": "Tacrine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cholinesterase", "object_type": "GENE"}]}
{"text": "Other cholinesterase inhibitors, including rivastigmine, with superior properties in terms of specificity of action and low risk of adverse effects, have now been introduced.", "spo_list": [{"subject": "rivastigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cholinesterase", "object_type": "GENE"}]}
{"text": "Diacylglycerol kinase (DGK) catalyzes the conversion of diacylglycerol to phosphatidic acid, making it an attractive candidate for a signal transduction component.", "spo_list": [{"subject": "diacylglycerol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Diacylglycerol kinase", "object_type": "GENE"}, {"subject": "diacylglycerol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DGK", "object_type": "GENE"}, {"subject": "phosphatidic acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Diacylglycerol kinase", "object_type": "GENE"}, {"subject": "phosphatidic acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "DGK", "object_type": "GENE"}]}
{"text": "We took advantage of the previous observations that phosphatidylserine inhibits DGK-delta (reviewed by Sakane, F., Imai, S., Kai, M., Wada, I., and Kanoh, H.", "spo_list": [{"subject": "phosphatidylserine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DGK-delta", "object_type": "GENE"}]}
{"text": "(+/-)-tamsulosin, an alpha 1A-adrenoceptor antagonist, inhibits the positive inotropic effect but not the accumulation of inositol phosphates in rabbit heart.", "spo_list": [{"subject": "(+/-)-tamsulosin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1A-adrenoceptor", "object_type": "GENE"}]}
{"text": "The influence of (+/-)-tamsulosin, a selective alpha 1A-adrenoceptor antagonist, on the positive inotropic effect and the accumulation of inositol phosphates that are induced via alpha 1-adrenoceptors was studied in comparison with that of another alpha 1A-adrenoceptor ligand oxymetazoline in the rabbit ventricular myocardium.", "spo_list": [{"subject": "(+/-)-tamsulosin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1A-adrenoceptor", "object_type": "GENE"}, {"subject": "oxymetazoline", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha 1A-adrenoceptor", "object_type": "GENE"}]}
{"text": "Phenylephrine elicited a concentration-dependent positive inotropic effect via alpha 1-adrenoceptors in the presence of either (+/-)-bupranolol or S(-)-timolol.", "spo_list": [{"subject": "Phenylephrine", "subject_type": "CHEMICAL", "predicate": "AGONIST-ACTIVATOR", "object": "alpha 1-adrenoceptors", "object_type": "GENE"}]}
{"text": "(+/-)-Tamsulosin effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of alpha 1B-adrenoceptors by treatment with chlorethylclonidine, which is an indication that the (+/-)-tamsulosin-sensitive subtype belongs to a class resistant to chlorethylclonidine.", "spo_list": [{"subject": "chlorethylclonidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "alpha 1B-adrenoceptors", "object_type": "GENE"}, {"subject": "phenylephrine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha 1B-adrenoceptors", "object_type": "GENE"}, {"subject": "(+/-)-Tamsulosin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1B-adrenoceptors", "object_type": "GENE"}]}
{"text": "(+/-)-Tamsulosin, over the range of concentrations at which it antagonized the positive inotropic effect mediated by alpha 1-adrenoceptors, did not affect the accumulation of [3H]inositol phosphates that was induced by 10 microM phenylephrine.", "spo_list": [{"subject": "(+/-)-Tamsulosin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1-adrenoceptors", "object_type": "GENE"}]}
{"text": "These results indicate that the positive inotropic effect, mediated via (+/-)-tamsulosin- and oxymetazoline-sensitive subtype of alpha 1-adrenoceptors, is exerted by a subcellular mechanism that is independent of the accumulation of inositol phosphates.", "spo_list": [{"subject": "oxymetazoline", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha 1-adrenoceptors", "object_type": "GENE"}, {"subject": "(+/-)-tamsulosin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1-adrenoceptors", "object_type": "GENE"}]}
{"text": "Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation.", "spo_list": [{"subject": "clenbuterol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "beta 2-adrenoceptor", "object_type": "GENE"}]}
{"text": "The potent anabolic effects of the beta 2-adrenoceptor agonist clenbuterol on skeletal muscle have been reported to be independent of actions on beta-adrenoceptors.", "spo_list": [{"subject": "clenbuterol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta 2-adrenoceptor", "object_type": "GENE"}]}
{"text": "These effects were not mimicked by oral administration of the beta 2-adrenoceptor agonist salbutamol even at high dose (52 mg/kg diet), and the effects of clenbuterol were not inhibited by addition of DL-propranolol (200 mg/kg diet).", "spo_list": [{"subject": "salbutamol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta 2-adrenoceptor", "object_type": "GENE"}, {"subject": "clenbuterol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "beta 2-adrenoceptor", "object_type": "GENE"}]}
{"text": "Although glutathione S-transferase omega 1 (GSTO1) and arsenic methyltransferase have been shown or thought to catalyze DMAs(V) reduction, their role in DMAs(V) reduction in vivo, or in cell extracts is uncertain.", "spo_list": [{"subject": "DMAs(V)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "arsenic methyltransferase", "object_type": "GENE"}, {"subject": "DMAs(V)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "glutathione S-transferase omega 1", "object_type": "GENE"}]}
{"text": "Pretreatment of rats with glutathione (GSH) depletors (phorone or BSO) delayed the elimination of DMAs(V) and the accumulation of RBC-bound DMAs, whereas the indirect methyltransferase inhibitor periodate-oxidized adenosine was without effect.", "spo_list": [{"subject": "adenosine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "methyltransferase", "object_type": "GENE"}]}
{"text": "Although thioredoxin reductase (TRR) inhibitors (aurothioglucose and Sb(III)) inhibited cytosolic DMAs(V) reduction, recombinant rat TRR plus NADPH, alone or when added to the cytosol, failed to support DMAs(V) reduction.", "spo_list": [{"subject": "aurothioglucose", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TRR", "object_type": "GENE"}, {"subject": "aurothioglucose", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "thioredoxin reductase", "object_type": "GENE"}, {"subject": "Sb(III)", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TRR", "object_type": "GENE"}, {"subject": "Sb(III)", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "thioredoxin reductase", "object_type": "GENE"}]}
{"text": "In the in vitro model we observed high permeability of imperatorin and isoimperatorin with the P-gp-mediated efflux ratios of 0.53 and 0.06, as well as medium permeability of cnidilin with 0.82.", "spo_list": [{"subject": "imperatorin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P-gp", "object_type": "GENE"}, {"subject": "isoimperatorin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P-gp", "object_type": "GENE"}, {"subject": "cnidilin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P-gp", "object_type": "GENE"}]}
{"text": "This hypothesis was tested by investigating whether, in subjects with essential hypertension, the natriuretic response to specific renin-angiotensin-aldosterone system (RAAS) blockade by renin-inhibitor remikiren could be predicted from pretreatment renal vascular tone.", "spo_list": [{"subject": "remikiren", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "renin", "object_type": "GENE"}, {"subject": "remikiren", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "angiotensin", "object_type": "GENE"}, {"subject": "remikiren", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "renin", "object_type": "GENE"}]}
{"text": "The specific activity of only ornithine aminotransferase (OAT), the rate-limiting enzyme in the conversion of ornithine to proline, increased in 2 weeks of hypertrophy.", "spo_list": [{"subject": "ornithine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ornithine aminotransferase", "object_type": "GENE"}, {"subject": "ornithine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "OAT", "object_type": "GENE"}, {"subject": "proline", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ornithine aminotransferase", "object_type": "GENE"}, {"subject": "proline", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "OAT", "object_type": "GENE"}]}
{"text": "Histamine H(1) blockade is one of the more prominent actions of the multi-receptor acting antipsychotic clozapine.", "spo_list": [{"subject": "clozapine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Histamine H(1)", "object_type": "GENE"}]}
{"text": "It is currently not known how much this H(1) antagonism of clozapine contributes to the therapeutic or adverse side effects of clozapine.", "spo_list": [{"subject": "clozapine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "H(1)", "object_type": "GENE"}]}
{"text": "In the current project, we found that the selective H(1) antagonist pyrilamine also reversed the dizocilpine-induced impairment in PPI of tactile startle with an auditory prepulse.", "spo_list": [{"subject": "pyrilamine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "H(1)", "object_type": "GENE"}]}
{"text": "In summary, the therapeutic effect of clozapine in reversing PPI impairment was mimicked by the H(1) antagonist pyrilamine, while pyrilamine had a mixed effect on cognition.", "spo_list": [{"subject": "pyrilamine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "H(1)", "object_type": "GENE"}, {"subject": "pyrilamine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "H(1)", "object_type": "GENE"}]}
{"text": "Thus, H(1) antagonism seems to play a role in part of the beneficial actions of antipsychotics, such as clozapine.", "spo_list": [{"subject": "clozapine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "H(1)", "object_type": "GENE"}]}
{"text": "A KCC inhibitor-[(dihydroindenyl)oxy] alkanoic acid (DIOA)-blocked RVD more in HCEC than RCEC.", "spo_list": [{"subject": "[(dihydroindenyl)oxy] alkanoic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KCC", "object_type": "GENE"}, {"subject": "DIOA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KCC", "object_type": "GENE"}]}
{"text": "Under isotonic conditions, N-ethylmaleimide (NEM) produced KCC activation and transient cell shrinkage.", "spo_list": [{"subject": "N-ethylmaleimide", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "KCC", "object_type": "GENE"}, {"subject": "NEM", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "KCC", "object_type": "GENE"}]}
{"text": "The lysosomal inhibitor chloroquine significantly increased RCAN1 accumulation in +/+ cells, consistent with the hypothesis that higher lysosomal pH impairs RCAN1 degradation, leading to a higher RCAN1/NFATc1 ratio and consequently NFATc1 inhibition.", "spo_list": [{"subject": "chloroquine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "RCAN1", "object_type": "GENE"}]}
{"text": "Phenytoin is principally metabolized by CYP2C9, and both are probable substrates of the drug transporter P-glycoprotein.", "spo_list": [{"subject": "Phenytoin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2C9", "object_type": "GENE"}, {"subject": "Phenytoin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "drug transporter", "object_type": "GENE"}, {"subject": "Phenytoin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P-glycoprotein", "object_type": "GENE"}]}
{"text": "DHFS is present exclusively in the mitochondria, making this compartment the sole site of synthesis of dihydrofolate in the plant cell.", "spo_list": [{"subject": "dihydrofolate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "DHFS", "object_type": "GENE"}]}
{"text": "High-glucose environment enhanced oxidative stress and increased interleukin-8 secretion from keratinocytes: New insights on impaired diabetic wound healing.", "spo_list": [{"subject": "glucose", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "interleukin-8", "object_type": "GENE"}]}
{"text": "Using cultured human keratinocytes and diabetic rat model, the current study showed that high-glucose environment enhanced IL-8 production via epidermal growth factor receptor (EGFR) -extracelluar signal-regulated kinase (ERK) pathway in a reactive oxygen species (ROS)-dependent manner in keratinocytes.", "spo_list": [{"subject": "glucose", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "IL-8", "object_type": "GENE"}]}
{"text": "In conclusion, IL-8 production and neutrophil infiltration are increased in high-glucose environment due to elevated ROS level and contributed to impaired wound healing in diabetic skin.", "spo_list": [{"subject": "glucose", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "IL-8", "object_type": "GENE"}]}
{"text": "Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.", "spo_list": [{"subject": "flupentixol", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "serotonin (2A) receptors", "object_type": "GENE"}, {"subject": "risperidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "serotonin (2A) receptors", "object_type": "GENE"}, {"subject": "haloperidol", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "serotonin (2A) receptors", "object_type": "GENE"}]}
{"text": "In vitro data show comparable affinity to dopamine D(2), D(1) and 5-HT(2A) receptors and recently, FLX showed to be not inferior to risperidone in schizophrenic patients with predominant negative symptomatology, which was implicated with flupentixol's interaction with 5-HT(2A) and/or D(1) receptors.", "spo_list": [{"subject": "FLX", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D(2)", "object_type": "GENE"}, {"subject": "FLX", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D(1)", "object_type": "GENE"}, {"subject": "FLX", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT(2A) receptors", "object_type": "GENE"}, {"subject": "FLX", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT(2A)", "object_type": "GENE"}, {"subject": "FLX", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D(1) receptors", "object_type": "GENE"}, {"subject": "risperidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D(2)", "object_type": "GENE"}, {"subject": "risperidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D(1)", "object_type": "GENE"}, {"subject": "risperidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT(2A) receptors", "object_type": "GENE"}, {"subject": "risperidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT(2A)", "object_type": "GENE"}, {"subject": "risperidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D(1) receptors", "object_type": "GENE"}]}
{"text": "CONCLUSIONS: We were able to demonstrate a moderate 5-HT(2A) and D(1) occupancy under clinically relevant doses of flupentixol, albeit lower than expected from in vitro data and clearly below saturation.", "spo_list": [{"subject": "flupentixol", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT(2A)", "object_type": "GENE"}, {"subject": "flupentixol", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D(1)", "object_type": "GENE"}]}
{"text": "Desipramine treatment decreases 3H-nisoxetine binding and norepinephrine transporter mRNA in SK-N-SHSY5Y cells.", "spo_list": [{"subject": "Desipramine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "norepinephrine transporter", "object_type": "GENE"}, {"subject": "3H-nisoxetine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "norepinephrine transporter", "object_type": "GENE"}]}
{"text": "The antidepressant desipramine has been shown to decrease synaptic membrane concentrations of the norepinephrine re-uptake transporter (NET) in vivo and in vitro, on both an acute and a chronic basis.", "spo_list": [{"subject": "desipramine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "norepinephrine re-uptake transporter", "object_type": "GENE"}, {"subject": "desipramine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "NET", "object_type": "GENE"}]}
{"text": "We have identified adenosine deaminase, an enzyme involved in purine metabolism whose deficiency is associated with severe combined immunodeficiency, as a Grb3-3 binding protein that is not able to bind to Grb2.", "spo_list": [{"subject": "purine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "adenosine deaminase", "object_type": "GENE"}]}
{"text": "Considerable attention has focused on the antitumor effect of histone deacetylase inhibitor (Trichostatin A, TSA) as well as the coding gene expression-induced apoptosis of cancer cells.", "spo_list": [{"subject": "Trichostatin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "histone deacetylase", "object_type": "GENE"}, {"subject": "TSA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "histone deacetylase", "object_type": "GENE"}]}
{"text": "Among these differentially expressed lncRNAs, the greatest change was noted for uc002mbe.2, which had more than 300 folds induction upon TSA treatment.", "spo_list": [{"subject": "TSA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "uc002mbe.2", "object_type": "GENE"}]}
{"text": "TSA selectively induced uc002mbe.2 in four studied HCC cell lines.", "spo_list": [{"subject": "TSA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "uc002mbe.2", "object_type": "GENE"}]}
{"text": "The TSA-induced uc002mbe.2 expression was positively correlated with the apoptotic effect of TSA in HCC cells.", "spo_list": [{"subject": "TSA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "uc002mbe.2", "object_type": "GENE"}]}
{"text": "Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or c-Kit.", "spo_list": [{"subject": "phenylaminopyrimidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "RTKs", "object_type": "GENE"}, {"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "RTKs", "object_type": "GENE"}, {"subject": "Gleevec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "RTKs", "object_type": "GENE"}, {"subject": "Imatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "RTKs", "object_type": "GENE"}, {"subject": "phenylaminopyrimidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFbeta-receptor", "object_type": "GENE"}, {"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFbeta-receptor", "object_type": "GENE"}, {"subject": "Gleevec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFbeta-receptor", "object_type": "GENE"}, {"subject": "Imatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFbeta-receptor", "object_type": "GENE"}, {"subject": "phenylaminopyrimidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "c-Kit", "object_type": "GENE"}, {"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "c-Kit", "object_type": "GENE"}, {"subject": "Gleevec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "c-Kit", "object_type": "GENE"}, {"subject": "Imatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "c-Kit", "object_type": "GENE"}]}
{"text": "STI571 binding to Flt3 is prevented by the phenylalanine 691 side-chain in the ATP binding center and mutating this site to threonine renders the corresponding Flt3 mutant sensitive to STI571.", "spo_list": [{"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Flt3", "object_type": "GENE"}, {"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Flt3", "object_type": "GENE"}]}
{"text": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.", "spo_list": [{"subject": "quinoxaline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Flt3", "object_type": "GENE"}, {"subject": "AG1296", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Flt3", "object_type": "GENE"}, {"subject": "quinoxaline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "AG1296", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "bis(1H-2-indolyl)-1-methanone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Flt3", "object_type": "GENE"}, {"subject": "bis(1H-2-indolyl)-1-methanone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "D-65476", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Flt3", "object_type": "GENE"}, {"subject": "D-65476", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "indolinones", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Flt3", "object_type": "GENE"}, {"subject": "indolinones", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "SU5416", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Flt3", "object_type": "GENE"}, {"subject": "SU5416", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "SU11248", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Flt3", "object_type": "GENE"}, {"subject": "SU11248", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "indolocarbazoles", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Flt3", "object_type": "GENE"}, {"subject": "indolocarbazoles", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "PKC412", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Flt3", "object_type": "GENE"}, {"subject": "PKC412", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "CEP-701", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Flt3", "object_type": "GENE"}, {"subject": "CEP-701", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "piperazonyl quinazoline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Flt3", "object_type": "GENE"}, {"subject": "piperazonyl quinazoline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "CT53518", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Flt3", "object_type": "GENE"}, {"subject": "CT53518", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}]}
{"text": "The beneficial role of 17beta-estradiol on blood pressure, cardiac hypertrophy, vascular osteopontin expression, perivascular fibrosis, and impaired NO-dependent relaxation of isolated aortic rings was completely abrogated by coadministration of medroxyprogesterone acetate.", "spo_list": [{"subject": "17beta-estradiol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "osteopontin", "object_type": "GENE"}, {"subject": "medroxyprogesterone acetate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "osteopontin", "object_type": "GENE"}]}
{"text": "Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.", "spo_list": [{"subject": "polyphenols", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mammalian isoforms I-XIV", "object_type": "GENE"}, {"subject": "phenolic acids", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mammalian isoforms I-XIV", "object_type": "GENE"}]}
{"text": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).", "spo_list": [{"subject": "phenolic acids", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "metalloenzyme", "object_type": "GENE"}, {"subject": "phenol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "metalloenzyme", "object_type": "GENE"}, {"subject": "p-hydroxybenzoic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "metalloenzyme", "object_type": "GENE"}, {"subject": "p-coumaric acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "metalloenzyme", "object_type": "GENE"}, {"subject": "caffeic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "metalloenzyme", "object_type": "GENE"}, {"subject": "ferulic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "metalloenzyme", "object_type": "GENE"}, {"subject": "gallic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "metalloenzyme", "object_type": "GENE"}, {"subject": "syringic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "metalloenzyme", "object_type": "GENE"}, {"subject": "quercetin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "metalloenzyme", "object_type": "GENE"}, {"subject": "ellagic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "metalloenzyme", "object_type": "GENE"}, {"subject": "phenolic acids", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "carbonic anhydrase", "object_type": "GENE"}, {"subject": "phenolic acids", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}, {"subject": "phenolic acids", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EC 4.2.1.1", "object_type": "GENE"}, {"subject": "phenol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "carbonic anhydrase", "object_type": "GENE"}, {"subject": "phenol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}, {"subject": "phenol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EC 4.2.1.1", "object_type": "GENE"}, {"subject": "p-hydroxybenzoic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "carbonic anhydrase", "object_type": "GENE"}, {"subject": "p-coumaric acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "carbonic anhydrase", "object_type": "GENE"}, {"subject": "caffeic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "carbonic anhydrase", "object_type": "GENE"}, {"subject": "ferulic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "carbonic anhydrase", "object_type": "GENE"}, {"subject": "gallic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "carbonic anhydrase", "object_type": "GENE"}, {"subject": "syringic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "carbonic anhydrase", "object_type": "GENE"}, {"subject": "quercetin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "carbonic anhydrase", "object_type": "GENE"}, {"subject": "ellagic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "carbonic anhydrase", "object_type": "GENE"}, {"subject": "p-hydroxybenzoic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}, {"subject": "p-coumaric acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}, {"subject": "caffeic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}, {"subject": "ferulic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}, {"subject": "gallic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}, {"subject": "syringic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}, {"subject": "quercetin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}, {"subject": "ellagic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}, {"subject": "p-hydroxybenzoic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EC 4.2.1.1", "object_type": "GENE"}, {"subject": "p-coumaric acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EC 4.2.1.1", "object_type": "GENE"}, {"subject": "caffeic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EC 4.2.1.1", "object_type": "GENE"}, {"subject": "ferulic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EC 4.2.1.1", "object_type": "GENE"}, {"subject": "gallic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EC 4.2.1.1", "object_type": "GENE"}, {"subject": "syringic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EC 4.2.1.1", "object_type": "GENE"}, {"subject": "quercetin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EC 4.2.1.1", "object_type": "GENE"}, {"subject": "ellagic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EC 4.2.1.1", "object_type": "GENE"}]}
{"text": "Phenols like the ones investigated here possess a CA inhibition mechanism distinct of that of the sulfonamides/sulfamates used clinically or the coumarins.", "spo_list": [{"subject": "Phenols", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}, {"subject": "sulfonamides", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}, {"subject": "sulfamates", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}, {"subject": "coumarins", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CA", "object_type": "GENE"}]}
{"text": "Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.", "spo_list": [{"subject": "buserelin", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "Luteinizing hormone-releasing hormone", "object_type": "GENE"}, {"subject": "buserelin", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "LHRH", "object_type": "GENE"}, {"subject": "goserelin", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "Luteinizing hormone-releasing hormone", "object_type": "GENE"}, {"subject": "goserelin", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "LHRH", "object_type": "GENE"}, {"subject": "leuprorelin", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "Luteinizing hormone-releasing hormone", "object_type": "GENE"}, {"subject": "leuprorelin", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "LHRH", "object_type": "GENE"}, {"subject": "triptorelin", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "Luteinizing hormone-releasing hormone", "object_type": "GENE"}, {"subject": "triptorelin", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "LHRH", "object_type": "GENE"}, {"subject": "buserelin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "gonadotrophin-releasing hormone (GnRH) receptor", "object_type": "GENE"}, {"subject": "goserelin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "gonadotrophin-releasing hormone (GnRH) receptor", "object_type": "GENE"}, {"subject": "leuprorelin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "gonadotrophin-releasing hormone (GnRH) receptor", "object_type": "GENE"}, {"subject": "triptorelin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "gonadotrophin-releasing hormone (GnRH) receptor", "object_type": "GENE"}, {"subject": "buserelin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "LH", "object_type": "GENE"}, {"subject": "goserelin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "LH", "object_type": "GENE"}, {"subject": "leuprorelin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "LH", "object_type": "GENE"}, {"subject": "triptorelin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "LH", "object_type": "GENE"}]}
{"text": "Two pure GnRH antagonists have been developed, abarelix and degarelix, that are devoid of any agonist effect on the GnRH receptor and consequently do not result in testosterone flare.", "spo_list": [{"subject": "abarelix", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "GnRH", "object_type": "GENE"}, {"subject": "degarelix", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "GnRH", "object_type": "GENE"}]}
{"text": "Abarelix was the first GnRH antagonist to be developed and was approved by the USA Food and Drug Administration in 2004 for the initiation of hormonal castration in advanced or metastasizing hormone-dependent prostate carcinoma, when rapid androgen suppression is necessary.", "spo_list": [{"subject": "Abarelix", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "GnRH", "object_type": "GENE"}]}
{"text": "Although acetylcholinesterase (AChE) is primarily a hydrolytic enzyme, metabolising the neurotransmitter acetylcholine in cholinergic synapses, it also has some non-catalytic functions in the brain which are far less well characterised.", "spo_list": [{"subject": "acetylcholine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "acetylcholinesterase", "object_type": "GENE"}, {"subject": "acetylcholine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "AChE", "object_type": "GENE"}]}
{"text": "Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.", "spo_list": [{"subject": "carbachol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "muscarinic acetylcholine receptor", "object_type": "GENE"}, {"subject": "muscarine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "muscarinic acetylcholine receptor", "object_type": "GENE"}, {"subject": "carbachol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "mAChR", "object_type": "GENE"}, {"subject": "muscarine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "mAChR", "object_type": "GENE"}, {"subject": "carbachol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "AChE", "object_type": "GENE"}, {"subject": "muscarine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "AChE", "object_type": "GENE"}, {"subject": "atropine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "mAChR", "object_type": "GENE"}, {"subject": "atropine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "AChE", "object_type": "GENE"}, {"subject": "carbachol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "AChE", "object_type": "GENE"}]}
{"text": "Aldo-keto reductases (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.", "spo_list": [{"subject": "oxygen", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Aldo-keto reductases", "object_type": "GENE"}, {"subject": "oxygen", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "AKRs", "object_type": "GENE"}, {"subject": "polycyclic aromatic hydrocarbons", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Aldo-keto reductases", "object_type": "GENE"}, {"subject": "polycyclic aromatic hydrocarbons", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "AKRs", "object_type": "GENE"}, {"subject": "PAHs", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Aldo-keto reductases", "object_type": "GENE"}, {"subject": "PAHs", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "AKRs", "object_type": "GENE"}, {"subject": "o-quinones", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Aldo-keto reductases", "object_type": "GENE"}, {"subject": "o-quinones", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "AKRs", "object_type": "GENE"}]}
{"text": "Exposure to PAHs, their metabolites, and ROS further increase AKRs isoform expression that may amplify oxidative damage.", "spo_list": [{"subject": "PAHs", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "AKRs", "object_type": "GENE"}]}
{"text": "Despite the importance of AKRs in PAHs metabolism, there are no studies that evaluate, in general human populations, the effect of PAHs on AKRs expression in peripheral blood lymphocytes (PBLs).", "spo_list": [{"subject": "PAHs", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "AKRs", "object_type": "GENE"}]}
{"text": "Cardiac hypertrophy, structural remodeling, and expression of the genes associated with fatty acid metabolism were examined in rats treated with triiodothyronine (T3) alone (8 μg/100 g body weight (BW), i.p.) for 15 days or along with a peroxisome proliferator-activated receptor alpha agonist bezafibrate (Bzf; 30 μg/100 g BW, oral) and were found to improve in the Bzf co-treated condition.", "spo_list": [{"subject": "bezafibrate", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "peroxisome proliferator-activated receptor alpha", "object_type": "GENE"}, {"subject": "Bzf", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "peroxisome proliferator-activated receptor alpha", "object_type": "GENE"}]}
{"text": "In vitro metabolism of the 5-hydroxytryptamine1B receptor antagonist elzasonan.", "spo_list": [{"subject": "elzasonan", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-hydroxytryptamine1B", "object_type": "GENE"}]}
{"text": "The rCYP data was normalized relative to the levels of each CYP form in native human liver microsomes to better assess the contribution of each rCYP in the metabolism of elzasonan.", "spo_list": [{"subject": "elzasonan", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCYP", "object_type": "GENE"}]}
{"text": "Cytochrome b5 has shown to be an essential component in P450 3A4 catalyzed 5-hydroxyelzasonan formation and provides insights on the disconnect between human liver microsomes data and that of rCYP.", "spo_list": [{"subject": "5-hydroxyelzasonan", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "P450 3A4", "object_type": "GENE"}]}
{"text": "Although the D1-like receptor, by itself, had no effect on VSMC proliferation, stimulation with fenoldopam, a D1-like receptor agonist, inhibited the stimulatory effect of insulin.", "spo_list": [{"subject": "fenoldopam", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "D1-like receptor", "object_type": "GENE"}, {"subject": "fenoldopam", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "insulin", "object_type": "GENE"}]}
{"text": "The inhibitory effect of fenoldopam on insulin-mediated VSMC proliferation was receptor specific, because its effect could be blocked by SCH23390, a D1-like receptor antagonist.", "spo_list": [{"subject": "fenoldopam", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "insulin", "object_type": "GENE"}, {"subject": "SCH23390", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "D1-like receptor", "object_type": "GENE"}]}
{"text": "Fenoldopam also inhibited insulin receptor mRNA and protein expression, which was time dependent and concentration dependent.", "spo_list": [{"subject": "Fenoldopam", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "insulin receptor", "object_type": "GENE"}]}
{"text": "A PKC or MAP kinase inhibitor blocked the inhibitory effect of fenoldopam on insulin receptor expression, indicating that PKC and MAP kinase were involved in the signaling pathway.", "spo_list": [{"subject": "fenoldopam", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "insulin receptor", "object_type": "GENE"}]}
{"text": "The altered activities of key enzymes such as glucose-6-phosphatase and fructose-1,6-bisphosphatase of carbohydrate metabolism significantly (p<0.05) increased whereas hexokinase, pyruvate kinase, glucose-6-phosphate dehydrogenase and glycogen content significantly (p<0.05) decreased in the liver of diabetic rats and also increased activities of aspartate transaminase (AST), alanine transaminase (ALT) and alkaline phosphatase (ALP).", "spo_list": [{"subject": "carbohydrate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "glucose-6-phosphatase", "object_type": "GENE"}, {"subject": "carbohydrate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "fructose-1,6-bisphosphatase", "object_type": "GENE"}]}
{"text": "Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers, heart mitochondrial lipid peroxidation, calcium, and a significant decrease in the activities/levels of heart mitochondrial glutathione peroxidase, glutathione reductase, reduced glutathione, isocitrate, succinate, malate, α-ketoglutarate and NADH-dehydrogenases, cytochrome-C-oxidase and adenosine triphosphate.", "spo_list": [{"subject": "Isoproterenol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "glutathione peroxidase", "object_type": "GENE"}, {"subject": "Isoproterenol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "glutathione peroxidase", "object_type": "GENE"}, {"subject": "Isoproterenol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "glutathione reductase", "object_type": "GENE"}, {"subject": "Isoproterenol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "glutathione reductase", "object_type": "GENE"}, {"subject": "Isoproterenol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NADH-dehydrogenases", "object_type": "GENE"}, {"subject": "Isoproterenol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cytochrome-C-oxidase", "object_type": "GENE"}, {"subject": "Isoproterenol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "NADH-dehydrogenases", "object_type": "GENE"}, {"subject": "Isoproterenol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cytochrome-C-oxidase", "object_type": "GENE"}]}
{"text": "Catalpol inhibits LPS plus IFN-γ-induced inflammatory response in astrocytes primary cultures.", "spo_list": [{"subject": "Catalpol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "IFN-γ", "object_type": "GENE"}]}
{"text": "Biochemical analyses showed that NO and ROS production and iNOS activity were significantly reduced by catalpol.", "spo_list": [{"subject": "catalpol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "iNOS", "object_type": "GENE"}]}
{"text": "Data at transcriptional level also demonstrated that catalpol potently attenuated gene expressions involved in inflammation, such as iNOS, COX-2 and TLR4.", "spo_list": [{"subject": "catalpol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "catalpol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "catalpol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TLR4", "object_type": "GENE"}]}
{"text": "In addition, our exploration further revealed that the suppressive action of catalpol on inflammation was mediated via inhibiting nuclear factor-κB (NF-κB) activation.", "spo_list": [{"subject": "catalpol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "nuclear factor-κB", "object_type": "GENE"}, {"subject": "catalpol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NF-κB", "object_type": "GENE"}]}
{"text": "Collectively, these results suggest that catalpol can exert inhibitory effects on the inflammatory reaction in astrocytes and that inactivation of NF-κB could be the major determinant for its anti-inflammatory mechanism.", "spo_list": [{"subject": "catalpol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NF-κB", "object_type": "GENE"}]}
{"text": "The two active sites of dimeric 5-aminolevulinate synthase (ALAS), a pyridoxal 5'-phosphate (PLP)-dependent enzyme, are located on the subunit interface with contribution of essential amino acids from each subunit.", "spo_list": [{"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "5-aminolevulinate synthase", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "ALAS", "object_type": "GENE"}]}
{"text": "PSMA acts as a glutamate carboxypeptidase (GCPII) on small molecule substrates, including folate, the anticancer drug methotrexate, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.", "spo_list": [{"subject": "folate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "GCPII", "object_type": "GENE"}, {"subject": "folate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "glutamate carboxypeptidase", "object_type": "GENE"}, {"subject": "folate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PSMA", "object_type": "GENE"}, {"subject": "methotrexate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PSMA", "object_type": "GENE"}, {"subject": "methotrexate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "glutamate carboxypeptidase", "object_type": "GENE"}, {"subject": "methotrexate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "GCPII", "object_type": "GENE"}, {"subject": "N-acetyl-l-aspartyl-l-glutamate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PSMA", "object_type": "GENE"}, {"subject": "N-acetyl-l-aspartyl-l-glutamate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "glutamate carboxypeptidase", "object_type": "GENE"}]}
{"text": "Unlike transferrin receptor, the protease domain of PSMA contains a binuclear zinc site, catalytic residues, and a proposed substrate-binding arginine patch.", "spo_list": [{"subject": "arginine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "transferrin receptor", "object_type": "GENE"}, {"subject": "arginine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "protease domain", "object_type": "GENE"}, {"subject": "arginine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PSMA", "object_type": "GENE"}]}
{"text": "Elucidation of the PSMA structure combined with docking studies and a proposed catalytic mechanism provides insight into the recognition of inhibitors and the natural substrate N-acetyl-l-aspartyl-l-glutamate.", "spo_list": [{"subject": "N-acetyl-l-aspartyl-l-glutamate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PSMA", "object_type": "GENE"}]}
{"text": "Whereas the addition of apomorphine in the low micromolar range produced an irreversible activation of the channel, application of higher concentrations caused a reversible voltage-dependent inhibition of heterologously expressed TRPA1 channels, resulting from a reduction of single-channel open times.", "spo_list": [{"subject": "apomorphine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TRPA1", "object_type": "GENE"}]}
{"text": "In addition, we provide evidence that apomorphine also acts on endogenous TRPA1 in cultured dorsal root ganglion neurons from rats and in the enterochromaffin model cell line QGP-1, from which serotonin is released upon activation of TRPA1.", "spo_list": [{"subject": "apomorphine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "TRPA1", "object_type": "GENE"}]}
{"text": "Our study shows that human TRPA1 is a target for apomorphine, suggesting that an activation of TRPA1 might contribute to adverse side effects such as nausea and painful injections, which can occur during treatment with apomorphine.", "spo_list": [{"subject": "apomorphine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "TRPA1", "object_type": "GENE"}, {"subject": "apomorphine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "TRPA1", "object_type": "GENE"}]}
{"text": "Intravenous (I.V.) cocaine (0.03-3 mg/kg) produced dose-dependent, rapid, and brief increases in blood pressure (BP) in conscious rats pretreated with the dopamine receptor antagonist, SCH 23390.", "spo_list": [{"subject": "SCH 23390", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "dopamine receptor", "object_type": "GENE"}]}
{"text": "Monoamine uptake inhibitors structurally analogous to cocaine (cocaethylene, CFT, betaCIT, CPT, (+)-cocaine, norcocaine, and benztropine) also produced this rapid pressor response, whereas structurally unrelated uptake inhibitors with diverse monoamine transporter selectivities (BTCP, indatraline, GBR 12935, mazindol, nomifensine, and zimeldine) either did not produce a rapid pressor response or produced only a small pressor response.", "spo_list": [{"subject": "BTCP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine transporter", "object_type": "GENE"}, {"subject": "zimeldine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine transporter", "object_type": "GENE"}, {"subject": "nomifensine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine transporter", "object_type": "GENE"}, {"subject": "mazindol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine transporter", "object_type": "GENE"}, {"subject": "GBR 12935", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine transporter", "object_type": "GENE"}, {"subject": "indatraline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine transporter", "object_type": "GENE"}]}
{"text": "At nonconvulsant doses, the sodium channel blockers acetylprocainamide, dibucaine, dyclonine, prilocaine, proparacaine, quinidine, and tetracaine produced a small pressor response or no increase in BP.", "spo_list": [{"subject": "acetylprocainamide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sodium channel", "object_type": "GENE"}, {"subject": "dibucaine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sodium channel", "object_type": "GENE"}, {"subject": "dyclonine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sodium channel", "object_type": "GENE"}, {"subject": "prilocaine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sodium channel", "object_type": "GENE"}, {"subject": "proparacaine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sodium channel", "object_type": "GENE"}, {"subject": "quinidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sodium channel", "object_type": "GENE"}, {"subject": "tetracaine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sodium channel", "object_type": "GENE"}]}
{"text": "The sodium channel-blocking action of cocaine per se does not appear to be involved in the rapid pressor response to cocaine.", "spo_list": [{"subject": "cocaine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sodium channel", "object_type": "GENE"}]}
{"text": "Binding of the agonist angiotensin II (AngII) and inverse agonist losartan in wild-type AT1R changed the accessibility of reporter cysteines, and the pattern was consistent with ligand-specific \"lid\" conformations of ECL2.", "spo_list": [{"subject": "cysteines", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "AT1R", "object_type": "GENE"}, {"subject": "losartan", "subject_type": "CHEMICAL", "predicate": "AGONIST-INHIBITOR", "object": "AT1R", "object_type": "GENE"}]}
{"text": "However, a lid conformation was induced by [Sar(1),Gln(2),Ile(8)] AngII, a specific analog that binds to the D281A mutant with better affinity than AngII.", "spo_list": [{"subject": "Sar", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "AngII", "object_type": "GENE"}, {"subject": "Sar", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "AngII", "object_type": "GENE"}, {"subject": "Gln", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "AngII", "object_type": "GENE"}, {"subject": "Gln", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "AngII", "object_type": "GENE"}, {"subject": "Ile", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "AngII", "object_type": "GENE"}, {"subject": "Ile", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "AngII", "object_type": "GENE"}, {"subject": "Sar", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D281A", "object_type": "GENE"}, {"subject": "Gln", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D281A", "object_type": "GENE"}, {"subject": "Ile", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D281A", "object_type": "GENE"}]}
{"text": "Additionally, MPTP significantly down-regulated Bcl-2 expression in the mitochondria of dopaminergic cells in the SN, followed by an increase in Bax expression, cytochrome C translocation to the cytosol, andcleaved-caspase-3 expression, whereas these were inhibited by CRE or EB treatment.", "spo_list": [{"subject": "MPTP", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Bcl-2", "object_type": "GENE"}, {"subject": "MPTP", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Bax", "object_type": "GENE"}, {"subject": "MPTP", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "caspase-3", "object_type": "GENE"}]}
{"text": "Following CdCl₂ treatment, ICAM2 was found to be upregulated during restructuring of the seminiferous epithelium, with round spermatids becoming increasingly immunoreactive for ICAM2 by 6-16 h. Interestingly, there was a loss in the binding of ICAM2 to actin during CdCl₂-induced germ cell loss, suggesting that a loss of ICAM2-actin interactions might have facilitated junction restructuring.", "spo_list": [{"subject": "CdCl₂", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ICAM2", "object_type": "GENE"}, {"subject": "CdCl₂", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "actin", "object_type": "GENE"}]}
{"text": "These variants are expected to encode either a full length (OATP2B1-FL) or shortened protein lacking 22 N-terminus amino acids (OATP2B-Short).", "spo_list": [{"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OATP2B1-FL", "object_type": "GENE"}, {"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OATP2B-Short", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OATP2B1-FL", "object_type": "GENE"}]}
{"text": "Little is known regarding the transport activity and regulation of OATP2B1 variants with N-terminus truncation.", "spo_list": [{"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "OATP2B1", "object_type": "GENE"}]}
{"text": "Using a transient heterologous cell expression system, we find that the transport activities of the short OATP2B1 variant towards substrates estrone sulfate and rosuvastatin are similar to the well-characterized full length variant.", "spo_list": [{"subject": "estrone sulfate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "short OATP2B1", "object_type": "GENE"}, {"subject": "rosuvastatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "short OATP2B1", "object_type": "GENE"}]}
{"text": "Mutation analysis of KYNU encoding kynureninase of the index case revealed homozygosity for a c.593 A > G substitution leading to a threonine-to-alanine (T198A) shift.", "spo_list": [{"subject": "threonine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "kynureninase", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "kynureninase", "object_type": "GENE"}]}
{"text": "Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX.", "spo_list": [{"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "factor XI apple 3 domain", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "factor IX", "object_type": "GENE"}]}
{"text": "To identify key amino acids involved in factor IX activation, recombinant factor XIa proteins containing alanine substitutions for wild-type sequence were expressed in 293 fibroblasts and tested in a plasma clotting assay.", "spo_list": [{"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "factor XIa", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "factor IX", "object_type": "GENE"}]}
{"text": "Substitutions for Ile(183)-Val(191) and Ser(195)-Ile(197) at the N terminus and for Ser(258)-Ser(264) at the C terminus of the A3 domain markedly decreased factor XI coagulant activity.", "spo_list": [{"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "A3 domain", "object_type": "GENE"}, {"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "A3 domain", "object_type": "GENE"}]}
{"text": "Amino acids between Ile(183) and Val(191) are necessary for proper factor IX activation, but additional sequence between Ser(195) and Ile(197) or between Phe(260) and Ser(265) is required for complete restoration of activation.", "spo_list": [{"subject": "Amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "factor IX", "object_type": "GENE"}]}
{"text": "Regarding urease inhibition, n-butanol was the most potent fraction (IC50: 97 µg/mL).", "spo_list": [{"subject": "n-butanol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "urease", "object_type": "GENE"}]}
{"text": "Blockade of LTC4 synthesis caused by additive inhibition of gIV-PLA2 phosphorylation: Effect of salmeterol and PDE4 inhibition in human eosinophils.", "spo_list": [{"subject": "LTC4", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "gIV-PLA2", "object_type": "GENE"}]}
{"text": "OBJECTIVE: To determine (a) whether PDE4 inhibition alone with rolipram blocked secretions of arachidonic acid (AA) and leukotriene C(4) (LTC(4)) caused by activation of eosinophils with formyl-met-leu-phe plus cytochalasin B (FMLP/B), (b) to determine if PDE4 inhibition plus beta(2)-adrenoceptor agonist act additively to augment endogenous cAMP concentration, and (c) to determine the mechanism by which additive inhibition of AA and LTC(4) synthesis is regulated by cAMP.", "spo_list": [{"subject": "rolipram", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE4", "object_type": "GENE"}]}
{"text": "RESULTS: Rolipram unmasked the inhibitory effect of beta(2)-adrenoceptor stimulation with salmeterol and significantly attenuated the stimulated release of AA and subsequent LTC(4).", "spo_list": [{"subject": "salmeterol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "beta(2)-adrenoceptor", "object_type": "GENE"}]}
{"text": "Inhibition corresponded to increased cAMP production caused by rolipram alone or rolipram plus salmeterol and blocked proportionately the phosphorylation and activation of gIV-PLA(2) in FMLP/B-activated eosinophils.", "spo_list": [{"subject": "rolipram", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "gIV-PLA(2)", "object_type": "GENE"}, {"subject": "salmeterol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "gIV-PLA(2)", "object_type": "GENE"}]}
{"text": "CONCLUSIONS: Inhibition of PDE4 by rolipram unmasks beta(2)-adrenergic blockade of LTC(4) synthesis caused by FMLP/B.", "spo_list": [{"subject": "rolipram", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE4", "object_type": "GENE"}]}
{"text": "Binding site of amiloride to urokinase plasminogen activator depends on species.", "spo_list": [{"subject": "amiloride", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "urokinase plasminogen activator", "object_type": "GENE"}]}
{"text": "By theoretical calculations we have determined most probable structure of amiloride/uPAs complexes.", "spo_list": [{"subject": "amiloride", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "uPAs", "object_type": "GENE"}]}
{"text": "Significant differences were observed in a different region (loop B93-B101), that we identified as binding site of amiloride to the tissue plasminogen activator (tPA).", "spo_list": [{"subject": "amiloride", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "tissue plasminogen activator", "object_type": "GENE"}, {"subject": "amiloride", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "tPA", "object_type": "GENE"}]}
{"text": "Amiloride is a specific inhibitor of uPA but does not inhibit tPA.", "spo_list": [{"subject": "Amiloride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "uPA", "object_type": "GENE"}]}
{"text": "Reboxetine, a selective norepinephrine reuptake inhibitor, exhibits high affinity and selectivity for the human norepinephrine transporter.", "spo_list": [{"subject": "Reboxetine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human norepinephrine transporter", "object_type": "GENE"}, {"subject": "Reboxetine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "human norepinephrine transporter", "object_type": "GENE"}]}
{"text": "Disruption of microtubule prevented insulin-induced actin remodeling and distal insulin signal transduction, with reduction in surface glucose transporter isoform 4 (GLUT4) and glucose uptake.", "spo_list": [{"subject": "glucose", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "glucose transporter isoform 4", "object_type": "GENE"}, {"subject": "glucose", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "GLUT4", "object_type": "GENE"}]}
{"text": "Though microtubule mediated actin remodeling through PKCζ, reorganization of microtubule depended on tyrosine phosphorylation of insulin receptor, the mechanism is different from insulin-induced actin remodeling, which relied on the activity of PI3-kinase and PKCζ.", "spo_list": [{"subject": "tyrosine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "insulin receptor", "object_type": "GENE"}]}
{"text": "The mRNA level for nestin (Nes, biomarker for stem Leydig cells) was significantly increased in the control testis on day 4 post-EDS, but not in the DEHP treated testes, suggesting that these nestin positive stem cells were differentiated into progenitor Leydig cells in the DEHP-treated testes.", "spo_list": [{"subject": "EDS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "nestin", "object_type": "GENE"}, {"subject": "EDS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Nes", "object_type": "GENE"}]}
{"text": "The concomitant application of subconvulsive dose of pentetrazole (55.0 mg/kg) with low dose of flumazenil (5.0 mg/kg) - a BDZ receptor antagonist, immediately induced BDZ withdrawal signs in these animals.", "spo_list": [{"subject": "flumazenil", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "BDZ receptor", "object_type": "GENE"}]}
{"text": "The non-selective adenosine receptor antagonist (caffeine), and the selective adenosine A1 receptor antagonist (DPCPX), injected 15 min before the application of pentetrazole and flumazenil, were able to intensify BDZ withdrawal signs in mice.", "spo_list": [{"subject": "caffeine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "adenosine receptor", "object_type": "GENE"}, {"subject": "DPCPX", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "adenosine A1 receptor", "object_type": "GENE"}]}
{"text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF- α).", "spo_list": [{"subject": "buthanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "buthanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "buthanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "inducible nitric oxide synthase", "object_type": "GENE"}, {"subject": "buthanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "buthanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "tumor necrosis factor-α", "object_type": "GENE"}, {"subject": "buthanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF- α", "object_type": "GENE"}, {"subject": "ethylacetate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "ethylacetate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "ethylacetate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "inducible nitric oxide synthase", "object_type": "GENE"}, {"subject": "ethylacetate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "ethylacetate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "tumor necrosis factor-α", "object_type": "GENE"}, {"subject": "ethylacetate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF- α", "object_type": "GENE"}, {"subject": "methanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "methanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "methanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "inducible nitric oxide synthase", "object_type": "GENE"}, {"subject": "methanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "methanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "tumor necrosis factor-α", "object_type": "GENE"}, {"subject": "methanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF- α", "object_type": "GENE"}, {"subject": "clerosterol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "clerosterol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "clerosterol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "inducible nitric oxide synthase", "object_type": "GENE"}, {"subject": "clerosterol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "clerosterol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "tumor necrosis factor-α", "object_type": "GENE"}, {"subject": "clerosterol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF- α", "object_type": "GENE"}, {"subject": "CLS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "CLS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "CLS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "inducible nitric oxide synthase", "object_type": "GENE"}, {"subject": "CLS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "CLS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "tumor necrosis factor-α", "object_type": "GENE"}, {"subject": "CLS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF- α", "object_type": "GENE"}]}
{"text": "In another experiment, topical application of CFB, CFE or CLS prior to UVB irradiation (200mJ/cm(2)) on BALB/c mice, inhibited the UVB-elevated protein levels of COX-2, iNOS, and TNF-α.", "spo_list": [{"subject": "CLS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "CLS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "CLS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF-α", "object_type": "GENE"}]}
{"text": "Wogonin inhibits H2O2-induced vascular permeability through suppressing the phosphorylation of caveolin-1.", "spo_list": [{"subject": "Wogonin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "caveolin-1", "object_type": "GENE"}, {"subject": "H2O2", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "caveolin-1", "object_type": "GENE"}]}
{"text": "We found that wogonin can suppress the H2O2-stimulated actin remodeling and albumin uptake of HUVECs, as well as transendothelial cell migration of the human breast carcinoma cell MDA-MB-231.", "spo_list": [{"subject": "wogonin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "actin", "object_type": "GENE"}, {"subject": "wogonin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "albumin", "object_type": "GENE"}, {"subject": "H2O2", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "actin", "object_type": "GENE"}, {"subject": "H2O2", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "albumin", "object_type": "GENE"}]}
{"text": "The mechanism revealed that wogonin inhibited H2O2-induced phosphorylation of caveolin-1 (cav-1) associating with the suppression of stabilization of VE-cadherin and β-catenin.", "spo_list": [{"subject": "wogonin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "caveolin-1", "object_type": "GENE"}, {"subject": "wogonin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cav-1", "object_type": "GENE"}, {"subject": "H2O2", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "caveolin-1", "object_type": "GENE"}, {"subject": "H2O2", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "cav-1", "object_type": "GENE"}, {"subject": "wogonin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "VE-cadherin", "object_type": "GENE"}, {"subject": "wogonin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "β-catenin", "object_type": "GENE"}]}
{"text": "Moreover, wogonin repressed anisomycin-induced phosphorylation of p38, cav-1 and vascular permeability.", "spo_list": [{"subject": "anisomycin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "p38", "object_type": "GENE"}, {"subject": "anisomycin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "cav-1", "object_type": "GENE"}, {"subject": "wogonin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "p38", "object_type": "GENE"}, {"subject": "wogonin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cav-1", "object_type": "GENE"}]}
{"text": "These results suggested that wogonin could inhibit H2O2-induced vascular permeability by downregulating the phosphorylation of cav-1, and that it might have a therapeutic potential for the diseases associated with the development of both oxidant and vascular permeability.", "spo_list": [{"subject": "wogonin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cav-1", "object_type": "GENE"}, {"subject": "H2O2", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "cav-1", "object_type": "GENE"}]}
{"text": "Neoechinulin A suppresses amyloid-β oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity.", "spo_list": [{"subject": "Neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "amyloid-β", "object_type": "GENE"}]}
{"text": "In this study, focus was given to evaluate the ability of neoechinulin A, an indole alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric amyloid-β 1-42 (Aβ42).", "spo_list": [{"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "amyloid-β 1-42", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Aβ42", "object_type": "GENE"}, {"subject": "indole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "amyloid-β 1-42", "object_type": "GENE"}, {"subject": "indole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Aβ42", "object_type": "GENE"}]}
{"text": "Neoechinulin A treatment significantly inhibited the generation of reactive oxygen and nitrogen species in Aβ42-activated BV-2 microglia cells.", "spo_list": [{"subject": "Neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Aβ42", "object_type": "GENE"}]}
{"text": "In addition, we found that neoechinulin A significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells.", "spo_list": [{"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "tumour necrosis factor-α", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF-α", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "interleukin-1β", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-1β", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "interleukin-6", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-6", "object_type": "GENE"}]}
{"text": "Further, activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by neoechinulin A. The molecular mechanism studies suggested that neoechinulin A may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-κB (NF-κB) p65 and p50 subunits.", "spo_list": [{"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mitogen-activated protein kinase", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MAPK", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "p38", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "apoptosis signal-regulating kinase 1", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ASK-1", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "nuclear factor-κB", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "NF-κB", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "p65", "object_type": "GENE"}, {"subject": "neoechinulin A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "p50", "object_type": "GENE"}]}
{"text": "Agomelatine, commonly known as melatonin receptor agonist, is a new antidepressant, which resynchronizes circadian rhythms with subjective and objective improvements in sleep quality and architecture, as melatonin does.", "spo_list": [{"subject": "Agomelatine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "melatonin receptor", "object_type": "GENE"}]}
{"text": "There were statistically significant increases in the activities of aspartate aminotransferase, alanine aminotransferase, levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) and 8-iso-prostane, and decreases in the activity of superoxide dismutase and level of glutathione in the group treated with paracetamol.", "spo_list": [{"subject": "paracetamol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "superoxide dismutase", "object_type": "GENE"}, {"subject": "paracetamol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "aspartate aminotransferase", "object_type": "GENE"}, {"subject": "paracetamol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "alanine aminotransferase", "object_type": "GENE"}, {"subject": "paracetamol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "tumor necrosis factor-alpha", "object_type": "GENE"}, {"subject": "paracetamol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "TNF-α", "object_type": "GENE"}, {"subject": "paracetamol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "interleukin-6", "object_type": "GENE"}, {"subject": "paracetamol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "IL-6", "object_type": "GENE"}]}
{"text": "In conclusion, agomelatine administration protects liver cells from paracetamol-induced hepatotoxicity via antioxidant activity and reduced proinflammatory cytokines, such as TNF-α and IL-6.", "spo_list": [{"subject": "paracetamol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "cytokines", "object_type": "GENE"}, {"subject": "paracetamol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "TNF-α", "object_type": "GENE"}, {"subject": "paracetamol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "IL-6", "object_type": "GENE"}, {"subject": "agomelatine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cytokines", "object_type": "GENE"}, {"subject": "agomelatine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF-α", "object_type": "GENE"}, {"subject": "agomelatine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-6", "object_type": "GENE"}]}
{"text": "Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone.", "spo_list": [{"subject": "corticosterone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "rat brain aldosterone receptors", "object_type": "GENE"}]}
{"text": "However, due to the very high affinity of CBG for corticosterone at 4 C, this slight contamination resulted in significant alterations in the apparent affinity of steroids competing for aldosterone-binding sites.", "spo_list": [{"subject": "corticosterone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "CBG", "object_type": "GENE"}]}
{"text": "Selective precipitation of cytosol receptors with 36% (NH4)2SO4 reduced CBG concentrations to negligible levels.", "spo_list": [{"subject": "(NH4)2SO4", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "CBG", "object_type": "GENE"}]}
{"text": "Readdition of a small quantity of dialyzed serum to cytosol preparations yielded a profile of steroid binding similar to that of the kidney mineralocorticoid receptor (aldosterone greater than desoxycorticosterone greater than corticosterone).", "spo_list": [{"subject": "steroid", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "mineralocorticoid receptor", "object_type": "GENE"}, {"subject": "aldosterone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "mineralocorticoid receptor", "object_type": "GENE"}, {"subject": "desoxycorticosterone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "mineralocorticoid receptor", "object_type": "GENE"}]}
{"text": "We found that, both in a cell-free system and in cells, NO/SNO donors such as S-nitrosocysteine and S-nitrosoglutathione readily induced the S-nitrosylation of Prx1, causing structural and functional alterations.", "spo_list": [{"subject": "S", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Prx1", "object_type": "GENE"}]}
{"text": "In particular, nitrosylation promoted disulfide formation involving the pair of catalytic cysteines (Cys-52 and Cys-173) and disrupted the oligomeric structure of Prx1, leading to loss of peroxidase activity.", "spo_list": [{"subject": "cysteines", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Prx1", "object_type": "GENE"}, {"subject": "Cys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Prx1", "object_type": "GENE"}, {"subject": "Cys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Prx1", "object_type": "GENE"}, {"subject": "cysteines", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "peroxidase", "object_type": "GENE"}, {"subject": "Cys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "peroxidase", "object_type": "GENE"}, {"subject": "Cys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "peroxidase", "object_type": "GENE"}]}
{"text": "A highly potent inhibition of the peroxidase catalytic reaction by NO/SNO was seen in assays employing the coupled Prx-Trx system.", "spo_list": [{"subject": "NO", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "peroxidase", "object_type": "GENE"}, {"subject": "SNO", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "peroxidase", "object_type": "GENE"}]}
{"text": "In this setting, S-nitrosocysteine (10 μm) effectively blocked the Trx-mediated regeneration of oxidized Prx1.", "spo_list": [{"subject": "S-nitrosocysteine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Trx", "object_type": "GENE"}, {"subject": "S-nitrosocysteine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "oxidized Prx1", "object_type": "GENE"}]}
{"text": "On the basis of data obtained in rabbits, the imidazoline receptor ligand rilmenidine has been suggested to decrease blood pressure in humans by activating central alpha(2A)-adrenoceptors.", "spo_list": [{"subject": "rilmenidine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "imidazoline receptor", "object_type": "GENE"}]}
{"text": "A prerequisite for this hypothesis was the unproved assumption that rabbit and human alpha(2A)-adrenoceptors are equally activated by rilmenidine.", "spo_list": [{"subject": "rilmenidine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "alpha(2A)-adrenoceptors", "object_type": "GENE"}]}
{"text": "Human atrial appendages and rabbit pulmonary arteries were used to determine the potencies of alpha(2)-adrenoceptor agonists in inhibiting the electrically (2 Hz) evoked [(3)H]norepinephrine release and of antagonists in counteracting the alpha(2)-adrenoceptor-mediated inhibition induced by moxonidine.", "spo_list": [{"subject": "moxonidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "alpha(2)-adrenoceptor", "object_type": "GENE"}]}
{"text": "In the rabbit pulmonary artery, rilmenidine and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the alpha(2)-autoreceptors, sharing this property with rauwolscine, phentolamine, and idazoxan.", "spo_list": [{"subject": "oxymetazoline", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(2)-autoreceptors", "object_type": "GENE"}, {"subject": "rilmenidine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(2)-autoreceptors", "object_type": "GENE"}, {"subject": "rauwolscine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(2)-autoreceptors", "object_type": "GENE"}, {"subject": "phentolamine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(2)-autoreceptors", "object_type": "GENE"}, {"subject": "idazoxan", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(2)-autoreceptors", "object_type": "GENE"}]}
{"text": "In addition, a partial nucleotide and amino acid sequence of the rabbit alpha(2A)-adrenoceptor (a region known to substantially influence the pharmacological characteristics of the alpha(2)-adrenoceptor) revealed marked differences between the rabbit and the human alpha(2A)-adrenoceptor.", "spo_list": [{"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "rabbit alpha(2A)-adrenoceptor", "object_type": "GENE"}]}
{"text": "The sympathetic nerves of both the human atrial appendages and rabbit pulmonary artery are endowed with alpha(2A)-autoreceptors, at which, however, both rilmenidine and oxymetazoline exhibit different properties (antagonism and agonism, respectively).", "spo_list": [{"subject": "rilmenidine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(2A)-autoreceptors", "object_type": "GENE"}, {"subject": "oxymetazoline", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha(2A)-autoreceptors", "object_type": "GENE"}]}
{"text": "The antagonistic property of rilmenidine at human alpha(2A)-adrenoceptors indicates that in contrast to the suggestion based on rabbit data, the hypotensive property of the drug in humans is not due to activation of alpha(2A)-adrenoceptors but other, presumably I(1)-imidazoline receptors, are probably involved.", "spo_list": [{"subject": "rilmenidine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "human alpha(2A)-adrenoceptors", "object_type": "GENE"}]}
{"text": "Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan.", "spo_list": [{"subject": "dimemorfan", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sigma-1 receptor", "object_type": "GENE"}]}
{"text": "This study therefore characterized the binding of DF to the sigma receptors and NMDA-linked PCP sites and examined the anticonvulsant as well as locomotor effects of DF in mice in comparison with those of DM and DR.", "spo_list": [{"subject": "DF", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sigma receptors", "object_type": "GENE"}]}
{"text": "We found that DF, DM, and DR were relative high-affinity ligands at sigma-1 receptors (Ki=151, 205, 144 nM, respectively) while all of them were with low affinity at sigma-2 receptors (Ki=4-11 microM).", "spo_list": [{"subject": "DF", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sigma-1 receptors", "object_type": "GENE"}, {"subject": "DM", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sigma-1 receptors", "object_type": "GENE"}, {"subject": "DR", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sigma-1 receptors", "object_type": "GENE"}, {"subject": "DF", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sigma-2 receptors", "object_type": "GENE"}, {"subject": "DM", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sigma-2 receptors", "object_type": "GENE"}, {"subject": "DR", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sigma-2 receptors", "object_type": "GENE"}]}
{"text": "Furthermore, since they have equipotent anticonvulsant effects and similar binding affinities to sigma-1 receptors, the very low affinity of DF at PCP sites may suggest that acting on the PCP sites may not be the requisite for mediating the anticonvulsant activity of these DM analogs.", "spo_list": [{"subject": "DF", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sigma-1 receptors", "object_type": "GENE"}, {"subject": "PCP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "sigma-1 receptors", "object_type": "GENE"}]}
{"text": "Structure activity relationship studies of tricyclic bispyran sulfone γ-secretase inhibitors.", "spo_list": [{"subject": "tricyclic bispyran sulfone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "γ-secretase", "object_type": "GENE"}]}
{"text": "An investigation is detailed of the structure activity relationships (SAR) of two sulfone side chains of compound (-)-1a (SCH 900229), a potent, PS1-selective γ-secretase inhibitor and clinical candidate for the treatment of Alzheimer's disease.", "spo_list": [{"subject": "SCH 900229", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "γ-secretase", "object_type": "GENE"}, {"subject": "SCH 900229", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PS1", "object_type": "GENE"}]}
{"text": "Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.", "spo_list": [{"subject": "bosutinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}]}
{"text": "Here, we characterized the target profile of the dual SRC/ABL inhibitor bosutinib employing a two-tiered approach using chemical proteomics to identify natural binders in whole cell lysates of primary CML and K562 cells in parallel to in vitro kinase assays against a large recombinant kinase panel.", "spo_list": [{"subject": "bosutinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "SRC", "object_type": "GENE"}, {"subject": "bosutinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ABL", "object_type": "GENE"}]}
{"text": "A comparison of bosutinib with dasatinib across the whole kinase panel revealed overlapping, but distinct, inhibition profiles.", "spo_list": [{"subject": "dasatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "bosutinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}]}
{"text": "Finally, bosutinib is the first kinase inhibitor shown to target CAMK2G, recently implicated in myeloid leukemia cell proliferation.", "spo_list": [{"subject": "bosutinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}, {"subject": "bosutinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CAMK2G", "object_type": "GENE"}]}
{"text": "Furthermore, sinapic acid reduced hepatic hydroxyproline content, which correlated with a reduction in the expression of type I collagen mRNA and histological analysis of collagen in liver tissue.", "spo_list": [{"subject": "sinapic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "type I collagen", "object_type": "GENE"}]}
{"text": "Additionally, the expression of hepatic fibrosis-related factors such as α-smooth muscle actin and transforming growth factor-β1 (TGF-β1), were reduced in rats treated with sinapic acid.", "spo_list": [{"subject": "sinapic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "α-smooth muscle actin", "object_type": "GENE"}, {"subject": "sinapic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "transforming growth factor-β1", "object_type": "GENE"}, {"subject": "sinapic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TGF-β1", "object_type": "GENE"}]}
{"text": "In conclusion, we find that sinapic acid exhibits hepatoprotective and antifibrotic effects against DMN-induced liver injury, most likely due to its antioxidant activities of scavenging radicals, its capacity to suppress TGF-β1 and its ability to attenuate activation of hepatic stellate cells.", "spo_list": [{"subject": "sinapic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TGF-β1", "object_type": "GENE"}]}
{"text": "Bile acid coenzyme A:amino acid N-acyltransferase (BAT) is responsible for the amidation of bile acids with the amino acids glycine and taurine.", "spo_list": [{"subject": "bile acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Bile acid coenzyme A:amino acid N-acyltransferase", "object_type": "GENE"}, {"subject": "bile acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "BAT", "object_type": "GENE"}]}
{"text": "On the other hand, in patients with a mean serum carvedilol level (Cmin) of less than 2.5 nmol/l up to 2 weeks after the start ofcarvedilol therapy, the degree of reduction in the BNP value after the 3rd month was significantly larger, relative to the patient group with Cmin over 2.5 nmol/l.", "spo_list": [{"subject": "carvedilol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "BNP", "object_type": "GENE"}]}
{"text": "Ribonucleotide reductase (RR) is responsible for the de novo conversion of the ribonucleoside diphosphates to deoxyribonucleoside diphosphates, which are essential for DNA synthesis and repair.", "spo_list": [{"subject": "ribonucleoside diphosphates", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Ribonucleotide reductase", "object_type": "GENE"}, {"subject": "ribonucleoside diphosphates", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "RR", "object_type": "GENE"}, {"subject": "deoxyribonucleoside diphosphates", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "RR", "object_type": "GENE"}, {"subject": "deoxyribonucleoside diphosphates", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Ribonucleotide reductase", "object_type": "GENE"}]}
{"text": "In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53. p53R2 (analyzed by Western blot and standardized relative to Coomassie Blue-stained band) was down-regulated in PC3 cells and up-regulated in KB cells after UV exposure.", "spo_list": [{"subject": "COOH", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "p53", "object_type": "GENE"}]}
{"text": "In PC3 cells, hydroxyurea inhibited hRRM2 and resulted in increased sensitivity to UV irradiation.", "spo_list": [{"subject": "hydroxyurea", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "hRRM2", "object_type": "GENE"}]}
{"text": "Synthesis, molecular modeling and evaluation of novel N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone derivatives as dual inhibitors for cholinesterases and Aβ aggregation.", "spo_list": [{"subject": "N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cholinesterases", "object_type": "GENE"}, {"subject": "N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Aβ", "object_type": "GENE"}]}
{"text": "To develop new drugs for treatment of Alzheimer's disease, a group of N'-2-(4-Benzylpiperidin-/piperazin-1-yl)acylhydrazones was designed, synthesized and tested for their ability to inhibit acetylcholinesterase, butyrylcholinesterase and aggregation of amyloid beta peptides (1-40, 1-42 and 1-40_1-42).", "spo_list": [{"subject": "N'-2-(4-Benzylpiperidin-/piperazin-1-yl)acylhydrazones", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "acetylcholinesterase", "object_type": "GENE"}, {"subject": "N'-2-(4-Benzylpiperidin-/piperazin-1-yl)acylhydrazones", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "butyrylcholinesterase", "object_type": "GENE"}]}
{"text": "The enzyme inhibition assay results indicated that compounds moderately inhibit both acetylcholinesterase and butyrylcholinesterase. β-Amyloid aggregation results showed that all compounds exhibited remarkable Aβ fibril aggregation inhibition activity with a nearly similar potential as the reference compound rifampicin, which makes them promising anti-Alzheimer drug candidates.", "spo_list": [{"subject": "rifampicin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Aβ", "object_type": "GENE"}]}
{"text": "We previously demonstrated that the somatostatinergic system, implicated in neuronal survival control, can be modulated by α-tocopherol in the rat dentate gyrus, increasing cyclic adenosine monophosphate response element binding protein phosphorylation.", "spo_list": [{"subject": "α-tocopherol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "cyclic adenosine monophosphate response element binding protein", "object_type": "GENE"}]}
{"text": "The Trx mimetics peptides (TXM) protected insulinoma INS 832/13 cells from oxidative stress induced by selectively inhibiting TrxR with auranofin (AuF).", "spo_list": [{"subject": "auranofin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TrxR", "object_type": "GENE"}, {"subject": "AuF", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TrxR", "object_type": "GENE"}]}
{"text": "The TXM peptides were effective in inhibiting AuF-induced MAPK, JNK and p38(MAPK) phosphorylation, in correlation with preventing caspase-3 cleavage and thereby PARP-1 dissociation.", "spo_list": [{"subject": "AuF", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "MAPK", "object_type": "GENE"}, {"subject": "AuF", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "JNK", "object_type": "GENE"}, {"subject": "AuF", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "p38", "object_type": "GENE"}, {"subject": "AuF", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "MAPK", "object_type": "GENE"}]}
{"text": "In general, antiproliferative activity is greatly enhanced by low levels of the glutathione synthase inhibitor l-buthionine sulfoxime.", "spo_list": [{"subject": "l-buthionine sulfoxime", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "glutathione synthase", "object_type": "GENE"}]}
{"text": "Mechanisms of cefadroxil uptake in the choroid plexus: studies in wild-type and PEPT2 knockout mice.", "spo_list": [{"subject": "cefadroxil", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PEPT2", "object_type": "GENE"}]}
{"text": "The choroid plexus uptake of [(3)H]cefadroxil was studied in peptide transporter 2 (PEPT2) wild-type and null mice as a function of temperature, transport inhibitors, pH, and saturability.", "spo_list": [{"subject": "[(3)H]cefadroxil", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "peptide transporter 2", "object_type": "GENE"}, {"subject": "[(3)H]cefadroxil", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PEPT2", "object_type": "GENE"}]}
{"text": "At normal pH (7.4) and temperature (37 degrees C), the uptake of 1 microM cefadroxil was reduced by 83% in PEPT2(-/-) mice as compared with PEPT2(+/+) mice (p < 0.001).", "spo_list": [{"subject": "cefadroxil", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PEPT2", "object_type": "GENE"}, {"subject": "cefadroxil", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PEPT2", "object_type": "GENE"}]}
{"text": "Glycylsarcosine coadministration could inhibit the uptake of cefadroxil in PEPT2(+/+) mice (p < 0.01) but not PEPT2(-/-) mice.", "spo_list": [{"subject": "Glycylsarcosine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PEPT2", "object_type": "GENE"}, {"subject": "cefadroxil", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PEPT2", "object_type": "GENE"}, {"subject": "cefadroxil", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PEPT2", "object_type": "GENE"}]}
{"text": "Although a proton-stimulated uptake of cefadroxil was demonstrated in PEPT2(+/+) mice (pH 6.5 versus pH 7.4; p < 0.01), no pH dependence was observed in PEPT2(-/-) mice.", "spo_list": [{"subject": "cefadroxil", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PEPT2", "object_type": "GENE"}, {"subject": "cefadroxil", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PEPT2", "object_type": "GENE"}]}
{"text": "These findings demonstrate that PEPT2 is the primary transporter responsible for cefadroxil uptake in the choroid plexus.", "spo_list": [{"subject": "cefadroxil", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PEPT2", "object_type": "GENE"}]}
{"text": "Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway.", "spo_list": [{"subject": "Arsenic trioxide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Notch", "object_type": "GENE"}]}
{"text": "ATO inhibited the phosphorylation and activation of AKT and STAT3 through Notch signaling blockade.", "spo_list": [{"subject": "ATO", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AKT", "object_type": "GENE"}, {"subject": "ATO", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "STAT3", "object_type": "GENE"}, {"subject": "ATO", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Notch", "object_type": "GENE"}]}
{"text": "These data show that the ATO is a promising new approach to decrease glioblastoma proliferation and recurrence by downregulation of Notch pathway.", "spo_list": [{"subject": "ATO", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Notch", "object_type": "GENE"}]}
{"text": "Point-mutation studies indicate that four amino acids, Leu/Phe(7.38), Leu/Phe(7.43), Ala/Pro(7.46), and Pro/Cys(7.47) in TMH7 are critical for ligand selectivity as well as receptor conformation.", "spo_list": [{"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TMH7", "object_type": "GENE"}, {"subject": "Leu", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TMH7", "object_type": "GENE"}, {"subject": "Phe", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TMH7", "object_type": "GENE"}, {"subject": "Leu", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TMH7", "object_type": "GENE"}, {"subject": "Phe", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TMH7", "object_type": "GENE"}, {"subject": "Ala", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TMH7", "object_type": "GENE"}, {"subject": "Pro", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TMH7", "object_type": "GENE"}, {"subject": "Pro", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TMH7", "object_type": "GENE"}, {"subject": "Cys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TMH7", "object_type": "GENE"}]}
{"text": "Furthermore, a combinatory mutation (Pro(7.31)-Pro(7.32)-Ser(7.33) motif to Ser-Glu-Pro in EL3 and Leu(7.38), Leu(7.43), Ala(7.46), and Pro(7.47) to those of rat GnRHR) in gmGnRH-2 exhibited an approximately 500-fold increased sensitivity to GnRH-I, indicating that these residues are critical for discriminating GnRH-II from GnRH-I.", "spo_list": [{"subject": "Pro", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "EL3", "object_type": "GENE"}, {"subject": "Pro", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "EL3", "object_type": "GENE"}, {"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "EL3", "object_type": "GENE"}, {"subject": "Ser-Glu-Pro", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "EL3", "object_type": "GENE"}, {"subject": "Leu", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "rat GnRHR", "object_type": "GENE"}, {"subject": "Leu", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "rat GnRHR", "object_type": "GENE"}, {"subject": "Ala", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "rat GnRHR", "object_type": "GENE"}, {"subject": "Pro", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "rat GnRHR", "object_type": "GENE"}]}
{"text": "[Trp(7)]GnRH-I and [Trp(8)]GnRH-I but not [His(5)]GnRH-I exhibit a higher potency in activating wild-type gmGnRHR-2 than native GnRH-I, indicating that amino acids at positions 7 and 8 of GnRHs are more important than position 5 for differential recognition by type I and type II GnRHRs.", "spo_list": [{"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "GnRHs", "object_type": "GENE"}]}
{"text": "Bile acids are signaling molecules that activate nuclear receptors, such as farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, and vitamin D receptor, and play a critical role in the regulation of lipid, glucose, energy, and drug metabolism.", "spo_list": [{"subject": "Bile acids", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "nuclear receptors", "object_type": "GENE"}, {"subject": "Bile acids", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "farnesoid X receptor", "object_type": "GENE"}, {"subject": "Bile acids", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "pregnane X receptor", "object_type": "GENE"}, {"subject": "Bile acids", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "constitutive androstane receptor", "object_type": "GENE"}, {"subject": "Bile acids", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "vitamin D receptor", "object_type": "GENE"}]}
{"text": "ABCG5 and ABCG8 themselves are regulated by cholesterol via liver X receptors (LXRs), which are also activated by oxysterols and some derivatives of plant sterols.", "spo_list": [{"subject": "sterols", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "LXRs", "object_type": "GENE"}]}
{"text": "NPC1L1 could recently be identified as a major sterol transporter for the intestinal uptake of cholesterol as well as plant sterols.", "spo_list": [{"subject": "cholesterol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "sterol transporter", "object_type": "GENE"}, {"subject": "sterols", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "sterol transporter", "object_type": "GENE"}, {"subject": "cholesterol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NPC1L1", "object_type": "GENE"}, {"subject": "sterols", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NPC1L1", "object_type": "GENE"}]}
{"text": "In an earlier report, DRD2 E8 A/A genotype was associated with reduced responsiveness to the dopamine D2 agonist apomorphine; however, it is not clear whether both findings share the same biological basis.", "spo_list": [{"subject": "apomorphine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "dopamine D2", "object_type": "GENE"}]}
{"text": "Cresyl saligenin phosphate makes multiple adducts on free histidine, but does not form an adduct on histidine 438 of human butyrylcholinesterase.", "spo_list": [{"subject": "histidine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "human butyrylcholinesterase", "object_type": "GENE"}]}
{"text": "CBDP irreversibly inhibits butyrylcholinesterase (BChE) in human plasma by forming adducts on the active site serine (Ser-198).", "spo_list": [{"subject": "CBDP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "butyrylcholinesterase", "object_type": "GENE"}, {"subject": "CBDP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BChE", "object_type": "GENE"}, {"subject": "serine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "butyrylcholinesterase", "object_type": "GENE"}, {"subject": "serine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "BChE", "object_type": "GENE"}, {"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "butyrylcholinesterase", "object_type": "GENE"}, {"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "BChE", "object_type": "GENE"}]}
{"text": "Mass spectral analysis of CBDP-inhibited BChE digested with Glu-C showed an o-hydroxybenzyl adduct (+106amu) on lysine 499, a residue far from the active site, but not on His-438.", "spo_list": [{"subject": "CBDP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BChE", "object_type": "GENE"}, {"subject": "lysine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "BChE", "object_type": "GENE"}, {"subject": "o-hydroxybenzyl", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "BChE", "object_type": "GENE"}, {"subject": "His", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "BChE", "object_type": "GENE"}]}
{"text": "Interestingly, miR-21 expression positively correlated with urine albumin creatine ratio (ACR), TIMP1, collagen IV (ColIV), and fibronectin (FN); while negatively correlated with creatine clearance ratio (Ccr) and MMP-9 protein.", "spo_list": [{"subject": "creatine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "miR-21", "object_type": "GENE"}, {"subject": "creatine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "miR-21", "object_type": "GENE"}]}
{"text": "Novel analgesic/anti-inflammatory agents: 1,5-diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors.", "spo_list": [{"subject": "nitric oxide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "1,5-diarylpyrrole nitrooxyalkyl ethers", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase-2", "object_type": "GENE"}]}
{"text": "New classes of pyrrole-derived nitrooxyalkyl inverse esters, carbonates, and ethers (7-10) as COX-2 selective inhibitors and NO donors were synthesized and are herein reported.", "spo_list": [{"subject": "pyrrole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "nitrooxyalkyl", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "esters", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "carbonates", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "ethers", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Nitrooxy derivatives showed NO-dependent vasorelaxing properties, while most of the compounds proved to be very potent and selective COX-2 inhibitors in in vitro experimental models.", "spo_list": [{"subject": "Nitrooxy", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Finally, molecular modeling and (1)H- and (13)C-NMR studies performed on compounds 6c,d, 9c, and 10b allowed the right conformation of nitrooxyalkyl ester and ether side chain of these molecules within the COX-2 active site to be assessed.", "spo_list": [{"subject": "nitrooxyalkyl ester and ether", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Ambrisentan is an endothelin type A (ET(A))-selective receptor antagonist that is metabolized primarily by glucuronidation but also undergoes oxidative metabolism by CYP3A4.", "spo_list": [{"subject": "Ambrisentan", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "endothelin type A (ET(A))-selective receptor", "object_type": "GENE"}, {"subject": "Ambrisentan", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A4", "object_type": "GENE"}]}
{"text": "The potential for ketoconazole, the archetypal strong inhibitor of CYP3A4, to alter the pharmacokinetic profile of ambrisentan and its oxidative metabolite, 4-hydroxymethyl ambrisentan, was assessed in an open-label, nonrandomized, 2-period, single-sequence study in 16 healthy men.", "spo_list": [{"subject": "ketoconazole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP3A4", "object_type": "GENE"}]}
{"text": "In summary, ketoconazole had no clinically significant effect on the pharmacokinetics or safety profile of ambrisentan; therefore, no changes in ambrisentan dose should be necessary when the drug is administered concomitantly with known CYP3A4 inhibitors.", "spo_list": [{"subject": "ketoconazole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP3A4", "object_type": "GENE"}]}
{"text": "In competition experiments with human lung glucocorticoid receptors we have determined the relative receptor affinities (RRA) of these substances with reference to dexamethasone (RRA = 100).", "spo_list": [{"subject": "dexamethasone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human lung glucocorticoid receptors", "object_type": "GENE"}]}
{"text": "Gemcitabine (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.", "spo_list": [{"subject": "Gemcitabine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytidine deaminase", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytidine deaminase", "object_type": "GENE"}, {"subject": "2',2'-difluorodeoxycytidine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytidine deaminase", "object_type": "GENE"}, {"subject": "Gemcitabine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CDA", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CDA", "object_type": "GENE"}, {"subject": "2',2'-difluorodeoxycytidine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CDA", "object_type": "GENE"}, {"subject": "Gemcitabine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "deoxycytidine kinase", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "deoxycytidine kinase", "object_type": "GENE"}, {"subject": "2',2'-difluorodeoxycytidine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "deoxycytidine kinase", "object_type": "GENE"}, {"subject": "Gemcitabine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DCK", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DCK", "object_type": "GENE"}, {"subject": "2',2'-difluorodeoxycytidine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DCK", "object_type": "GENE"}]}
{"text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.", "spo_list": [{"subject": "cytarabine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CDA", "object_type": "GENE"}, {"subject": "cytarabine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Lys27Gln", "object_type": "GENE"}, {"subject": "cytarabine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Ala70Thr", "object_type": "GENE"}, {"subject": "cytarabine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DCK", "object_type": "GENE"}, {"subject": "cytarabine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Ile24Val", "object_type": "GENE"}, {"subject": "cytarabine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Ala119Gly", "object_type": "GENE"}, {"subject": "cytarabine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Pro122Ser", "object_type": "GENE"}, {"subject": "Ara-C", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CDA", "object_type": "GENE"}, {"subject": "Ara-C", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Lys27Gln", "object_type": "GENE"}, {"subject": "Ara-C", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Ala70Thr", "object_type": "GENE"}, {"subject": "Ara-C", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DCK", "object_type": "GENE"}, {"subject": "Ara-C", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Ile24Val", "object_type": "GENE"}, {"subject": "Ara-C", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Ala119Gly", "object_type": "GENE"}, {"subject": "Ara-C", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Pro122Ser", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CDA", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Lys27Gln", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Ala70Thr", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DCK", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Ile24Val", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Ala119Gly", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Pro122Ser", "object_type": "GENE"}, {"subject": "2',2'-difluorodeoxyuridine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CDA", "object_type": "GENE"}, {"subject": "2',2'-difluorodeoxyuridine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Lys27Gln", "object_type": "GENE"}, {"subject": "2',2'-difluorodeoxyuridine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Ala70Thr", "object_type": "GENE"}, {"subject": "2',2'-difluorodeoxyuridine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DCK", "object_type": "GENE"}, {"subject": "2',2'-difluorodeoxyuridine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Ile24Val", "object_type": "GENE"}, {"subject": "2',2'-difluorodeoxyuridine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Ala119Gly", "object_type": "GENE"}, {"subject": "2',2'-difluorodeoxyuridine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Pro122Ser", "object_type": "GENE"}, {"subject": "dFdU", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CDA", "object_type": "GENE"}]}
{"text": "All three CDA proteins showed similar K(m) and V(max) for Ara-C and dFdC deamination, except for CDA70Thr, which had a 2.5-fold lower K(m) and 6-fold lower V(max) for Ara-C deamination.", "spo_list": [{"subject": "Ara-C", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CDA", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CDA", "object_type": "GENE"}, {"subject": "Ara-C", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CDA", "object_type": "GENE"}]}
{"text": "All four DCK proteins yielded comparable metabolic activity for Ara-C and dFdC monophosphorylation, except for DCK24Val, which demonstrated an approximately 2-fold increase (P < 0.05) in the intrinsic clearance of dFdC monophosphorylation due to a 40% decrease in K(m) (P < 0.05).", "spo_list": [{"subject": "Ara-C", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DCK", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DCK", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DCK", "object_type": "GENE"}]}
{"text": "In conclusion, the Lys27Gln substitution does not significantly modulate CDA activity toward dFdC, and therefore would not contribute to interindividual variability in response to gemcitabine.", "spo_list": [{"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CDA", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Lys27Gln", "object_type": "GENE"}]}
{"text": "The higher in vitro catalytic efficiency of DCK24Val toward dFdC monophosphorylation may be relevant to dFdC clinical response.", "spo_list": [{"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DCK", "object_type": "GENE"}, {"subject": "dFdC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "DCK", "object_type": "GENE"}]}
{"text": "The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).", "spo_list": [{"subject": "17-phenyl trinor PGE2", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "EP1", "object_type": "GENE"}, {"subject": "17-phenyl trinor PGE2", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "EP1", "object_type": "GENE"}, {"subject": "butaprost", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "EP2 receptors", "object_type": "GENE"}, {"subject": "butaprost", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "EP2", "object_type": "GENE"}, {"subject": "SC-51089", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "EP1", "object_type": "GENE"}, {"subject": "SC-51089", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "EP1", "object_type": "GENE"}, {"subject": "SC-51089", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "EP1", "object_type": "GENE"}, {"subject": "AH 6809", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "EP1", "object_type": "GENE"}, {"subject": "AH 6809", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "EP2 receptors", "object_type": "GENE"}, {"subject": "AH 6809", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "EP1", "object_type": "GENE"}, {"subject": "AH 6809", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "EP2", "object_type": "GENE"}, {"subject": "AH 6809", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "EP1", "object_type": "GENE"}, {"subject": "AH 6809", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "EP2", "object_type": "GENE"}]}
{"text": "In addition to this evidence (for the involvement of EP2 receptors), evidence for the involvement of EP1 receptors in the PGE1 mediated stimulation of Na,K-ATPase beta subunit gene transcription includes the stimulatory effect of 17-phenyl trinor PGE2, as well as the inhibitory effects of SC-51089.", "spo_list": [{"subject": "PGE1", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Na,K-ATPase beta", "object_type": "GENE"}, {"subject": "17-phenyl trinor PGE2", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Na,K-ATPase beta", "object_type": "GENE"}, {"subject": "SC-51089", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Na,K-ATPase beta", "object_type": "GENE"}]}
{"text": "Also consistent with the involvement of Gq coupled EP1 receptors, the PGE1 stimulation is inhibited by the PKCI vector (encoding the PKC inhibitory domain), the PKC inhibitor Go 6976, thapsigargin, as well as the calmodulin antagonists W7 and W13.", "spo_list": [{"subject": "thapsigargin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PKC", "object_type": "GENE"}, {"subject": "Go 6976", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PKC", "object_type": "GENE"}, {"subject": "W7", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "calmodulin", "object_type": "GENE"}, {"subject": "W13", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "calmodulin", "object_type": "GENE"}]}
{"text": "Our results showed that low dose BPA and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of Oct4 and Nanog proteins, while only BPA could downregulate the expression of E-cadherin protein.", "spo_list": [{"subject": "BPA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Oct4", "object_type": "GENE"}, {"subject": "BPA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Nanog", "object_type": "GENE"}, {"subject": "BPA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "E-cadherin", "object_type": "GENE"}]}
{"text": "Neither the superoxide radical scavenger, tiron, nor the inhibitor of the dopamine (DA) transporter, GBR 12909, prevented the metabolites' toxicity.", "spo_list": [{"subject": "GBR 12909", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dopamine (DA) transporter", "object_type": "GENE"}]}
{"text": "Importantly, pre-treatment with buthionine sulfoximine (BSO), an inhibitor of γ-GCS, prevented α-MeDA induced increase in GSH levels, but did not augment this metabolite cytotoxicity.", "spo_list": [{"subject": "buthionine sulfoximine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "γ-GCS", "object_type": "GENE"}, {"subject": "BSO", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "γ-GCS", "object_type": "GENE"}]}
{"text": "The tyrosine hydroxylase inhibitor α-methyltyrosine (300µM, 24h) completely abolished MeHg-induced DA release.", "spo_list": [{"subject": "α-methyltyrosine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine hydroxylase", "object_type": "GENE"}]}
{"text": "MeHg significantly increased DA precursor accumulation in cells treated with 3-hydroxybenzylhydrazine (10µM), revealing that MeHg increases tyrosine hydroxylase activity.", "spo_list": [{"subject": "MeHg", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "tyrosine hydroxylase", "object_type": "GENE"}]}
{"text": "Histamine enhances the depolarizing afterpotential of immunohistochemically identified vasopressin neurons in the rat supraoptic nucleus via H1-receptor activation.", "spo_list": [{"subject": "Histamine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "H1-receptor", "object_type": "GENE"}]}
{"text": "The enhancement of the depolarizing afterpotential by histamine was mimicked by the histamine H1-receptor agonist 2-thiazolylethylamine and was reduced or blocked by the H1-receptor antagonist promethazine, but was not blocked or reduced in the presence of the histamine H2-receptor antagonist, cimetidine.", "spo_list": [{"subject": "cimetidine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "histamine H2-receptor", "object_type": "GENE"}, {"subject": "2-thiazolylethylamine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "histamine H1-receptor", "object_type": "GENE"}, {"subject": "promethazine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "H1-receptor", "object_type": "GENE"}]}
{"text": "In summary, these results show that the excitatory effect of histamine on immunohistochemically identified vasopressin neurons in the supraoptic nucleus is due in part to the H1-receptor-mediated enhancement of the depolarizing afterpotential independent of any change in the afterhyperpolarizing potential or membrane potential.", "spo_list": [{"subject": "histamine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "H1-receptor", "object_type": "GENE"}]}
{"text": "Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.", "spo_list": [{"subject": "moclobemide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine oxidase-A", "object_type": "GENE"}, {"subject": "moclobemide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine oxidase", "object_type": "GENE"}, {"subject": "toloxatone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine oxidase-A", "object_type": "GENE"}, {"subject": "toloxatone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine oxidase", "object_type": "GENE"}]}
{"text": "1. The effects of two reversible, predominantly monoamine oxidase-A (MAO-A) inhibitors, moclobemide (150 mg three times daily) and toloxatone (400-200-400 mg day-1) on monoamine metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects.", "spo_list": [{"subject": "moclobemide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine oxidase-A", "object_type": "GENE"}, {"subject": "toloxatone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine oxidase-A", "object_type": "GENE"}]}
{"text": "4. Before the next drug intake, MAO-A inhibition, as judged by the decrease of plasma DHPG concentration, was significantly different from placebo with moclobemide but not with toloxatone.", "spo_list": [{"subject": "moclobemide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MAO-A", "object_type": "GENE"}, {"subject": "toloxatone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MAO-A", "object_type": "GENE"}]}
{"text": "Antiretroviral protease inhibitors lopinavir (LPV) and ritonavir (RTV) are reported BSEP inhibitors.", "spo_list": [{"subject": "lopinavir", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "protease", "object_type": "GENE"}, {"subject": "LPV", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "protease", "object_type": "GENE"}, {"subject": "ritonavir", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "protease", "object_type": "GENE"}, {"subject": "RTV", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "protease", "object_type": "GENE"}, {"subject": "lopinavir", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BSEP", "object_type": "GENE"}, {"subject": "LPV", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BSEP", "object_type": "GENE"}, {"subject": "ritonavir", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BSEP", "object_type": "GENE"}, {"subject": "RTV", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BSEP", "object_type": "GENE"}]}
{"text": "Adenine phosphoribosyltransferase plays a role in purine salvage by catalyzing the direct conversion of adenine to adenosine monophosphate.", "spo_list": [{"subject": "adenine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Adenine phosphoribosyltransferase", "object_type": "GENE"}, {"subject": "adenosine monophosphate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Adenine phosphoribosyltransferase", "object_type": "GENE"}]}
{"text": "We have expressed and characterized recombinant, N-terminally His-tagged human adenine phosphoribosyltransferase.", "spo_list": [{"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "human adenine phosphoribosyltransferase", "object_type": "GENE"}]}
{"text": "Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect.", "spo_list": [{"subject": "minoxidil", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "prostaglandin synthase-1", "object_type": "GENE"}]}
{"text": "We thus speculated that activation of PGHS-1 might be a mechanism by which minoxidil (2,4-diamino-6-piperidinopyrimidine-3-oxyde) stimulates hair growth in vivo.", "spo_list": [{"subject": "minoxidil", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PGHS-1", "object_type": "GENE"}, {"subject": "2,4-diamino-6-piperidinopyrimidine-3-oxyde", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PGHS-1", "object_type": "GENE"}]}
{"text": "We demonstrate here that minoxidil is a potent activator of purified PGHS-1 (AC50 = 80 microM), as assayed by oxygen consumption and PGE2 production.", "spo_list": [{"subject": "minoxidil", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PGHS-1", "object_type": "GENE"}]}
{"text": "We studied in a clinical trial whether isolated isoflavone treatment in postmenopausal women could affect reverse cholesterol transport as evaluated by adenosine triphosphate-binding cassette A1- (ABCA1), dependent cholesterol efflux from macrophages.", "spo_list": [{"subject": "cholesterol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "adenosine triphosphate-binding cassette A1", "object_type": "GENE"}, {"subject": "cholesterol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ABCA1", "object_type": "GENE"}]}
{"text": "[H]-Cholesterol-labeled J774 macrophage cells, with and without ABCA1 up-regulation, were incubated with the samples, and ABCA1-dependent cholesterol efflux and serum lipid and lipoprotein levels were assessed.", "spo_list": [{"subject": "cholesterol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ABCA1", "object_type": "GENE"}]}
{"text": "Thus, isoflavone supplementation did not affect ABCA1-dependent cholesterol efflux to serum.", "spo_list": [{"subject": "cholesterol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ABCA1", "object_type": "GENE"}]}
{"text": "However, as a novel finding, isoflavone treatment increased a subclass of high-density lipoprotein, the pre-beta high-density lipoprotein levels by 18% without affecting any other serum lipid concentrations.", "spo_list": [{"subject": "isoflavone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "high-density lipoprotein", "object_type": "GENE"}, {"subject": "isoflavone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "pre-beta high-density lipoprotein", "object_type": "GENE"}]}
{"text": "ABCA1-facilitated cholesterol efflux and lipid parameters did not differ between equol-producing and non-equol-producing women.", "spo_list": [{"subject": "cholesterol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ABCA1", "object_type": "GENE"}]}
{"text": "CONCLUSION: In postmenopausal women, isolated isoflavone treatment does not affect ABCA1-dependent cholesterol efflux potential from macrophages but increases circulating pre-beta high-density lipoprotein level, which could provide beneficial vascular effects.", "spo_list": [{"subject": "cholesterol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ABCA1", "object_type": "GENE"}, {"subject": "isoflavone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "pre-beta high-density lipoprotein", "object_type": "GENE"}]}
{"text": "Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes.", "spo_list": [{"subject": "Gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "nitric-oxide synthase", "object_type": "GENE"}, {"subject": "nitric-oxide", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "nitric-oxide synthase", "object_type": "GENE"}]}
{"text": "Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of inducible nitric-oxide synthase (iNOS) in human U373MG astroglial cells and primary astrocytes.", "spo_list": [{"subject": "Gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "inducible nitric-oxide synthase", "object_type": "GENE"}, {"subject": "Gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "Gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cytokine", "object_type": "GENE"}, {"subject": "NO", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "inducible nitric-oxide synthase", "object_type": "GENE"}, {"subject": "NO", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "iNOS", "object_type": "GENE"}, {"subject": "nitric-oxide", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "inducible nitric-oxide synthase", "object_type": "GENE"}, {"subject": "nitric-oxide", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "iNOS", "object_type": "GENE"}]}
{"text": "Similar to gemfibrozil, clofibrate, another fibrate drug, also inhibited the expression of iNOS.", "spo_list": [{"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "clofibrate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "fibrate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "iNOS", "object_type": "GENE"}]}
{"text": "Inhibition of human iNOS promoter-driven luciferase activity by gemfibrozil in cytokine-stimulated U373MG astroglial cells suggests that this compound inhibits the transcription of iNOS.", "spo_list": [{"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "human iNOS promoter", "object_type": "GENE"}]}
{"text": "Since gemfibrozil is known to activate peroxisome proliferator-activated receptor-alpha (PPAR-alpha), we investigated the role of PPAR-alpha in gemfibrozil-mediated inhibition of iNOS.", "spo_list": [{"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "peroxisome proliferator-activated receptor-alpha", "object_type": "GENE"}, {"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PPAR-alpha", "object_type": "GENE"}, {"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PPAR-alpha", "object_type": "GENE"}, {"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "iNOS", "object_type": "GENE"}]}
{"text": "Gemfibrozil induced peroxisome proliferator-responsive element (PPRE)-dependent luciferase activity, which was inhibited by the expression of DeltahPPAR-alpha, the dominant-negative mutant of human PPAR-alpha.", "spo_list": [{"subject": "Gemfibrozil", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "peroxisome proliferator-responsive element", "object_type": "GENE"}, {"subject": "Gemfibrozil", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "PPRE", "object_type": "GENE"}]}
{"text": "However, DeltahPPAR-alpha was unable to abrogate gemfibrozil-mediated inhibition of iNOS suggesting that gemfibrozil inhibits iNOS independent of PPAR-alpha.", "spo_list": [{"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "iNOS", "object_type": "GENE"}]}
{"text": "Interestingly, gemfibrozil strongly inhibited the activation of NF-kappaB, AP-1, and C/EBPbeta but not that of GAS in cytokine-stimulated astroglial cells.", "spo_list": [{"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NF-kappaB", "object_type": "GENE"}, {"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AP-1", "object_type": "GENE"}, {"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "C/EBPbeta", "object_type": "GENE"}]}
{"text": "These results suggest that gemfibrozil inhibits the induction of iNOS probably by inhibiting the activation of NF-kappaB, AP-1, and C/EBPbeta and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases.", "spo_list": [{"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "iNOS", "object_type": "GENE"}, {"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NF-kappaB", "object_type": "GENE"}, {"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AP-1", "object_type": "GENE"}, {"subject": "gemfibrozil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "C/EBPbeta", "object_type": "GENE"}]}
{"text": "Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans.", "spo_list": [{"subject": "serotonin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "serotonin 5-HT(4) receptor", "object_type": "GENE"}, {"subject": "SB-207266", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "serotonin 5-HT(4) receptor", "object_type": "GENE"}]}
{"text": "BACKGROUND: Serotonin 5-HT(4) receptors are located on enteric cholinergic neurones and may regulate peristalsis.", "spo_list": [{"subject": "Serotonin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Serotonin 5-HT(4) receptors", "object_type": "GENE"}]}
{"text": "METHODS: Part A compared the effects of placebo to four doses of a 5-HT(4) receptor antagonist (SB-207266) on the cisapride mediated increase in plasma aldosterone (a 5-HT(4) mediated response) and orocaecal transit in 18 subjects.", "spo_list": [{"subject": "cisapride", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT(4)", "object_type": "GENE"}, {"subject": "SB-207266", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT(4)", "object_type": "GENE"}, {"subject": "SB-207266", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT(4)", "object_type": "GENE"}]}
{"text": "PNU-282987 on the other hand displayed an increase in anxiety-like behavior at a higher dose (10 mg/kg) that was significantly reduced by the serotonin 5-HT1a receptor antagonist WAY-100135.", "spo_list": [{"subject": "WAY-100135", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "serotonin 5-HT1a receptor", "object_type": "GENE"}]}
{"text": "However the α7 receptor antagonist methyllycaconitine was unable to reverse these anxiety-like effects seen with PNU-282987.", "spo_list": [{"subject": "methyllycaconitine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "α7 receptor", "object_type": "GENE"}]}
{"text": "Peginesatide, a polyethylene glycol (PEG)ylated peptide-based erythropoiesis-stimulating agent, stimulates the erythropoietin receptor dimer that governs erythropoiesis.", "spo_list": [{"subject": "Peginesatide", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "erythropoietin receptor", "object_type": "GENE"}, {"subject": "polyethylene glycol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "erythropoietin receptor", "object_type": "GENE"}, {"subject": "PEG", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "erythropoietin receptor", "object_type": "GENE"}]}
{"text": "Indomethacin, piroxicam, and sulindac sulfide were found to preferentially inhibit PGHS-1.", "spo_list": [{"subject": "Indomethacin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PGHS-1", "object_type": "GENE"}, {"subject": "piroxicam", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PGHS-1", "object_type": "GENE"}, {"subject": "sulindac sulfide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PGHS-1", "object_type": "GENE"}]}
{"text": "6-Methoxy-2-naphthylacetic acid, the active metabolite of Relafen, inhibits murine PGHS-2 preferentially.", "spo_list": [{"subject": "6-Methoxy-2-naphthylacetic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PGHS-2", "object_type": "GENE"}, {"subject": "Relafen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PGHS-2", "object_type": "GENE"}]}
{"text": "Aspirin irreversibly inhibits PGHS-1, preventing this isozyme from forming PGH2 or any other oxygenated product; in contrast, aspirin treatment of PGHS-2 causes this enzyme to form 15-hydroxy-5c,8c,11c,13t-eicosatetraenoic acid (15-HETE) instead of PGH2.", "spo_list": [{"subject": "Aspirin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PGHS-1", "object_type": "GENE"}, {"subject": "15-hydroxy-5c,8c,11c,13t-eicosatetraenoic acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PGHS-2", "object_type": "GENE"}, {"subject": "15-HETE", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PGHS-2", "object_type": "GENE"}]}
{"text": "In alpha(2A)-adrenoceptor transfected cells the rank order of agonist potency was A-54741 (mean pEC(50)=8.96)>dexmedetomidine (8.88)>UK-14304 (8.42)>B-HT 920 (7.05)>noradrenaline (6.92).", "spo_list": [{"subject": "A-54741", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha(2A)-adrenoceptor", "object_type": "GENE"}, {"subject": "dexmedetomidine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha(2A)-adrenoceptor", "object_type": "GENE"}, {"subject": "UK-14304", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha(2A)-adrenoceptor", "object_type": "GENE"}, {"subject": "B-HT 920", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha(2A)-adrenoceptor", "object_type": "GENE"}, {"subject": "noradrenaline", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha(2A)-adrenoceptor", "object_type": "GENE"}]}
{"text": "3. The selective alpha(2)-adrenoceptor ligand rauwolscine antagonized acidification rate changes with an affinity independent of the agonist used; the affinity (mean pK(B)) against noradrenaline was 8.43.", "spo_list": [{"subject": "rauwolscine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha(2)-adrenoceptor", "object_type": "GENE"}]}
{"text": "4. The selective alpha(1)-adrenoceptor ligands prazosin and doxazosin (each 3 microM) had no effect on noradrenaline responses.", "spo_list": [{"subject": "prazosin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha(1)-adrenoceptor", "object_type": "GENE"}, {"subject": "doxazosin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha(1)-adrenoceptor", "object_type": "GENE"}]}
{"text": "The Ki for mycophenolic acid inhibition of the L263F variant was comparable with the wild-type, and the variant Km for inosine 5'-monophosphate and nicotinamide adenine dinucleotide did not change significantly.", "spo_list": [{"subject": "mycophenolic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "L263F", "object_type": "GENE"}]}
{"text": "Recent literature shows that Brassica vegetables (Cruciferae) possess therapeutic effects particularly ascribed due to their content in glucosinolates, which upon myrosinase hydrolysis release the corresponding isothiocyanates.", "spo_list": [{"subject": "isothiocyanates", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "myrosinase", "object_type": "GENE"}, {"subject": "glucosinolates", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "myrosinase", "object_type": "GENE"}]}
{"text": "RESULTS: By Western blot analysis of spinal cord tissues, we have demonstrated that treatment with bioactive RS -GRA significantly decreased nuclear factor (NF)-kB translocation, pro-inflammatory cytokine production such as interleukin-1β (IL-1β), and apoptosis (Bax and caspase 3 expression).", "spo_list": [{"subject": "RS -GRA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "nuclear factor (NF)-kB", "object_type": "GENE"}, {"subject": "RS -GRA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cytokine", "object_type": "GENE"}, {"subject": "RS -GRA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "interleukin-1β", "object_type": "GENE"}, {"subject": "RS -GRA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-1β", "object_type": "GENE"}, {"subject": "RS -GRA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Bax", "object_type": "GENE"}, {"subject": "RS -GRA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "caspase 3", "object_type": "GENE"}]}
{"text": "The solubility-driven structural modification of (pyridin-3-yl) benzoxazinyl-oxazolidinones is described, which resulted in the development of a new series of benzoxazinyl-oxazolidinone analogues with high antibacterial activity against Gram-positive pathogens, including that against linezolid-resistant strains and low hERG inhibition.", "spo_list": [{"subject": "benzoxazinyl-oxazolidinone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "hERG", "object_type": "GENE"}]}
{"text": "Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification.", "spo_list": [{"subject": "pSer", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Pin1", "object_type": "GENE"}, {"subject": "pThr", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Pin1", "object_type": "GENE"}, {"subject": "Pro", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Pin1", "object_type": "GENE"}, {"subject": "pSer", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "peptidyl-prolyl cis/trans-isomerase A1", "object_type": "GENE"}, {"subject": "pThr", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "peptidyl-prolyl cis/trans-isomerase A1", "object_type": "GENE"}, {"subject": "Pro", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "peptidyl-prolyl cis/trans-isomerase A1", "object_type": "GENE"}]}
{"text": "Incubation of purified Pin1 with HNE followed by MALDI-TOF/TOF mass spectrometry resulted in detection of Michael adducts at the active site residues His-157 and Cys-113.", "spo_list": [{"subject": "His", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Pin1", "object_type": "GENE"}, {"subject": "Cys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Pin1", "object_type": "GENE"}]}
{"text": "Furthermore, orbitrap MS data support the adduction of Cys-113 in the Pin1 active site upon HNE treatment of MDA-MB-231 cells. siRNA knockdown of Pin1 in MDA-MB-231 cells partially protected the cells from HNE-induced toxicity.", "spo_list": [{"subject": "Cys", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Pin1", "object_type": "GENE"}]}
{"text": "Galanin attenuates cyclic AMP regulatory element-binding protein (CREB) phosphorylation induced by chronic morphine and naloxone challenge in Cath.a cells and primary striatal cultures.", "spo_list": [{"subject": "morphine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "cyclic AMP regulatory element-binding protein", "object_type": "GENE"}, {"subject": "naloxone", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "cyclic AMP regulatory element-binding protein", "object_type": "GENE"}, {"subject": "morphine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "CREB", "object_type": "GENE"}, {"subject": "naloxone", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "CREB", "object_type": "GENE"}]}
{"text": "As a result of this study, microgrewiapine A (1) was found to be a selective cytotoxic agent for colon cancer cells over normal colon cells and to exhibit nicotinic receptor antagonistic activity for both the hα3β4 and hα4β2 receptor subtypes.", "spo_list": [{"subject": "microgrewiapine A", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "nicotinic receptor", "object_type": "GENE"}]}
{"text": "Mechanistic Aspects of hSOD1 Maturation from the Solution Structure of Cu(I) -Loaded hCCS Domain 1 and Analysis of Disulfide-Free hSOD1 Mutants.", "spo_list": [{"subject": "Cu(I)", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "hSOD1", "object_type": "GENE"}, {"subject": "Cu(I)", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "hCCS Domain 1", "object_type": "GENE"}]}
{"text": "We recently showed that the first domain of human CCS (hCCSD1) is responsible for copper transfer to its protein partner, human SOD1 (hSOD1).", "spo_list": [{"subject": "copper", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human CCS", "object_type": "GENE"}, {"subject": "copper", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "hCCSD1", "object_type": "GENE"}, {"subject": "copper", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human SOD1", "object_type": "GENE"}, {"subject": "copper", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "hSOD1", "object_type": "GENE"}]}
{"text": "The NMR solution structure of the copper(I)-loaded form of hCCSD1 reported here contributes further to characterization of the copper-transfer mechanism to hSOD1.", "spo_list": [{"subject": "copper(I)", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "hCCSD1", "object_type": "GENE"}]}
{"text": "NMR spectroscopy was also used to examine the hSOD1 mutants C57A, C146A, and C57A/C146A, which are unable to form the structurally conserved disulfide bond in SOD1, in order to investigate the role of these cysteines during hSOD1 copper acquisition.", "spo_list": [{"subject": "cysteines", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "hSOD1", "object_type": "GENE"}]}
{"text": "Together, the information on both hCCS and hSOD1, along with a sequence analysis of eukaryotic CCSD1, allows us to propose important mechanistic aspects regarding the copper-transfer process from hCCS to hSOD1.", "spo_list": [{"subject": "copper", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "hCCS", "object_type": "GENE"}, {"subject": "copper", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "hSOD1", "object_type": "GENE"}]}
{"text": "Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.", "spo_list": [{"subject": "zolmitriptan", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5HT1B/1D", "object_type": "GENE"}, {"subject": "Zomig", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5HT1B/1D", "object_type": "GENE"}, {"subject": "311C90", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5HT1B/1D", "object_type": "GENE"}]}
{"text": "Zolmitriptan (Zomig; formerly 311C90) is a novel 5-hydroxytryptamine (5HT)1B/1D receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura.", "spo_list": [{"subject": "311C90", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-hydroxytryptamine (5HT)1B/1D", "object_type": "GENE"}, {"subject": "Zolmitriptan", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-hydroxytryptamine (5HT)1B/1D", "object_type": "GENE"}, {"subject": "Zomig", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-hydroxytryptamine (5HT)1B/1D", "object_type": "GENE"}]}
{"text": "Consistent with its selectivity for 5HT1B/1D receptors, zolmitriptan produces constriction of various isolated blood vessels, most notably cranial arteries.", "spo_list": [{"subject": "zolmitriptan", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5HT1B/1D", "object_type": "GENE"}]}
{"text": "These actions are consistent with a pre-junctional inhibition of neuropeptide release from perivascular afferents of the trigeminal nerve, as confirmed by independent studies showing that zolmitriptan blocks elevations of calcitonin-gene-related peptide in jugular venous blood during electrical stimulation of the trigeminal ganglion.", "spo_list": [{"subject": "zolmitriptan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "calcitonin-gene-related peptide", "object_type": "GENE"}]}
{"text": "The compounds 5'-azacytidine (AZC) and procainamide (PCA) belong to inhibitors of DNMT1, whose low activity correlates with increase in transcription of various genes.", "spo_list": [{"subject": "5'-azacytidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DNMT1", "object_type": "GENE"}, {"subject": "AZC", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DNMT1", "object_type": "GENE"}, {"subject": "procainamide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DNMT1", "object_type": "GENE"}, {"subject": "PCA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DNMT1", "object_type": "GENE"}]}
{"text": "However, the flowcytometric analysis revealed that AZC and PCA decreased intracellular contents of CD3-zeta chain in these cells in dose dependent manner.", "spo_list": [{"subject": "AZC", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "CD3-zeta chain", "object_type": "GENE"}, {"subject": "PCA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "CD3-zeta chain", "object_type": "GENE"}]}
{"text": "DBDCT up-regulated the expression of Bax, down-regulated the expression of Bcl-2, and significantly increased the ratio of Bax/Bcl-2.", "spo_list": [{"subject": "DBDCT", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Bax", "object_type": "GENE"}, {"subject": "DBDCT", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Bcl-2", "object_type": "GENE"}, {"subject": "DBDCT", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Bax", "object_type": "GENE"}, {"subject": "DBDCT", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Bcl-2", "object_type": "GENE"}]}
{"text": "DBDCT also caused the phosphorylation of JNK and p38(MAPK).", "spo_list": [{"subject": "DBDCT", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "JNK", "object_type": "GENE"}, {"subject": "DBDCT", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "p38", "object_type": "GENE"}, {"subject": "DBDCT", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "MAPK", "object_type": "GENE"}]}
{"text": "Assessment of the abuse liability of ABT-288, a novel histamine H3 receptor antagonist.", "spo_list": [{"subject": "ABT-288", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "histamine H3 receptor", "object_type": "GENE"}]}
{"text": "RATIONALE: Histamine H3 receptor antagonists, such as ABT-288, have been shown to possess cognitive-enhancing and wakefulness-promoting effects.", "spo_list": [{"subject": "ABT-288", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "Histamine H3 receptor", "object_type": "GENE"}]}
{"text": "CONCLUSIONS: The sum of these preclinical data, the first of their kind applied to H3 antagonists, indicates that ABT-288 is unlikely to possess a high potential for abuse in the human population and suggests that H3 antagonists, as a class, are similar in this regard.", "spo_list": [{"subject": "ABT-288", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "H3", "object_type": "GENE"}]}
{"text": "Mouse brain serine racemase catalyzes specific elimination of L-serine to pyruvate.", "spo_list": [{"subject": "L-serine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Mouse brain serine racemase", "object_type": "GENE"}, {"subject": "pyruvate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Mouse brain serine racemase", "object_type": "GENE"}]}
{"text": "D-Serine was previously identified in mammalian brain and was shown to be a co-agonist at the 'glycine' site of the N-methyl-D-aspartate (NMDA)-type receptors.", "spo_list": [{"subject": "glycine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "N-methyl-D-aspartate (NMDA)-type receptors", "object_type": "GENE"}, {"subject": "D-Serine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "N-methyl-D-aspartate (NMDA)-type receptors", "object_type": "GENE"}]}
{"text": "Racemization of serine is catalyzed by serine racemase, a pyridoxal 5'-phosphate-dependent enzyme expressed mainly in brain and liver.", "spo_list": [{"subject": "serine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "serine racemase", "object_type": "GENE"}]}
{"text": "Contribution of the Na+-K+-2Cl- cotransporter NKCC1 to Cl- secretion in rat OMCD.", "spo_list": [{"subject": "Cl-", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NKCC1", "object_type": "GENE"}, {"subject": "Cl-", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Na+-K+-2Cl- cotransporter", "object_type": "GENE"}]}
{"text": "The purpose of this study was to determine whether rat outer medullary collecting duct (OMCD) secretes Cl- and whether transepithelial Cl- transport occurs, in part, through Cl- uptake across the basolateral membrane mediated by NKCC1 in series with Cl- efflux across the apical membrane.", "spo_list": [{"subject": "Cl-", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NKCC1", "object_type": "GENE"}, {"subject": "Cl-", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NKCC1", "object_type": "GENE"}]}
{"text": "Bumetanide-sensitive Cl- secretion was dependent on extracellular Na+ and either K+ or NH, consistent with the ion dependency of NKCC1-mediated Cl- transport.", "spo_list": [{"subject": "Cl-", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NKCC1", "object_type": "GENE"}]}
{"text": "In conclusion, OMCD tubules from deoxycorticosterone pivalate-treated rats secrete Cl- into the luminal fluid through NKCC1-mediated Cl- uptake across the basolateral membrane in series with Cl- efflux across the apical membrane.", "spo_list": [{"subject": "Cl-", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NKCC1", "object_type": "GENE"}, {"subject": "Cl-", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NKCC1", "object_type": "GENE"}, {"subject": "Cl-", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NKCC1", "object_type": "GENE"}]}
{"text": "The physiological role of NKCC1-mediated Cl- uptake remains to be determined.", "spo_list": [{"subject": "Cl-", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NKCC1", "object_type": "GENE"}]}
{"text": "At least 4 h of estrogen pre-treatment was required to elicit protection, an effect that was blocked by the ER antagonist, ICI 182,780.", "spo_list": [{"subject": "ICI 182,780", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "ER", "object_type": "GENE"}]}
{"text": "Moreover, ERalpha mediated the protection afforded by estrogen since only the ERalpha agonist, HPTE, but not the ERbeta agonist, DPN, protected against dopamine cell loss.", "spo_list": [{"subject": "DPN", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "ERbeta", "object_type": "GENE"}]}
{"text": "Phenothiazines inhibit S100A4 function by inducing protein oligomerization.", "spo_list": [{"subject": "Phenothiazines", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "S100A4", "object_type": "GENE"}]}
{"text": "Using a unique biosensor-based assay, trifluoperazine (TFP) was identified as an inhibitor that disrupts the S100A4/myosin-IIA interaction.", "spo_list": [{"subject": "trifluoperazine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "S100A4", "object_type": "GENE"}, {"subject": "trifluoperazine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "myosin-IIA", "object_type": "GENE"}, {"subject": "TFP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "S100A4", "object_type": "GENE"}, {"subject": "TFP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "myosin-IIA", "object_type": "GENE"}]}
{"text": "To examine the interaction of S100A4 with TFP, we determined the 2.3 A crystal structure of human Ca(2+)-S100A4 bound to TFP.", "spo_list": [{"subject": "TFP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "S100A4", "object_type": "GENE"}]}
{"text": "Two TFP molecules bind within the hydrophobic target binding pocket of Ca(2+)-S100A4 with no significant conformational changes observed in the protein upon complex formation.", "spo_list": [{"subject": "TFP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "S100A4", "object_type": "GENE"}]}
{"text": "NMR chemical shift perturbations are consistent with the crystal structure and demonstrate that TFP binds to the target binding cleft of S100A4 in solution.", "spo_list": [{"subject": "TFP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "S100A4", "object_type": "GENE"}]}
{"text": "Remarkably, TFP binding results in the assembly of five Ca(2+)-S100A4/TFP dimers into a tightly packed pentameric ring.", "spo_list": [{"subject": "TFP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "S100A4", "object_type": "GENE"}]}
{"text": "Within each pentamer most of the contacts between S100A4 dimers occurs through the TFP moieties.", "spo_list": [{"subject": "TFP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "S100A4", "object_type": "GENE"}]}
{"text": "The Ca(2+)-S100A4/prochlorperazine (PCP) complex exhibits a similar pentameric assembly.", "spo_list": [{"subject": "prochlorperazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "S100A4", "object_type": "GENE"}, {"subject": "PCP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "S100A4", "object_type": "GENE"}]}
{"text": "Equilibrium sedimentation and cross-linking studies demonstrate the cooperative formation of a similarly sized S100A4/TFP oligomer in solution.", "spo_list": [{"subject": "TFP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "S100A4", "object_type": "GENE"}]}
{"text": "Assays examining the ability of TFP to block S100A4-mediated disassembly of myosin-IIA filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization.", "spo_list": [{"subject": "TFP", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "S100A4", "object_type": "GENE"}, {"subject": "TFP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "S100A4", "object_type": "GENE"}, {"subject": "TFP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "myosin-IIA", "object_type": "GENE"}, {"subject": "TFP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "S100A4", "object_type": "GENE"}]}
{"text": "Together these studies support a unique mode of inhibition in which phenothiazines disrupt the S100A4/myosin-IIA interaction by sequestering S100A4 via small molecule-induced oligomerization.", "spo_list": [{"subject": "phenothiazines", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "S100A4", "object_type": "GENE"}, {"subject": "phenothiazines", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "myosin-IIA", "object_type": "GENE"}]}
{"text": "Treatment with carvedilol reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and NGF-beta to the baseline values.", "spo_list": [{"subject": "carvedilol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "HIF-1alpha", "object_type": "GENE"}, {"subject": "carvedilol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "VEGF", "object_type": "GENE"}, {"subject": "carvedilol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "BNP", "object_type": "GENE"}, {"subject": "carvedilol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "NGF-beta", "object_type": "GENE"}]}
{"text": "Increased immunohistochemical labeling of HIF-1alpha, VEGF, and BNP in the ventricular myocardium was observed in the shunt group and carvedilol again normalized the labeling.", "spo_list": [{"subject": "carvedilol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "HIF-1alpha", "object_type": "GENE"}, {"subject": "carvedilol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "VEGF", "object_type": "GENE"}, {"subject": "carvedilol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "BNP", "object_type": "GENE"}]}
{"text": "Treatment with carvedilol is associated with a reversal of abnormal regulation of HIF-1alpha and VEGF in the failing ventricular myocardium.", "spo_list": [{"subject": "carvedilol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "HIF-1alpha", "object_type": "GENE"}, {"subject": "carvedilol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "VEGF", "object_type": "GENE"}]}
{"text": "Pentosan polysulfate sodium (PPS) has been shown to exert antitumor activity by antagonizing the binding of bFGF to cell surface receptors.", "spo_list": [{"subject": "sodium", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "bFGF", "object_type": "GENE"}, {"subject": "sodium", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "bFGF", "object_type": "GENE"}]}
{"text": "Effect of lintitript, a new CCK-A receptor antagonist, on gastric emptying of a solid-liquid meal in humans.", "spo_list": [{"subject": "lintitript", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "CCK-A receptor", "object_type": "GENE"}]}
{"text": "We studied the role of endogenous CCK in the emptying of a solid/liquid meal administering the new, highly specific and potent CCK-A receptor antagonist lintitript.", "spo_list": [{"subject": "lintitript", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "CCK-A receptor", "object_type": "GENE"}]}
{"text": "Lintitript markedly increased postprandial plasma CCK release (P<0.001) while distinctly reducing postprandial PP levels (P<0.01) as compared to placebo.", "spo_list": [{"subject": "Lintitript", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CCK", "object_type": "GENE"}, {"subject": "Lintitript", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "PP", "object_type": "GENE"}]}
{"text": "The study demonstrates for the first time the marked gastrokinetic properties of the new CCK-A receptor antagonist lintitript in humans.", "spo_list": [{"subject": "lintitript", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "CCK-A receptor", "object_type": "GENE"}]}
{"text": "Diet, physical exercise and Orlistat administration increase serum Anti-Müllerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).", "spo_list": [{"subject": "Orlistat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Anti-Müllerian Hormone", "object_type": "GENE"}, {"subject": "Orlistat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "AMH", "object_type": "GENE"}]}
{"text": "We concluded that in overweight and obese women with PCOS Orlistat administration, combined with diet and physical exercise, for 24 weeks, resulted in significant weight loss, improvement of hyperandrogenism and insulin sensitivity, and increased serum AMH levels.", "spo_list": [{"subject": "Orlistat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "AMH", "object_type": "GENE"}]}
{"text": "COX-1 inhibition was measured as percentage inhibition of serum TXB2 generation in clotting whole blood, and as closure time with use of the platelet function analyser PFA-100.", "spo_list": [{"subject": "TXB2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-1", "object_type": "GENE"}]}
{"text": "Cholinesterase inhibitors enhance cholinergic transmission directly by inhibiting the enzyme acetylcholinesterase (AChE) which hydrolyses acetylcholine.", "spo_list": [{"subject": "acetylcholine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "acetylcholinesterase", "object_type": "GENE"}, {"subject": "acetylcholine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "AChE", "object_type": "GENE"}]}
{"text": "This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogues developed for the treatment of AD.", "spo_list": [{"subject": "tacrine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cholinesterase", "object_type": "GENE"}, {"subject": "donepezil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cholinesterase", "object_type": "GENE"}, {"subject": "rivastigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cholinesterase", "object_type": "GENE"}, {"subject": "galantamine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cholinesterase", "object_type": "GENE"}, {"subject": "xanthostigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cholinesterase", "object_type": "GENE"}, {"subject": "para-aminobenzoic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cholinesterase", "object_type": "GENE"}, {"subject": "coumarin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cholinesterase", "object_type": "GENE"}, {"subject": "flavonoid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cholinesterase", "object_type": "GENE"}, {"subject": "pyrrolo-isoxazole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cholinesterase", "object_type": "GENE"}]}
{"text": "Chronic insulin (24 h) activates NHE3 through the classic phosphatidylinositol 3-kinase-serum- and glucocorticoid-dependent kinase 1 (PI3K-SGK1) pathway as insulin stimulates SGK1 phosphorylation and the insulin effect can be blocked by the PI3K inhibitor wortmannin or a dominant-negative SGK1.", "spo_list": [{"subject": "wortmannin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "phosphatidylinositol 3-kinase", "object_type": "GENE"}, {"subject": "wortmannin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PI3K", "object_type": "GENE"}, {"subject": "wortmannin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PI3K", "object_type": "GENE"}]}
{"text": "Hydrogen sulphide (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS).", "spo_list": [{"subject": "L-cysteine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cystathionine-gamma-lyase", "object_type": "GENE"}, {"subject": "Hydrogen sulphide", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "cystathionine-gamma-lyase", "object_type": "GENE"}, {"subject": "H(2)S", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "cystathionine-gamma-lyase", "object_type": "GENE"}, {"subject": "Hydrogen sulphide", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "CSE", "object_type": "GENE"}, {"subject": "H(2)S", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "CSE", "object_type": "GENE"}, {"subject": "L-cysteine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CSE", "object_type": "GENE"}, {"subject": "Hydrogen sulphide", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "cystathionine-beta-synthase", "object_type": "GENE"}, {"subject": "Hydrogen sulphide", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "CBS", "object_type": "GENE"}, {"subject": "H(2)S", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "cystathionine-beta-synthase", "object_type": "GENE"}, {"subject": "H(2)S", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "CBS", "object_type": "GENE"}, {"subject": "L-cysteine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cystathionine-beta-synthase", "object_type": "GENE"}, {"subject": "L-cysteine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CBS", "object_type": "GENE"}]}
{"text": "In this study, we investigated the presence of H(2)S and the expression of H(2)S synthesizing enzymes, CSE and CBS, in isolated mouse pancreatic acini.", "spo_list": [{"subject": "H(2)S", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "CSE", "object_type": "GENE"}, {"subject": "H(2)S", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "CBS", "object_type": "GENE"}]}
{"text": "Caerulein increased the levels of H(2)S and CSE mRNA expression while CBS mRNA expression was decreased.", "spo_list": [{"subject": "Caerulein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CSE", "object_type": "GENE"}, {"subject": "Caerulein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "CBS", "object_type": "GENE"}]}
{"text": "In addition, cells pre-treated with DL-propargylglycine (PAG, 3 mM), a CSE inhibitor, reduced the formation of H(2)S in caerulein treated cells, suggesting that CSE may be the main enzyme involved in H(2)S formation in mouse acinar cells.", "spo_list": [{"subject": "DL-propargylglycine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CSE", "object_type": "GENE"}, {"subject": "PAG", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CSE", "object_type": "GENE"}, {"subject": "H(2)S", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "CSE", "object_type": "GENE"}]}
{"text": "Furthermore, substance P (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue caerulein-treated acinar cells.", "spo_list": [{"subject": "caerulein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "substance P", "object_type": "GENE"}, {"subject": "caerulein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "SP", "object_type": "GENE"}, {"subject": "caerulein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "SP", "object_type": "GENE"}, {"subject": "caerulein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "preprotachykinin-A", "object_type": "GENE"}, {"subject": "caerulein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PPT-A", "object_type": "GENE"}, {"subject": "caerulein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "neurokinin-1 receptor", "object_type": "GENE"}, {"subject": "caerulein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "NK-1R", "object_type": "GENE"}]}
{"text": "Inhibition of endogenous production of H(2)S by PAG significantly suppressed SP concentration, PPT-A expression and NK1-R expression in the acini.", "spo_list": [{"subject": "H(2)S", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "SP", "object_type": "GENE"}, {"subject": "H(2)S", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "PPT-A", "object_type": "GENE"}, {"subject": "H(2)S", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "NK1-R", "object_type": "GENE"}]}
{"text": "To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, sodium hydrosulphide (NaHS), (10, 50 and 100 muM), that resulted in a significant increase in SP concentration and expression of PPT-A and NK1-R in acinar cells.", "spo_list": [{"subject": "sodium hydrosulphide", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "SP", "object_type": "GENE"}, {"subject": "NaHS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "SP", "object_type": "GENE"}, {"subject": "sodium hydrosulphide", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PPT-A", "object_type": "GENE"}, {"subject": "NaHS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PPT-A", "object_type": "GENE"}, {"subject": "sodium hydrosulphide", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "NK1-R", "object_type": "GENE"}, {"subject": "NaHS", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "NK1-R", "object_type": "GENE"}]}
{"text": "These results suggest that the pro-inflammatory effect of H(2)S may be mediated by SP-NK-1R related pathway in mouse pancreatic acinar cells.", "spo_list": [{"subject": "H(2)S", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "NK-1R", "object_type": "GENE"}, {"subject": "H(2)S", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "SP", "object_type": "GENE"}]}
{"text": "RESULTS: Ethanol given to rats in drinking water decreased the level of p-CREB protein in the nucleus accumbens (-75 %) at the time of exposure to ethanol.", "spo_list": [{"subject": "Ethanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "p-CREB", "object_type": "GENE"}]}
{"text": "The decrement of p-CREB protein in the nucleus accumbens remained at 24 h (-35 %) and 72 h (-28 %) of ethanol withdrawal, which recovered toward control level after 7 d of ethanol withdrawal.", "spo_list": [{"subject": "ethanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "p-CREB", "object_type": "GENE"}, {"subject": "ethanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "p-CREB", "object_type": "GENE"}]}
{"text": "However, when naloxone was administered concurrently with ethanol treatment, it antagonized the down-regulation of p-CREB protein in the nucleus accumbens (142 %) of rats exposed to ethanol.", "spo_list": [{"subject": "ethanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "p-CREB", "object_type": "GENE"}, {"subject": "ethanol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "p-CREB", "object_type": "GENE"}]}
{"text": "Activation of an apoptotic signal transduction pathway involved in the upregulation of calpain and apoptosis-inducing factor in aldosterone-induced primary cultured cardiomyocytes.", "spo_list": [{"subject": "aldosterone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "calpain", "object_type": "GENE"}, {"subject": "aldosterone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "apoptosis-inducing factor", "object_type": "GENE"}]}
{"text": "In this study, aldosterone (ALD)-induced apoptosis of cardiomyocyte was evaluated based on the previous studies, and the roles of calpain signaling were clarified.", "spo_list": [{"subject": "aldosterone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "calpain", "object_type": "GENE"}, {"subject": "ALD", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "calpain", "object_type": "GENE"}]}
{"text": "ALD increased calpain expression and caspase-3 activity and promoted Bid cleavage.", "spo_list": [{"subject": "ALD", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "calpain", "object_type": "GENE"}, {"subject": "ALD", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "caspase-3", "object_type": "GENE"}]}
{"text": "The upregulation of calpain, tBid and caspase-3 activity were further inhibited by treatment with EGTA in the presence of ALD.", "spo_list": [{"subject": "EGTA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "calpain", "object_type": "GENE"}, {"subject": "EGTA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "tBid", "object_type": "GENE"}, {"subject": "EGTA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "caspase-3", "object_type": "GENE"}, {"subject": "ALD", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "caspase-3", "object_type": "GENE"}, {"subject": "ALD", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "tBid", "object_type": "GENE"}, {"subject": "ALD", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "calpain", "object_type": "GENE"}]}
{"text": "Additionally, AIF levels in the cytosol decreased due to EGTA but not due to calpeptin.", "spo_list": [{"subject": "EGTA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "AIF", "object_type": "GENE"}]}
{"text": "Furthermore, treatment with spironoclactone not only attenuated the pro-apoptotic effect of ALD but reversed the ALD-induced increase of calpain and AIF levels.", "spo_list": [{"subject": "ALD", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "calpain", "object_type": "GENE"}, {"subject": "ALD", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "AIF", "object_type": "GENE"}, {"subject": "spironoclactone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "calpain", "object_type": "GENE"}, {"subject": "spironoclactone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "AIF", "object_type": "GENE"}]}
{"text": "Cerebral histamine H1 receptor (H(1)R) binding was measured in 10 patients with major depression and in 10 normal age-matched subjects using PET and [(11)C]-doxepin.", "spo_list": [{"subject": "[(11)C]-doxepin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "histamine H1 receptor", "object_type": "GENE"}, {"subject": "[(11)C]-doxepin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "H(1)R", "object_type": "GENE"}]}
{"text": "It was found that expression of Sim2 protein in cortical neurons was increased in streptozotocin-induced diabetes mellitus rat model.", "spo_list": [{"subject": "streptozotocin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Sim2", "object_type": "GENE"}]}
{"text": "Moreover, curcumin alleviated Sim2 expression, and reversely raised Drebrin expression in neurons treated with hyperglycaemia.", "spo_list": [{"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Sim2", "object_type": "GENE"}, {"subject": "curcumin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Drebrin", "object_type": "GENE"}]}
{"text": "Allicin treatment showed reduced production of pro-inflammatory cytokines and NO and increased HO-1 activity.", "spo_list": [{"subject": "Allicin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cytokines", "object_type": "GENE"}, {"subject": "Allicin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "HO-1", "object_type": "GENE"}]}
{"text": "Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.", "spo_list": [{"subject": "ketorolac tromethamine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase", "object_type": "GENE"}, {"subject": "bromfenac sodium", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase", "object_type": "GENE"}]}
{"text": "METHODS: Cyclooxygenase activity and selectivity was determined in vitro by measuring prostaglandin E(2) (PGE(2)) production following incubation of varying concentrations of NSAID with human recombinant COX-1 or COX-2 and arachidonic acid.", "spo_list": [{"subject": "prostaglandin E(2)", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Cyclooxygenase", "object_type": "GENE"}, {"subject": "PGE(2)", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Cyclooxygenase", "object_type": "GENE"}]}
{"text": "The group treated with pyridostigmine alone showed decreased plasma butyrylcholinesterase (BChE) activity (87% of control), whereas pyridostigmine plus exercise significantly decreased the BChE activity (79% of control), indicating an interactive effect of the combination.", "spo_list": [{"subject": "pyridostigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "butyrylcholinesterase", "object_type": "GENE"}, {"subject": "pyridostigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BChE", "object_type": "GENE"}, {"subject": "pyridostigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BChE", "object_type": "GENE"}]}
{"text": "However, AChE activity in triceps muscle decreased significantly (78% of control) in the group treated with pyridostigmine plus exercise.", "spo_list": [{"subject": "pyridostigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}]}
{"text": "Creatine phosphokinase activity in plasma increased slightly (compared to control, pyridostigmine or exercise group) in mice treated with pyridostigmine plus exercise, which may be indicative of perturbation in the integrity of the skeletal muscle due to combination.", "spo_list": [{"subject": "pyridostigmine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Creatine phosphokinase", "object_type": "GENE"}, {"subject": "pyridostigmine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Creatine phosphokinase", "object_type": "GENE"}]}
{"text": "Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene.", "spo_list": [{"subject": "chlorpheniramine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "histamine H1-receptor", "object_type": "GENE"}, {"subject": "dimethindene", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "histamine H1-receptor", "object_type": "GENE"}]}
{"text": "Analysis of coenzyme binding by human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase using 5'-[p-(fluorosulfonyl)benzoyl]adenosine, an affinity labeling cofactor analog.", "spo_list": [{"subject": "5'-[p-(fluorosulfonyl)benzoyl]adenosine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase", "object_type": "GENE"}, {"subject": "5'-[p-(fluorosulfonyl)benzoyl]adenosine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "steroid 5----4-ene-isomerase", "object_type": "GENE"}]}
{"text": "Affinity alkylation with 2 alpha-bromoacetoxyprogesterone suggests that the dehydrogenase and isomerase substrate steroids bind at different sites on the same protein.", "spo_list": [{"subject": "steroids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "dehydrogenase", "object_type": "GENE"}]}
{"text": "The affinity labeling nucleotide analog, 5'-[p-(fluorosulfonyl)benzoyl]adenosine (FSA), inactivates the dehydrogenase and isomerase activities at similar rates in an irreversible manner which follows first order kinetics with respect to both time and alkylator concentration (0.2-0.6 mM).", "spo_list": [{"subject": "nucleotide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dehydrogenase", "object_type": "GENE"}, {"subject": "5'-[p-(fluorosulfonyl)benzoyl]adenosine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dehydrogenase", "object_type": "GENE"}, {"subject": "FSA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dehydrogenase", "object_type": "GENE"}]}
{"text": "The 3 beta-hydroxysteroid substrate, pregnenolone, protects isomerase as well as dehydrogenase from inactivation by FSA.", "spo_list": [{"subject": "FSA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dehydrogenase", "object_type": "GENE"}]}
{"text": "In addition to the N-terminal and Src homology 2 domains that mediate these interactions, SOCS proteins contain a C-terminal SOCS box.", "spo_list": [{"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Src homology 2 domains", "object_type": "GENE"}, {"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "SOCS box", "object_type": "GENE"}]}
{"text": "In mature lung tissue of healthy donors, polySia was exclusively attached to the transmembrane isoform NCAM-140 and located to intracellular compartments of epithelial cells.", "spo_list": [{"subject": "polySia", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NCAM-140", "object_type": "GENE"}]}
{"text": "Processing of polysialylated NCAM was reproduced in a mouse model by bleomycin administration leading to an activation of the inflammasome and secretion of interleukin (IL)-1β.", "spo_list": [{"subject": "bleomycin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "interleukin (IL)-1β", "object_type": "GENE"}]}
{"text": "As shown in a cell culture model, polySia-NCAM-140 was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by IL-1β or lipopolysaccharide induced metalloprotease-mediated ectodomain shedding, resulting in the secretion of soluble polySia-NCAM.", "spo_list": [{"subject": "polySia", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NCAM-140", "object_type": "GENE"}]}
{"text": "Interestingly, polySia chains of secreted NCAM neutralized the cytotoxic activity of extracellular histones as well as DNA/histone-network-containing \"neutrophil extracellular traps\", which are formed during invasion of microorganisms.", "spo_list": [{"subject": "polySia", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NCAM", "object_type": "GENE"}]}
{"text": "We previously employed a chemical genomic strategy to identify a novel small molecule, MAC13243, as a likely inhibitor of the bacterial lipoprotein targeting chaperone, LolA.", "spo_list": [{"subject": "MAC13243", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "bacterial lipoprotein", "object_type": "GENE"}, {"subject": "MAC13243", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "chaperone", "object_type": "GENE"}, {"subject": "MAC13243", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "LolA", "object_type": "GENE"}]}
{"text": "We provide STD NMR data which confirms a physical interaction between LolA and the thiourea degradation product of MAC13243, with a Kd of ~150 μM.", "spo_list": [{"subject": "MAC13243", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "LolA", "object_type": "GENE"}, {"subject": "thiourea", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "LolA", "object_type": "GENE"}]}
{"text": "Taken together, we conclude that the thiourea series of compounds share a similar cellular mechanism that includes interaction with LolA in addition to the well-characterized target MreB.", "spo_list": [{"subject": "thiourea", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "LolA", "object_type": "GENE"}, {"subject": "thiourea", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "MreB", "object_type": "GENE"}]}
{"text": "Interestingly, Acrolein increased proteins' levels of amyloid precursor protein (APP), β-secretase (BACE-1) and the amyloid β-peptide transporter receptor for advanced glycation end products, and decreased A-disintegrin and metalloprotease (ADAM) 10 levels.", "spo_list": [{"subject": "Acrolein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "amyloid precursor protein", "object_type": "GENE"}, {"subject": "Acrolein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "β-secretase", "object_type": "GENE"}, {"subject": "Acrolein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "BACE-1", "object_type": "GENE"}, {"subject": "Acrolein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "amyloid β-peptide transporter", "object_type": "GENE"}, {"subject": "Acrolein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "receptor for advanced glycation end products", "object_type": "GENE"}, {"subject": "Acrolein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "A-disintegrin and metalloprotease (ADAM) 10", "object_type": "GENE"}]}
{"text": "Moreover, Acrolein resulted in activation of astrocytes, up-regulation of BACE-1 in cortex and down-regulation of ADAM-10 in hippocampus and cortex.", "spo_list": [{"subject": "Acrolein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "BACE-1", "object_type": "GENE"}, {"subject": "Acrolein", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "ADAM-10", "object_type": "GENE"}]}
{"text": "Also, SB365 showed anti-angiogenic activity by decreasing the expression of HIF-1α and VEGF.", "spo_list": [{"subject": "SB365", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "HIF-1α", "object_type": "GENE"}, {"subject": "SB365", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "VEGF", "object_type": "GENE"}]}
{"text": "When further examined for its anticancer mechanism, SB365 effectively suppressed the AKT/mTOR pathway both in vitro and in vivo.", "spo_list": [{"subject": "SB365", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AKT", "object_type": "GENE"}, {"subject": "SB365", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mTOR", "object_type": "GENE"}]}
{"text": "Taken together, our study demonstrated that SB365 inhibits the AKT/mTOR pathway, leading to the suppression of tumor growth and angiogenesis together with induction of apoptosis.", "spo_list": [{"subject": "SB365", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AKT", "object_type": "GENE"}, {"subject": "SB365", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mTOR", "object_type": "GENE"}]}
{"text": "The ability of sorafenib to inhibit oncogenic PDGFRbeta and FLT3 mutants and overcome resistance to other small molecule inhibitors.", "spo_list": [{"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFRbeta", "object_type": "GENE"}, {"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}]}
{"text": "Sorafenib (BAY43-9006, Nexavar) is a small molecule B-RAF inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against receptor tyrosine kinases from the platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR) families.", "spo_list": [{"subject": "Sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "B-RAF", "object_type": "GENE"}, {"subject": "BAY43-9006", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "B-RAF", "object_type": "GENE"}, {"subject": "Nexavar", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "B-RAF", "object_type": "GENE"}]}
{"text": "We investigated the efficacy of sorafenib at inhibiting mutants of the receptor tyrosine kinases PDGFRbeta, KIT, and FLT3, which are implicated in the pathogenesis of myeloid malignancies.", "spo_list": [{"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "receptor tyrosine kinases", "object_type": "GENE"}, {"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFRbeta", "object_type": "GENE"}, {"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KIT", "object_type": "GENE"}, {"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}]}
{"text": "RESULTS: We show that sorafenib is a potent inhibitor of ETV6-PDGFRbeta and FLT3 mutants, including some of the mutants that confer resistance to PKC412 and other FLT3 inhibitors.", "spo_list": [{"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ETV6", "object_type": "GENE"}, {"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFRbeta", "object_type": "GENE"}, {"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}, {"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}]}
{"text": "Sorafenib induced a cell cycle block and apoptosis in the acute myeloid leukemia cell lines MV4-11 and MOLM-13, both expressing FLT3 with an internal tandem duplication, whereas no effect was observed on four other acute myeloid leukemia cell lines.", "spo_list": [{"subject": "Sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}]}
{"text": "INTERPRETATION AND CONCLUSIONS: These results warrant further clinical studies of sorafenib for the treatment of myeloid malignancies expressing activated forms of PDGFRbeta and FLT3.", "spo_list": [{"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFRbeta", "object_type": "GENE"}, {"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLT3", "object_type": "GENE"}]}
{"text": "The contractions to 5-HT were inhibited by ketanserin and alosetron indicating involvement of 5-HT(2A) and 5-HT(3) receptors, respectively.", "spo_list": [{"subject": "ketanserin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-HT(2A)", "object_type": "GENE"}, {"subject": "alosetron", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-HT(3)", "object_type": "GENE"}]}
{"text": "α-Amino-α´-Halomethylketones: Synthetic Methodologies and Pharmaceutical Applications as Serine and Cysteine Protease Inhibitors. α-Amino-α´-halomethylketones are interesting scaffolds bearing (at least) two sequential electrophilic carbons that by interacting with the nucleophilic moieties of several enzymes, represent the ideal candidates for in vivo and in vitro inhibition studies.", "spo_list": [{"subject": "α-Amino-α´-Halomethylketones", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Serine and Cysteine Protease", "object_type": "GENE"}]}
{"text": "Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance.", "spo_list": [{"subject": "GW572016", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EGFR", "object_type": "GENE"}, {"subject": "GW572016", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HER2", "object_type": "GENE"}, {"subject": "GW572016", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}]}
{"text": "To gauge the potential clinical utility of targeting both EGFR and HER2 to control growth and radiosensitize human breast cancers, we examined the effect of a dual EGFR/HER2 inhibitor, GW572016, on the proliferation and radiation response of either EGFR- or HER2-overexpressing human breast cancer cell lines.", "spo_list": [{"subject": "GW572016", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EGFR", "object_type": "GENE"}, {"subject": "GW572016", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HER2", "object_type": "GENE"}]}
{"text": "RESULTS: GW572016 inhibited constitutive and/or ligand-induced EGFR or HER2 tyrosine phosphorylation of all five cell lines, which correlated with the antiproliferative response in all but one cell line.", "spo_list": [{"subject": "GW572016", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EGFR", "object_type": "GENE"}, {"subject": "GW572016", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HER2", "object_type": "GENE"}, {"subject": "tyrosine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "EGFR", "object_type": "GENE"}, {"subject": "tyrosine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "HER2", "object_type": "GENE"}]}
{"text": "Exploration of potential mechanisms of resistance in SUM185 cells revealed failure of GW572016 to inhibit downstream ERK and Akt activation, despite inhibition of HER2 phosphorylation.", "spo_list": [{"subject": "GW572016", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HER2", "object_type": "GENE"}]}
{"text": "CONCLUSION: GW572016 potently inhibits receptor phosphorylation in either EGFR- or HER2-overexpressing cell lines and has both antiproliferative and radiosensitizing effects.", "spo_list": [{"subject": "GW572016", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EGFR", "object_type": "GENE"}, {"subject": "GW572016", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HER2", "object_type": "GENE"}]}
{"text": "Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin.", "spo_list": [{"subject": "atorvastatin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dipeptidyl peptidase-IV", "object_type": "GENE"}, {"subject": "atorvastatin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DPP-IV", "object_type": "GENE"}]}
{"text": "In this report, we show that the hypolipidemic agent atorvastatin is a competitive inhibitor of porcine DPP-IV in vitro, with K(i)=57.8+/-2.3 microM.", "spo_list": [{"subject": "atorvastatin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "porcine DPP-IV", "object_type": "GENE"}]}
{"text": "These results may have implications in the development of novel DPP-IV inhibitors based on the use of atorvastatin as a lead compound for the treatment of type 2 diabetes.", "spo_list": [{"subject": "atorvastatin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DPP-IV", "object_type": "GENE"}]}
{"text": "BACKGROUND: Recent epidemiologic and laboratory studies have suggested that non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the risk of breast cancer through inhibition of cyclooxygenase-2 (COX-2).", "spo_list": [{"subject": "steroidal", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "steroidal", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "METHODS: We conducted a case-control study to measure the association between selective cox-2 inhibitors, particularly celecoxib, rofecoxib, valdecoxib and non-specific NSAID subgroups, and breast cancer risk.", "spo_list": [{"subject": "celecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cox-2", "object_type": "GENE"}, {"subject": "rofecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cox-2", "object_type": "GENE"}, {"subject": "valdecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cox-2", "object_type": "GENE"}]}
{"text": "With exposure to rofecoxib, a selective COX-2 inhibitor, breast cancer risk reduction was appreciable (46%), suggesting a possible role for selective COX-2 inhibitors in breast cancer prophylaxis.", "spo_list": [{"subject": "rofecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "rofecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist.", "spo_list": [{"subject": "LY541850", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "mGlu2", "object_type": "GENE"}, {"subject": "LY541850", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "mGlu3", "object_type": "GENE"}]}
{"text": "LY541850 was claimed from human mGlu receptors expressed in non-neuronal cells to be a selective orthosteric mGlu2 agonist and mGlu3 antagonist.", "spo_list": [{"subject": "LY541850", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "mGlu2", "object_type": "GENE"}, {"subject": "LY541850", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "mGlu3", "object_type": "GENE"}]}
{"text": "These results confirm the selective mGlu2 agonist and mGlu3 antagonist actions of LY541850.", "spo_list": [{"subject": "LY541850", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "mGlu2", "object_type": "GENE"}, {"subject": "LY541850", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "mGlu3", "object_type": "GENE"}]}
{"text": "Apolipoprotein E3 (apoE3) safeguards pig proximal tubular LLC-PK1 cells against reduction in SGLT1 activity induced by gentamicin C. Megalin, a family of endocytic receptors related to the low-density lipoprotein (LDL) receptor, is a major pathway for proximal tubular aminoglycoside accumulation.", "spo_list": [{"subject": "gentamicin C", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "SGLT1", "object_type": "GENE"}, {"subject": "aminoglycoside", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "endocytic receptors", "object_type": "GENE"}, {"subject": "aminoglycoside", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "low-density lipoprotein (LDL) receptor", "object_type": "GENE"}]}
{"text": "In this study, using a model of gentamicin C (GMC)-induced reduction in SGLT1 activity, we examined whether ligands for megalin protect LLC-PK1 cells from the GMC-induced reduction in SGLT1 activity.", "spo_list": [{"subject": "gentamicin C", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "SGLT1", "object_type": "GENE"}, {"subject": "GMC", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "SGLT1", "object_type": "GENE"}, {"subject": "GMC", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "SGLT1", "object_type": "GENE"}]}
{"text": "Then the cells were treated with various concentrations of apoE3, lactoferrin and bovine serum albumin with or without 100 microg/ml of GMC, and the SGLT1-dependent methyl alpha-D-glucopyranoside (AMG) uptake and levels of SGLT1 expression were determined.", "spo_list": [{"subject": "methyl alpha-D-glucopyranoside", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SGLT1", "object_type": "GENE"}, {"subject": "AMG", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SGLT1", "object_type": "GENE"}]}
{"text": "Synthesis and in vitro evaluation of N-Aryl pyrido-quinazolines derivatives as potent EGFR inhibitors.", "spo_list": [{"subject": "N-Aryl pyrido-quinazolines", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EGFR", "object_type": "GENE"}]}
{"text": "A series of pyrido-quinazolines have been synthesised, characterised and tested for their in vitro EGFR tyrosine kinase inhibitory activity.", "spo_list": [{"subject": "pyrido-quinazolines", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EGFR", "object_type": "GENE"}, {"subject": "pyrido-quinazolines", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase", "object_type": "GENE"}]}
{"text": "Pemetrexed disodium (ALIMTA) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase.", "spo_list": [{"subject": "Pemetrexed disodium", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "thymidylate synthase", "object_type": "GENE"}, {"subject": "Pemetrexed disodium", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dihydrofolate reductase", "object_type": "GENE"}, {"subject": "Pemetrexed disodium", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "glycinamide ribonucleotide formyltransferase", "object_type": "GENE"}, {"subject": "ALIMTA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "thymidylate synthase", "object_type": "GENE"}, {"subject": "ALIMTA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dihydrofolate reductase", "object_type": "GENE"}, {"subject": "ALIMTA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "glycinamide ribonucleotide formyltransferase", "object_type": "GENE"}]}
{"text": "Although the inhibition of cyclooxygenases by aspirin, which leads to its anti-inflammatory/analgesic properties, has been well studied, the mechanisms involved in its chemopreventive effects as well as some of its adverse effects are as yet ill-defined.", "spo_list": [{"subject": "aspirin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenases", "object_type": "GENE"}]}
{"text": "Studies over the past decades suggest that, besides cyclooxygenases, aspirin acetylates other cellular proteins.", "spo_list": [{"subject": "aspirin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cyclooxygenases", "object_type": "GENE"}]}
{"text": "In a recent study using protein-specific anti-acetyl lysine antibodies and immunological methods, we demonstrated the ability of aspirin to acetylate the tumor suppressor protein p53.", "spo_list": [{"subject": "aspirin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "tumor suppressor protein p53", "object_type": "GENE"}]}
{"text": "The phosphodiesterase (PDE) 4 is the predominant cyclic AMP degrading enzyme in a variety of inflammatory cells including eosinophils, neutrophils, macrophages, T cells and monocytes.", "spo_list": [{"subject": "cyclic AMP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "phosphodiesterase (PDE) 4", "object_type": "GENE"}]}
{"text": "Consequently, PDE4 inhibitors including cilomilast and AWD 12-281 have been tested in several models of allergic and irritant skin inflammation.", "spo_list": [{"subject": "cilomilast", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE4", "object_type": "GENE"}, {"subject": "AWD 12-281", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE4", "object_type": "GENE"}]}
{"text": "Results of early clinical trials with both topically (cipamfylline, CP80,633) and systemically (CC-10004) active PDE4 inhibitors demonstrated efficacy in atopic dermatitis and in the case of CC-10004, also in psoriasis.", "spo_list": [{"subject": "cipamfylline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE4", "object_type": "GENE"}, {"subject": "CP80,633", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE4", "object_type": "GENE"}]}
{"text": "Human stearoyl-CoA desaturase 1 (SCD-1) gene expression is negatively regulated by thyroid hormone without direct binding of thyroid hormone receptor to the gene promoter.", "spo_list": [{"subject": "thyroid hormone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Human stearoyl-CoA desaturase 1", "object_type": "GENE"}, {"subject": "thyroid hormone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "SCD-1", "object_type": "GENE"}]}
{"text": "Dietary carbohydrates increase SCD-1 gene expression in liver by sterol response element binding protein (SREBP)-1c-dependent and SREBP-1c -independent pathways.", "spo_list": [{"subject": "carbohydrates", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "SCD-1", "object_type": "GENE"}]}
{"text": "Previous report demonstrated that thyroid hormone (TH) negatively regulates mouse SCD-1 gene promoter before SREBP-1c was revealed.", "spo_list": [{"subject": "thyroid hormone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "mouse SCD-1 gene promoter", "object_type": "GENE"}]}
{"text": "Dopamine D2-receptor imaging with 123I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier?", "spo_list": [{"subject": "123I-iodobenzamide", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Dopamine D2-receptor", "object_type": "GENE"}]}
{"text": "Two migraine patients were studied by in vivo SPECT using the dopamine D2-receptor specific radioligand 123I-3-iodo-6-methoxybenzamide (123I-IBZM) during ergotamine abuse and after withdrawal.", "spo_list": [{"subject": "123I-3-iodo-6-methoxybenzamide", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D2-receptor", "object_type": "GENE"}, {"subject": "123I-IBZM", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D2-receptor", "object_type": "GENE"}]}
{"text": "Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial.", "spo_list": [{"subject": "leukotriene", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "leukotriene receptor", "object_type": "GENE"}, {"subject": "pranlukast", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "leukotriene receptor", "object_type": "GENE"}]}
{"text": "Pranlukast is a new, orally active, selective inhibitor of CysLt1 leukotriene receptor.", "spo_list": [{"subject": "leukotriene", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "CysLt1", "object_type": "GENE"}, {"subject": "leukotriene", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "leukotriene receptor", "object_type": "GENE"}, {"subject": "Pranlukast", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CysLt1", "object_type": "GENE"}, {"subject": "Pranlukast", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "leukotriene receptor", "object_type": "GENE"}]}
{"text": "Finally, we showed that chlorate activated endocrine cell development by inducing neurogenin 3 (Neurog3) expression in early endocrine progenitor cells.", "spo_list": [{"subject": "chlorate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "neurogenin 3", "object_type": "GENE"}, {"subject": "chlorate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Neurog3", "object_type": "GENE"}]}
{"text": "Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis.", "spo_list": [{"subject": "Dasatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KIT", "object_type": "GENE"}, {"subject": "Dasatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "D816V", "object_type": "GENE"}, {"subject": "BMS-354825", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "D816V", "object_type": "GENE"}]}
{"text": "Dasatinib (BMS-354825) is a novel orally bioavailable SRC/ABL inhibitor that has activity against multiple imatinib-resistant BCR-ABL isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia (CML).", "spo_list": [{"subject": "Dasatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "SRC", "object_type": "GENE"}, {"subject": "Dasatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ABL", "object_type": "GENE"}, {"subject": "BMS-354825", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "SRC", "object_type": "GENE"}, {"subject": "BMS-354825", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ABL", "object_type": "GENE"}]}
{"text": "In this study, we demonstrate significant inhibitory activity of dasatinib against both wild-type KIT and the KITD816V mutation in the nanomolar range in in vitro and cell-based kinase assays.", "spo_list": [{"subject": "dasatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KIT", "object_type": "GENE"}, {"subject": "dasatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KIT", "object_type": "GENE"}, {"subject": "dasatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "D816V", "object_type": "GENE"}]}
{"text": "Additionally, dasatinib leads to growth inhibition of a KITD816V-harboring human masto-cytosis cell line.", "spo_list": [{"subject": "dasatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KIT", "object_type": "GENE"}, {"subject": "dasatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "D816V", "object_type": "GENE"}]}
{"text": "Computer modeling suggests that the KITD816V mutation destabilizes the inactive conformation of the KIT activation loop to which imatinib binds, but it is not predicted to impair binding of KIT by dasatinib.", "spo_list": [{"subject": "imatinib", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "KIT", "object_type": "GENE"}, {"subject": "imatinib", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "KIT activation loop", "object_type": "GENE"}, {"subject": "imatinib", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "KIT", "object_type": "GENE"}, {"subject": "dasatinib", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "KIT", "object_type": "GENE"}, {"subject": "dasatinib", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "KIT", "object_type": "GENE"}]}
{"text": "2. Incubation of rat aortic membranes with the irreversible alpha 1B-adrenoceptor antagonist, chloroethylclonidine (CEC: 10 microM) did not change the KD of [3H]-prazosin binding in comparison to untreated membranes, but reduced by 88% the total number of binding sites (Bmax).", "spo_list": [{"subject": "chloroethylclonidine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1B-adrenoceptor", "object_type": "GENE"}, {"subject": "CEC", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1B-adrenoceptor", "object_type": "GENE"}, {"subject": "[3H]-prazosin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha 1B-adrenoceptor", "object_type": "GENE"}]}
{"text": "As opposed to the rat and flounder orthologs, hNaDC-3 was hardly inhibited by lithium concentrations up to 5 mM.", "spo_list": [{"subject": "lithium", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "hNaDC-3", "object_type": "GENE"}]}
{"text": "Intravenous treatment, during coronary artery occlusion, with the melanocortin analogs [Nle(4), D-Phe(7)]α-melanocyte-stimulating hormone (NDP-α-MSH) and adrenocorticotropic hormone 1-24 [ACTH-(1-24)], induced a left ventricle up-regulation of pJAK2, pERK1/2 and pTyr-STAT3 (JAK-dependent), and a reduction in pJNK and TNF-α levels; these effects of NDP-α-MSH and ACTH-(1-24) were associated with over-expression of the pro-survival proteins HO-1 and Bcl-XL, and marked decrease of the myocardial infarct size.", "spo_list": [{"subject": "Nle", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "α-melanocyte-stimulating hormone", "object_type": "GENE"}, {"subject": "D-Phe", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "α-melanocyte-stimulating hormone", "object_type": "GENE"}, {"subject": "Nle", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "α-MSH", "object_type": "GENE"}, {"subject": "D-Phe", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "α-MSH", "object_type": "GENE"}]}
{"text": "Blockade of JAK and ERK pathways with AG490 and U0126, respectively, abrogated the myocardial infarct size reduction by NDP-α-MSH.", "spo_list": [{"subject": "AG490", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "JAK", "object_type": "GENE"}, {"subject": "U0126", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ERK", "object_type": "GENE"}]}
{"text": "RESULTS: DZN induced histophatological damages and elevated the level of cardiac marker CK-MB.", "spo_list": [{"subject": "DZN", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CK-MB", "object_type": "GENE"}]}
{"text": "Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.", "spo_list": [{"subject": "DZN", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "caspase 3", "object_type": "GENE"}, {"subject": "Crocin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "caspase 3", "object_type": "GENE"}, {"subject": "vitamin E", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "caspase 3", "object_type": "GENE"}, {"subject": "DZN", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "cytochrome c", "object_type": "GENE"}, {"subject": "Crocin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "CK-MB", "object_type": "GENE"}, {"subject": "Crocin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Bax", "object_type": "GENE"}, {"subject": "Crocin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Bcl2", "object_type": "GENE"}, {"subject": "vitamin E", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "CK-MB", "object_type": "GENE"}, {"subject": "vitamin E", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Bax", "object_type": "GENE"}, {"subject": "vitamin E", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Bcl2", "object_type": "GENE"}]}
{"text": "Cembranoid and long-chain alkanol sites on the nicotinic acetylcholine receptor and their allosteric interaction.", "spo_list": [{"subject": "long-chain alkanol", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "nicotinic acetylcholine receptor", "object_type": "GENE"}, {"subject": "Cembranoid", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "nicotinic acetylcholine receptor", "object_type": "GENE"}]}
{"text": "Long-chain alkanols are general anesthetics which can also act as uncharged noncompetitive inhibitors of the peripheral nicotinic acetylcholine receptor (AChR) by binding to one or more specific sites on the AChR.", "spo_list": [{"subject": "Long-chain alkanols", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "nicotinic acetylcholine receptor", "object_type": "GENE"}, {"subject": "Long-chain alkanols", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "AChR", "object_type": "GENE"}]}
{"text": "Cembranoids are naturally occurring, uncharged noncompetitive inhibitors of peripheral and neuronal AChRs, which have no demonstrable general anesthetic activity in vivo.", "spo_list": [{"subject": "Cembranoids", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChRs", "object_type": "GENE"}]}
{"text": "We found compounds that inhibited Panx1 currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.", "spo_list": [{"subject": "carbenoxolone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Panx1", "object_type": "GENE"}, {"subject": "disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Panx1", "object_type": "GENE"}, {"subject": "DIDS", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Panx1", "object_type": "GENE"}, {"subject": "disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Panx1", "object_type": "GENE"}, {"subject": "5-nitro-2-(3-phenylpropylamino)benzoic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Panx1", "object_type": "GENE"}, {"subject": "indanyloxyacetic acid 94", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Panx1", "object_type": "GENE"}, {"subject": "probenecid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Panx1", "object_type": "GENE"}, {"subject": "flufenamic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Panx1", "object_type": "GENE"}, {"subject": "niflumic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Panx1", "object_type": "GENE"}]}
{"text": "Triphosphate nucleotides (ATP, GTP, and UTP) rapidly and reversibly inhibited Panx1 currents via mechanism(s) independent of purine receptors.", "spo_list": [{"subject": "Triphosphate nucleotides", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Panx1", "object_type": "GENE"}, {"subject": "ATP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Panx1", "object_type": "GENE"}, {"subject": "GTP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Panx1", "object_type": "GENE"}, {"subject": "UTP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Panx1", "object_type": "GENE"}]}
{"text": "When Panx1 was coexpressed with purinergic P2X(7) receptor (P2X(7)R), DIDS was found to act as a P2X(7)R antagonist to inhibit ATP-evoked currents, but none of the other compounds inhibited P2X(7)R currents.", "spo_list": [{"subject": "DIDS", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "P2X(7)R", "object_type": "GENE"}]}
{"text": "Enhancement of radiosensitivity by topoisomerase II inhibitor, amrubicin and amrubicinol, in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction.", "spo_list": [{"subject": "amrubicin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "topoisomerase II", "object_type": "GENE"}, {"subject": "amrubicinol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "topoisomerase II", "object_type": "GENE"}]}
{"text": "Similar to AMR and AMROH, adriamycin and etoposide (VP-16) are DNA topoisomerase II inhibitors.", "spo_list": [{"subject": "AMR", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DNA topoisomerase II", "object_type": "GENE"}, {"subject": "AMROH", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DNA topoisomerase II", "object_type": "GENE"}, {"subject": "adriamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DNA topoisomerase II", "object_type": "GENE"}, {"subject": "etoposide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DNA topoisomerase II", "object_type": "GENE"}, {"subject": "VP-16", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DNA topoisomerase II", "object_type": "GENE"}]}
{"text": "Synthesis, radiosynthesis, and biological evaluation of carbon-11 labeled 2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.", "spo_list": [{"subject": "carbon-11 labeled 2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "serotonin transporter", "object_type": "GENE"}]}
{"text": "2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane (mZIENT, 1) and 2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane (mZBrENT, 2) were synthesized and evaluated for binding to the human serotonin, dopamine, and norepinephrine transporters (SERT, DAT, and NET, respectively) using transfected cells.", "spo_list": [{"subject": "2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SERT", "object_type": "GENE"}, {"subject": "mZIENT", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SERT", "object_type": "GENE"}, {"subject": "2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SERT", "object_type": "GENE"}, {"subject": "mZBrENT", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SERT", "object_type": "GENE"}, {"subject": "2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "mZIENT", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "mZBrENT", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NET", "object_type": "GENE"}, {"subject": "mZIENT", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NET", "object_type": "GENE"}, {"subject": "2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NET", "object_type": "GENE"}, {"subject": "mZBrENT", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NET", "object_type": "GENE"}]}
{"text": "MicroPET imaging in nonhuman primates with [11C]1 and [11C]2 demonstrated that both tracers behave similarly in vivo with high uptake being observed in the SERT-rich brain regions and peak uptake being achieved in about 55 min postinjection.", "spo_list": [{"subject": "11C", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SERT", "object_type": "GENE"}, {"subject": "11C", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SERT", "object_type": "GENE"}]}
{"text": "Chase studies with citalopram and methylphenidate demonstrated that this uptake is the result of preferential binding to the SERT.", "spo_list": [{"subject": "citalopram", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SERT", "object_type": "GENE"}, {"subject": "methylphenidate", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SERT", "object_type": "GENE"}]}
{"text": "Thymidylate synthase (TS) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/LV (Orzel), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.", "spo_list": [{"subject": "2-deoxythymidine-5-monophosphate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Thymidylate synthase", "object_type": "GENE"}, {"subject": "2-deoxythymidine-5-monophosphate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "TS", "object_type": "GENE"}]}
{"text": "While fluoropyrimidine antimetabolites have other sites of action, antifolates ZD1694 (raltitrexed, Tomudex) and AG337 (Thymitag) are more specific and potent TS inhibitors.", "spo_list": [{"subject": "ZD1694", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TS", "object_type": "GENE"}, {"subject": "raltitrexed", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TS", "object_type": "GENE"}, {"subject": "Tomudex", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TS", "object_type": "GENE"}, {"subject": "AG337", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TS", "object_type": "GENE"}, {"subject": "Thymitag", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TS", "object_type": "GENE"}]}
{"text": "The availability of the 5-FU prodrugs offers the possibility of greater therapeutic selectivity based on the demonstration that thymidine phosphorylase, the activating enzyme for 5-FU, is expressed at a higher level in tumor tissue compared with normal tissue counterparts.", "spo_list": [{"subject": "5-FU", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "thymidine phosphorylase", "object_type": "GENE"}]}
{"text": "The identity of the lung beta-ADHs was further demonstrated by their characteristic pH-activity profiles for ethanol oxidation, Km values for NAD and ethanol, and inhibition by 4-methylpyrazole or 1,10-phenanthroline.", "spo_list": [{"subject": "ethanol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "beta-ADHs", "object_type": "GENE"}, {"subject": "4-methylpyrazole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "beta-ADHs", "object_type": "GENE"}, {"subject": "1,10-phenanthroline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "beta-ADHs", "object_type": "GENE"}, {"subject": "ethanol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "beta-ADHs", "object_type": "GENE"}]}
{"text": "These findings indicate that human pulmonary ethanol-metabolizing activities differ significantly with respect to genetic polymorphism at both the ADH2 and the ALDH2 loci.", "spo_list": [{"subject": "ethanol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ADH2", "object_type": "GENE"}, {"subject": "ethanol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ALDH2", "object_type": "GENE"}]}
{"text": "The results suggest that individuals with high Vmax beta 2-ADH and deficient in low-Km mitochondrial ALDH2, accounting for approximately 45% of the Chinese population, may end up with acetaldehyde accumulation during alcohol consumption, rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite.", "spo_list": [{"subject": "alcohol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "beta 2-ADH", "object_type": "GENE"}, {"subject": "acetaldehyde", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "beta 2-ADH", "object_type": "GENE"}, {"subject": "acetaldehyde", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ALDH2", "object_type": "GENE"}, {"subject": "alcohol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ALDH2", "object_type": "GENE"}]}
{"text": "Everolimus (RAD001, Afinitor((R)) Novartis) is the first oral inhibitor of mTOR (mammalian target of rapamycin) to reach the oncology clinic.", "spo_list": [{"subject": "Everolimus", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mTOR", "object_type": "GENE"}, {"subject": "Everolimus", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mammalian target of rapamycin", "object_type": "GENE"}, {"subject": "RAD001", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mTOR", "object_type": "GENE"}, {"subject": "RAD001", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mammalian target of rapamycin", "object_type": "GENE"}, {"subject": "Afinitor((R)) Novartis", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mTOR", "object_type": "GENE"}, {"subject": "Afinitor((R)) Novartis", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mammalian target of rapamycin", "object_type": "GENE"}]}
{"text": "A phase III randomized placebo-controlled trial has examined the impact of everolimus in patients with clear cell renal cancers and progressive disease on or within 6 months of the VEGFR tyrosine kinase inhibitors sunitinib and/or sorafenib.", "spo_list": [{"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGFR", "object_type": "GENE"}, {"subject": "sorafenib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase", "object_type": "GENE"}, {"subject": "sunitinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VEGFR", "object_type": "GENE"}, {"subject": "sunitinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase", "object_type": "GENE"}]}
{"text": "State-dependent cocaine block of sodium channel isoforms, chimeras, and channels coexpressed with the beta1 subunit.", "spo_list": [{"subject": "cocaine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sodium channel", "object_type": "GENE"}]}
{"text": "Cocaine block of human cardiac (hH1) and rat skeletal (mu1) muscle sodium channels was examined under whole-cell voltage clamp in transiently transfected HEK293t cells.", "spo_list": [{"subject": "Cocaine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "human cardiac (hH1)", "object_type": "GENE"}, {"subject": "Cocaine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "rat skeletal (mu1) muscle sodium channels", "object_type": "GENE"}]}
{"text": "Cocaine block of hH1 channels was greater than block of mu1 channels at voltages between -120 mV and -90 mV, suggesting that greater steady-state inactivation of hH1 channels in this voltage range makes them more susceptible to cocaine block.", "spo_list": [{"subject": "Cocaine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "hH1 channels", "object_type": "GENE"}, {"subject": "Cocaine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mu1 channels", "object_type": "GENE"}, {"subject": "Cocaine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "hH1 channels", "object_type": "GENE"}, {"subject": "cocaine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "hH1 channels", "object_type": "GENE"}]}
{"text": "Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.", "spo_list": [{"subject": "[125I]iodocyanopindolol", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-hydroxytryptamine1B", "object_type": "GENE"}]}
{"text": "Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states.", "spo_list": [{"subject": "cisapride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "human ether-a-go-go-related gene (HERG) potassium channel", "object_type": "GENE"}]}
{"text": "2 In a chronic transfection model using CHO-K1 cells, cisapride inhibited HERG tail currents after a step to +25 mV with similar potency at room and physiological temperatures (IC50 16.", "spo_list": [{"subject": "cisapride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HERG", "object_type": "GENE"}]}
{"text": "6 In conclusion, HERG channel inhibition by cisapride exhibits features consistent with open and inactivated state binding and is sensitive to external potassium concentration.", "spo_list": [{"subject": "cisapride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HERG", "object_type": "GENE"}]}
{"text": "Despite a low amino acid identity between TWIK-1 and TREK-1 (approximately 28%), both channel proteins share the same overall structural arrangement consisting of two pore-forming domains and four transmembrane segments (TMS).", "spo_list": [{"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TWIK-1", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TREK-1", "object_type": "GENE"}]}
{"text": "TREK-1 currents are insensitive to pharmacological agents that block TWIK-1 activity such as quinine and quinidine.", "spo_list": [{"subject": "quinine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TWIK-1", "object_type": "GENE"}, {"subject": "quinidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TWIK-1", "object_type": "GENE"}]}
{"text": "Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution.", "spo_list": [{"subject": "(-)-galanthamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "acetylcholinesterase", "object_type": "GENE"}]}
{"text": "The inhibitor binds at the base of the active site gorge of TcAChE, interacting with both the choline-binding site (Trp-84) and the acyl-binding pocket (Phe-288, Phe-290).", "spo_list": [{"subject": "Trp", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "choline-binding site", "object_type": "GENE"}, {"subject": "Phe", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "acyl-binding pocket", "object_type": "GENE"}, {"subject": "Phe", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "acyl-binding pocket", "object_type": "GENE"}, {"subject": "Trp", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TcAChE", "object_type": "GENE"}, {"subject": "Phe", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TcAChE", "object_type": "GENE"}, {"subject": "Phe", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TcAChE", "object_type": "GENE"}]}
{"text": "OBJECTIVE: Fondaparinux sodium is the first in a new class of synthetic factor Xa inhibitors that binds reversibly with high affinity to antithrombin III.", "spo_list": [{"subject": "Fondaparinux sodium", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "factor Xa", "object_type": "GENE"}, {"subject": "Fondaparinux sodium", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "antithrombin III", "object_type": "GENE"}]}
{"text": "Results: The administration of prallethrin 1.6% w/w created significant increased changes in the levels of total WBC, lymphocytes, RBC, hemoglobin, packed cell volume, platelets, mean corpuscular volume, and mean corpuscular hemoglobin in rats after 24, 48, and 72 h of continuous inhalation; however, there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of CK, γ-GT, SOD, NO, MDA, AFP, IL-2, and TNFα were recorded.", "spo_list": [{"subject": "prallethrin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "hemoglobin", "object_type": "GENE"}, {"subject": "prallethrin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "hemoglobin", "object_type": "GENE"}]}
{"text": "RATIONALE: There is substantial evidence that lisuride can produce effects linked to 5-HT(1A) receptor occupancy.", "spo_list": [{"subject": "lisuride", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT(1A)", "object_type": "GENE"}]}
{"text": "These conclusions are surprising when one considers that the potent interaction of lisuride with 5-HT(1A) receptors has been demonstrated in several different laboratories and that activation of 5-HT(1A) and 5-HT(1B) receptors can modulate dopaminergically mediated responses.", "spo_list": [{"subject": "lisuride", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT(1A)", "object_type": "GENE"}]}
{"text": "RESULTS: In drug discrimination studies, lisuride fully mimicked the 5-HT(1A) agonist LY 293284, only partially substituted for LSD and DOI, and failed to substitute for (+)-amphetamine.", "spo_list": [{"subject": "lisuride", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT(1A)", "object_type": "GENE"}, {"subject": "LY 293284", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT(1A)", "object_type": "GENE"}]}
{"text": "Only pMPPI [4-iodo-N-[2-[4-(methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridynyl-benzamide hydrochloride], a selective 5-HT(1A) antagonist, was effective in inhibiting all 5-HT syndrome behaviors produced by lisuride, whereas pMPPI was without effect on any behavior induced by LSD.", "spo_list": [{"subject": "4-iodo-N-[2-[4-(methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridynyl-benzamide hydrochloride", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT(1A)", "object_type": "GENE"}]}
{"text": "Lisuride dose dependently decreased body temperature in rats with a potency similar to that of the selective 5-HT(1A) agonist LY 293284.", "spo_list": [{"subject": "LY 293284", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT(1A)", "object_type": "GENE"}]}
{"text": "The tetra-aspartate motif in the trypsinogen activation peptide binds calcium (KD ~1.6 mM), which stimulates autoactivation.", "spo_list": [{"subject": "calcium", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "tetra-aspartate motif", "object_type": "GENE"}]}
{"text": "The COX pathway generates inflammatory prostaglandins, while the 5-LOX pathway generates inflammatory leukotrienes.", "spo_list": [{"subject": "prostaglandins", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX", "object_type": "GENE"}, {"subject": "leukotrienes", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "5-LOX", "object_type": "GENE"}]}
{"text": "They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed COX-1/COX-2 inhibitor ibuprofen; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (FLAP) inhibitor MK-886.", "spo_list": [{"subject": "NS-398", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "ibuprofen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-1", "object_type": "GENE"}, {"subject": "ibuprofen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "REV 5901", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-LOX", "object_type": "GENE"}, {"subject": "MK-886", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-LOX activating protein", "object_type": "GENE"}, {"subject": "MK-886", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FLAP", "object_type": "GENE"}]}
{"text": "6-DHSG was metabolised by GSH to form a GSH conjugate (GS-6-DHSG) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of glutathione-S-transferase (GST).", "spo_list": [{"subject": "GS-6-DHSG", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "glutathione-S-transferase", "object_type": "GENE"}, {"subject": "GS-6-DHSG", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "GST", "object_type": "GENE"}, {"subject": "6-DHSG", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "glutathione-S-transferase", "object_type": "GENE"}, {"subject": "6-DHSG", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "GST", "object_type": "GENE"}]}
{"text": "Interestingly, GPx1a was the most sensitive to selenium availability in non stressful conditions, whereas GPx1b1 and GPx1b2 were highly induced by exposure to selenium levels that had some toxic effects on the cells.", "spo_list": [{"subject": "selenium", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "GPx1b1", "object_type": "GENE"}, {"subject": "selenium", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "GPx1b2", "object_type": "GENE"}]}
{"text": "The effect of histamine-H1 receptor antagonism with terfenadine on concentration-related AMP-induced bronchoconstriction in asthma.", "spo_list": [{"subject": "terfenadine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "histamine-H1 receptor", "object_type": "GENE"}]}
{"text": "Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.", "spo_list": [{"subject": "Metformin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "AMP-activated protein kinase", "object_type": "GENE"}]}
{"text": "AMP-activated protein kinase (AMPK) activity increases in response to depletion of cellular energy stores, and this enzyme has been implicated in the stimulation of glucose uptake into skeletal muscle and the inhibition of liver gluconeogenesis.", "spo_list": [{"subject": "glucose", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "AMP-activated protein kinase", "object_type": "GENE"}, {"subject": "glucose", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "AMPK", "object_type": "GENE"}]}
{"text": "We recently reported that AMPK is activated by metformin in cultured rat hepatocytes, mediating the inhibitory effects of the drug on hepatic glucose production.", "spo_list": [{"subject": "metformin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "AMPK", "object_type": "GENE"}]}
{"text": "In the present study, we evaluated whether therapeutic doses of metformin increase AMPK activity in vivo in subjects with type 2 diabetes.", "spo_list": [{"subject": "metformin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "AMPK", "object_type": "GENE"}]}
{"text": "Metformin treatment for 10 weeks significantly increased AMPK alpha2 activity in the skeletal muscle, and this was associated with increased phosphorylation of AMPK on Thr172 and decreased acetyl-CoA carboxylase-2 activity.", "spo_list": [{"subject": "Metformin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "AMPK alpha2", "object_type": "GENE"}, {"subject": "Metformin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "AMPK", "object_type": "GENE"}, {"subject": "Metformin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "acetyl-CoA carboxylase-2", "object_type": "GENE"}]}
{"text": "The increase in AMPK alpha2 activity was likely due to a change in muscle energy status because ATP and phosphocreatine concentrations were lower after metformin treatment.", "spo_list": [{"subject": "metformin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "AMPK alpha2", "object_type": "GENE"}]}
{"text": "Metformin-induced increases in AMPK activity were associated with higher rates of glucose disposal and muscle glycogen concentrations.", "spo_list": [{"subject": "Metformin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "AMPK", "object_type": "GENE"}]}
{"text": "Acute and chronic PLZ administration increase brain GABA levels, an effect due, at least in part, to an inhibition of the activity of the GABA metabolizing enzyme, GABA transaminase (GABA-T).", "spo_list": [{"subject": "GABA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "GABA transaminase", "object_type": "GENE"}, {"subject": "GABA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "GABA-T", "object_type": "GENE"}, {"subject": "PLZ", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "GABA transaminase", "object_type": "GENE"}, {"subject": "PLZ", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "GABA-T", "object_type": "GENE"}]}
{"text": "As with GABA, the metabolism of alanine involves a pyridoxal phosphate-dependent transaminase.", "spo_list": [{"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "pyridoxal phosphate-dependent transaminase", "object_type": "GENE"}]}
{"text": "3. In the study reported here, the effects of acute PLZ treatment on the levels of various amino acids, some of which are also metabolized by pyridoxal phosphate-dependent transaminases were compared in rat whole brain.", "spo_list": [{"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "pyridoxal phosphate-dependent transaminases", "object_type": "GENE"}]}
{"text": "4. The elevation in brain alanine levels could be explained, at least in part, by a time- and dose-dependent inhibitory effect of PLZ on alanine transaminase (ALA-T), although as with GABA the increases are higher than expected from the degree of enzyme inhibition produced.", "spo_list": [{"subject": "PLZ", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "alanine transaminase", "object_type": "GENE"}, {"subject": "PLZ", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ALA-T", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "alanine transaminase", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ALA-T", "object_type": "GENE"}]}
{"text": "In addition, we also showed that the elevation in alanine levels and the inhibition of alanine transaminase in the brain are retained after 14 days of PLZ treatment, and that PLZ produces a marked increase in extracellular levels of alanine.", "spo_list": [{"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "alanine transaminase", "object_type": "GENE"}, {"subject": "PLZ", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "alanine transaminase", "object_type": "GENE"}]}
{"text": "In macrophages, levels of TNF-α, IFN-γ, NO, IL-6 and IL-10 were increased by CDM used alone or in combination with HSV-2.", "spo_list": [{"subject": "CDM", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "TNF-α", "object_type": "GENE"}, {"subject": "CDM", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "IFN-γ", "object_type": "GENE"}, {"subject": "CDM", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "IL-6", "object_type": "GENE"}, {"subject": "CDM", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "IL-10", "object_type": "GENE"}]}
{"text": "Besides, CDM not only synergized TNF-α production combined with IFN-γ, but also prolonged its expression in time.", "spo_list": [{"subject": "CDM", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "TNF-α", "object_type": "GENE"}, {"subject": "CDM", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "IFN-γ", "object_type": "GENE"}]}
{"text": "Results indicate that CDM inhibits HSV-2 multiplication in epithelial cells and also increases cytokine production in macrophages, both important actions to the clearance of infecting virus in the mouse vagina.", "spo_list": [{"subject": "CDM", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "cytokine", "object_type": "GENE"}]}
{"text": "We apply DFTB in a QM/MM framework to perform vibrational analysis of buried aspartic acids in bacteriorhodopsin and channelrhodopsin-2.", "spo_list": [{"subject": "aspartic acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "bacteriorhodopsin", "object_type": "GENE"}, {"subject": "aspartic acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "channelrhodopsin-2", "object_type": "GENE"}]}
{"text": "Olopatadine hydrochloride (olopatadine, 11-[(Z)-3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid monohydrochloride) is a novel antiallergic/histamine H1-receptor antagonistic drug that was synthesized and evaluated in our laboratories.", "spo_list": [{"subject": "Olopatadine hydrochloride", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "histamine H1-receptor", "object_type": "GENE"}, {"subject": "olopatadine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "histamine H1-receptor", "object_type": "GENE"}, {"subject": "11-[(Z)-3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid monohydrochloride", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "histamine H1-receptor", "object_type": "GENE"}]}
{"text": "Olopatadine is a selective histamine H1-receptor antagonist possessing inhibitory effects on the release of inflammatory lipid mediators such as leukotriene and thromboxane from human polymorphonuclear leukocytes and eosinophils.", "spo_list": [{"subject": "Olopatadine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "histamine H1-receptor", "object_type": "GENE"}]}
{"text": "In terms of the mechanisms, we found that fatty acid amide hydrolase (FAAH) which degrades anandamide, was upregulated after nerve injury at both ages, so that this upregulation likely did not account for the age-dependent differences.", "spo_list": [{"subject": "anandamide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "fatty acid amide hydrolase", "object_type": "GENE"}, {"subject": "anandamide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FAAH", "object_type": "GENE"}]}
{"text": "However, enzymes contributing to oxidative metabolism of anandamide, namely cyclooxygenase-1 and Cyp2D6, were increased in the brain of aged mice, possibly enhancing the oxidative breakdown of anandamide.", "spo_list": [{"subject": "anandamide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cyclooxygenase-1", "object_type": "GENE"}, {"subject": "anandamide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Cyp2D6", "object_type": "GENE"}, {"subject": "anandamide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cyclooxygenase-1", "object_type": "GENE"}, {"subject": "anandamide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Cyp2D6", "object_type": "GENE"}]}
{"text": "In untrained and trained treated animals with the amnesic dose (1.0mg/kg) of METH SERT binding in several areas including hippocampus and cortex decreased, more remarkably in the trained animals.", "spo_list": [{"subject": "METH", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "SERT", "object_type": "GENE"}]}
{"text": "Of these, the thrombin inhibitor dabigatran and factor Xa inhibitor rivaroxaban have recently been licensed for thromboprophylaxis after orthopaedic surgery mainly in Europe.", "spo_list": [{"subject": "dabigatran", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "thrombin", "object_type": "GENE"}, {"subject": "rivaroxaban", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "factor Xa", "object_type": "GENE"}]}
{"text": "In addition, the factor Xa inhibitor apixaban is in late-stage clinical development.", "spo_list": [{"subject": "apixaban", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "factor Xa", "object_type": "GENE"}]}
{"text": "The anti-amnesic effect of minaprine on the cycloheximide-induced memory impairment was also antagonized by a serotonin (5-HT) releaser, p-chloroamphetamine, and by a 5-HT precursor, 5-hydroxytryptophan, whereas a 5-HT1A-selective agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, was inactive.", "spo_list": [{"subject": "8-hydroxy-2-(di-n-propylamino)tetralin", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT1A", "object_type": "GENE"}]}
{"text": "The memory-improving effect of minaprine on cycloheximide-induced amnesia was potentiated by a selective 5-HT2 antagonist, ritanserin.", "spo_list": [{"subject": "ritanserin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT2", "object_type": "GENE"}]}
{"text": "RESULTS: By epifluorescence microscopy, approximately 40% of infected HEK 293 cells demonstrated EGFP expression. beta2AR density measured with [3H]dihydroalprenolol ([3H]DHA) increased either 13- or 77-fold in infected cells compared to mock infected controls depending on the culture conditions used.", "spo_list": [{"subject": "[3H]dihydroalprenolol", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "beta2AR", "object_type": "GENE"}, {"subject": "[3H]DHA", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "beta2AR", "object_type": "GENE"}]}
{"text": "The [3H]DHA binding was to a single receptor population with a dissociation constant of 0.42 nM, as would be expected for wild-type beta2AR.", "spo_list": [{"subject": "[3H]DHA", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "beta2AR", "object_type": "GENE"}]}
{"text": "Agonist competition assays with [3H]DHA showed the following rank order of potency: isoproterenol>epinephrine> norepinephrine, consistent with beta2AR interaction.", "spo_list": [{"subject": "isoproterenol", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "beta2AR", "object_type": "GENE"}, {"subject": "epinephrine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "beta2AR", "object_type": "GENE"}, {"subject": "norepinephrine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "beta2AR", "object_type": "GENE"}, {"subject": "[3H]DHA", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "beta2AR", "object_type": "GENE"}]}
{"text": "Phorbol esters and norepinephrine destabilize alpha 1B-adrenergic receptor mRNA in vascular smooth muscle cells.", "spo_list": [{"subject": "norepinephrine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha 1B-adrenergic receptor", "object_type": "GENE"}]}
{"text": "The mechanism by which norepinephrine (NE) down-regulates alpha 1B-adrenergic receptor (alpha-AR) mRNA was studied in rabbit aortic smooth muscle cells.", "spo_list": [{"subject": "norepinephrine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha 1B-adrenergic receptor", "object_type": "GENE"}, {"subject": "NE", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha 1B-adrenergic receptor", "object_type": "GENE"}, {"subject": "norepinephrine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha-AR", "object_type": "GENE"}, {"subject": "NE", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha-AR", "object_type": "GENE"}]}
{"text": "NE, phorbol esters, and bradykinin each decreased alpha-AR mRNA levels by 70-80%.", "spo_list": [{"subject": "NE", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha-AR", "object_type": "GENE"}, {"subject": "phorbol esters", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha-AR", "object_type": "GENE"}]}
{"text": "The protein kinase C inhibitor (+)-1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H-7) abolished the effects of phorbol esters and NE and decreased basal mRNA levels by 52 +/- 3%.", "spo_list": [{"subject": "(+)-1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "protein kinase C", "object_type": "GENE"}, {"subject": "H-7", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "protein kinase C", "object_type": "GENE"}]}
{"text": "Neither ryanodine nor EGTA inhibited down-regulation of alpha-AR mRNA by NE.", "spo_list": [{"subject": "EGTA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "alpha-AR", "object_type": "GENE"}, {"subject": "NE", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha-AR", "object_type": "GENE"}, {"subject": "ryanodine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "alpha-AR", "object_type": "GENE"}]}
{"text": "Actinomycin D caused alpha-AR mRNA level to decrease with a half-life of 3.2 +/- 0.4 h and blocked the effect of H-7 to decrease basal alpha-AR mRNA level.", "spo_list": [{"subject": "Actinomycin D", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha-AR", "object_type": "GENE"}, {"subject": "Actinomycin D", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha-AR", "object_type": "GENE"}]}
{"text": "Both NE and phorbol esters increased the rate of alpha-AR mRNA degradation.", "spo_list": [{"subject": "phorbol esters", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha-AR", "object_type": "GENE"}, {"subject": "NE", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha-AR", "object_type": "GENE"}]}
{"text": "In NE-desensitized cells, phorbol esters and bradykinin each caused the expected down-regulation of alpha-AR mRNA.", "spo_list": [{"subject": "NE", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha-AR", "object_type": "GENE"}, {"subject": "phorbol esters", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alpha-AR", "object_type": "GENE"}]}
{"text": "The protein phosphatase inhibitor okadaic acid prolonged the normally transient effect of NE for at least 24 h. We conclude that protein kinase C exerts two opposing effects on alpha-AR mRNA levels, 1) a decrease in the stability of the mRNA that requires the sustained phosphorylation of a protein kinase C substrate and 2) a permissive effect on alpha-AR gene transcription.", "spo_list": [{"subject": "okadaic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "protein phosphatase", "object_type": "GENE"}]}
{"text": "Repression of farnesyltransferase (FNTA) by siRNA and the enzyme inhibitor manumycin A caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing hApoA-I and cholesterol ester transfer protein transgenes.", "spo_list": [{"subject": "manumycin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "farnesyltransferase", "object_type": "GENE"}, {"subject": "manumycin A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "FNTA", "object_type": "GENE"}, {"subject": "manumycin A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ApoA-I", "object_type": "GENE"}, {"subject": "manumycin A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "hApoA-I", "object_type": "GENE"}]}
{"text": "Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects.", "spo_list": [{"subject": "JZL184", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Monoacylglycerol Lipase", "object_type": "GENE"}]}
{"text": "The monoacylglycerol lipase (MAGL) inhibitor JZL184 produces antinociceptive and anti-inflammatory effects.", "spo_list": [{"subject": "JZL184", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoacylglycerol lipase", "object_type": "GENE"}, {"subject": "JZL184", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MAGL", "object_type": "GENE"}]}
{"text": "Mice given daily injections of high dose JZL184 (≥16 mg/kg) for six days displayed decreased CB(1) receptor density and function in brain, as assessed in [(3)H]SR141716A binding and CP55,940-stimulated [(35)S]GTPγS binding assays, respectively.", "spo_list": [{"subject": "[(3)H]SR141716A", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "CB(1)", "object_type": "GENE"}, {"subject": "CP55,940", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "CB(1)", "object_type": "GENE"}, {"subject": "(35)S", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "CB(1)", "object_type": "GENE"}]}
{"text": "Triclosan inhibited both cyclooxygenase 1 and cyclo-oxygenase 2 with IC-50 values of 43 microM and 227 microM, respectively.", "spo_list": [{"subject": "Triclosan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase 1", "object_type": "GENE"}, {"subject": "Triclosan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclo-oxygenase 2", "object_type": "GENE"}]}
{"text": "Triclosan also inhibited 5-lipoxygenase with an IC-50 of 43 microM.", "spo_list": [{"subject": "Triclosan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-lipoxygenase", "object_type": "GENE"}]}
{"text": "The 15-lipoxygenase was similarly inhibited by triclosan with an IC-50 of 61 microM.", "spo_list": [{"subject": "triclosan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "15-lipoxygenase", "object_type": "GENE"}]}
{"text": "Hence, triclosan has the ability to inhibit both the cyclo-oxygenase and lipoxygenase pathways of arachidonic acid metabolism with similar efficacy.", "spo_list": [{"subject": "triclosan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclo-oxygenase", "object_type": "GENE"}, {"subject": "triclosan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "lipoxygenase", "object_type": "GENE"}, {"subject": "arachidonic acid", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cyclo-oxygenase", "object_type": "GENE"}, {"subject": "arachidonic acid", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "lipoxygenase", "object_type": "GENE"}]}
{"text": "In cell culture experiments, it was found that triclosan inhibited IL-1 beta induced prostaglandin E2 production by human gingival fibroblasts in a concentration dependent manner, and at relatively low concentrations.", "spo_list": [{"subject": "triclosan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "IL-1 beta", "object_type": "GENE"}, {"subject": "prostaglandin E2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "IL-1 beta", "object_type": "GENE"}]}
{"text": "The potency of MrIA was greater for inhibition of uptake by hNET of [3H]norepinephrine (Ki 1.89 microM) than [3H]dopamine (Ki 4.33 microM), and the human dopamine transporter and serotonin transporter were not inhibited by MrIA (to 7 microM).", "spo_list": [{"subject": "[3H]norepinephrine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "hNET", "object_type": "GENE"}, {"subject": "[3H]dopamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "hNET", "object_type": "GENE"}]}
{"text": "Of 18 mutations where hNET amino acid residues were exchanged with those of the human dopamine transporter, MrIA had increased potency for inhibition of [3H]norepinephrine uptake for three mutations (in predicted extracellular loops 3 and 4 and transmembrane domain (TMD) 8) and decreased potency for one mutation (in TMD6 and intracellular loop (IL) 3).", "spo_list": [{"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "hNET", "object_type": "GENE"}]}
{"text": "A comparison of the results with previous data for desipramine and cocaine inhibition of norepinephrine uptake by the mutant hNETs reveals that MrIA binding to hNET occurs at a site that is distinct from but overlaps with the binding sites for tricyclic antidepressants and cocaine.", "spo_list": [{"subject": "norepinephrine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "hNETs", "object_type": "GENE"}, {"subject": "tricyclic", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "hNET", "object_type": "GENE"}, {"subject": "cocaine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "hNET", "object_type": "GENE"}]}
{"text": "Pharmacogenetic analysis of two genes, the warfarin metabolic enzyme CYP2C9 and warfarin target enzyme, vitamin K epoxide reductase complex 1 VKORC1, confirmed their influence on warfarin maintenance dose.", "spo_list": [{"subject": "warfarin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2C9", "object_type": "GENE"}]}
{"text": "Possession of CYP2C9*2 or CYP2C9*3 variant alleles, which result in decreased enzyme activity, is associated with a significant decrease in the mean warfarin dose.", "spo_list": [{"subject": "warfarin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2C9", "object_type": "GENE"}, {"subject": "warfarin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2C9", "object_type": "GENE"}]}
{"text": "Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.", "spo_list": [{"subject": "DFMO", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ornithine decarboxylase", "object_type": "GENE"}, {"subject": "DL-alpha-difluoromethylornithine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ornithine decarboxylase", "object_type": "GENE"}, {"subject": "DL-alpha-difluoromethylornithine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ODC", "object_type": "GENE"}, {"subject": "DFMO", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ODC", "object_type": "GENE"}, {"subject": "putrescine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ornithine decarboxylase", "object_type": "GENE"}, {"subject": "spermidine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ornithine decarboxylase", "object_type": "GENE"}, {"subject": "spermine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ornithine decarboxylase", "object_type": "GENE"}, {"subject": "putrescine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ODC", "object_type": "GENE"}, {"subject": "spermidine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ODC", "object_type": "GENE"}, {"subject": "spermine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ODC", "object_type": "GENE"}]}
{"text": "Inhibition of S-adenosylmethionine decarboxylase by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); DEGBG] led to depletion of spermidine and spermine with a significant accumulation of putrescine and induction of ODC.", "spo_list": [{"subject": "diethylglyoxal bis-(guanylhydrazone)", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "S-adenosylmethionine decarboxylase", "object_type": "GENE"}, {"subject": "DEGBG", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "S-adenosylmethionine decarboxylase", "object_type": "GENE"}, {"subject": "spermidine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "S-adenosylmethionine decarboxylase", "object_type": "GENE"}, {"subject": "spermine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "S-adenosylmethionine decarboxylase", "object_type": "GENE"}]}
{"text": "The above results indicate that polyamine depletion delays the onset of apoptosis in IEC-6 cells and confers protection against DNA damaging agents, suggesting that polyamines might be involved in the caspase activating signal cascade.", "spo_list": [{"subject": "polyamines", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "caspase", "object_type": "GENE"}]}
{"text": "The 5-HT(1/2/5/7)-receptor antagonist methysergide and the 5-HT(2A/2B/2C)-receptor antagonist LY 53857 enhanced clomipramine-induced hyperglycemia, while the 5-HT(1A/1B)-receptor antagonist (-)-propranolol and the 5-HT(3/4)-receptor antagonist tropisetron did not affect it.", "spo_list": [{"subject": "LY 53857", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT(2A/2B/2C)-receptor", "object_type": "GENE"}, {"subject": "(-)-propranolol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT(1A/1B)-receptor", "object_type": "GENE"}, {"subject": "tropisetron", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT(3/4)-receptor", "object_type": "GENE"}]}
{"text": "The 5-HT(2B/2C)-receptor antagonist SB 206553 facilitated hyperglycemia induced by clomipramine, although the 5-HT(2A)-receptor antagonist ketanserin was without effect.", "spo_list": [{"subject": "SB 206553", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT(2B/2C)-receptor", "object_type": "GENE"}, {"subject": "ketanserin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT(2A)", "object_type": "GENE"}]}
{"text": "These results suggest that clomipramine induces hyperglycemia in mice by blocking the 5-HT(2B )and/or 5-HT(2C) receptors, which results in facilitation of adrenaline release.", "spo_list": [{"subject": "clomipramine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-HT(2B )", "object_type": "GENE"}, {"subject": "clomipramine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-HT(2C)", "object_type": "GENE"}]}
{"text": "The discovery of an inducible oxidase whose apparent substrate preference is spermine indicates that polyamine catabolism is more complex than that originally proposed.", "spo_list": [{"subject": "spermine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "oxidase", "object_type": "GENE"}]}
{"text": "Purified PAOh1/SMO oxidizes both spermine (K(m)=1.6 microM) and N(1)-acetylspermine (K(m)=51 microM), but does not oxidize spermidine.", "spo_list": [{"subject": "spermine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PAOh1", "object_type": "GENE"}, {"subject": "spermine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SMO", "object_type": "GENE"}, {"subject": "N(1)-acetylspermine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SMO", "object_type": "GENE"}, {"subject": "N(1)-acetylspermine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PAOh1", "object_type": "GENE"}]}
{"text": "The purified human enzyme also does not oxidize eight representative antitumor polyamine analogues; however, specific oligamine analogues were found to be potent inhibitors of the oxidation of spermine by PAOh1/SMO.", "spo_list": [{"subject": "spermine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PAOh1", "object_type": "GENE"}, {"subject": "spermine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SMO", "object_type": "GENE"}]}
{"text": "Role of organic cation/carnitine transporter 1 in uptake of phenformin and inhibitory effect on complex I respiration in mitochondria.", "spo_list": [{"subject": "phenformin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "organic cation/carnitine transporter 1", "object_type": "GENE"}, {"subject": "phenformin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "complex I", "object_type": "GENE"}]}
{"text": "Phenformin causes lactic acidosis in clinical situations due to inhibition of mitochondrial respiratory chain complex I. It is reportedly taken up by hepatocytes and exhibits mitochondrial toxicity in the liver.", "spo_list": [{"subject": "Phenformin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mitochondrial respiratory chain complex I", "object_type": "GENE"}]}
{"text": "In this study, uptake of phenformin and [(14)C]tetraethylammonium (TEA) and complex I inhibition by phenformin were examined in isolated liver and heart mitochondria.", "spo_list": [{"subject": "phenformin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "complex I", "object_type": "GENE"}]}
{"text": "Inhibition by phenformin of oxygen consumption via complex I respiration in isolated rat liver mitochondria was greater than that in heart mitochondria, whereas inhibitory effect of phenformin on complex I respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts.", "spo_list": [{"subject": "phenformin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "complex I", "object_type": "GENE"}, {"subject": "phenformin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "complex I", "object_type": "GENE"}]}
{"text": "These observations suggest that uptake of phenformin into liver mitochondria is at least partly mediated by OCTN1 and functionally relevant to its inhibition potential of complex I respiration.", "spo_list": [{"subject": "phenformin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "OCTN1", "object_type": "GENE"}, {"subject": "phenformin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "complex I", "object_type": "GENE"}]}
{"text": "Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder.", "spo_list": [{"subject": "arachidonic acid", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "brain microsomal long-chain fatty acyl-CoA synthetases", "object_type": "GENE"}, {"subject": "arachidonoyl-CoA", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "brain microsomal long-chain fatty acyl-CoA synthetases", "object_type": "GENE"}, {"subject": "Valproic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "brain microsomal long-chain fatty acyl-CoA synthetases", "object_type": "GENE"}]}
{"text": "RATIONALE: Several drugs used to treat bipolar disorder (lithium and carbamazepine), when administered chronically to rats, reduce the turnover of arachidonic acid, but not docosahexaenoic acid, in brain phospholipids by decreasing the activity of an arachidonic acid-selective phospholipase A(2).", "spo_list": [{"subject": "lithium", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "phospholipase A(2)", "object_type": "GENE"}, {"subject": "carbamazepine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "phospholipase A(2)", "object_type": "GENE"}]}
{"text": "MATERIALS AND METHODS/RESULTS: By isolating rat brain microsomal long-chain fatty acyl-CoA synthetases (Acsl), we show in vitro that valproic acid is a non-competitive inhibitor of Acsl, as it reduces the maximal velocity of the reaction without changing the affinity of the substrate for the enzyme.", "spo_list": [{"subject": "valproic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Acsl", "object_type": "GENE"}]}
{"text": "CONCLUSIONS: This study shows that valproic acid acts as a non-competitive inhibitor of brain microsomal Acsl, and that inhibition is substrate-selective.", "spo_list": [{"subject": "valproic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "brain microsomal Acsl", "object_type": "GENE"}]}
{"text": "Crystal structures of protein phosphatase-1 bound to motuporin and dihydromicrocystin-LA: elucidation of the mechanism of enzyme inhibition by cyanobacterial toxins.", "spo_list": [{"subject": "motuporin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "protein phosphatase-1", "object_type": "GENE"}, {"subject": "dihydromicrocystin-LA", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "protein phosphatase-1", "object_type": "GENE"}]}
{"text": "A previous crystal structure of a microcystin bound to the catalytic subunit of protein phosphatase-1 (PP-1c) showed distinct changes in the active site region when compared with protein phosphatase-1 structures bound to other toxins.", "spo_list": [{"subject": "microcystin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "protein phosphatase-1", "object_type": "GENE"}, {"subject": "microcystin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PP-1c", "object_type": "GENE"}]}
{"text": "We have elucidated the crystal structures of the cyanotoxins, motuporin (nodularin-V) and dihydromicrocystin-LA bound to human protein phosphatase-1c (gamma isoform).", "spo_list": [{"subject": "motuporin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human protein phosphatase-1c (gamma isoform)", "object_type": "GENE"}, {"subject": "nodularin-V", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human protein phosphatase-1c (gamma isoform)", "object_type": "GENE"}, {"subject": "dihydromicrocystin-LA", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human protein phosphatase-1c (gamma isoform)", "object_type": "GENE"}]}
{"text": "Comparisons of the structures of the cyanobacterial toxin:phosphatase complexes explain the biochemical mechanism by which microcystins but not nodularins permanently modify their protein phosphatase targets by covalent addition to an active site cysteine residue.", "spo_list": [{"subject": "microcystins", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "protein phosphatase", "object_type": "GENE"}, {"subject": "cysteine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "protein phosphatase", "object_type": "GENE"}]}
{"text": "The treatment of mice with Fe-NTA alone enhances ornithine decarboxylase activity to 4.6 folds, protein carbonyl formation increased up to 2.9 folds and DNA synthesis expressed in terms of [(3)H] thymidine incorporation increased to 3.2 folds, and antioxidants and antioxidant enzymes decreased to 1.8-2.5 folds, compared with the corresponding saline-treated controls.", "spo_list": [{"subject": "Fe-NTA", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "ornithine decarboxylase", "object_type": "GENE"}]}
{"text": "Full agonists to the peroxisome proliferator-activated receptor (PPAR)γ, such as Rosiglitazone, have been associated with a series of undesired side effects, such as weight gain, fluid retention, cardiac hypertrophy, and hepatotoxicity.", "spo_list": [{"subject": "Rosiglitazone", "subject_type": "CHEMICAL", "predicate": "AGONIST-ACTIVATOR", "object": "peroxisome proliferator-activated receptor (PPAR)γ", "object_type": "GENE"}]}
{"text": "Experimental as well as clinical reports support the hypothesis that calcium channel blockers such as verapamil may be an appropriate therapeutic approach in LQTS.", "spo_list": [{"subject": "verapamil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "calcium channel", "object_type": "GENE"}]}
{"text": "METHODS AND RESULTS: In 8 Langendorff-perfused rabbit hearts, veratridine (0.1 microM), an inhibitor of sodium channel inactivation, led to a marked increase in QT-interval and simultaneously recorded monophasic ventricular action potentials (MAPs) (p < 0.05) thereby mimicking LQT3.", "spo_list": [{"subject": "veratridine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sodium channel", "object_type": "GENE"}]}
{"text": "Moreover, minocycline efficiently suppressed the release of cytochrome c from mitochondria of the liver tissues from Jo2-challenged mice.", "spo_list": [{"subject": "minocycline", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cytochrome c", "object_type": "GENE"}]}
{"text": "4. Our results suggest that easing of Fas-triggered fulminant hepatitis by minocycline may involve a mitochondrial apoptotic pathway, probably through preventing cytochrome c release and thereby blocking downstream caspase activation.", "spo_list": [{"subject": "minocycline", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cytochrome c", "object_type": "GENE"}, {"subject": "minocycline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "caspase", "object_type": "GENE"}]}
{"text": "We examined the effect of JTH-601 (3- inverted question markN-[2-(4-hydroxy-2-isopropyl-5-methylphenoxy)ethyl]-N-methylaminom ethyl inverted question mark-4-methoxy-2,5,6-trimethylphenol hemifumarate), a new alpha(1L)-adrenoceptor antagonist, on prostatic function in isolated canine prostate and in anesthetized dogs.", "spo_list": [{"subject": "JTH-601", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1L)-adrenoceptor", "object_type": "GENE"}, {"subject": "N-[2-(4-hydroxy-2-isopropyl-5-methylphenoxy)ethyl]-N-methylaminom", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1L)-adrenoceptor", "object_type": "GENE"}, {"subject": "ethyl", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1L)-adrenoceptor", "object_type": "GENE"}, {"subject": "4-methoxy-2,5,6-trimethylphenol hemifumarate", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1L)-adrenoceptor", "object_type": "GENE"}]}
{"text": "In these tissues, JTH-601, prazosin (a non-selective alpha(1)-adrenoceptor antagonist), and tamsulosin (an alpha(1A)-adrenoceptor antagonist) competitively antagonized contraction in a concentration-dependent manner.", "spo_list": [{"subject": "JTH-601", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1)-adrenoceptor", "object_type": "GENE"}, {"subject": "prazosin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1)-adrenoceptor", "object_type": "GENE"}, {"subject": "tamsulosin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1A)-adrenoceptor", "object_type": "GENE"}]}
{"text": "JTH-601 is expected to be an effective alpha(1)-adrenoceptor antagonist for the treatment of urinary outlet obstruction by benign prostatic hypertrophy with a minimum effect on the cardiovascular system.", "spo_list": [{"subject": "JTH-601", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1)-adrenoceptor", "object_type": "GENE"}]}
{"text": "Amino acid sequences of cynomolgus FMO1-5, respectively, shared high sequence identities (94-98%) and were closely clustered in a phylogenetic tree, with human FMO1-5.", "spo_list": [{"subject": "Amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "FMO1-5", "object_type": "GENE"}]}
{"text": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.", "spo_list": [{"subject": "benzydamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Cynomolgus FMO1", "object_type": "GENE"}, {"subject": "benzydamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO2", "object_type": "GENE"}, {"subject": "benzydamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO3", "object_type": "GENE"}, {"subject": "benzydamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO5", "object_type": "GENE"}, {"subject": "methimazole", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO1", "object_type": "GENE"}, {"subject": "methimazole", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO3", "object_type": "GENE"}, {"subject": "methimazole", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO3", "object_type": "GENE"}, {"subject": "trimethylamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO1", "object_type": "GENE"}, {"subject": "trimethylamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO3", "object_type": "GENE"}, {"subject": "trimethylamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO3", "object_type": "GENE"}]}
{"text": "Rates of benzydamine N-oxygenation (catalyzed by FMO3) varied (approximately 20-fold) among the 28 cynomolgus livers and were significantly correlated with FMO3 protein expression, indicating that the inter-animal variations in benzydamine N-oxygenation might be partly accounted for by the variable FMO3 expression.", "spo_list": [{"subject": "benzydamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO3", "object_type": "GENE"}, {"subject": "N", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO3", "object_type": "GENE"}, {"subject": "benzydamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO3", "object_type": "GENE"}, {"subject": "N", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO3", "object_type": "GENE"}]}
{"text": "Cynomolgus FMO6 metabolized benzydamine only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, FMO2, FMO3, and FMO5 which were all functional.", "spo_list": [{"subject": "benzydamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Cynomolgus FMO6", "object_type": "GENE"}, {"subject": "benzydamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO1", "object_type": "GENE"}, {"subject": "benzydamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO2", "object_type": "GENE"}, {"subject": "benzydamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO3", "object_type": "GENE"}, {"subject": "benzydamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "FMO5", "object_type": "GENE"}]}
{"text": "Metabolism of triethylenetetramine and 1,12-diamino-3,6,9-triazadodecane by the spermidine/spermine-N(1)-acetyltransferase and thialysine acetyltransferase.", "spo_list": [{"subject": "triethylenetetramine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "spermidine/spermine-N(1)-acetyltransferase", "object_type": "GENE"}, {"subject": "1,12-diamino-3,6,9-triazadodecane", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "spermidine/spermine-N(1)-acetyltransferase", "object_type": "GENE"}, {"subject": "triethylenetetramine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "thialysine acetyltransferase", "object_type": "GENE"}, {"subject": "1,12-diamino-3,6,9-triazadodecane", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "thialysine acetyltransferase", "object_type": "GENE"}]}
{"text": "We recently showed that TETA is metabolized in vitro by polyamine catabolic enzyme spermidine/spermine-N(1)-acetyltransferase (SSAT1) and by thialysine acetyltransferase (SSAT2) to its monoacetylated derivative (MAT).", "spo_list": [{"subject": "TETA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "spermidine/spermine-N(1)-acetyltransferase", "object_type": "GENE"}, {"subject": "polyamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "spermidine/spermine-N(1)-acetyltransferase", "object_type": "GENE"}, {"subject": "polyamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SSAT1", "object_type": "GENE"}, {"subject": "TETA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SSAT1", "object_type": "GENE"}, {"subject": "TETA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "thialysine acetyltransferase", "object_type": "GENE"}, {"subject": "TETA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SSAT2", "object_type": "GENE"}]}
{"text": "The acetylation of TETA is increased in SSAT1-overexpressing mice compared with wild-type mice.", "spo_list": [{"subject": "TETA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SSAT1", "object_type": "GENE"}]}
{"text": "However, SSAT1-deficient mice metabolize TETA at the same rate as the wild-type mice, indicating the existence of another N-acetylase respons 2ible for its metabolism in mice.", "spo_list": [{"subject": "TETA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "N-acetylase", "object_type": "GENE"}]}
{"text": "Here, we show that siRNA-mediated knockdown of SSAT2 in HEPG2 cells and in primary hepatocytes from the SSAT1-deficient or wild-type mice reduced the metabolism of TETA to MAT.", "spo_list": [{"subject": "TETA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SSAT2", "object_type": "GENE"}]}
{"text": "By contrast, 1,12-diamino-3,6,9-triazadodecane(SpmTrien), a charge-deficient spermine analog, was an extremely poor substrate of human recombinant SSAT2 and was metabolized by SSAT1 in HEPG2 cells and in wild-type primary hepatocytes.", "spo_list": [{"subject": "1,12-diamino-3,6,9-triazadodecane", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human recombinant SSAT2", "object_type": "GENE"}, {"subject": "SpmTrien", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human recombinant SSAT2", "object_type": "GENE"}, {"subject": "spermine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human recombinant SSAT2", "object_type": "GENE"}, {"subject": "1,12-diamino-3,6,9-triazadodecane", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SSAT1", "object_type": "GENE"}, {"subject": "SpmTrien", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SSAT1", "object_type": "GENE"}, {"subject": "spermine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SSAT1", "object_type": "GENE"}]}
{"text": "Thus, despite the similar structures of TETA and SpmTrien, SSAT2 is the main acetylator of TETA, whereas SpmTrien is primarily acetylated by SSAT1.", "spo_list": [{"subject": "TETA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SSAT2", "object_type": "GENE"}, {"subject": "SpmTrien", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "SSAT1", "object_type": "GENE"}]}
{"text": "The potency of the antipsychotic drug, risperidone, to antagonize alpha 1A-adrenoceptor-mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney, and alpha 1B-adrenoceptor-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of alpha 1-adrenoceptor subtype-discriminating antagonists.", "spo_list": [{"subject": "risperidone", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1A-adrenoceptor", "object_type": "GENE"}, {"subject": "risperidone", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1B-adrenoceptor", "object_type": "GENE"}, {"subject": "risperidone", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}]}
{"text": "However, at guinea-pig and mouse splenic alpha 1B-adrenoceptors, the affinity values of risperidone were 10-fold lower than those of prazosin.", "spo_list": [{"subject": "risperidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "guinea-pig and mouse splenic alpha 1B-adrenoceptors", "object_type": "GENE"}, {"subject": "prazosin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "guinea-pig and mouse splenic alpha 1B-adrenoceptors", "object_type": "GENE"}]}
{"text": "The CYP2B6*6 Allele Significantly Alters the N-demethylation of Ketamine Enantiomers In Vitro.", "spo_list": [{"subject": "Ketamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2B6*6", "object_type": "GENE"}]}
{"text": "Ketamine is primarily metabolized to norketamine by hepatic cytochrome P450 (CYP) 2B6 and CYP3A4-mediated N-demethylation.", "spo_list": [{"subject": "Ketamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytochrome P450 (CYP) 2B6", "object_type": "GENE"}, {"subject": "Ketamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A4", "object_type": "GENE"}]}
{"text": "The CYP2B6*6 allele is associated with reduced enzyme expression and activity that may lead to interindividual variability in ketamine metabolism.", "spo_list": [{"subject": "ketamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2B6*6", "object_type": "GENE"}]}
{"text": "We examined the N-demethylation of individual ketamine enantiomers using human liver microsomes (HLMs) genotyped for the CYP2B6*6 allele, insect cell expressed recombinant CYP2B6 and CYP3A4 enzymes and COS-1 cell expressed recombinant CYP2B6.1 and CYP2B6.6 protein variant.", "spo_list": [{"subject": "ketamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2B6*6", "object_type": "GENE"}]}
{"text": "The intrinsic clearance for both ketamine enantiomers by the high affinity enzyme in HLMs with CYP2B6*1/*1 genotype were at least 2-fold and 6-fold higher, respectively, than those for CYP2B6*1/*6 genotype and CYP2B6*6/*6 genotype.", "spo_list": [{"subject": "ketamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2B6*1", "object_type": "GENE"}]}
{"text": "ThioTEPA (CYP2B6 inhibitor, 25 μM) and the monoclonal antibody against CYP2B6 but not troleandomycin (CYP3A4 inhibitor, 25 μM) or the monoclonal antibody against CYP3A4 inhibited ketamine N-demethylation at clinically relevant concentrations.", "spo_list": [{"subject": "ThioTEPA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP2B6", "object_type": "GENE"}, {"subject": "troleandomycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP3A4", "object_type": "GENE"}]}
{"text": "These results indicate a major role of CYP2B6 in ketamine N-demethylation in vitro and a significant impact of the CYP2B6*6 allele on enzyme-ketamine binding and catalytic activity.", "spo_list": [{"subject": "ketamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2B6", "object_type": "GENE"}, {"subject": "ketamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2B6*6", "object_type": "GENE"}]}
{"text": "This study was designed to determine the gastroprotective properties of cinitapride (CNT), a novel prokinetic benzamide derivative agonist of 5-HT4 and 5-HT1 receptors and 5-HT2 antagonist, on mucosal injury produced by 50% (v/v) ethanol.", "spo_list": [{"subject": "benzamide", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT4", "object_type": "GENE"}, {"subject": "benzamide", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT1", "object_type": "GENE"}, {"subject": "benzamide", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT2", "object_type": "GENE"}, {"subject": "cinitapride", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT2", "object_type": "GENE"}, {"subject": "CNT", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "5-HT2", "object_type": "GENE"}, {"subject": "cinitapride", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT4", "object_type": "GENE"}, {"subject": "cinitapride", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT1", "object_type": "GENE"}, {"subject": "CNT", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT4", "object_type": "GENE"}, {"subject": "CNT", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT1", "object_type": "GENE"}]}
{"text": "Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.", "spo_list": [{"subject": "sitagliptin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dipeptidyl peptidase-4", "object_type": "GENE"}]}
{"text": "AIM: To assess the efficacy and safety of a 24-week treatment with sitagliptin, a highly selective once-daily oral dipeptidyl peptidase-4 (DPP-4) inhibitor, in patients with type 2 diabetes who had inadequate glycaemic control [glycosylated haemoglobin (HbA(1c)) >or=7.5% and <or=10.5%] while on glimepiride alone or in combination with metformin.", "spo_list": [{"subject": "sitagliptin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dipeptidyl peptidase-4", "object_type": "GENE"}, {"subject": "sitagliptin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DPP-4", "object_type": "GENE"}]}
{"text": "OBJECTIVES: The aim of this study was to determine whether cocaine's sympathomimetic actions can be reversed by a potent centrally acting alpha2 adrenergic receptor (AR) agonist (dexmedetomidine).", "spo_list": [{"subject": "dexmedetomidine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha2 adrenergic receptor", "object_type": "GENE"}, {"subject": "dexmedetomidine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "AR", "object_type": "GENE"}]}
{"text": "Using the alpha 1-adrenoceptor subtype-selective antagonists chlorethylclonidine (CEC), WB4101, and 5-methyl-urapidil, we have examined the possible heterogeneity in the alpha 1-adrenoceptor populations in rabbit aorta.", "spo_list": [{"subject": "chlorethylclonidine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}, {"subject": "CEC", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}, {"subject": "WB4101", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}, {"subject": "5-methyl-urapidil", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}]}
{"text": "Radioligand binding studies with the nonselective alpha 1-adrenoceptor antagonist radioligand 125I-BE2254 showed that 73-87% of the binding sites in rabbit aorta are CEC sensitive and they are predominantly low affinity sites both for WB4101 (pKd = 8.1) and for 5-methylurapidil (pKd = 7.1).", "spo_list": [{"subject": "125I-BE2254", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}, {"subject": "125I-BE2254", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}, {"subject": "CEC", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}, {"subject": "WB4101", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}, {"subject": "5-methylurapidil", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}]}
{"text": "The Schild plots for the competitive antagonists WB4101 and 5-methyl-urapidil against alpha 1a-adrenoceptor-selective agonist methoxamine-induced contraction were linear and had slopes not significantly different from unity, with a pA2 of 9.07 +/- 0.07 (n = 5) for WB4101 and 9.09 +/- 0.05 (n = 3) for 5-methyl-urapidil.", "spo_list": [{"subject": "WB4101", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1a-adrenoceptor", "object_type": "GENE"}, {"subject": "5-methyl-urapidil", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1a-adrenoceptor", "object_type": "GENE"}, {"subject": "methoxamine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha 1a-adrenoceptor", "object_type": "GENE"}, {"subject": "WB4101", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1a-adrenoceptor", "object_type": "GENE"}, {"subject": "5-methyl-urapidil", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1a-adrenoceptor", "object_type": "GENE"}]}
{"text": "Computer-assisted analysis of these curvilinear Schild plots in a two-receptor system indicated that alpha 1-adrenoceptor populations responsible for the constrictive response are predominantly (approximately 80-90%) low affinity sites for the two antagonists (pKd approximately 8.1 for WB4101 and pKd approximately 7.1 for 5-methyl-urapidil) and a small population (approximately 10-20%) are high affinity sites (pKd approximately 9.1 for both WB4101 and 5-methyl-urapidil), which was in good agreement with radioligand binding studies.", "spo_list": [{"subject": "WB4101", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}, {"subject": "5-methyl-urapidil", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}, {"subject": "WB4101", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}, {"subject": "5-methyl-urapidil", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha 1-adrenoceptor", "object_type": "GENE"}]}
{"text": "All neurotrophic effects were blocked by the unselective D2/D3 receptor antagonist sulpiride (5 microm) and by the selective D3 receptor antagonist SB-277011-A at a low dose (50 nm).", "spo_list": [{"subject": "SB-277011-A", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "D3 receptor", "object_type": "GENE"}]}
{"text": "Quinpirole and 7-OH-DPAT also increased the phosphorylation of extracellular signal-regulated kinase (ERK) within minutes, an effect blocked by pretreatment with SB-277011-A.", "spo_list": [{"subject": "7-OH-DPAT", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "extracellular signal-regulated kinase", "object_type": "GENE"}, {"subject": "7-OH-DPAT", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "ERK", "object_type": "GENE"}, {"subject": "Quinpirole", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "extracellular signal-regulated kinase", "object_type": "GENE"}, {"subject": "Quinpirole", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "ERK", "object_type": "GENE"}, {"subject": "SB-277011-A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ERK", "object_type": "GENE"}, {"subject": "SB-277011-A", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "extracellular signal-regulated kinase", "object_type": "GENE"}]}
{"text": "Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs.", "spo_list": [{"subject": "Imatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KIT", "object_type": "GENE"}, {"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KIT", "object_type": "GENE"}, {"subject": "Gleevec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KIT", "object_type": "GENE"}, {"subject": "Glivec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "KIT", "object_type": "GENE"}, {"subject": "Imatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ABL", "object_type": "GENE"}, {"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ABL", "object_type": "GENE"}, {"subject": "Gleevec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ABL", "object_type": "GENE"}, {"subject": "Glivec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ABL", "object_type": "GENE"}, {"subject": "Imatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BCR", "object_type": "GENE"}, {"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BCR", "object_type": "GENE"}, {"subject": "Gleevec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BCR", "object_type": "GENE"}, {"subject": "Glivec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BCR", "object_type": "GENE"}, {"subject": "Imatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ABL", "object_type": "GENE"}, {"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ABL", "object_type": "GENE"}, {"subject": "Gleevec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ABL", "object_type": "GENE"}, {"subject": "Glivec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ABL", "object_type": "GENE"}, {"subject": "Imatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFRA", "object_type": "GENE"}, {"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFRA", "object_type": "GENE"}, {"subject": "Gleevec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFRA", "object_type": "GENE"}, {"subject": "Glivec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFRA", "object_type": "GENE"}, {"subject": "Imatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFRB,", "object_type": "GENE"}, {"subject": "STI571", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFRB,", "object_type": "GENE"}, {"subject": "Gleevec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFRB,", "object_type": "GENE"}, {"subject": "Glivec", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDGFRB,", "object_type": "GENE"}]}
{"text": "In the hot-plate test in mice, the antinociceptive action of the alpha 2-adrenoceptor agonist, UK 14,304, was abolished by the alpha 2-adrenoceptor antagonist, idazoxan, the potent alpha 2A-adrenoceptor antagonist, RX 821002 and the preferential alpha 2A-adrenoceptor antagonist, BRL 44408.", "spo_list": [{"subject": "UK 14,304", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha 2-adrenoceptor", "object_type": "GENE"}, {"subject": "idazoxan", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 2-adrenoceptor", "object_type": "GENE"}, {"subject": "RX 821002", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 2A-adrenoceptor", "object_type": "GENE"}, {"subject": "BRL 44408", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha 2A-adrenoceptor", "object_type": "GENE"}]}
{"text": "The preferential alpha 2A-adrenoceptor partial agonist, guanfacine, partially inhibited UK 14,304-induced antinociception.", "spo_list": [{"subject": "guanfacine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha 2A-adrenoceptor", "object_type": "GENE"}, {"subject": "UK 14,304", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha 2A-adrenoceptor", "object_type": "GENE"}]}
{"text": "A series of studies is reviewed that assesses the relationship between cytokines released at the site of tissue injury and NSAID analgesia, and the in vivo selectivity of a selective cyclooxygenase (COX)-2 inhibitor (celecoxib) in comparison to a dual COX-1/COX-2 inhibitor (ketorolac).", "spo_list": [{"subject": "ketorolac", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-1", "object_type": "GENE"}, {"subject": "ketorolac", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "celecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase (COX)-2", "object_type": "GENE"}]}
{"text": "Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of prostaglandin E2 (PGE2; a product of both COX-1 and COX-2) and thromboxane B2 (as a biomarker for COX-1 activity) with parallel assessments of pain.", "spo_list": [{"subject": "prostaglandin E2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-1", "object_type": "GENE"}, {"subject": "prostaglandin E2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-2", "object_type": "GENE"}, {"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-1", "object_type": "GENE"}, {"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-2", "object_type": "GENE"}]}
{"text": "The time course of PGE2 production was consistent with early release due to COX-1 activity followed by increased production 2-3 hours after surgery, consistent with COX-2 expression.", "spo_list": [{"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-1", "object_type": "GENE"}, {"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Celecoxib selectively suppressed PGE2 but not TxB2 at time points consistent with COX-2 activity, while producing analgesia.", "spo_list": [{"subject": "Celecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-2", "object_type": "GENE"}]}
{"text": "These studies demonstrate the ability to assess the time course and selective effects of COX-2 inhibitors in vivo and suggest that suppression of COX-2 mediated PGE2 is temporally related to NSAID analgesia.", "spo_list": [{"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Etoposide (VP-16) is a topoisomerase-II (topo II) inhibitor chemotherapeutic agent.", "spo_list": [{"subject": "Etoposide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "topoisomerase-II", "object_type": "GENE"}, {"subject": "Etoposide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "topo II", "object_type": "GENE"}, {"subject": "VP-16", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "topoisomerase-II", "object_type": "GENE"}, {"subject": "VP-16", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "topo II", "object_type": "GENE"}]}
{"text": "MXF or VP-16 slightly affected cellular topo II activity in nuclear extracts derived from drug-treated cells while the combination enhanced inhibitory activity and the reduction in band depletion of topo II.", "spo_list": [{"subject": "MXF", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "topo II", "object_type": "GENE"}, {"subject": "VP-16", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "topo II", "object_type": "GENE"}]}
{"text": "Apoptosis studies (DAPI staining and caspase 3 activity) showed a marked increase in the presence of MXF and VP-16 compared to VP-16 alone.", "spo_list": [{"subject": "MXF", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "caspase 3", "object_type": "GENE"}, {"subject": "VP-16", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "caspase 3", "object_type": "GENE"}, {"subject": "VP-16", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "caspase 3", "object_type": "GENE"}]}
{"text": "In conclusion, the results suggest that the enhancement in the reduction of topo II activity by the combined MXF/VP-16 treatments was probably due to the increase in the level of the DNA-enzyme cleavable complexes formed by both drugs.", "spo_list": [{"subject": "VP-16", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "topo II", "object_type": "GENE"}, {"subject": "MXF", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "topo II", "object_type": "GENE"}]}
{"text": "Synthesis and cancer stem cell-based activity of substituted 5-morpholino-7H-thieno[3,2-b]pyran-7-ones designed as next generation PI3K inhibitors.", "spo_list": [{"subject": "5-morpholino-7H-thieno[3,2-b]pyran-7-ones", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PI3K", "object_type": "GENE"}]}
{"text": "Our previous work, built on the early pioneering multikinase inhibitor LY294002, resulted in the only PI3K vascular-targeted PI3K inhibitor prodrug, SF1126, which has now completed Phase I clinical trials.", "spo_list": [{"subject": "LY294002", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PI3K", "object_type": "GENE"}, {"subject": "LY294002", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PI3K", "object_type": "GENE"}, {"subject": "SF1126", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PI3K", "object_type": "GENE"}, {"subject": "SF1126", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PI3K", "object_type": "GENE"}]}
{"text": "This work resulted in the discovery of the 5-morpholino-7H-thieno[3,2-b]pyran-7-one system as the foundation of a new compound class of potential PI3K inhibitors having improved potency toward PI3K.", "spo_list": [{"subject": "5-morpholino-7H-thieno[3,2-b]pyran-7-one", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PI3K", "object_type": "GENE"}, {"subject": "5-morpholino-7H-thieno[3,2-b]pyran-7-one", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PI3K", "object_type": "GENE"}]}
{"text": "Pinosylvin was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3β (GSK-3β) signaling pathway.", "spo_list": [{"subject": "Pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "ocal adhesion kinase", "object_type": "GENE"}, {"subject": "Pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "FAK", "object_type": "GENE"}, {"subject": "Pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "c-Src", "object_type": "GENE"}, {"subject": "Pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "extracellular signal-regulated kinase", "object_type": "GENE"}, {"subject": "Pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "ERK", "object_type": "GENE"}, {"subject": "Pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "phosphoinositide 3-kinase", "object_type": "GENE"}, {"subject": "Pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "PI3K", "object_type": "GENE"}, {"subject": "Pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Akt", "object_type": "GENE"}, {"subject": "Pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "glycogen synthase kinase 3β", "object_type": "GENE"}, {"subject": "Pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "GSK-3β", "object_type": "GENE"}]}
{"text": "Subsequently, pinosylvin suppressed the nuclear translocation of β-catenin, one of downstream molecules of PI3K/Akt/GSK-3β signaling, and these events led to the sequential downregulation of β-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.", "spo_list": [{"subject": "pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "β-catenin", "object_type": "GENE"}, {"subject": "pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "PI3K", "object_type": "GENE"}, {"subject": "pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Akt", "object_type": "GENE"}, {"subject": "pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "GSK-3β", "object_type": "GENE"}, {"subject": "pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "β-catenin", "object_type": "GENE"}, {"subject": "pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "BMP4", "object_type": "GENE"}, {"subject": "pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "ID2", "object_type": "GENE"}, {"subject": "pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "survivin", "object_type": "GENE"}, {"subject": "pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cyclin D1", "object_type": "GENE"}, {"subject": "pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "MMP7", "object_type": "GENE"}, {"subject": "pinosylvin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "c-Myc", "object_type": "GENE"}]}
{"text": "Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors.", "spo_list": [{"subject": "5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "JAK3", "object_type": "GENE"}, {"subject": "5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}]}
{"text": "We report the discovery of a novel series of ATP-competitive Janus kinase 3 (JAK3) inhibitors based on the 5H-pyrrolo[2,3-b]pyrazine scaffold.", "spo_list": [{"subject": "5H-pyrrolo[2,3-b]pyrazine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Janus kinase 3", "object_type": "GENE"}, {"subject": "5H-pyrrolo[2,3-b]pyrazine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "JAK3", "object_type": "GENE"}]}
{"text": "Serum amyloid A upsurge precedes standard biomarkers of hepatotoxicity in ritodrine-injected mice.", "spo_list": [{"subject": "ritodrine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Serum amyloid A", "object_type": "GENE"}]}
{"text": "Importantly, expression of the acute-phase reactant serum amyloid A (SAA) significantly increased after ritodrine injection, with values indicating the largest fold-change.", "spo_list": [{"subject": "ritodrine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "serum amyloid A", "object_type": "GENE"}, {"subject": "ritodrine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "SAA", "object_type": "GENE"}]}
{"text": "The increase in SAA expression is specific to ritodrine-induced liver damage, because SAA expression was not induced by other hepatotoxic drugs such as acetaminophen, valproic acid, or metformin.", "spo_list": [{"subject": "ritodrine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "SAA", "object_type": "GENE"}]}
{"text": "Our in vitro studies showed that cyclic adenosine 3',5'-monophosphate (cAMP) accumulation was not a primary cause of the ritodrine-induced SAA increase.", "spo_list": [{"subject": "ritodrine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "SAA", "object_type": "GENE"}]}
{"text": "Discovery of a novel series of quinolone α7 nicotinic acetylcholine receptor agonists.", "spo_list": [{"subject": "quinolone", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "α7 nicotinic acetylcholine receptor", "object_type": "GENE"}]}
{"text": "High throughput screening led to the identification of a novel series of quinolone α7 nicotinic acetylcholine receptor (nAChR) agonists.", "spo_list": [{"subject": "quinolone", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "α7 nicotinic acetylcholine receptor", "object_type": "GENE"}, {"subject": "quinolone", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "nAChR", "object_type": "GENE"}]}
{"text": "Reductions in striatal dopamine and tyrosine hydroxylase content were also less pronounced with EHT treatment.", "spo_list": [{"subject": "EHT", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "tyrosine hydroxylase", "object_type": "GENE"}]}
{"text": "The neuroinflammatory response to MPTP was markedly attenuated, and indices of oxidative stress and JNK activation were significantly prevented with EHT.", "spo_list": [{"subject": "EHT", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "JNK", "object_type": "GENE"}]}
{"text": "In cultured primary microglia and astrocytes, EHT had a direct anti-inflammatory effect demonstrated by repression of lipopolysaccharide-induced NFκB activation, iNOS induction, and nitric oxide production.", "spo_list": [{"subject": "EHT", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NFκB", "object_type": "GENE"}, {"subject": "EHT", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "iNOS", "object_type": "GENE"}]}
{"text": "The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.", "spo_list": [{"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Hsp90", "object_type": "GENE"}, {"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}]}
{"text": "Improper function of these proteins can be induced by selective disruption of their complexes with Hsp90 using the benzoquinonoid ansamycin geldanamycin.", "spo_list": [{"subject": "benzoquinonoid ansamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Hsp90", "object_type": "GENE"}, {"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Hsp90", "object_type": "GENE"}]}
{"text": "In this study, we demonstrate that geldanamycin treatment blocks interleukin (IL)-2 secretion, IL-2 receptor expression, and proliferation of stimulated T-lymphocytes.", "spo_list": [{"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "interleukin (IL)-2", "object_type": "GENE"}, {"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-2 receptor", "object_type": "GENE"}]}
{"text": "Moreover, geldanamycin decreases the amount and phosphorylation of Lck and Raf-1 kinases and prevents activation of the extracellular signal regulated kinase (ERK)-2 kinase.", "spo_list": [{"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Lck", "object_type": "GENE"}, {"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Lck", "object_type": "GENE"}, {"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Raf-1", "object_type": "GENE"}, {"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinases", "object_type": "GENE"}, {"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Raf-1", "object_type": "GENE"}, {"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "kinases", "object_type": "GENE"}, {"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "extracellular signal regulated kinase (ERK)-2", "object_type": "GENE"}, {"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}]}
{"text": "Geldanamycin also disrupts the T-cell receptor-mediated activation of nuclear factor of activated T-cells (NF-AT).", "spo_list": [{"subject": "Geldanamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "T-cell receptor", "object_type": "GENE"}, {"subject": "Geldanamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "nuclear factor of activated T-cells", "object_type": "GENE"}, {"subject": "Geldanamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NF-AT", "object_type": "GENE"}]}
{"text": "Through demonstrating the selective inhibition of kinase-related T-lymphocyte responses by geldanamycin, our results emphasize the substantial role of Hsp90-kinase complexes in T-cell activation.", "spo_list": [{"subject": "geldanamycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "kinase", "object_type": "GENE"}]}
{"text": "Doses of dimethocaine (1.7 mg/kg) and cocaine (0.3 mg/kg) which produced full (> 80%) substitution for cocaine were administered in combination with the dopamine D1 receptor antagonist SCH 39166 ((-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H -benzo [d]naphtho-(2,1-b)azepine) and the dopamine D2 receptor antagonist raclopride (both at 0.003-0.03 mg/kg).", "spo_list": [{"subject": "SCH 39166", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "dopamine D1 receptor", "object_type": "GENE"}, {"subject": "raclopride", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "dopamine D2 receptor", "object_type": "GENE"}, {"subject": "(-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H -benzo [d]naphtho-(2,1-b)azepine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "dopamine D1 receptor", "object_type": "GENE"}]}
{"text": "To establish the relative importance of these subtypes, we compared the effects of sumatriptan with those of a selective 5-HT1F receptor agonist (LY 344864) on c-fos protein expression in the trigeminal nucleus caudalis. c-fos expression was induced in urethane-anaesthetized rats by intracisternal capsaicin administration.", "spo_list": [{"subject": "LY 344864", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "5-HT1F", "object_type": "GENE"}, {"subject": "capsaicin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "c-fos", "object_type": "GENE"}]}
{"text": "Sumatriptan and LY 344864 decreased the number of capsaicin-induced c-fos-like immunoreactive cells within trigeminal nucleus caudalis (ID50 = 0.04 and 0.6 mg kg(-1)).", "spo_list": [{"subject": "capsaicin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "c-fos", "object_type": "GENE"}, {"subject": "Sumatriptan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "c-fos", "object_type": "GENE"}, {"subject": "LY 344864", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "c-fos", "object_type": "GENE"}]}
{"text": "The effect of sumatriptan, but not of LY 344864, was prevented by pretreatment with the antagonist SDZ 21-009, which displays high affinity for rat 5-HT1B receptors.", "spo_list": [{"subject": "SDZ 21-009", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "rat 5-HT1B", "object_type": "GENE"}]}
{"text": "Activating glucocorticoid receptor-ERK signaling pathway contributes to ginsenoside Rg1 protection against β-amyloid peptide-induced human endothelial cells apoptosis.", "spo_list": [{"subject": "ginsenoside Rg1", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "glucocorticoid receptor", "object_type": "GENE"}, {"subject": "ginsenoside Rg1", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "ERK", "object_type": "GENE"}, {"subject": "ginsenoside Rg1", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "β-amyloid peptide", "object_type": "GENE"}]}
{"text": "Rg1 attenuated the Aβ25-35-associated mitochondrial apoptotic events, accompanied by inhibiting HIF-1α expression followed by intracellular reactive nitrogen species generation, and protein nitrotyrosination.", "spo_list": [{"subject": "Rg1", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Aβ25-35", "object_type": "GENE"}, {"subject": "Rg1", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "HIF-1α", "object_type": "GENE"}]}
{"text": "These protective effects were abolished by glucocorticoid receptor (GR) antagonist RU486 or p-ERK inhibitor U0126 rather than estrogen receptor α antagonist ICI 82,780.", "spo_list": [{"subject": "RU486", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "GR", "object_type": "GENE"}, {"subject": "RU486", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "glucocorticoid receptor", "object_type": "GENE"}, {"subject": "U0126", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "p-ERK", "object_type": "GENE"}, {"subject": "ICI 82,780", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "estrogen receptor α", "object_type": "GENE"}]}
{"text": "Taken together, our results suggested that Rg1 protected against Aβ25-35-induced apoptosis at least in part by two complementary GR-dependent ERK phosphorylation pathways: (1) down-regulating HIF-1α initiated protein nitrotyrosination, and (2) inhibiting mitochondrial apoptotic cascades.", "spo_list": [{"subject": "Rg1", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Aβ25-35", "object_type": "GENE"}, {"subject": "Rg1", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "HIF-1α", "object_type": "GENE"}, {"subject": "Rg1", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "ERK", "object_type": "GENE"}]}
{"text": "These data provided a novel insight to the mechanisms of Rg1protective effects on Aβ25-35-induced endothelial cells apoptosis, suggesting that GR-ERK signaling pathway might play an important role in it.", "spo_list": [{"subject": "Rg1", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Aβ25-35", "object_type": "GENE"}]}
{"text": "Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.", "spo_list": [{"subject": "rasagiline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine oxidase", "object_type": "GENE"}]}
{"text": "Rasagiline [N-propargyl-l(R)-aminoindan] is a second-generation propargylamine pharmacophore that selectively and irreversibly inhibits brain MAO-B and is specifically designed for the treatment of Parkinson's disease (PD).", "spo_list": [{"subject": "N-propargyl-l(R)-aminoindan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MAO-B", "object_type": "GENE"}, {"subject": "propargylamine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MAO-B", "object_type": "GENE"}, {"subject": "Rasagiline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MAO-B", "object_type": "GENE"}]}
{"text": "Based on the results from those studies, we concluded that rasagiline PO QD, at the therapeutic dosage range of 0.5 to 1 rag/d, is effective and well tolerated and completely, selectively, and specifically inhibited MAO-B.", "spo_list": [{"subject": "rasagiline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MAO-B", "object_type": "GENE"}]}
{"text": "Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.", "spo_list": [{"subject": "Phenelzine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine oxidase", "object_type": "GENE"}]}
{"text": "Phenelzine (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.", "spo_list": [{"subject": "Phenelzine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine oxidase", "object_type": "GENE"}, {"subject": "PLZ", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine oxidase", "object_type": "GENE"}, {"subject": "Phenelzine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MAO", "object_type": "GENE"}, {"subject": "PLZ", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MAO", "object_type": "GENE"}, {"subject": "Phenelzine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "GABA-transaminase", "object_type": "GENE"}, {"subject": "Phenelzine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "GABA-T", "object_type": "GENE"}, {"subject": "PLZ", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "GABA-transaminase", "object_type": "GENE"}, {"subject": "PLZ", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "GABA-T", "object_type": "GENE"}]}
{"text": "PLZ is also a substrate for MAO, and studies suggest that a metabolite formed by the action of this enzyme on PLZ may be responsible for the increase in GABA observed.", "spo_list": [{"subject": "PLZ", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "MAO", "object_type": "GENE"}]}
{"text": "To determine whether a metabolite formed by the action of MAO on PLZ may be responsible for the elevation in brain ORN observed, animals were pretreated with vehicle or the MAO inhibitor tranylcypromine (TCP) before vehicle or PLZ (15 mg/kg), and brains collected 3 h later.", "spo_list": [{"subject": "tranylcypromine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MAO", "object_type": "GENE"}, {"subject": "TCP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MAO", "object_type": "GENE"}]}
{"text": "ORN levels (measured by an HPLC procedure) were dose- and time-dependently increased in PLZ-treated animals, with levels reaching approximately 650% of control at 6 and 12 h. Pretreatment with TCP completely abolished the PLZ-induced increase in brain ORN, suggesting, as with GABA, that a metabolite of PLZ formed by the action of MAO is responsible for the elevation of brain ORN observed.", "spo_list": [{"subject": "PLZ", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "MAO", "object_type": "GENE"}]}
{"text": "Bevantolol: a beta-1 adrenoceptor antagonist with unique additional actions.", "spo_list": [{"subject": "Bevantolol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "beta-1 adrenoceptor", "object_type": "GENE"}]}
{"text": "UNLABELLED: Bevantolol is a beta-1 adrenoceptor antagonist that has been shown to be as effective as other beta blockers for the treatment of angina pectoris and hypertension.", "spo_list": [{"subject": "Bevantolol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "beta-1 adrenoceptor", "object_type": "GENE"}]}
{"text": "It is suggested that all the additional actions of bevantolol can be attributed to a partial agonist action on alpha-adrenoceptors.", "spo_list": [{"subject": "bevantolol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha-adrenoceptors", "object_type": "GENE"}]}
{"text": "Functional divergence of a unique C-terminal domain of leucyl-tRNA synthetase to accommodate its splicing and aminoacylation roles.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "leucyl-tRNA synthetase", "object_type": "GENE"}, {"subject": "leucyl", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "leucyl-tRNA synthetase", "object_type": "GENE"}]}
{"text": "Leucyl-tRNA synthetase (LeuRS) performs dual essential roles in group I intron RNA splicing as well as protein synthesis within the yeast mitochondria.", "spo_list": [{"subject": "Leucyl", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Leucyl-tRNA synthetase", "object_type": "GENE"}]}
{"text": "Herein, we determined that a fiveamino acid C-terminal deletion of LeuRS, which does not complement a null strain, can form a ternary complex with the bI4 intron and its maturase splicing partner.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "LeuRS", "object_type": "GENE"}]}
{"text": "The x-ray co-crystal structure of LeuRS showed that a C-terminal extension of about 60 amino acids forms a discrete domain, which is unique among the LeuRSs and interacts with the corner of the L-shaped tRNALeu.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "LeuRSs", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "LeuRSs", "object_type": "GENE"}]}
{"text": "Interestingly, deletion of the entire yeast mitochondrial LeuRS C-terminal domain enhanced its aminoacylation and amino acid editing activities.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "yeast mitochondrial LeuRS", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "yeast mitochondrial LeuRS", "object_type": "GENE"}]}
{"text": "In striking contrast, deletion of the corresponding C-terminal domain of Escherichia coli LeuRS abolished aminoacylation of tRNALeu and also amino acid editing of mischarged tRNA molecules.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Escherichia coli LeuRS", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Escherichia coli LeuRS", "object_type": "GENE"}]}
{"text": "We propose that the secondary role of yeast mitochondrial LeuRS in RNA splicing has impacted the functional evolution of this critical C-terminal domain.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "yeast mitochondrial LeuRS", "object_type": "GENE"}]}
{"text": "The initial fragment hits were thoroughly validated biophysically by isothermal titration calorimetry (ITC) and NMR techniques and observed by X-ray crystallography to bind in a shallow surface pocket that is occupied in the native complex by the side chain of a phenylalanine from the conserved FxxA interaction motif found in BRCA2.", "spo_list": [{"subject": "phenylalanine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "FxxA interaction motif", "object_type": "GENE"}, {"subject": "phenylalanine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "BRCA2", "object_type": "GENE"}]}
{"text": "Treatment with EVn-50 or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.", "spo_list": [{"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Histone 3", "object_type": "GENE"}, {"subject": "Tyr", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Cdk1", "object_type": "GENE"}, {"subject": "EVn-50", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Histone 3", "object_type": "GENE"}, {"subject": "VB1", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Histone 3", "object_type": "GENE"}, {"subject": "EVn-50", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Cdk1", "object_type": "GENE"}, {"subject": "VB1", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Cdk1", "object_type": "GENE"}, {"subject": "EVn-50", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "cyclin B1", "object_type": "GENE"}, {"subject": "VB1", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "cyclin B1", "object_type": "GENE"}, {"subject": "EVn-50", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Cdc25c", "object_type": "GENE"}, {"subject": "VB1", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "Cdc25c", "object_type": "GENE"}]}
{"text": "Optimization of 5-hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase.", "spo_list": [{"subject": "5-hydroxytryptamines", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "phospholipase A2", "object_type": "GENE"}, {"subject": "5-hydroxytryptamines", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "leukotriene A4 hydrolase", "object_type": "GENE"}]}
{"text": "Dual function inhibitors targeting phospholipase A(2) (PLA(2)) and leukotriene A(4) hydrolase (LTA(4)H) may balance the arachidonic acid (AA) metabolic network and be used as new anti-inflammatory drugs.", "spo_list": [{"subject": "arachidonic acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "phospholipase A(2)", "object_type": "GENE"}, {"subject": "arachidonic acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PLA(2)", "object_type": "GENE"}, {"subject": "arachidonic acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "leukotriene A(4) hydrolase", "object_type": "GENE"}, {"subject": "arachidonic acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "LTA(4)H", "object_type": "GENE"}]}
{"text": "In previous study, we discovered multi-target drugs towards the AA metabolic network, among which a dual-target inhibitor (JMC08-4) for human nonpancreatic secretory phospholipase A(2) (hnps-PLA(2)) and human leukotriene A(4) hydrolase (LTA(4)H-h) was found.", "spo_list": [{"subject": "JMC08-4", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "human nonpancreatic secretory phospholipase A(2)", "object_type": "GENE"}, {"subject": "JMC08-4", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "hnps-PLA(2)", "object_type": "GENE"}, {"subject": "JMC08-4", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "human leukotriene A(4) hydrolase", "object_type": "GENE"}, {"subject": "JMC08-4", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "LTA(4)H-h", "object_type": "GENE"}]}
{"text": "Epi increased the activity of the human WNT6 promoter through Cav1-dependent binding of β-catenin to the proximal WNT6 promoter.", "spo_list": [{"subject": "Epi", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "human WNT6 promoter", "object_type": "GENE"}, {"subject": "Epi", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "WNT6 promoter", "object_type": "GENE"}]}
{"text": "Epi increased both WNT6/Wnt6 and Cav1 expression in human GC cells and within the tumor area of a murine model of GC (CEA424-SV40 TAg).", "spo_list": [{"subject": "Epi", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "WNT6", "object_type": "GENE"}, {"subject": "Epi", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Wnt6", "object_type": "GENE"}, {"subject": "Epi", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Cav1", "object_type": "GENE"}]}
{"text": "These results showed that WNT6 and Cav1 are upregulated by chemotherapeutics and enhance the resistance of GC cells to anthracycline drugs.", "spo_list": [{"subject": "anthracycline", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Cav1", "object_type": "GENE"}, {"subject": "anthracycline", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "WNT6", "object_type": "GENE"}]}
{"text": "5-(N,N-dimethyl)-amiloride (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.", "spo_list": [{"subject": "5-(N,N-dimethyl)-amiloride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NHE", "object_type": "GENE"}, {"subject": "DMA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NHE", "object_type": "GENE"}, {"subject": "5-(N,N-dimethyl)-amiloride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NHE1", "object_type": "GENE"}, {"subject": "5-(N,N-dimethyl)-amiloride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NHE2", "object_type": "GENE"}, {"subject": "5-(N,N-dimethyl)-amiloride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NHE3", "object_type": "GENE"}, {"subject": "DMA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NHE1", "object_type": "GENE"}, {"subject": "DMA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NHE2", "object_type": "GENE"}, {"subject": "DMA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NHE3", "object_type": "GENE"}]}
{"text": "Nevertheless, 3 mM DMA, a higher concentration that inhibits NHE1, NHE2, and NHE3, significantly increased DBS.", "spo_list": [{"subject": "DMA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NHE1", "object_type": "GENE"}, {"subject": "DMA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NHE2", "object_type": "GENE"}, {"subject": "DMA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NHE3", "object_type": "GENE"}]}
{"text": "Moreover, S1611 and S3226, both specific inhibitors of NHE3 only, or perfusion with Na+-free solutions, dose dependently increased DBS, as measured by pH-stat and CO2-sensitive electrode, without affecting intracellular pH.", "spo_list": [{"subject": "S1611", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NHE3", "object_type": "GENE"}, {"subject": "S3226", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NHE3", "object_type": "GENE"}]}
{"text": "Nevertheless, coperfusion with 0.1 and 0.3 mM 5-nitro-2-(3-phenylpropylamino) benzoic acid, which inhibits the cystic fibrosis transmembrane conductor regulator (CFTR), dose dependently inhibited S3226-induced DBS.", "spo_list": [{"subject": "5-nitro-2-(3-phenylpropylamino) benzoic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cystic fibrosis transmembrane conductor regulator", "object_type": "GENE"}, {"subject": "5-nitro-2-(3-phenylpropylamino) benzoic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CFTR", "object_type": "GENE"}]}
{"text": "In conclusion, only specific apical NHE3 inhibition increased DBS, whereas prostaglandin synthesis, Na+-HCO3- cotransporter activation, or intracellular HCO3- formation by carbonic anhydrase was not involved.", "spo_list": [{"subject": "HCO3", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "carbonic anhydrase", "object_type": "GENE"}]}
{"text": "2. Indomethacin treatment led to an increase in lipid peroxidation, glutathione peroxidase and glucose-6-phosphate dehydrogenase activities and to a decrease in catalase activity and glutathione levels in gastric mucosa.", "spo_list": [{"subject": "Indomethacin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "glutathione peroxidase", "object_type": "GENE"}, {"subject": "Indomethacin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "glucose-6-phosphate dehydrogenase", "object_type": "GENE"}, {"subject": "Indomethacin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "catalase", "object_type": "GENE"}]}
{"text": "The results suggested that both the EtOAc extract and berberine were able to activate PPARα/β/γ, and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine.", "spo_list": [{"subject": "EtOAc", "subject_type": "CHEMICAL", "predicate": "AGONIST-ACTIVATOR", "object": "PPARα/β/γ", "object_type": "GENE"}, {"subject": "berberine", "subject_type": "CHEMICAL", "predicate": "AGONIST-ACTIVATOR", "object": "PPARα/β/γ", "object_type": "GENE"}, {"subject": "berberine", "subject_type": "CHEMICAL", "predicate": "AGONIST-ACTIVATOR", "object": "PPARα/β/γ", "object_type": "GENE"}, {"subject": "berberine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "PPARs", "object_type": "GENE"}]}
{"text": "Phosphatidylserine (PtdSer) is made in mammalian cells by two PtdSer synthases, PSS1 and PSS2.", "spo_list": [{"subject": "Phosphatidylserine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PtdSer synthases", "object_type": "GENE"}, {"subject": "Phosphatidylserine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PSS1", "object_type": "GENE"}, {"subject": "Phosphatidylserine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PSS2", "object_type": "GENE"}]}
{"text": "Moreover, a normal level of expression of PSS1 and/or PSS2 is not required for generating the pool of PtdSer externalized during apoptosis.", "spo_list": [{"subject": "PtdSer", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PSS1", "object_type": "GENE"}, {"subject": "PtdSer", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PSS2", "object_type": "GENE"}]}
{"text": "Relative to WT, electrophysiological recordings from ADNFLE mouse layer II/III cortical pyramidal cells reveal a >20-fold increase in nicotine-evoked inhibitory postsynaptic currents with no effect on excitatory postsynaptic currents. i.p. injection of a subthreshold dose of picrotoxin, a use-dependent gamma-aminobutyric acid receptor antagonist, reduces cortical electroencephalogram delta power and transiently inhibits spontaneous seizure activity in ADNFLE mutant mice.", "spo_list": [{"subject": "picrotoxin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "gamma-aminobutyric acid receptor", "object_type": "GENE"}]}
{"text": "The objective of the present study was to compare the anti-inflammatory effects of the preferential COX-2 inhibitor etodolac with the non-selective COX inhibitor phenylbutazone in horses with lipopolysaccharide (LPS)-induced synovitis.", "spo_list": [{"subject": "phenylbutazone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX", "object_type": "GENE"}]}
{"text": "In addition, both drugs significantly reduced PGE2 levels (P<0.05) 6-h following LPS injection, whereas the probable COX-1 prostanoid TXB2 was significantly reduced by phenylbutazone (P<0.05), but not etodolac.", "spo_list": [{"subject": "phenylbutazone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "COX-1", "object_type": "GENE"}]}
{"text": "The discovery that METH and AMPH activate the rTAAR1 motivated us to study the effect of these drugs on the mouse TAAR1 (mTAAR1) and a human-rat chimera (hrChTAAR1).", "spo_list": [{"subject": "METH", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "rTAAR1", "object_type": "GENE"}, {"subject": "AMPH", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "rTAAR1", "object_type": "GENE"}]}
{"text": "Furthermore, because S-(+)-isomers of METH and AMPH are reported to be more potent and efficacious in vivo than R-(-), we determined the enantiomeric selectivity of all three species of TAAR1.", "spo_list": [{"subject": "METH", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "TAAR1", "object_type": "GENE"}, {"subject": "AMPH", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "TAAR1", "object_type": "GENE"}]}
{"text": "EC50 values for S-(+)-METH were 0.89, 0.92, and 4.44 microM for rTAAR1, mTAAR1, and h-rChTAAR1, respectively.", "spo_list": [{"subject": "S-(+)-METH", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "rTAAR1", "object_type": "GENE"}, {"subject": "S-(+)-METH", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "mTAAR1", "object_type": "GENE"}, {"subject": "S-(+)-METH", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "h-rChTAAR1", "object_type": "GENE"}]}
{"text": "PEA was a potent and full agonist at each species of TAAR1, whereas TYR was a full agonist for the rodent TAAR1s but was a partial agonist at h-rChTAAR1.", "spo_list": [{"subject": "PEA", "subject_type": "CHEMICAL", "predicate": "AGONIST-ACTIVATOR", "object": "TAAR1", "object_type": "GENE"}, {"subject": "TYR", "subject_type": "CHEMICAL", "predicate": "AGONIST-ACTIVATOR", "object": "rodent TAAR1s", "object_type": "GENE"}, {"subject": "TYR", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "h-rChTAAR1", "object_type": "GENE"}]}
{"text": "Interestingly, both isomers of METH were full agonists at mTAAR1 and h-rChTAAR1, whereas both were partial agonists at rTAAR1.", "spo_list": [{"subject": "METH", "subject_type": "CHEMICAL", "predicate": "AGONIST-ACTIVATOR", "object": "mTAAR1", "object_type": "GENE"}, {"subject": "METH", "subject_type": "CHEMICAL", "predicate": "AGONIST-ACTIVATOR", "object": "h-rChTAAR1", "object_type": "GENE"}, {"subject": "METH", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "rTAAR1", "object_type": "GENE"}]}
{"text": "LPA1-induced cytoskeleton reorganization therefore makes a previously unrecognized but critically important contribution to the profibrotic activities of LPA by driving MRTF-dependent CTGF expression, which, in turn, drives fibroblast proliferation.-Sakai, N., Chun, J., Duffield, J. S., Wada, T., Luster, A. D., Tager, A. M. LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.", "spo_list": [{"subject": "LPA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CTGF", "object_type": "GENE"}]}
{"text": "Similar to cocaine, other local anesthetics bind to the dopamine transporter (DAT) and inhibit DA uptake in rodent and monkey brain.", "spo_list": [{"subject": "cocaine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine transporter", "object_type": "GENE"}, {"subject": "cocaine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}]}
{"text": "DAT occupancy was determined by displacement of 8-(2-[(18)F]fluroethyl)2beta-carbomethoxy-3beta-(4-chlorophenyl)nortropane (FECNT).", "spo_list": [{"subject": "8-(2-[(18)F]fluroethyl)2beta-carbomethoxy-3beta-(4-chlorophenyl)nortropane", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "FECNT", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}]}
{"text": "DAT occupancy was between 66 and 82% and <10-41% for doses of dimethocaine and procaine that maintained maximum response rates, respectively.", "spo_list": [{"subject": "dimethocaine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}, {"subject": "procaine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}]}
{"text": "There was close correspondence between peak increases in DA and DAT occupancy.", "spo_list": [{"subject": "DA", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "DAT", "object_type": "GENE"}]}
{"text": "24(S)-hydroxycholesterol is actively eliminated from neuronal cells by ABCA1.", "spo_list": [{"subject": "24(S)-hydroxycholesterol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ABCA1", "object_type": "GENE"}]}
{"text": "High cholesterol turnover catalyzed by cholesterol 24-hydroxylase is essential for neural functions, especially learning.", "spo_list": [{"subject": "cholesterol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cholesterol 24-hydroxylase", "object_type": "GENE"}]}
{"text": "Because 24(S)-hydroxycholesterol (24-OHC), produced by 24-hydroxylase, induces apoptosis of neuronal cells, it is vital to eliminate it rapidly from cells.", "spo_list": [{"subject": "24(S)-hydroxycholesterol", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "24-hydroxylase", "object_type": "GENE"}, {"subject": "24-OHC", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "24-hydroxylase", "object_type": "GENE"}]}
{"text": "The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.", "spo_list": [{"subject": "24-OHC", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ABCA1", "object_type": "GENE"}, {"subject": "24-OHC", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ABCG1", "object_type": "GENE"}, {"subject": "TO901317", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ABCA1", "object_type": "GENE"}, {"subject": "TO901317", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ABCG1", "object_type": "GENE"}, {"subject": "retinoic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ABCA1", "object_type": "GENE"}, {"subject": "retinoic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ABCG1", "object_type": "GENE"}, {"subject": "TO901317", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "nuclear receptors", "object_type": "GENE"}, {"subject": "TO901317", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "LXR", "object_type": "GENE"}, {"subject": "TO901317", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "RXR", "object_type": "GENE"}, {"subject": "retinoic acid", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "nuclear receptors", "object_type": "GENE"}, {"subject": "retinoic acid", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "LXR", "object_type": "GENE"}, {"subject": "retinoic acid", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "RXR", "object_type": "GENE"}]}
{"text": "To confirm the role of each transporter, we analyzed HEK293 cells stably expressing human ABCA1 or ABCG1; we clearly observed 24-OHC efflux in the presence of HDL, whereas efflux in the presence of apolipoprotein A-I was marginal.", "spo_list": [{"subject": "24-OHC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human ABCA1", "object_type": "GENE"}, {"subject": "24-OHC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ABCG1", "object_type": "GENE"}]}
{"text": "These results suggest that ABCA1 actively eliminates 24-OHC in the presence of HDL as a lipid acceptor and protects neuronal cells.", "spo_list": [{"subject": "24-OHC", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ABCA1", "object_type": "GENE"}]}
{"text": "The two basic mainstays of gastrointestinal stromal tumours (GIST) treatment are surgery and imatinib, a selective tyrosine kinase inhibitor that allows achieving a stable or responding disease in about 80% of patients with unresectable/metastatic GIST.", "spo_list": [{"subject": "imatinib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase", "object_type": "GENE"}]}
{"text": "Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.", "spo_list": [{"subject": "denufosol tetrasodium", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "P2Y2 receptor", "object_type": "GENE"}]}
{"text": "Denufosol tetrasodium (INS37217) is a selective P2Y(2) agonist that stimulates ciliary beat frequency and Cl(-) secretion in normal and cystic fibrosis (CF) airway epithelia, and is being investigated as an inhaled treatment for CF.", "spo_list": [{"subject": "Denufosol tetrasodium", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "P2Y(2)", "object_type": "GENE"}, {"subject": "INS37217", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "P2Y(2)", "object_type": "GENE"}]}
{"text": "The Cl(-) secretory response is mediated via a non-CFTR pathway, and the driving force for Cl(-) secretion is enhanced by the effect of P2Y(2) activation to also inhibit epithelial Na(+) transport.", "spo_list": [{"subject": "Cl(-)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CFTR", "object_type": "GENE"}]}
{"text": "Denufosol is metabolically more stable and better tolerated, and may enhance mucociliary clearance for a longer period of time than previously investigated P2Y(2) agonists.", "spo_list": [{"subject": "Denufosol", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "P2Y(2)", "object_type": "GENE"}]}
{"text": "Here, we have now found that activation of p38 MAPK by anisomycin potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes. siRNA knockdown of p38 MAPK abrogated the ability of anisomycin to synergistically induce CYP2B6 mRNA.", "spo_list": [{"subject": "anisomycin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "p38", "object_type": "GENE"}, {"subject": "anisomycin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "MAPK", "object_type": "GENE"}, {"subject": "anisomycin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CYP2B6", "object_type": "GENE"}, {"subject": "anisomycin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "CAR", "object_type": "GENE"}, {"subject": "anisomycin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CYP2B6", "object_type": "GENE"}]}
{"text": "In addition to CYP2B6, anisomycin co-treatment potentiated an increase in CYP2A7 and CYP2C9 mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs.", "spo_list": [{"subject": "anisomycin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CYP2A7", "object_type": "GENE"}, {"subject": "anisomycin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CYP2C9", "object_type": "GENE"}, {"subject": "anisomycin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CYP2B6", "object_type": "GENE"}]}
{"text": "Interaction of human alpha-lactalbumin with fatty acids: determination of binding parameters.", "spo_list": [{"subject": "fatty acids", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human alpha-lactalbumin", "object_type": "GENE"}]}
{"text": "The interaction of holo- and apo-forms of human alpha-lactalbumin with fatty acids was studied by a partition equilibrium method.", "spo_list": [{"subject": "fatty acids", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human alpha-lactalbumin", "object_type": "GENE"}]}
{"text": "Apo-alpha-lactalbumin, obtained by treatment with EDTA, displays one binding site for fatty acids, the association constants for oleic and palmitic acids being 1.9.10(6) and 4.2.10(5) M(-1), respectively.", "spo_list": [{"subject": "fatty acids", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Apo-alpha-lactalbumin", "object_type": "GENE"}, {"subject": "oleic and palmitic acids", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Apo-alpha-lactalbumin", "object_type": "GENE"}]}
{"text": "Mutation of a single amino acid residue in the potential BiP binding site increased the secretion efficiency of factor VIII by threefold.", "spo_list": [{"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "BiP binding site", "object_type": "GENE"}]}
{"text": "We propose that Cu(I) binds the type-1 copper ion-binding site in the A1 domain and provides the essential requirement for a stable interaction between the heavy and light chains.", "spo_list": [{"subject": "Cu(I)", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "type-1 copper ion-binding site", "object_type": "GENE"}, {"subject": "Cu(I)", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "A1 domain", "object_type": "GENE"}]}
{"text": "Exposure to Cu NPs decreased cell viability to 73% (p<0.01) and significantly (p<0.05) elevated levels of lactate dehydrogenase, intracellular reactive oxygen species and interleukin-8 that mirrored our findings from subacute in vivo inhalation studies in mice.", "spo_list": [{"subject": "Cu", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "lactate dehydrogenase", "object_type": "GENE"}, {"subject": "Cu", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "interleukin-8", "object_type": "GENE"}]}
{"text": "Second, ICRF-187, a Top2 catalytic inhibitor known to deplete Top2β, specifically sensitized MEFs to CPT.", "spo_list": [{"subject": "ICRF-187", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Top2", "object_type": "GENE"}, {"subject": "ICRF-187", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Top2β", "object_type": "GENE"}]}
{"text": "To explore the molecular basis for CPT hypersensitivity in Top2β-deficient cells, we found that upon CPT exposure, the RNA polymerase II large subunit (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2β-deficient cells.", "spo_list": [{"subject": "CPT", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "RNA polymerase II large subunit", "object_type": "GENE"}, {"subject": "CPT", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "RNAP LS", "object_type": "GENE"}, {"subject": "CPT", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "RNAP LS", "object_type": "GENE"}]}
{"text": "Altogether, our findings support a model in which Top2β deficiency promotes CPT-induced apoptosis in quiescent non-S-phase cells, possibly due to RNAP LS depletion and p53 accumulation.", "spo_list": [{"subject": "CPT", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "RNAP LS", "object_type": "GENE"}, {"subject": "CPT", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "p53", "object_type": "GENE"}]}
{"text": "The myosin-18Aα isoform, additionally, has an N-terminal PDZ domain.", "spo_list": [{"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PDZ domain", "object_type": "GENE"}]}
{"text": "Both myosin-18A isoforms bound N-methylanthraniloyl-nucleotides, but the rate of ATP hydrolysis was very slow (<0.002 s(-1)) and not significantly enhanced by actin.", "spo_list": [{"subject": "N-methylanthraniloyl-nucleotides", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "myosin-18A", "object_type": "GENE"}]}
{"text": "Introduction: 5-Lipoxygenase (5-LO) is a crucial enzyme of the arachidonic acid (AA) cascade and catalyzes the formation of bioactive leukotrienes (LTs) with the help of FLAP, the 5-LO-activating protein.", "spo_list": [{"subject": "arachidonic acid", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "5-Lipoxygenase", "object_type": "GENE"}, {"subject": "arachidonic acid", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "5-LO", "object_type": "GENE"}]}
{"text": "This aminophospholipid \"flippase\" selectively transports PS to the cytosolic leaflet of the bilayer and is sensitive to vanadate, Ca(2+), and modification by sulfhydryl reagents.", "spo_list": [{"subject": "PS", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "flippase", "object_type": "GENE"}]}
{"text": "The purified Atp8a1 is inactive in detergent micelles or in micelles containing phosphatidylcholine, phosphatidic acid, or phosphatidylinositol, is minimally activated by phosphatidylglycerol or phosphatidylethanolamine (PE), and is maximally activated by PS.", "spo_list": [{"subject": "phosphatidylglycerol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Atp8a1", "object_type": "GENE"}, {"subject": "phosphatidylethanolamine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Atp8a1", "object_type": "GENE"}, {"subject": "PE", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Atp8a1", "object_type": "GENE"}, {"subject": "PS", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Atp8a1", "object_type": "GENE"}]}
{"text": "Similar to the plasma membrane PS transporter, Atp8a1 is activated only by the naturally occurring sn-1,2-glycerol isomer of PS and not the sn-2,3-glycerol stereoisomer.", "spo_list": [{"subject": "sn-1,2-glycerol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "plasma membrane PS transporter", "object_type": "GENE"}, {"subject": "sn-1,2-glycerol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Atp8a1", "object_type": "GENE"}]}
{"text": "Weakly translocated lipids (PE, phosphatidylhydroxypropionate, and phosphatidylhomoserine) are also weak Atp8a1 activators.", "spo_list": [{"subject": "PE", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Atp8a1", "object_type": "GENE"}, {"subject": "phosphatidylhydroxypropionate", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Atp8a1", "object_type": "GENE"}, {"subject": "phosphatidylhomoserine", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Atp8a1", "object_type": "GENE"}]}
{"text": "However, N-methyl-phosphatidylserine, which is transported by the plasma membrane flippase at a rate equivalent to PS, is incapable of activating Atp8a1 activity.", "spo_list": [{"subject": "N-methyl-phosphatidylserine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "flippase", "object_type": "GENE"}]}
{"text": "These results indicate that the ATPase activity of the secretory granule Atp8a1 is activated by phospholipids binding to a specific site whose properties (PS selectivity, dependence upon glycerol but not serine, stereochemistry, and vanadate sensitivity) are similar to, but distinct from, the properties of the substrate binding site of the plasma membrane flippase.", "spo_list": [{"subject": "PS", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "Atp8a1", "object_type": "GENE"}, {"subject": "PS", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "ATPase", "object_type": "GENE"}]}
{"text": "Inhibition of testicular LDH-X from laboratory animals and man by gossypol and its isomers.", "spo_list": [{"subject": "gossypol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "LDH-X", "object_type": "GENE"}]}
{"text": "The inhibitory effect of (+)-, (-)-, (+/-)-gossypol and (+/-)-gossypol acetic acid upon testicular cytosolic LDH-X was measured in vitro.", "spo_list": [{"subject": "(+/-)-gossypol acetic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "LDH-X", "object_type": "GENE"}, {"subject": "(+)-, (-)-, (+/-)-gossypol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "LDH-X", "object_type": "GENE"}]}
{"text": "Gossypol acetic acid (0-100 mumol/l) inhibited LDH-X prepared from the testes of the mouse greater than rabbit greater than human greater than rat greater than hamster.", "spo_list": [{"subject": "Gossypol acetic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "LDH-X", "object_type": "GENE"}]}
{"text": "Gossypol and its isomers were non-competitive inhibitors of human and hamster LDH-X with respect to the coenzyme NADH, competitive inhibitors of human LDH-X and noncompetitive-competitive inhibitors of hamster LDH-X with respect to the substrate alpha-ketobutyrate.", "spo_list": [{"subject": "Gossypol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "human and hamster LDH-X", "object_type": "GENE"}, {"subject": "NADH", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "human LDH-X", "object_type": "GENE"}, {"subject": "alpha-ketobutyrate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "hamster LDH-X", "object_type": "GENE"}]}
{"text": "For MICA3, a surface loop containing the sequence PEVKEK and two adjacent exposed helixes were identified in the PLP binding domain as well as a region of the C terminus of GAD65 that has previously been identified as critical for MICA3 binding.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "GAD65", "object_type": "GENE"}]}
{"text": "Peptide sequences selected using MICA4 were rich in basic or hydroxyl-containing amino acids, and the surface of the GAD65 PLP-binding domain surrounding Lys358, which is known to be critical for MICA4 binding, was likewise rich in these amino acids.", "spo_list": [{"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "GAD65 PLP-binding domain", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "GAD65 PLP-binding domain", "object_type": "GENE"}]}
{"text": "The current U.S. military and civilian oxime countermeasure, 2-[(hydroxyimino)methyl]-1-methylpyridin-1-ium chloride (2-PAM), is under consideration for replacement with a more effective acetylcholinesterase reactivator, 1,1'-methylenebis{4-hydroxyiminomethyl}pyridinium dimethanesulfonate (MMB-4).", "spo_list": [{"subject": "MMB-4", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "acetylcholinesterase", "object_type": "GENE"}, {"subject": "1,1'-methylenebis{4-hydroxyiminomethyl}pyridinium dimethanesulfonate", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "acetylcholinesterase", "object_type": "GENE"}]}
{"text": "Drosophila GABA-gated chloride channel: modified [3H]EBOB binding site associated with Ala-->Ser or Gly mutants of Rdl subunit.", "spo_list": [{"subject": "Gly", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Rdl", "object_type": "GENE"}, {"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Rdl", "object_type": "GENE"}, {"subject": "Ala", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Rdl", "object_type": "GENE"}, {"subject": "[3H]EBOB", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Drosophila GABA-gated chloride channel", "object_type": "GENE"}]}
{"text": "The non-competitive blocker site of the GABA-gated chloride ion channel in normal susceptible strains of Drosophila melanogaster and simulans binds 4-n-[3H]propyl-4'-ethynylbicycloorthobenzoate ([3H]EBOB) at specific sites with KdS of 1.6-1.9 nM and BmaxS of 171-181 fmol/mg protein.", "spo_list": [{"subject": "4-n-[3H]propyl-4'-ethynylbicycloorthobenzoate", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "GABA-gated chloride ion channel", "object_type": "GENE"}, {"subject": "[3H]EBOB", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "GABA-gated chloride ion channel", "object_type": "GENE"}]}
{"text": "Cyclodiene resistance in D. melanogaster has been attributed to a mutation resulting in an Ala302-->Ser replacement in the Rdl GABA receptor subunit and in D. simulans to an homologous Ala-->Ser or Gly replacement.", "spo_list": [{"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Rdl GABA receptor", "object_type": "GENE"}, {"subject": "Ala", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Rdl GABA receptor", "object_type": "GENE"}, {"subject": "Ser", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Rdl GABA receptor", "object_type": "GENE"}, {"subject": "Gly", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Rdl GABA receptor", "object_type": "GENE"}]}
{"text": "The channel activators avermectin and moxidectin usually retain their inhibitory potency in the Rdl subunit mutants.", "spo_list": [{"subject": "avermectin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Rdl", "object_type": "GENE"}, {"subject": "moxidectin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Rdl", "object_type": "GENE"}]}
{"text": "In contrast, the Ala-->Gly replacement has less impact in protecting the chloride channel from the action of insecticidal blockers.", "spo_list": [{"subject": "Gly", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "chloride channel", "object_type": "GENE"}, {"subject": "Ala", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "chloride channel", "object_type": "GENE"}]}
{"text": "Because of their low asparagine synthetase (ASNS) expression and asparagine biosynthesis, acute lymphoblastic leukemia (ALL) cells are exquisitely sensitive to asparagine depletion.", "spo_list": [{"subject": "asparagine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "asparagine synthetase", "object_type": "GENE"}, {"subject": "asparagine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ASNS", "object_type": "GENE"}]}
{"text": "Asparagine secretion by MSCs was directly related to their ASNS expression levels, suggesting a mechanism - increased concentrations of asparagine in the leukemic cell microenvironment - for the protective effects we observed.", "spo_list": [{"subject": "Asparagine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ASNS", "object_type": "GENE"}]}
{"text": "Quercetin and rutin also increased alkaline phosphatase activity by about 150 and 240% and demonstrated mineralization up to 110 and 200% respectively as compared to control (which was considered as 100%).", "spo_list": [{"subject": "Quercetin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "alkaline phosphatase", "object_type": "GENE"}, {"subject": "rutin", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "alkaline phosphatase", "object_type": "GENE"}]}
{"text": "Further, both the flavonoids were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like osteopontin, osterix, RunX2, osteoprotegerin and osteocalcin.", "spo_list": [{"subject": "flavonoids", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "osteopontin", "object_type": "GENE"}, {"subject": "flavonoids", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "osterix", "object_type": "GENE"}, {"subject": "flavonoids", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "RunX2", "object_type": "GENE"}, {"subject": "flavonoids", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "osteoprotegerin", "object_type": "GENE"}, {"subject": "flavonoids", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "osteocalcin", "object_type": "GENE"}]}
{"text": "Human and rat renin and angiotensinogen genes were downregulated in dTGR and were increased by losartan and cilazapril treatments, whereas no changes in the expression of rat ACE and AT1A receptor genes were observed.", "spo_list": [{"subject": "losartan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Human and rat renin", "object_type": "GENE"}, {"subject": "cilazapril", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "angiotensinogen", "object_type": "GENE"}, {"subject": "losartan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "angiotensinogen", "object_type": "GENE"}, {"subject": "cilazapril", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Human and rat renin", "object_type": "GENE"}]}
{"text": "Endothelial NO synthase expression was increased by cilazapril but not by losartan.", "spo_list": [{"subject": "cilazapril", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "Endothelial NO synthase", "object_type": "GENE"}]}
{"text": "The inhibitory effect of endothelin-1 on the contraction induced by 5-HT is abolished by deendothelialization, by the endothelin ET(B) receptor antagonist RES 701-1, by indomethacin, or by glibenclamide.", "spo_list": [{"subject": "RES 701-1", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "endothelin ET(B) receptor", "object_type": "GENE"}]}
{"text": "The potentiation of the contractile effect induced by 5-HT is only somewhat modified by deendothelialization, but abolished by the thromboxane A2 receptor antagonists GR32191 and ridogrel.", "spo_list": [{"subject": "GR32191", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "thromboxane A2 receptor", "object_type": "GENE"}, {"subject": "ridogrel", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "thromboxane A2 receptor", "object_type": "GENE"}]}
{"text": "The drug had a potent cytotoxic effect on RIN cells expressing GLUT2, but had no effect on cells lacking GLUT2 expression, as indicated by histological analysis and measurement of the blood glucose levels of treated animals.", "spo_list": [{"subject": "glucose", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "GLUT2", "object_type": "GENE"}]}
{"text": "Consistent with these data, only GLUT2-expressing RIN or AtT-20ins cells transported STZ efficiently.", "spo_list": [{"subject": "STZ", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "GLUT2", "object_type": "GENE"}]}
{"text": "We conclude that expression of GLUT2 is required for efficient killing of neuroendocrine cells by STZ, and this effect is related to specific recognition of the drug as a transported substrate by GLUT2 but not GLUT1.", "spo_list": [{"subject": "STZ", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "GLUT2", "object_type": "GENE"}, {"subject": "STZ", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "GLUT2", "object_type": "GENE"}]}
{"text": "In this work, the metabolism of four frequently prescribed inhaled GCs, triamcinolone acetonide, flunisolide, budesonide, and fluticasone propionate, by the CYP3A family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites.", "spo_list": [{"subject": "triamcinolone acetonide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A", "object_type": "GENE"}, {"subject": "flunisolide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A", "object_type": "GENE"}, {"subject": "budesonide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A", "object_type": "GENE"}, {"subject": "fluticasone propionate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A", "object_type": "GENE"}]}
{"text": "CYP3A5, which is particularly relevant to GC metabolism in the lungs, was also shown to efficiently metabolize triamcinolone acetonide, budesonide, and fluticasone propionate.", "spo_list": [{"subject": "triamcinolone acetonide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A5", "object_type": "GENE"}, {"subject": "budesonide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A5", "object_type": "GENE"}, {"subject": "fluticasone propionate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A5", "object_type": "GENE"}]}
{"text": "In contrast, flunisolide was only metabolized via CYP3A4, with no significant turnover by CYP3A5 or CYP3A7.", "spo_list": [{"subject": "flunisolide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A4", "object_type": "GENE"}]}
{"text": "Expression of L-type pyruvate kinase (L-PK) is upregulated in the liver by dietary carbohydrate.", "spo_list": [{"subject": "carbohydrate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "L-type pyruvate kinase", "object_type": "GENE"}, {"subject": "carbohydrate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "L-PK", "object_type": "GENE"}]}
{"text": "UNLABELLED: Bile acid-coenzyme A:amino acid N-acyltransferase (BAAT) is the sole enzyme responsible for conjugation of primary and secondary bile acids to taurine and glycine.", "spo_list": [{"subject": "bile acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Bile acid-coenzyme A:amino acid N-acyltransferase", "object_type": "GENE"}, {"subject": "bile acids", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "BAAT", "object_type": "GENE"}, {"subject": "taurine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Bile acid-coenzyme A:amino acid N-acyltransferase", "object_type": "GENE"}, {"subject": "taurine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "BAAT", "object_type": "GENE"}, {"subject": "glycine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Bile acid-coenzyme A:amino acid N-acyltransferase", "object_type": "GENE"}, {"subject": "glycine", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "BAAT", "object_type": "GENE"}]}
{"text": "The absence or presence of a cytosolic pool of BAAT has important implications for the intracellular transport of unconjugated/deconjugated bile salts.", "spo_list": [{"subject": "bile salts", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "BAAT", "object_type": "GENE"}]}
{"text": "Induction of HO-1 through p38 MAPK/Nrf2 signaling pathway by ethanol extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264.7 cells and CLP-induced septic mice.", "spo_list": [{"subject": "ethanol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "HO-1", "object_type": "GENE"}, {"subject": "ethanol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "p38", "object_type": "GENE"}, {"subject": "ethanol", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "MAPK", "object_type": "GENE"}]}
{"text": "The induction of HO-1 by EIH was inhibited by SB203580 but not by SP600125, PD98059, nor LY294002.", "spo_list": [{"subject": "SB203580", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HO-1", "object_type": "GENE"}]}
{"text": "TAA increased the number and area of glutathione S-transferase placental form (GST-P)(+) liver cell foci and the numbers of proliferating and apoptotic cells in randomly selected areas in liver sections.", "spo_list": [{"subject": "TAA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "glutathione S-transferase placental form", "object_type": "GENE"}, {"subject": "TAA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "GST-P", "object_type": "GENE"}]}
{"text": "TAA also increased the numbers of ED2(+), cyclooxygenase-2(+), and heme oxygenase-1(+) liver cells, as well as the number of CD3(+) lymphocytes.", "spo_list": [{"subject": "TAA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "TAA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "heme oxygenase-1", "object_type": "GENE"}, {"subject": "TAA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "CD3", "object_type": "GENE"}]}
{"text": "Design, Synthesis, Biological Evaluation, and Docking Studies of (S)-Phenylalanine Derivatives with a 2-Cyanopyrrolidine Moiety as Potent Dipeptidyl Peptidase 4 Inhibitors.", "spo_list": [{"subject": "(S)-Phenylalanine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Dipeptidyl Peptidase 4", "object_type": "GENE"}, {"subject": "2-Cyanopyrrolidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Dipeptidyl Peptidase 4", "object_type": "GENE"}]}
{"text": "Biological evaluation revealed that most tested compounds were potent dipeptidyl peptidase 4 (DPP-4) inhibitors, among them, the cyclopropyl-substituted phenylalanine derivative 11h displayed the most potent DPP-4 inhibitory activity with an IC50 value of 0.247 μM.", "spo_list": [{"subject": "cyclopropyl-substituted phenylalanine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "DPP-4", "object_type": "GENE"}]}
{"text": "The treatment with arsenic exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total protein, albumin, bilirubin, cholesterol, urea and creatinine).", "spo_list": [{"subject": "arsenic", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "alanine aminotransferase", "object_type": "GENE"}, {"subject": "arsenic", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "aspartate aminotransferase", "object_type": "GENE"}, {"subject": "arsenic", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "alkaline phosphatase", "object_type": "GENE"}, {"subject": "arsenic", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "albumin", "object_type": "GENE"}]}
{"text": "Phospholipase C beta (PLC-beta)-coupled G protein-coupled receptor (GPCR) activities traditionally are assessed by measuring Ca2+ triggered by D-myo-inositol 1,4,5-trisphosphate (IP3), a PLC-beta hydrolysis product, or by measuring the production of inositol phosphate using cumbersome radioactive assays.", "spo_list": [{"subject": "D-myo-inositol 1,4,5-trisphosphate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PLC-beta", "object_type": "GENE"}, {"subject": "IP3", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PLC-beta", "object_type": "GENE"}, {"subject": "inositol phosphate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PLC-beta", "object_type": "GENE"}]}
{"text": "It has been known for decades that lithium chloride (LiCl) leads to D-myo-inositol 1-phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase, the final enzyme of the IP3 metabolic cascade.", "spo_list": [{"subject": "lithium chloride", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "GPCR", "object_type": "GENE"}, {"subject": "LiCl", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "GPCR", "object_type": "GENE"}, {"subject": "lithium chloride", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "inositol monophosphatase", "object_type": "GENE"}, {"subject": "LiCl", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "inositol monophosphatase", "object_type": "GENE"}, {"subject": "IP3", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "inositol monophosphatase", "object_type": "GENE"}, {"subject": "D-myo-inositol 1-phosphate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "inositol monophosphatase", "object_type": "GENE"}]}
{"text": "These results suggest that ganglioside-bound Aβ (GAβ), which acts as an endogenous seed for Aβ fibril formation in AD brains, is generated on ASIGN on synaptosomal membranes.", "spo_list": [{"subject": "ganglioside", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Aβ", "object_type": "GENE"}, {"subject": "ganglioside", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Aβ", "object_type": "GENE"}]}
{"text": "Lung inflammation, IL-4 production, and airway mast cell activity were also prevented under this early short-term treatment with PGE2.", "spo_list": [{"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "IL-4", "object_type": "GENE"}]}
{"text": "Local PGE2 administration prevented the increase of airway IL-13 and osteopontin and kept lung plasmacytoid dendritic cell counts close to baseline.", "spo_list": [{"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "IL-13", "object_type": "GENE"}, {"subject": "PGE2", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "osteopontin", "object_type": "GENE"}]}
{"text": "In support of this observation, elongation can be reversed by the tyrosine kinase inhibitor SU5402, mRNA for the FGFR antagonist sprouty4, or FGF8 morpholino.", "spo_list": [{"subject": "SU5402", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase", "object_type": "GENE"}]}
{"text": "Topotecan is a topoisomerase I inhibitor which is currently evaluated as an adjuvant agent for malignant glioma.", "spo_list": [{"subject": "Topotecan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "topoisomerase I", "object_type": "GENE"}]}
{"text": "High p53 protein levels, but not genetic or functional p53 status, were associated with increased topotecan-induced DNA/topoisomerase I complex formation.", "spo_list": [{"subject": "topotecan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "p53", "object_type": "GENE"}]}
{"text": "Examination of phosphorylation in retinoblastoma (Rb) protein, we found an inhibitory effect by glucosamine at 20 and 50 mM.", "spo_list": [{"subject": "glucosamine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "retinoblastoma (Rb) protein", "object_type": "GENE"}]}
{"text": "Glucosamine at 50 mM was demonstrated to elevate both the mRNA and protein expression of p53 and heme oxygenase-1 (HO-1), but also caused a reduction in p21 protein expression.", "spo_list": [{"subject": "Glucosamine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "p53", "object_type": "GENE"}, {"subject": "Glucosamine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "heme oxygenase-1", "object_type": "GENE"}, {"subject": "Glucosamine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "p21", "object_type": "GENE"}]}
{"text": "In addition, glucosamine attenuated p21 protein stability via the proteasomal proteolytic pathway, as well as inducing p21 nuclear accumulation.", "spo_list": [{"subject": "glucosamine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "p21", "object_type": "GENE"}, {"subject": "glucosamine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "p21", "object_type": "GENE"}]}
{"text": "Altogether, our results suggest that a high dose of glucosamine may inhibit cell proliferation through apoptosis and disturb cell cycle progression with a halt at G(0)/G(1) phase, and that this occurs, at least in part, by a reduction in Rb phosphorylation together with modulation of p21, p53 and HO-1 expression, and nuclear p21 accumulation.", "spo_list": [{"subject": "glucosamine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Rb", "object_type": "GENE"}, {"subject": "glucosamine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "p21", "object_type": "GENE"}]}
{"text": "Insulin-like growth factor (IGF)-binding protein (IGFBP)-related proteins (IGFBP-rPs) are newly described cysteine-rich proteins that share significant aminoterminal structural similarity with the conventional IGFBPs and are involved in a diversity of biological functions, including growth regulation.", "spo_list": [{"subject": "cysteine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Insulin-like growth factor (IGF)-binding protein (IGFBP)-related proteins", "object_type": "GENE"}, {"subject": "cysteine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "IGFBP-rPs", "object_type": "GENE"}]}
{"text": "Moreover, IGFBP-rP2 noticeably increased in response to TGF-beta1 and all-trans retinoic acid (atRA) in HPEC and PC-3 cells, and it decreased in response to IGF-I in HPEC.", "spo_list": [{"subject": "all-trans retinoic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "IGFBP-rP2", "object_type": "GENE"}, {"subject": "atRA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "IGFBP-rP2", "object_type": "GENE"}]}
{"text": "Although the data collected on IGFBP-rP3 in prostate are modest, its role as a growth stimulator and/or protooncogene is supported by its preferential expression in cancerous cells and its down-regulation by atRA.", "spo_list": [{"subject": "atRA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IGFBP-rP3", "object_type": "GENE"}]}
{"text": "Although a significant platelet hyperreactivity was observed in the patients, the HPA-1 genotype did not influence basal or ADP-induced CD62P expression.", "spo_list": [{"subject": "ADP", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CD62P", "object_type": "GENE"}]}
{"text": "In no other subject any activation of platelets by GP IIb/IIIa inhibitors was observed and there were no statistically significant differences between HPA-1 genotypes with respect to the effects of GP IIb/IIIa inhibitors on basal or ADP-stimulated CD62P expression.", "spo_list": [{"subject": "ADP", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CD62P", "object_type": "GENE"}]}
{"text": "1. CGP 12177A mediates cardiostimulation by activation of the 'putative' beta(4)-adrenoceptor; however, it has recently been reported that disruption of the beta(1)-adrenoceptor gene abolishes this effect.", "spo_list": [{"subject": "CGP 12177A", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "beta(4)-adrenoceptor", "object_type": "GENE"}]}
{"text": "CGP 12177A but not isoprenaline initiated arrhythmias at lower concentrations following beta(1)-adrenoceptor overexpression.", "spo_list": [{"subject": "CGP 12177A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "beta(1)-adrenoceptor", "object_type": "GENE"}]}
{"text": "5. (125)I-Cyanopindolol saturation binding in Adv.beta(1) myocytes demonstrated approximately 18-fold increase in beta(1)-adrenoceptors.", "spo_list": [{"subject": "(125)I-Cyanopindolol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "beta(1)-adrenoceptors", "object_type": "GENE"}]}
{"text": "(3)H-CGP 12177A saturation binding, in the presence of propranolol, increased approximately 5-fold following overexpression of beta(1)-adrenoceptors.", "spo_list": [{"subject": "(3)H-CGP 12177A", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "beta(1)-adrenoceptors", "object_type": "GENE"}, {"subject": "propranolol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "beta(1)-adrenoceptors", "object_type": "GENE"}]}
{"text": "An investigation of the absolute configuration of the potent histamine H3 receptor antagonist GT-2331 using vibrational circular dichroism.", "spo_list": [{"subject": "GT-2331", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "histamine H3 receptor", "object_type": "GENE"}]}
{"text": "Among the possible transporters involved in the uptake of Cd(2+) and Mn(2+), the expression of ZIP8 (Zrt-, Irt-related protein 8), encoded by Slc39a8, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.", "spo_list": [{"subject": "Cd(2+)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ZIP8", "object_type": "GENE"}, {"subject": "Cd(2+)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Zrt-, Irt-related protein 8", "object_type": "GENE"}, {"subject": "Cd(2+)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Slc39a8", "object_type": "GENE"}, {"subject": "Mn(2+)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ZIP8", "object_type": "GENE"}, {"subject": "Mn(2+)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Zrt-, Irt-related protein 8", "object_type": "GENE"}, {"subject": "Mn(2+)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Slc39a8", "object_type": "GENE"}]}
{"text": "These results suggest that ZIP8 plays a pivotal role in the transport and toxicity of Cd(2+) and Mn(2+) in RBL-2H3 cells.", "spo_list": [{"subject": "Cd(2+)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ZIP8", "object_type": "GENE"}, {"subject": "Mn(2+)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "ZIP8", "object_type": "GENE"}]}
{"text": "Suppression of TβR1 by the pharmacological inhibitor (SB431542) markedly reduced VEGF release by HFL-1 in response to CSE and this effect was confirmed by TβR1 siRNA.", "spo_list": [{"subject": "SB431542", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "TβR1", "object_type": "GENE"}, {"subject": "SB431542", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "VEGF", "object_type": "GENE"}]}
{"text": "A review of the structural and functional features of olmesartan medoxomil, an angiotensin receptor blocker.", "spo_list": [{"subject": "olmesartan medoxomil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "angiotensin receptor", "object_type": "GENE"}]}
{"text": "The marked antihypertensive efficacy of olmesartan medoxomil may result from a unique pharmacological interaction of the drug with the AT1 receptor, resulting in a potent, long-lasting, dose-dependent blockade of A-II.", "spo_list": [{"subject": "olmesartan medoxomil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "A-II", "object_type": "GENE"}]}
{"text": "Upamostat (Mesupron®) is a new small molecule serine protease inhibitor.", "spo_list": [{"subject": "Upamostat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "serine protease", "object_type": "GENE"}, {"subject": "Mesupron", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "serine protease", "object_type": "GENE"}]}
{"text": "The BH(4) treatment was associated with a 2-fold increase in eNOS activity as well as a 70% reduction in endothelial O(2)(-) production compared with those in fructose-fed rats.", "spo_list": [{"subject": "BH(4)", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "eNOS", "object_type": "GENE"}]}
{"text": "The BH(4) treatment also partially improved the insulin sensitivity and blood pressure, as well as the serum triglyceride concentration, in the fructose-fed rats.", "spo_list": [{"subject": "BH(4)", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "insulin", "object_type": "GENE"}]}
{"text": "The mitochondrial respiratory chain complex IV (cytochrome c oxidase) is a multi-subunit enzyme that transfers electrons from cytochrome c to molecular oxygen, yielding water.", "spo_list": [{"subject": "oxygen", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "mitochondrial respiratory chain complex IV", "object_type": "GENE"}, {"subject": "oxygen", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytochrome c oxidase", "object_type": "GENE"}]}
{"text": "Galantamine is a reversible, competitive acetylcholinesterase (AChE) inhibitor and allosteric potentiating ligand of nicotinic acetylcholine receptors (nAChR-APL) that shares many common structural elements with morphinan-based opioids.", "spo_list": [{"subject": "Galantamine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "acetylcholinesterase", "object_type": "GENE"}, {"subject": "Galantamine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AChE", "object_type": "GENE"}, {"subject": "Galantamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "nicotinic acetylcholine receptors", "object_type": "GENE"}, {"subject": "Galantamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "nAChR", "object_type": "GENE"}]}
{"text": "The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.", "spo_list": [{"subject": "codeine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "nAChR", "object_type": "GENE"}, {"subject": "eseroline", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "nAChR", "object_type": "GENE"}, {"subject": "galantamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "nAChR", "object_type": "GENE"}, {"subject": "codeine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "AChE", "object_type": "GENE"}, {"subject": "eseroline", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "AChE", "object_type": "GENE"}, {"subject": "galantamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "AChE", "object_type": "GENE"}]}
{"text": "In Alexander cells, only when they were transfected with FXR+RXR, GW4064 caused up-regulation of SHP and OSTβ, and a down-regulation of CYP27A1.", "spo_list": [{"subject": "GW4064", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "SHP", "object_type": "GENE"}, {"subject": "GW4064", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "OSTβ", "object_type": "GENE"}, {"subject": "GW4064", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "CYP27A1", "object_type": "GENE"}]}
{"text": "Moreover, GCs have a synergistic effect on GW4064-induced FXR activation, whereas chenodeoxycholate and GW4064 have an additive effect.", "spo_list": [{"subject": "GW4064", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "FXR", "object_type": "GENE"}]}
{"text": "Of note, reciprocal expression of Asmt and Bhmt is an important clue that altered S-adenosylhomocysteine metabolism underlies brain injury in WD, which is directly correlated to the decreased expression of S-adenosylhomocysteine hydrolase in hepatic tissue in LEC rats.", "spo_list": [{"subject": "S-adenosylhomocysteine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE_PRODUCT-OF", "object": "Asmt", "object_type": "GENE"}, {"subject": "S-adenosylhomocysteine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Bhmt", "object_type": "GENE"}, {"subject": "S-adenosylhomocysteine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "S-adenosylhomocysteine hydrolase", "object_type": "GENE"}]}
{"text": "Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production.", "spo_list": [{"subject": "Thalidomide", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF-alpha", "object_type": "GENE"}]}
{"text": "Thalidomide has been shown to suppress TNF-alpha production from macrophages.", "spo_list": [{"subject": "Thalidomide", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF-alpha", "object_type": "GENE"}]}
{"text": "Furthermore, thalidomide abolished the LPS-induced increase in CD14 expression and [Ca2+]i elevation in KCs.", "spo_list": [{"subject": "thalidomide", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "CD14", "object_type": "GENE"}]}
{"text": "Moreover, thalidomide reduced the LPS-induced TNF-alpha production by KCs by decreasing TNF-alpha messenger RNA.", "spo_list": [{"subject": "thalidomide", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF-alpha", "object_type": "GENE"}, {"subject": "thalidomide", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF-alpha", "object_type": "GENE"}]}
{"text": "CONCLUSIONS: These results collectively indicate that thalidomide prevents alcoholic liver injury through suppression of TNF-alpha production and abolishment of KC sensitization.", "spo_list": [{"subject": "thalidomide", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF-alpha", "object_type": "GENE"}]}
{"text": "Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding.", "spo_list": [{"subject": "anthranilic acid sulfonamides", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "methionine aminopeptidase-2", "object_type": "GENE"}]}
{"text": "As part of an effort to discover orally active reversible inhibitors of MetAP2, a series of anthranilic acid sulfonamides with micromolar affinities for human MetAP2 were identified using affinity selection by mass spectrometry (ASMS) screening.", "spo_list": [{"subject": "anthranilic acid sulfonamides", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "MetAP2", "object_type": "GENE"}, {"subject": "anthranilic acid sulfonamides", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "human MetAP2", "object_type": "GENE"}]}
{"text": "Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6.", "spo_list": [{"subject": "tranylcypromine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine oxidase", "object_type": "GENE"}]}
{"text": "1. The inhibitory effects of tranylcypromine, a nonselective irreversible inhibitor of monoamine oxidase (MAO), on three cytochrome P450 (CYP) enzymes, namely CYP2C9, CYP2C19, and CYP2D6, have been evaluated in vitro.", "spo_list": [{"subject": "tranylcypromine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "monoamine oxidase", "object_type": "GENE"}, {"subject": "tranylcypromine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MAO", "object_type": "GENE"}]}
{"text": "4. The results demonstrated that tranylcypromine is a competitive inhibitor of CYP2C19 (Ki = 32 microM) and CYP2D6 (Ki = 367 microM) and a noncompetitive inhibitor of CYP2C9 (Ki = 56 microM).", "spo_list": [{"subject": "tranylcypromine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP2C19", "object_type": "GENE"}, {"subject": "tranylcypromine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP2D6", "object_type": "GENE"}, {"subject": "tranylcypromine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP2C9", "object_type": "GENE"}]}
{"text": "Fibrates bind to the peroxisome proliferator-activated receptor (PPAR)-alpha, and thiazolidinediones are ligands of PPAR-gamma.", "spo_list": [{"subject": "Fibrates", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "peroxisome proliferator-activated receptor (PPAR)-alpha", "object_type": "GENE"}, {"subject": "thiazolidinediones", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PPAR-gamma", "object_type": "GENE"}]}
{"text": "To elucidate the target genes regulated by these compounds, we treated Zucker diabetic fatty rats (ZDF) for 15 days with a PPAR-alpha-specific compound, fenofibrate, a PPAR-gamma-specific ligand, rosiglitazone, and a PPAR-alpha/-gamma coagonist, GW2331, and measured the levels of several messenger RNAs (mRNAs) in liver by real-time polymerase chain reaction.", "spo_list": [{"subject": "rosiglitazone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PPAR-gamma", "object_type": "GENE"}]}
{"text": "Fenofibrate and GW2331 induced expression of acyl-coenzyme A (CoA) oxidase and enoyl-CoA hydratase and reduced apolipoprotein C-III and phosphoenolpyruvate carboxykinase mRNAs.", "spo_list": [{"subject": "Fenofibrate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "acyl-coenzyme A (CoA) oxidase", "object_type": "GENE"}, {"subject": "GW2331", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "acyl-coenzyme A (CoA) oxidase", "object_type": "GENE"}, {"subject": "Fenofibrate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "enoyl-CoA hydratase", "object_type": "GENE"}, {"subject": "GW2331", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "enoyl-CoA hydratase", "object_type": "GENE"}, {"subject": "Fenofibrate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "apolipoprotein C-III", "object_type": "GENE"}, {"subject": "GW2331", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "apolipoprotein C-III", "object_type": "GENE"}, {"subject": "Fenofibrate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "phosphoenolpyruvate carboxykinase", "object_type": "GENE"}, {"subject": "GW2331", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "phosphoenolpyruvate carboxykinase", "object_type": "GENE"}]}
{"text": "Rosiglitazone modestly increased apolipoprotein C-III mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue.", "spo_list": [{"subject": "Rosiglitazone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "apolipoprotein C-III", "object_type": "GENE"}, {"subject": "Rosiglitazone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "glucose transporter 4", "object_type": "GENE"}, {"subject": "Rosiglitazone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "phosphoenolpyruvate carboxykinase", "object_type": "GENE"}]}
{"text": "This study identified four clinically approved antihypertensive drugs (efonidipine, felodipine, isradipine, and nitrendipine) as potent T-channel blockers (IC(50) < 3 microM).", "spo_list": [{"subject": "efonidipine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "T-channel", "object_type": "GENE"}, {"subject": "felodipine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "T-channel", "object_type": "GENE"}, {"subject": "isradipine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "T-channel", "object_type": "GENE"}, {"subject": "nitrendipine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "T-channel", "object_type": "GENE"}]}
{"text": "Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model.", "spo_list": [{"subject": "CP-101,606", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "NR2B", "object_type": "GENE"}, {"subject": "CP-101,606", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "NR2B", "object_type": "GENE"}]}
{"text": "In order to examine the site of action of an NR2B subtype-selective NMDA antagonist CP-101,606, we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration.", "spo_list": [{"subject": "CP-101,606", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "NMDA", "object_type": "GENE"}, {"subject": "CP-101,606", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "NR2B", "object_type": "GENE"}]}
{"text": "A receptor binding assay using rat forebrain and spinal cord membrane preparations demonstrated that [3H]CP-101,606 bound to the brain NR2B receptor with a greater extent compared to the spinal cord one.", "spo_list": [{"subject": "[3H]CP-101,606", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "NR2B", "object_type": "GENE"}]}
{"text": "These findings suggest that the anti-allodynia effect of CP-101,606 is ascribable to blockade of NR2B receptors at the brain, but not at the spinal cord.", "spo_list": [{"subject": "CP-101,606", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "NR2B", "object_type": "GENE"}]}
{"text": "In contrast, intrathecal injection of a non-selective NMDA antagonist, memantine, significantly inhibited CCI-induced mechanical allodynia at a dose of 300 nmol, indicating the difference in the site of action between the non-selective NMDA antagonist and the NR2B-specific NMDA antagonist.", "spo_list": [{"subject": "memantine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "NMDA", "object_type": "GENE"}]}
{"text": "Each statin induced apoA-I expression (mRNA and protein) dose-dependently: the rank order of the apoA-I induction pitavastatin (3 microM)>simvastatin (10 microM)>atorvastatin (30 microM).", "spo_list": [{"subject": "pitavastatin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "apoA-I", "object_type": "GENE"}, {"subject": "simvastatin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "apoA-I", "object_type": "GENE"}, {"subject": "atorvastatin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "apoA-I", "object_type": "GENE"}]}
{"text": "The induction of apoA-I by statins disappeared with addition of mevalonate, which indicates that the effect is HMG-CoA reductase inhibition-dependent.", "spo_list": [{"subject": "mevalonate", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "apoA-I", "object_type": "GENE"}]}
{"text": "Based on HMG-CoA reductase inhibition, pitavastatin-induced apoA-I more efficiently than simvastatin and atorvastatin.", "spo_list": [{"subject": "pitavastatin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "apoA-I", "object_type": "GENE"}, {"subject": "simvastatin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "apoA-I", "object_type": "GENE"}, {"subject": "atorvastatin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "apoA-I", "object_type": "GENE"}]}
{"text": "Further study revealed that pitavastatin increased ABCA1 mRNA in HMG-CoA reductase-dependent manner and that Rho and Rho kinase inhibitor (C3T and Y27632) increased apoA-I production in the HepG2 cells.", "spo_list": [{"subject": "pitavastatin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ABCA1", "object_type": "GENE"}, {"subject": "Y27632", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Rho", "object_type": "GENE"}, {"subject": "Y27632", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Rho kinase", "object_type": "GENE"}, {"subject": "Y27632", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "apoA-I", "object_type": "GENE"}]}
{"text": "These results suggest that pitavastatin efficiently increases apoA-I in the culture medium of HepG2 cells by promoting apoA-I production through inhibition of HMG-CoA reductase and suppression of Rho activity and by protecting apoA-I from catabolism through ABCA1 induction and lipidation of apoA-I.", "spo_list": [{"subject": "pitavastatin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "apoA-I", "object_type": "GENE"}, {"subject": "pitavastatin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "apoA-I", "object_type": "GENE"}, {"subject": "pitavastatin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "HMG-CoA reductase", "object_type": "GENE"}, {"subject": "pitavastatin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Rho", "object_type": "GENE"}, {"subject": "pitavastatin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ABCA1", "object_type": "GENE"}, {"subject": "pitavastatin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "apoA-I", "object_type": "GENE"}]}
{"text": "Maqui berry (Aristotelia chilensis) and the constituent delphinidin glycoside inhibit photoreceptor cell death induced by visible light.", "spo_list": [{"subject": "delphinidin glycoside", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "photoreceptor", "object_type": "GENE"}]}
{"text": "These findings indicate that MBE and its anthocyanidins suppress the light-induced photoreceptor cell death by inhibiting ROS production, suggesting that the inhibition of phosphorylated-p38 may be involved in the underlying mechanism.", "spo_list": [{"subject": "anthocyanidins", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "phosphorylated-p38", "object_type": "GENE"}]}
{"text": "The bacterial enzyme maltodextrin phosphorylase (MalP) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins, removing the non-reducing glucosyl residues of linear oligosaccharides as glucose-1-phosphate (Glc1P).", "spo_list": [{"subject": "glucose-1-phosphate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "MalP", "object_type": "GENE"}, {"subject": "glucose-1-phosphate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "maltodextrin phosphorylase", "object_type": "GENE"}, {"subject": "Glc1P", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "maltodextrin phosphorylase", "object_type": "GENE"}, {"subject": "Glc1P", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "MalP", "object_type": "GENE"}]}
{"text": "In the active MalP enzyme, the residue Arg569 stabilizes the negative-charged Glc1P, whereas in the inactive form of GP this key residue is held away from the catalytic site by loop 280s and an allosteric transition of the mammalian enzyme is required for activation.", "spo_list": [{"subject": "Glc1P", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "MalP", "object_type": "GENE"}]}
{"text": "The comparison between MalP structures shows that His377, through a hydrogen bond with the 6-hydroxyl group of Glc1P substrate, triggers a conformational change of the 380s loop.", "spo_list": [{"subject": "Glc1P", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "MalP", "object_type": "GENE"}, {"subject": "6-hydroxyl", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "MalP", "object_type": "GENE"}]}
{"text": "Real-time quantitative reverse-transcription polymerase chain reaction and immunohistochemical analysis were performed to determine mRNA levels and receptor protein expressions respectively, for alpha(1A)-, alpha(1B)- and alpha(1D)-adrenoceptors in hamster ureteral smooth muscle. alpha(1)-Adrenoceptor antagonists were tested against the phenylephrine (alpha(1)-adrenoceptor agonist)-induced contraction in isolated hamster ureteral preparations using a functional experimental approach.", "spo_list": [{"subject": "phenylephrine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha(1)-adrenoceptor", "object_type": "GENE"}]}
{"text": "Noradrenaline and phenylephrine (alpha(1)-adrenoceptor agonist) each produced a concentration-dependent tonic contraction, their pD(2) values being 6.87+/-0.08 and 6.10+/-0.05, respectively.", "spo_list": [{"subject": "Noradrenaline", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha(1)-adrenoceptor", "object_type": "GENE"}, {"subject": "phenylephrine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha(1)-adrenoceptor", "object_type": "GENE"}]}
{"text": "Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and BMY-7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective alpha(1D)-adrenoceptor antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).", "spo_list": [{"subject": "Prazosin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1)-adrenoceptor", "object_type": "GENE"}, {"subject": "silodosin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1A)-adrenoceptor", "object_type": "GENE"}, {"subject": "BMY-7378", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1D)-adrenoceptor", "object_type": "GENE"}, {"subject": "8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha(1D)-adrenoceptor", "object_type": "GENE"}, {"subject": "phenylephrine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha(1)-adrenoceptor", "object_type": "GENE"}, {"subject": "phenylephrine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha(1A)-adrenoceptor", "object_type": "GENE"}, {"subject": "phenylephrine", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "alpha(1D)-adrenoceptor", "object_type": "GENE"}]}
{"text": "Recombinant P2X3/CASK expression in HEK cells increased serine phosphorylation of P2X3 receptors, typically associated with receptor upregulation.", "spo_list": [{"subject": "serine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "P2X3", "object_type": "GENE"}]}
{"text": "The reduction of P2X3 expression levels was reversed by the proteasomal inhibitor MG-132.", "spo_list": [{"subject": "MG-132", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "P2X3", "object_type": "GENE"}]}
{"text": "Mitochondria in the steroidogenic cells of the adrenal, gonad, placenta and brain contain the cholesterol side-chain cleavage enzyme, P450scc, and its two electron-transfer partners, ferredoxin reductase and ferredoxin.", "spo_list": [{"subject": "cholesterol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P450scc", "object_type": "GENE"}]}
{"text": "The precise fashion in which these proteins interact and move cholesterol from the OMM to P450scc, and the means by which cholesterol is loaded into the OMM, remain unclear.", "spo_list": [{"subject": "cholesterol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P450scc", "object_type": "GENE"}]}
{"text": "The N-terminal portion of TSG-6 shows sequence homology to members of the cartilage link protein family of hyaluronan binding proteins.", "spo_list": [{"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TSG-6", "object_type": "GENE"}]}
{"text": "The C-terminal half of TSG-6 contains a so-called CUB domain, characteristic for developmentally regulated proteins.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "TSG-6", "object_type": "GENE"}]}
{"text": "The protein that binds TSG-6 was purified from human serum and identified as inter-alpha-inhibitor (I alpha I) by N-terminal microsequencing.", "spo_list": [{"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "I alpha I", "object_type": "GENE"}, {"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "inter-alpha-inhibitor", "object_type": "GENE"}]}
{"text": "A naloxone-steroid hybrid azine with selective and long-acting opioid antagonism at delta receptors in vitro.", "spo_list": [{"subject": "naloxone-steroid hybrid azine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "delta receptors", "object_type": "GENE"}]}
{"text": "The interaction of naloxone estrone azine (N-EH) with various opioid receptor types was studied in vitro.", "spo_list": [{"subject": "naloxone estrone azine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "opioid receptor", "object_type": "GENE"}, {"subject": "N-EH", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "opioid receptor", "object_type": "GENE"}]}
{"text": "When the anti-corticosterone drug aminoglutethimide (CYP11A1 inhibitor) was administered to B16F10 mice, corticosterone levels in splenic tissue or serum and CYP11A1 mRNA expression were decreased at 14 days after tumor inoculation.", "spo_list": [{"subject": "aminoglutethimide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP11A1", "object_type": "GENE"}, {"subject": "aminoglutethimide", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "CYP11A1", "object_type": "GENE"}]}
{"text": "Terbinafine resistance was transmitted with the mutated alleles in gene replacement experiments, proving that single amino acid substitutions in the Erg1 protein were sufficient to confer the resistance phenotype.", "spo_list": [{"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Erg1", "object_type": "GENE"}]}
{"text": "The amino acid changes caused by the point mutations were clustered in two regions of the Erg1 protein.", "spo_list": [{"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Erg1", "object_type": "GENE"}]}
{"text": "Interestingly, all exchanges identified involved amino acids which are conserved in the squalene epoxidases of yeasts and mammals.", "spo_list": [{"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "squalene epoxidases", "object_type": "GENE"}]}
{"text": "The results demonstrated that β-ionone-induced apoptosis in a dose-dependent manner in SGC-7901 cells treated with β-ionone (25, 50, 100 and 200 μmol/L) for 24 h. β-ionone was also shown to induce the expression of cleaved-caspase-3 and inhibit bcl-2 expression in SGC-7901 cells in a dose-dependent manner.", "spo_list": [{"subject": "β-ionone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "caspase-3", "object_type": "GENE"}, {"subject": "β-ionone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "bcl-2", "object_type": "GENE"}]}
{"text": "The significantly decreased levels of p-PI3K and p-AKT expression were observed in SGC-7901 cells after β-ionone treatments in a time- and dose-dependent manner (P < 0.01).", "spo_list": [{"subject": "β-ionone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "p-PI3K", "object_type": "GENE"}, {"subject": "β-ionone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "p-AKT", "object_type": "GENE"}]}
{"text": "Upon differentiation, osteoclasts express vesicular glutamate transporter 1 (VGLUT1), which is essential for vesicular storage and subsequent exocytosis of glutamate in neurons.", "spo_list": [{"subject": "glutamate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "vesicular glutamate transporter 1", "object_type": "GENE"}, {"subject": "glutamate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "VGLUT1", "object_type": "GENE"}]}
{"text": "VGLUT1 is localized in transcytotic vesicles and accumulates L-glutamate.", "spo_list": [{"subject": "L-glutamate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "VGLUT1", "object_type": "GENE"}]}
{"text": "Reuptake of extracellular noradrenaline (NA) into superior cervical ganglion (SCG) neurones is mediated by means of the noradrenaline transporter (NAT, uptake 1).", "spo_list": [{"subject": "noradrenaline", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "noradrenaline transporter", "object_type": "GENE"}, {"subject": "noradrenaline", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NAT", "object_type": "GENE"}, {"subject": "NA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "noradrenaline transporter", "object_type": "GENE"}, {"subject": "NA", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NAT", "object_type": "GENE"}]}
{"text": "The ensuing radioactive outflow from these cultures was enhanced by desipramine and reserpine, but reduced (in the presence of desipramine) by the OCT3 inhibitors cyanine 863, oestradiol and corticosterone.", "spo_list": [{"subject": "oestradiol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "OCT3", "object_type": "GENE"}, {"subject": "corticosterone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "OCT3", "object_type": "GENE"}]}
{"text": "The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters.", "spo_list": [{"subject": "MPP+", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "OCT", "object_type": "GENE"}, {"subject": "guanidine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "OCT", "object_type": "GENE"}, {"subject": "choline", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "OCT", "object_type": "GENE"}, {"subject": "amantadine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "OCT", "object_type": "GENE"}, {"subject": "MPP+", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "transmembrane transporters", "object_type": "GENE"}, {"subject": "guanidine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "transmembrane transporters", "object_type": "GENE"}, {"subject": "choline", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "transmembrane transporters", "object_type": "GENE"}, {"subject": "amantadine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "transmembrane transporters", "object_type": "GENE"}, {"subject": "[3H]-MPP+", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "OCT", "object_type": "GENE"}, {"subject": "[3H]-MPP+", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "transmembrane transporters", "object_type": "GENE"}]}
{"text": "However, desipramine at a low concentration essentially blocked the radioactive outflow induced by all of these substances with the exception of MPP+, indicating the NAT and not an OCT as their primary site of action.", "spo_list": [{"subject": "MPP+", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NAT", "object_type": "GENE"}]}
{"text": "Our observations indicate an OCT-mediated transmembrane transport of [3H]-MPP+.", "spo_list": [{"subject": "[3H]-MPP+", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "OCT", "object_type": "GENE"}]}
{"text": "Amongst the three OCTs expressed in the SCG, OCT3 best fits the profile of substrates and antagonists that cause trans-stimulation and trans-inhibition, respectively, of [3H]-MPP+ release.", "spo_list": [{"subject": "[3H]-MPP+", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "OCT3", "object_type": "GENE"}, {"subject": "[3H]-MPP+", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "OCTs", "object_type": "GENE"}]}
{"text": "No influence of moderate hepatic impairment on the pharmacokinetics of lumiracoxib, an oral COX-2 selective inhibitor.", "spo_list": [{"subject": "lumiracoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics (PK) of the novel cyclooxygenase-2 (COX-2) selective inhibitor lumiracoxib (Prexige), so that dose recommendations for clinical use can be provided.", "spo_list": [{"subject": "lumiracoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "lumiracoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "Prexige", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase-2", "object_type": "GENE"}, {"subject": "Prexige", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "LY294002, a specific PI3K/AKT inhibitor, selectively activated the p38 MAPK kinase pathway and enhanced c-Jun phosphorylation, but did not activate JNK.", "spo_list": [{"subject": "LY294002", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PI3K", "object_type": "GENE"}, {"subject": "LY294002", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AKT", "object_type": "GENE"}, {"subject": "LY294002", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "p38", "object_type": "GENE"}, {"subject": "LY294002", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "MAPK", "object_type": "GENE"}, {"subject": "LY294002", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "kinase", "object_type": "GENE"}, {"subject": "LY294002", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "c-Jun", "object_type": "GENE"}]}
{"text": "The pharmacological inhibitors SB203580 (p38 inhibitor) and SP600125 (a JNK inhibitor) protected primary cultures of rat CGCs from LY294002-induced apoptosis.", "spo_list": [{"subject": "SB203580", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "p38", "object_type": "GENE"}, {"subject": "SP600125", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "JNK", "object_type": "GENE"}]}
{"text": "Terbinafine: mode of action and properties of the squalene epoxidase inhibition.", "spo_list": [{"subject": "Terbinafine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "squalene epoxidase", "object_type": "GENE"}]}
{"text": "Terbinafine (Lamisil) has primarily fungicidal action against many fungi as a result of its specific mechanism of squalene epoxidase inhibition.", "spo_list": [{"subject": "Terbinafine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "squalene epoxidase", "object_type": "GENE"}, {"subject": "Lamisil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "squalene epoxidase", "object_type": "GENE"}]}
{"text": "Terbinafine is a potent non-competitive inhibitor of squalene epoxidase from Candida (Ki = 30 nM).", "spo_list": [{"subject": "Terbinafine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "squalene epoxidase", "object_type": "GENE"}]}
{"text": "In contrast, inhibition of rat liver squalene epoxidase only occurs at higher drug concentrations (Ki = 77 microM), and is competitive with squalene.", "spo_list": [{"subject": "squalene", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "rat liver squalene epoxidase", "object_type": "GENE"}]}
{"text": "Moreover, we show that USP22 is acetylated on multiple lysine residues and that alteration of a single lysine (K129) within the ZnF-UBP domain is sufficient to alter interaction of the DUBm with the core SAGA complex.", "spo_list": [{"subject": "lysine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "USP22", "object_type": "GENE"}, {"subject": "lysine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "ZnF-UBP domain", "object_type": "GENE"}]}
{"text": "Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats.", "spo_list": [{"subject": "Torasemide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "angiotensin II", "object_type": "GENE"}]}
{"text": "Isometric contraction induced by a submaximal concentration of Ang II (10(-7) mol/L) was reduced in a dose-dependent way by torasemide (IC(50)=0.5+/-0.04 micromol/L).", "spo_list": [{"subject": "torasemide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Ang II", "object_type": "GENE"}]}
{"text": "The stimulatory effect of [Ca(2+)](i) induced by a submaximal concentration of Ang II (10(-7) mol/L) was blocked by torasemide (IC(50)=0.5+/-0.3 nmol/L).", "spo_list": [{"subject": "torasemide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Ang II", "object_type": "GENE"}]}
{"text": "Our findings suggest that torasemide blocks the vasoconstrictor action of Ang II in vitro.", "spo_list": [{"subject": "torasemide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Ang II", "object_type": "GENE"}]}
{"text": "This action can be related to the ability of torasemide to block the increase of [Ca(2+)](i) induced by Ang II in VSMCs.", "spo_list": [{"subject": "torasemide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Ang II", "object_type": "GENE"}]}
{"text": "GPxs reduce hydroperoxides to the corresponding alcohols by means of glutathione (GSH).", "spo_list": [{"subject": "alcohols", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "GPxs", "object_type": "GENE"}]}
{"text": "The cardiovascular effects of three different acetylcholinesterase inhibitors: physostigmine, tacrine and rivastigmine injected by intravenous (i.v.) route were compared in freely moving Wistar rats.", "spo_list": [{"subject": "physostigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "acetylcholinesterase", "object_type": "GENE"}, {"subject": "tacrine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "acetylcholinesterase", "object_type": "GENE"}, {"subject": "rivastigmine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "acetylcholinesterase", "object_type": "GENE"}]}
{"text": "Tacrine was chosen as a model to study the mechanisms underlying the cardiovascular effects of i.v. cholinesterase inhibitors.", "spo_list": [{"subject": "Tacrine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cholinesterase", "object_type": "GENE"}]}
{"text": "The alpha1-adrenoceptor antagonist prazosin or the vasopressin V1 receptor antagonist, [beta-mercapto-beta,beta-cyclopenta-methylenepropionyl1, O-Me-Tyr2, Arg8] vasopressin partially but significantly reduced tacrine pressor effect and mostly abolished it when administered concomitantly.", "spo_list": [{"subject": "prazosin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "alpha1-adrenoceptor", "object_type": "GENE"}, {"subject": "[beta-mercapto-beta,beta-cyclopenta-methylenepropionyl1, O-Me-Tyr2, Arg8] vasopressin", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "vasopressin V1 receptor", "object_type": "GENE"}]}
{"text": "The tacrine pressor response was inhibited in a dose-dependent manner by the i.c.v. administration of the non-selective muscarinic receptor antagonist atropine (ID50 = 1.45 microg), the muscarinic M1 receptor antagonist pirenzepine (ID50 = 4.33 microg), the muscarinic M2 receptor antagonist methoctramine (ID50 = 1.39 microg) and the muscarinic M3 receptor antagonist para-fluoro-hexahydro-sila-difenidol (ID50 = 31.19 microg).", "spo_list": [{"subject": "atropine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "muscarinic receptor", "object_type": "GENE"}, {"subject": "pirenzepine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "muscarinic M1 receptor", "object_type": "GENE"}, {"subject": "methoctramine", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "muscarinic M2 receptor", "object_type": "GENE"}, {"subject": "para-fluoro-hexahydro-sila-difenidol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "muscarinic M3 receptor", "object_type": "GENE"}]}
{"text": "Alendronate inhibition of protein-tyrosine-phosphatase-meg1.", "spo_list": [{"subject": "Alendronate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "protein-tyrosine-phosphatase-meg1", "object_type": "GENE"}]}
{"text": "Here we report that alendronate is a potent inhibitor of the protein-tyrosine-phosphatase-meg1 (PTPmeg1).", "spo_list": [{"subject": "alendronate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "protein-tyrosine-phosphatase-meg1", "object_type": "GENE"}, {"subject": "alendronate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PTPmeg1", "object_type": "GENE"}]}
{"text": "With either substrate, alendronate was a slow binding inhibitor of PTPmeg1.", "spo_list": [{"subject": "alendronate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PTPmeg1", "object_type": "GENE"}]}
{"text": "Among the other bisphosphonates studied, alendronate was more potent and selective for PTPmeg1.", "spo_list": [{"subject": "alendronate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PTPmeg1", "object_type": "GENE"}, {"subject": "bisphosphonates", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PTPmeg1", "object_type": "GENE"}]}
{"text": "The hydrolysis of fluorescein diphosphate by PTP epsilon and PTPmeg1 was sensitive to alendronate, with IC50 values of less than 1 microM; PTPsigma, however, under the same conditions, was inhibited by only 50% with 141 microM alendronate.", "spo_list": [{"subject": "diphosphate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PTP epsilon", "object_type": "GENE"}, {"subject": "diphosphate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PTPmeg1", "object_type": "GENE"}, {"subject": "alendronate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PTPsigma", "object_type": "GENE"}]}
{"text": "Alendronate inhibited PTPmeg1 with an IC50 value of 23 microM, PTPsigma with an IC50 value of 2 microM, and did not inhibit PTP epsilon at concentrations up to 1 mM.", "spo_list": [{"subject": "Alendronate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PTPmeg1", "object_type": "GENE"}, {"subject": "Alendronate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PTPsigma", "object_type": "GENE"}]}
{"text": "The alendronate inhibition of these three PTPs and two substrates is consistent with the formation of a ternary complex comprised of enzyme, substrate, and inhibitor.", "spo_list": [{"subject": "alendronate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PTPs", "object_type": "GENE"}]}
{"text": "PTP inhibition by hisphosphonates or vanadate was diminished by the metal chelating agent EDTA, or by the reducing agent dithiothreitol, suggesting that a metal ion and the oxidation of a cysteine residue are required for full inhibition.", "spo_list": [{"subject": "hisphosphonates", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PTP", "object_type": "GENE"}, {"subject": "vanadate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PTP", "object_type": "GENE"}, {"subject": "cysteine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PTP", "object_type": "GENE"}]}
{"text": "These observations show substrate- and enzyme-specific PTP inhibition by alendronate and support the possibility that a certain PTP(s) may be the molecular target for alendronate action.", "spo_list": [{"subject": "alendronate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PTP", "object_type": "GENE"}]}
{"text": "Ozone plus PM(2.5) exposure, however, induced CRP, IL-6, CK, LDH and MDA increase, SOD and HRV decrease significantly in a dose-response way.", "spo_list": [{"subject": "Ozone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CRP", "object_type": "GENE"}, {"subject": "Ozone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "IL-6", "object_type": "GENE"}, {"subject": "Ozone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "CK", "object_type": "GENE"}, {"subject": "Ozone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "LDH", "object_type": "GENE"}, {"subject": "Ozone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "SOD", "object_type": "GENE"}]}
{"text": "In humans, methionine synthase deficiency results in the accumulation of methyltetrahydrofolate at the expense of folate derivatives required for purine and thymidylate biosynthesis.", "spo_list": [{"subject": "methyltetrahydrofolate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "methionine synthase", "object_type": "GENE"}]}
{"text": "Here, we report that a specific 29-amino acid peptide derived from the intracellular domain fragment of p75(NTR) interacts with and potentiates binding of NGF to TrkA-expressing cells, leading to increased neurite outgrowth in sympathetic neurons as a result of enhanced Erk1/2 and Akt signaling.", "spo_list": [{"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "p75(NTR)", "object_type": "GENE"}]}
{"text": "An endogenous intracellular domain fragment of p75(NTR) (p75(ICD)) containing these 29 amino acids is produced by regulated proteolysis of the full-length receptor.", "spo_list": [{"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "p75(NTR)", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "p75(ICD)", "object_type": "GENE"}]}
{"text": "Experimentation using isoforms of alefacept engineered to have amino acid substitutions in the IgG1 C(H)2 domain that impact Fc gamma R binding indicate that alefacept mediates cognate interactions between cells expressing human CD2 and CD16 to activate cells, e.g., increase extracellular signal-regulated kinase phosphorylation, up-regulate cell surface expression of the activation marker CD25, and induce release of granzyme B. In the systems used, this signaling is shown to require binding to CD2 and CD16 and be mediated through CD16, but not CD2.", "spo_list": [{"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "IgG1 C(H)2 domain", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "alefacept", "object_type": "GENE"}]}
{"text": "An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes.", "spo_list": [{"subject": "telmisartan", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "angiotensin II AT1 receptor", "object_type": "GENE"}, {"subject": "telmisartan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "GLUT4", "object_type": "GENE"}, {"subject": "glucose", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "GLUT4", "object_type": "GENE"}]}
{"text": "Treatment of both differentiating adipocytes and fully differentiated adipocytes with telmisartan caused a dose-dependent increase in mRNA levels for PPARgamma target genes such as aP2 and adiponectin.", "spo_list": [{"subject": "telmisartan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PPARgamma", "object_type": "GENE"}, {"subject": "telmisartan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "aP2", "object_type": "GENE"}, {"subject": "telmisartan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "adiponectin", "object_type": "GENE"}]}
{"text": "By contrast, telmisartan attenuated 11beta-hydroxysteroid dehydrogenase type 1 mRNA level in differentiated adipocytes.", "spo_list": [{"subject": "telmisartan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "11beta-hydroxysteroid dehydrogenase type 1", "object_type": "GENE"}]}
{"text": "Of note, we demonstrated for the first time that telmisartan augmented GLUT4 protein expression and 2-deoxy glucose uptake both in basal and insulin-stimulated state of adipocytes, which may contribute, at least partly, to its insulin-sensitizing ability.", "spo_list": [{"subject": "telmisartan", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "GLUT4", "object_type": "GENE"}, {"subject": "2-deoxy glucose", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "GLUT4", "object_type": "GENE"}]}
{"text": "Epididymal tissue from wild-type mice responded in vitro to noradrenaline and isoprenaline with increased glycerol release, reduced IL-6 release, and increased cAMP accumulation.", "spo_list": [{"subject": "noradrenaline", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-6", "object_type": "GENE"}, {"subject": "isoprenaline", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "IL-6", "object_type": "GENE"}]}
{"text": "An intermediate GTX2,3-aldehyde was first synthesized by activating the NH2 group of the 2nd and 8th amino acid residues with three different aldehydes and two artificial complete antigens GTX2,3-aldehyde-bovine serum albumin (BSA) and GTX2,3-aldehyde- keyhole limpet hemocyanin (KLH) were then prepared by cross-linking the intermediate with BSA or KLH.", "spo_list": [{"subject": "GTX2,3-aldehyde", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "keyhole limpet hemocyanin", "object_type": "GENE"}, {"subject": "GTX2,3-aldehyde", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "KLH", "object_type": "GENE"}, {"subject": "GTX2,3-aldehyde", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "bovine serum albumin", "object_type": "GENE"}, {"subject": "GTX2,3-aldehyde", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "BSA", "object_type": "GENE"}]}
{"text": "To evaluate to what extent the regional differences in expression of P-gp and P450 enzymes affect the absorption of a dual substrate, we investigated the transport of darunavir across different small intestinal segments (duodenum, proximal jejunum and ileum).", "spo_list": [{"subject": "darunavir", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P-gp", "object_type": "GENE"}, {"subject": "darunavir", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P450 enzymes", "object_type": "GENE"}]}
{"text": "The involvement of P-gp in the absorption of darunavir was clearly shown by coperfusion of darunavir with the P-gp inhibitor zosuquidar.", "spo_list": [{"subject": "zosuquidar", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "P-gp", "object_type": "GENE"}, {"subject": "darunavir", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P-gp", "object_type": "GENE"}]}
{"text": "Involvement of P450 mediated metabolism in the absorption of darunavir could not be demonstrated in this rat model.", "spo_list": [{"subject": "darunavir", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P450", "object_type": "GENE"}]}
{"text": "Upon studying the drug-drug interaction of darunavir with ketoconazole, data were indicative for an inhibitory effect of ketoconazole on P-gp as the main mechanism for the increased transport of darunavir across the small intestine.", "spo_list": [{"subject": "ketoconazole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "P-gp", "object_type": "GENE"}, {"subject": "darunavir", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P-gp", "object_type": "GENE"}]}
{"text": "As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.", "spo_list": [{"subject": "estradiol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "17beta-hydroxysteroid-dehydrogenase type 1", "object_type": "GENE"}, {"subject": "progestogens", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sulfatase", "object_type": "GENE"}, {"subject": "dydrogesterone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sulfatase", "object_type": "GENE"}, {"subject": "medrogestone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sulfatase", "object_type": "GENE"}, {"subject": "promegestone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sulfatase", "object_type": "GENE"}, {"subject": "nomegestrol acetate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sulfatase", "object_type": "GENE"}, {"subject": "norelgestromin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "sulfatase", "object_type": "GENE"}, {"subject": "progestogens", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "17beta-hydroxysteroid-dehydrogenase type 1", "object_type": "GENE"}, {"subject": "dydrogesterone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "17beta-hydroxysteroid-dehydrogenase type 1", "object_type": "GENE"}, {"subject": "medrogestone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "17beta-hydroxysteroid-dehydrogenase type 1", "object_type": "GENE"}, {"subject": "promegestone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "17beta-hydroxysteroid-dehydrogenase type 1", "object_type": "GENE"}, {"subject": "nomegestrol acetate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "17beta-hydroxysteroid-dehydrogenase type 1", "object_type": "GENE"}, {"subject": "norelgestromin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "17beta-hydroxysteroid-dehydrogenase type 1", "object_type": "GENE"}, {"subject": "estradiol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "sulfatase", "object_type": "GENE"}]}
{"text": "Cell culture studies demonstrated that PKAA is capable of delivering anti-TNF (tumor necrosis factor)-α siRNA to lipopolysaccharide (LPS)-stimulated macrophages and significantly inhibits the expression of TNF-α.", "spo_list": [{"subject": "PKAA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "TNF-α", "object_type": "GENE"}]}
{"text": "PKAA/anti-TNF-α siRNA nanocomplexes significantly reduced the ALT (alanine transaminase) and the hepatic cellular damages in APAP-intoxicated mice.", "spo_list": [{"subject": "PKAA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "ALT", "object_type": "GENE"}, {"subject": "PKAA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "alanine transaminase", "object_type": "GENE"}]}
{"text": "4. After 7 days of DMI administration the number of beta-adrenoceptors was lower in frontal and occipital cortex and hippocampus.", "spo_list": [{"subject": "DMI", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "beta-adrenoceptors", "object_type": "GENE"}]}
{"text": "The DMI induced reduction in beta-adrenoceptors did not differ in OB and sham-operated control rats.", "spo_list": [{"subject": "DMI", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "beta-adrenoceptors", "object_type": "GENE"}]}
{"text": "5. DMI administration for up to 21 days produced a progressive reduction in the number of 5-HT2A receptors in frontal cortex, without significant alterations in occipital cortex.", "spo_list": [{"subject": "DMI", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-HT2A", "object_type": "GENE"}]}
{"text": "6. The time course of the reduction in the number of 5-HT2A receptors was similar to that of the DMI-induced behavioural changes whereas that for the reduction in beta-adrenoceptors was clearly different.", "spo_list": [{"subject": "DMI", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-HT2A", "object_type": "GENE"}, {"subject": "DMI", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "beta-adrenoceptors", "object_type": "GENE"}]}
{"text": "7. The present results suggest that the action of DMI in this animal model is unlikely to be directly related to a reduction in beta-adrenoceptors but may be related to a reduction in frontal cortical 5-HT2A receptors.", "spo_list": [{"subject": "DMI", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-HT2A", "object_type": "GENE"}, {"subject": "DMI", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "beta-adrenoceptors", "object_type": "GENE"}]}
{"text": "Among the isolated compounds, trans-dihydromorin (8), oxyresveratrol (9), and steppogenin (12) were found to exhibit significant tyrosinase inhibition activities.", "spo_list": [{"subject": "trans-dihydromorin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosinase", "object_type": "GENE"}, {"subject": "oxyresveratrol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosinase", "object_type": "GENE"}, {"subject": "steppogenin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosinase", "object_type": "GENE"}]}
{"text": "Tyrosine kinase inhibitors are quinazoline-derived, low molecular weight synthetic molecules that can block the intracellular tyrosine kinase domain of several receptors, including EGFR, Erb2, and vascular endothelial growth factor receptor, and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of EGFR signaling.", "spo_list": [{"subject": "quinazoline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Tyrosine kinase", "object_type": "GENE"}, {"subject": "quinazoline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "tyrosine kinase domain", "object_type": "GENE"}, {"subject": "quinazoline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "EGFR", "object_type": "GENE"}, {"subject": "quinazoline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Erb2", "object_type": "GENE"}, {"subject": "quinazoline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "vascular endothelial growth factor receptor", "object_type": "GENE"}, {"subject": "quinazoline", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "EGFR", "object_type": "GENE"}]}
{"text": "3D-QSAR-assisted drug design: identification of a potent quinazoline-based Aurora kinase inhibitor.", "spo_list": [{"subject": "quinazoline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Aurora kinase", "object_type": "GENE"}]}
{"text": "Three different 3D-QSAR models were built and validated by using a set of 66 pyrazole (Model I) and furanopyrimidine (Model II) compounds with IC(50) values toward Aurora kinase A ranging from 33 nM to 10.5 μM.", "spo_list": [{"subject": "pyrazole", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Aurora kinase A", "object_type": "GENE"}, {"subject": "furanopyrimidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Aurora kinase A", "object_type": "GENE"}]}
{"text": "Based on these suggestions, the rational redesign of furanopyrimidine 24 (clog P=7.41; Aurora A IC(50) =43 nM; HCT-116 IC(50) =400 nM) led to the identification of quinazoline 67 (clog P=5.28; Aurora A IC(50) =25 nM; HCT-116 IC(50) =23 nM).", "spo_list": [{"subject": "furanopyrimidine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Aurora A", "object_type": "GENE"}, {"subject": "quinazoline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Aurora A", "object_type": "GENE"}]}
{"text": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and alpha-linolenic acid (LNA) and the expression of PBMC D6D and D5D genes.", "spo_list": [{"subject": "linoleic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "D6D", "object_type": "GENE"}, {"subject": "LA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "D6D", "object_type": "GENE"}, {"subject": "alpha-linolenic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "D6D", "object_type": "GENE"}, {"subject": "LNA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "D6D", "object_type": "GENE"}, {"subject": "linoleic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "D5D", "object_type": "GENE"}, {"subject": "LA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "D5D", "object_type": "GENE"}, {"subject": "alpha-linolenic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "D5D", "object_type": "GENE"}, {"subject": "LNA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "D5D", "object_type": "GENE"}]}
{"text": "CONCLUSION: Intake of high SFAs and MUFAs appears to increase expression of PBMC D6D and D5D genes, whilst high EFAs intake appears to decrease expression of PBMC D6D and D5D genes.", "spo_list": [{"subject": "MUFAs", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "D6D", "object_type": "GENE"}, {"subject": "SFAs", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "D6D", "object_type": "GENE"}, {"subject": "SFAs", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "D5D", "object_type": "GENE"}, {"subject": "MUFAs", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "D5D", "object_type": "GENE"}, {"subject": "EFAs", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "D6D", "object_type": "GENE"}, {"subject": "EFAs", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "D5D", "object_type": "GENE"}]}
{"text": "The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, all-trans retinoic acid (atRA), which regulates the expression of a battery of target genes through several families of nuclear receptors (RARs, RXRs and PPARβ/δ), polymorphic retinoic acid (RA) response elements and multiple coregulators.", "spo_list": [{"subject": "all-trans retinoic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "nuclear receptors", "object_type": "GENE"}, {"subject": "all-trans retinoic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "RARs", "object_type": "GENE"}, {"subject": "all-trans retinoic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "RXRs", "object_type": "GENE"}, {"subject": "all-trans retinoic acid", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "polymorphic retinoic acid (RA) response elements", "object_type": "GENE"}, {"subject": "atRA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "nuclear receptors", "object_type": "GENE"}, {"subject": "atRA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "RARs", "object_type": "GENE"}, {"subject": "atRA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "RXRs", "object_type": "GENE"}, {"subject": "atRA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "polymorphic retinoic acid (RA) response elements", "object_type": "GENE"}]}
{"text": "High-resolution NMR spectroscopy was used to determine the docking of a substrate (prostaglandin H2) mimic (U46619) to the engineered prostacyclin (PGI2) synthase (PGIS) in solution.", "spo_list": [{"subject": "prostaglandin H2", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "prostacyclin (PGI2) synthase", "object_type": "GENE"}, {"subject": "U46619", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "prostacyclin (PGI2) synthase", "object_type": "GENE"}, {"subject": "prostaglandin H2", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PGIS", "object_type": "GENE"}, {"subject": "U46619", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PGIS", "object_type": "GENE"}]}
{"text": "The binding of U46619 to the PGIS protein was demonstrated by 1D NMR titration, and the significant perturbation of the chemical shifts of protons at C-11, H2C, and H20 of U46619 were observed upon U46619 binding to the engineered PGIS in a concentration-dependent manner.", "spo_list": [{"subject": "U46619", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PGIS", "object_type": "GENE"}, {"subject": "U46619", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PGIS", "object_type": "GENE"}, {"subject": "C-11", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PGIS", "object_type": "GENE"}, {"subject": "H2C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PGIS", "object_type": "GENE"}, {"subject": "H20", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PGIS", "object_type": "GENE"}, {"subject": "U46619", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PGIS", "object_type": "GENE"}]}
{"text": "The detailed conformational change and 3D structure of the PGIS-bound U46619 were further demonstrated by 2D 1H NMR experiments using the transferred NOE technique.", "spo_list": [{"subject": "U46619", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PGIS", "object_type": "GENE"}]}
{"text": "The distances between the protons H20 and H2, H18 and H2, and H18 and H4 are shorter following their binding to the PGIS in solution-down to within 5 A. These shorter distances resulted in a widely open conformation, where the triangle shape of the unbound U46619 changed to a more compact conformation with an oval shape.", "spo_list": [{"subject": "H20", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PGIS", "object_type": "GENE"}, {"subject": "H2", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PGIS", "object_type": "GENE"}, {"subject": "H18", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PGIS", "object_type": "GENE"}, {"subject": "H2", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PGIS", "object_type": "GENE"}, {"subject": "H4", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PGIS", "object_type": "GENE"}, {"subject": "H18", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "PGIS", "object_type": "GENE"}]}
{"text": "The bound conformation of U46619 fits the crystal structure of the PGIS substrate binding pocket considerably better than that of the unbound U46619.", "spo_list": [{"subject": "U46619", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PGIS", "object_type": "GENE"}]}
{"text": "For example, Trp282 could be one of the most important residues and is suspected to play a role in the determination of specific catalytic function, which has been established by the docking studies using the NMR structure of the PGIS-bound form of U46619 and the PGIS crystal structure.", "spo_list": [{"subject": "U46619", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PGIS", "object_type": "GENE"}, {"subject": "U46619", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PGIS", "object_type": "GENE"}]}
{"text": "The noted conformational changes where the C-6 position is closer to the C-9 position of U46619 provided the first experimental data for understanding the molecular mechanism of the catalytic function of PGIS in the isomerization of PGH2 to prostacyclin.", "spo_list": [{"subject": "U46619", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PGIS", "object_type": "GENE"}]}
{"text": "By synthesizing and testing a series of alanine point-mutated cyclic peptides, we identified which amino acid was important for the inhibition of the phospholamban function.", "spo_list": [{"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "cyclic peptides", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "cyclic peptides", "object_type": "GENE"}, {"subject": "amino acid", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "phospholamban", "object_type": "GENE"}]}
{"text": "The structures of active and inactive alanine-mutated cyclic peptides, and of phospholamban (1-36), were determined by NMR.", "spo_list": [{"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "cyclic peptides", "object_type": "GENE"}]}
{"text": "Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B. The vaginal aminopeptidase enzymatic activity of different species was determined spectrofluorometrically.", "spo_list": [{"subject": "4-methoxy-2-naphthylamide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "aminopeptidase N", "object_type": "GENE"}, {"subject": "L-alanine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "aminopeptidase N", "object_type": "GENE"}, {"subject": "4-methoxy-2-naphthylamide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "leucine aminopeptidase", "object_type": "GENE"}, {"subject": "L-leucine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "leucine aminopeptidase", "object_type": "GENE"}, {"subject": "4-methoxy-2-naphthylamide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "aminopeptidase A", "object_type": "GENE"}, {"subject": "L-glutamic acid", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "aminopeptidase A", "object_type": "GENE"}, {"subject": "4-methoxy-2-naphthylamide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "aminopeptidase B", "object_type": "GENE"}, {"subject": "L-arginine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "aminopeptidase B", "object_type": "GENE"}]}
{"text": "The inhibition of aminopeptidase activity in the presence of bestatin and puromycin inhibitors was also investigated.", "spo_list": [{"subject": "bestatin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "aminopeptidase", "object_type": "GENE"}, {"subject": "puromycin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "aminopeptidase", "object_type": "GENE"}]}
{"text": "Telmisartan is an angiotensin II receptor blocker (ARB) displaying unique pharmacologic properties, including a longer half life than any other ARB, that result in large and sustained reductions of blood pressure.", "spo_list": [{"subject": "Telmisartan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "angiotensin II receptor", "object_type": "GENE"}]}
{"text": "Xanthines are classical antagonists for adenosine receptors for many of their pharmacological actions may be due to blockade of adenosine receptors.", "spo_list": [{"subject": "Xanthines", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "adenosine receptors", "object_type": "GENE"}, {"subject": "Xanthines", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "adenosine receptors", "object_type": "GENE"}]}
{"text": "To study the mechanism underlying this phenomenon, the effects of the nonselective beta-adrenoceptor antagonists propranolol [no intrinsic sympathomimetic activity (ISA)], alprenolol (weak ISA) and mepindolol (strong ISA) on lymphocyte beta 2-adrenoceptor density--assessed by (+/-)-[125I]-iodocyanopindolol (ICYP) binding--and plasma renin activity (PRA) were investigated in male healthy volunteers aged 23-35 years.", "spo_list": [{"subject": "propranolol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "beta-adrenoceptor", "object_type": "GENE"}, {"subject": "alprenolol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "beta-adrenoceptor", "object_type": "GENE"}, {"subject": "mepindolol", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "beta-adrenoceptor", "object_type": "GENE"}]}
{"text": "Propranolol treatment (4 X 40 mg/day) increased the density of beta 2-adrenoceptors by 25% after 2 days; concomitantly PRA and heart rate were reduced.", "spo_list": [{"subject": "Propranolol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "beta 2-adrenoceptors", "object_type": "GENE"}]}
{"text": "Beta 2-Adrenoceptor density, however, declined slowly being still significantly increased after 3 days, although propranolol was not detectable in plasma after 24 h. The affinity of ICYP to beta 2-adrenoceptors was not changed during or after treatment.", "spo_list": [{"subject": "ICYP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "beta 2-adrenoceptors", "object_type": "GENE"}]}
{"text": "Mepindolol treatment (2 X 5 mg/day) caused a 30% decrease of beta 2-adrenoceptor density and PRA after 2 days; both parameters remained reduced during treatment.", "spo_list": [{"subject": "Mepindolol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "beta 2-adrenoceptor", "object_type": "GENE"}]}
{"text": "The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study.", "spo_list": [{"subject": "serotonin", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "cytochrome P450", "object_type": "GENE"}, {"subject": "5-methoxytryptamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytochrome P450", "object_type": "GENE"}]}
{"text": "Of the rat CYP isoforms studied, CYP2D isoforms were the most efficient in catalyzing the O-demethylation of 5-methoxytryptamine to serotonin, but they were less effective than the human isoform CYP2D6.", "spo_list": [{"subject": "O", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2D", "object_type": "GENE"}, {"subject": "5-methoxytryptamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2D", "object_type": "GENE"}, {"subject": "serotonin", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "CYP2D", "object_type": "GENE"}, {"subject": "O", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human isoform CYP2D6", "object_type": "GENE"}, {"subject": "5-methoxytryptamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "human isoform CYP2D6", "object_type": "GENE"}, {"subject": "serotonin", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "human isoform CYP2D6", "object_type": "GENE"}]}
{"text": "The reaction was inhibited by the specific CYP2D inhibitors quinine and fluoxetine.", "spo_list": [{"subject": "quinine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP2D", "object_type": "GENE"}, {"subject": "fluoxetine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CYP2D", "object_type": "GENE"}]}
{"text": "Human liver microsomes of the wild-type CYP2D6 metabolized 5-methoxytryptamine to serotonin more effectively than did the defective CYP2D6*4*4 ones.", "spo_list": [{"subject": "5-methoxytryptamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2D6", "object_type": "GENE"}, {"subject": "serotonin", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "CYP2D6", "object_type": "GENE"}, {"subject": "5-methoxytryptamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP2D6", "object_type": "GENE"}, {"subject": "serotonin", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "CYP2D6", "object_type": "GENE"}]}
{"text": "The obtained results indicate that rat brain CYP2D isoforms catalyze the formation of serotonin from 5-methoxytryptamine, and that the deficit or genetic defect of CYP2D may affect serotonin metabolism in the brain.", "spo_list": [{"subject": "serotonin", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "rat brain CYP2D", "object_type": "GENE"}, {"subject": "5-methoxytryptamine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rat brain CYP2D", "object_type": "GENE"}, {"subject": "serotonin", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "CYP2D", "object_type": "GENE"}]}
{"text": "OBJECTIVE: Celecoxib and rofecoxib are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit the cyclo-oxygenase-2 (COX-2) isoenzyme at therapeutic concentrations.", "spo_list": [{"subject": "Celecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclo-oxygenase-2", "object_type": "GENE"}, {"subject": "Celecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "rofecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclo-oxygenase-2", "object_type": "GENE"}, {"subject": "rofecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "This study was conducted in order to understand the association between acute renal failure and the two COX-2 inhibitors celecoxib and rofecoxib.", "spo_list": [{"subject": "celecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "rofecoxib", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "Tamoxifen blocks the action of estrogen by binding to the ER, and possesses both ER-agonist and antagonist properties.", "spo_list": [{"subject": "Tamoxifen", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ER", "object_type": "GENE"}, {"subject": "estrogen", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "ER", "object_type": "GENE"}, {"subject": "Tamoxifen", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "ER", "object_type": "GENE"}, {"subject": "Tamoxifen", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "ER", "object_type": "GENE"}]}
{"text": "Fulvestrant is a novel ER antagonist that destroys the ER and its signaling pathway and is not associated with tamoxifen-like agonist effects.", "spo_list": [{"subject": "Fulvestrant", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "ER", "object_type": "GENE"}, {"subject": "Fulvestrant", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ER", "object_type": "GENE"}]}
{"text": "Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons.", "spo_list": [{"subject": "copper", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rat Ctr1", "object_type": "GENE"}, {"subject": "platinum", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rat Ctr1", "object_type": "GENE"}]}
{"text": "Heterologous expression of rCtr1 in HEK293 cells (HEK/rCtr1 cells) increased the uptake and cytotoxicity of copper, oxaliplatin, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.", "spo_list": [{"subject": "copper", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}, {"subject": "copper", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}, {"subject": "oxaliplatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}, {"subject": "oxaliplatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}, {"subject": "cisplatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}, {"subject": "cisplatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}, {"subject": "carboplatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}, {"subject": "carboplatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}]}
{"text": "Cultured rat DRG neurons endogenously expressed rCtr1 protein on their neuronal cell body plasma membranes and cytoplasm, and displayed substantial capacity for taking up copper, but were resistant to copper toxicity.", "spo_list": [{"subject": "copper", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}]}
{"text": "The uptake of copper by both cultured rat DRG neurons and HEK/rCtr1 cells was saturable and inhibited by cold temperature, silver and zinc, consistent with it being mediated by rCtr1.", "spo_list": [{"subject": "copper", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}]}
{"text": "In conclusion, rCtr1 can transport copper and platinum drugs, and sensitizes cells to their cytotoxicities.", "spo_list": [{"subject": "copper", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}, {"subject": "platinum", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}]}
{"text": "DRG neurons display substantial capacity for accumulating copper via a transport process mediated by rCtr1, but appear able to resist copper toxicity and use alternative mechanisms to take up oxaliplatin.", "spo_list": [{"subject": "copper", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}, {"subject": "oxaliplatin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "rCtr1", "object_type": "GENE"}]}
{"text": "The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/D5 (SCH23390), D2/D3 (raclopride, amisulpride) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.", "spo_list": [{"subject": "SCH23390", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "D1", "object_type": "GENE"}, {"subject": "SCH23390", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "D5", "object_type": "GENE"}, {"subject": "raclopride", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "D2", "object_type": "GENE"}, {"subject": "raclopride", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "D3", "object_type": "GENE"}, {"subject": "amisulpride", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "D2", "object_type": "GENE"}, {"subject": "amisulpride", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "D3", "object_type": "GENE"}, {"subject": "S33084", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "D3", "object_type": "GENE"}]}
{"text": "Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain.", "spo_list": [{"subject": "lovastatin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "LFA-1", "object_type": "GENE"}, {"subject": "lovastatin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "CD11a I-domain", "object_type": "GENE"}]}
{"text": "We report here that lovastatin, a drug clinically used for lowering cholesterol levels, inhibits the interaction of human LFA-1 with its counter-receptor intercellular adhesion molecule-1.", "spo_list": [{"subject": "lovastatin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "intercellular adhesion molecule-1", "object_type": "GENE"}, {"subject": "lovastatin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "human LFA-1", "object_type": "GENE"}]}
{"text": "Miglustat, an imino sugar that reversibly inhibits glucosylceramide synthase and reduces intracellular substrate burden, is an oral treatment for patients with type 1 GD that was recently approved in the United States for symptomatic patients with mild to moderate clinical manifestations for whom ERT is not an option.", "spo_list": [{"subject": "Miglustat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "glucosylceramide synthase", "object_type": "GENE"}, {"subject": "imino sugar", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "glucosylceramide synthase", "object_type": "GENE"}]}
{"text": "Cell-pre-incubation with bradykinin induced changes in ABCG expression levels after 7-ketostigmasterol-incubation; however, the energetic metabolism inhibition reduced NPC1L1 expression only in 7-ketocholesterol-incubated cells.", "spo_list": [{"subject": "7-ketocholesterol", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "NPC1L1", "object_type": "GENE"}]}
{"text": "As a prodrug leflunomide is completely converted to its active metabolite A 77 1726 (M1) which blocks the dihydroorotate dehydrogenase, a key enzyme of the pyrimidine de novo synthesis.", "spo_list": [{"subject": "leflunomide", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dihydroorotate dehydrogenase", "object_type": "GENE"}, {"subject": "A 77 1726", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dihydroorotate dehydrogenase", "object_type": "GENE"}]}
{"text": "Losartan: a selective angiotensin II type 1 (AT1) receptor antagonist for the treatment of heart failure.", "spo_list": [{"subject": "Losartan", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "angiotensin II type 1 (AT1) receptor", "object_type": "GENE"}]}
{"text": "Losartan (COZAAR) is the prototype of a new class of potent and selective angiotensin II (AII) type 1 (AT(1)) receptor antagonists with the largest published preclinical and clinical data base.", "spo_list": [{"subject": "Losartan", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "angiotensin II (AII) type 1 (AT(1)) receptor", "object_type": "GENE"}, {"subject": "COZAAR", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "angiotensin II (AII) type 1 (AT(1)) receptor", "object_type": "GENE"}]}
{"text": "Losartan (parent compound), has moderate affinity for the AT(1) receptor (competitive inhibition).", "spo_list": [{"subject": "Losartan", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "AT(1) receptor", "object_type": "GENE"}]}
{"text": "Losartan is well-absorbed orally as an active drug and is rapidly converted via oxidation in the human liver to a more potent metabolite (designated E3174) with an affinity 20- to 30-times greater for the AT(1) receptor (non-competitive inhibition).", "spo_list": [{"subject": "Losartan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AT(1) receptor", "object_type": "GENE"}, {"subject": "Losartan", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "AT(1) receptor", "object_type": "GENE"}]}
{"text": "Clinical experience in heart failure is growing, and recent data suggest an improved survival with losartan versus captopril, a drug from the angiotensin-converting-enzyme inhibitor class with proven benefit in this population.", "spo_list": [{"subject": "captopril", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "angiotensin-converting-enzyme", "object_type": "GENE"}, {"subject": "losartan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "angiotensin-converting-enzyme", "object_type": "GENE"}]}
{"text": "The current comprehensive losartan clinical end-point programme (4 large scale morbidity/mortality trials) should provide evidence regarding the efficacy of direct blockade of the AT(1) receptor with losartan compared to standard therapy: 1) The Losartan Heart Failure Survival Study - ELITE II, 2) The Losartan Post-Myocardial Infarction Survival Study - OPTIMAAL, 3) The Losartan Hypertension Survival Study - LIFE and 4) The Losartan Renal Protection Study - RENAAL.", "spo_list": [{"subject": "losartan", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "AT(1) receptor", "object_type": "GENE"}]}
{"text": "Exposure of cells to 4mM NaF for 24h induced caspase-3 activation, ultrastructural alterations, and resulted in the translocation of Bax to the mitochondria and the release of cytochrome c from the mitochondrial inter-membrane space into the cytosol, indicating that fluoride-mediated apoptosis is mitochondria-dependent.", "spo_list": [{"subject": "NaF", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "caspase-3", "object_type": "GENE"}]}
{"text": "Fluoride treatment also increased phosphorylation of JNK and ERK, but not p38, and apoptosis induced by fluoride was notably or partly suppressed by treatment with JNK or ERK inhibitors, respectively.", "spo_list": [{"subject": "Fluoride", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "JNK", "object_type": "GENE"}, {"subject": "Fluoride", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "ERK", "object_type": "GENE"}]}
{"text": "The CSN/IRF5 interaction occurred on the carboxyl and amino termini of IRF5; a single internal deletion from amino acids 455 to 466 (Δ455-466) was found to significantly reduce IRF5 protein stability.", "spo_list": [{"subject": "amino", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "IRF5", "object_type": "GENE"}, {"subject": "carboxyl", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "IRF5", "object_type": "GENE"}, {"subject": "amino acids", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "IRF5", "object_type": "GENE"}]}
{"text": "Proline dehydrogenase (PRODH) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) catalyze the two-step oxidation of proline to glutamate.", "spo_list": [{"subject": "proline", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Proline dehydrogenase", "object_type": "GENE"}, {"subject": "proline", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PRODH", "object_type": "GENE"}, {"subject": "proline", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Delta(1)-pyrroline-5-carboxylate dehydrogenase", "object_type": "GENE"}, {"subject": "proline", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P5CDH", "object_type": "GENE"}, {"subject": "glutamate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Proline dehydrogenase", "object_type": "GENE"}, {"subject": "glutamate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PRODH", "object_type": "GENE"}, {"subject": "glutamate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Delta(1)-pyrroline-5-carboxylate dehydrogenase", "object_type": "GENE"}, {"subject": "glutamate", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "P5CDH", "object_type": "GENE"}]}
{"text": "The 2.0-A resolution structure of Thermus thermophilus PRODH reveals a distorted (betaalpha)(8) barrel catalytic core domain and a hydrophobic alpha-helical domain located above the carboxyl-terminal ends of the strands of the barrel.", "spo_list": [{"subject": "carboxyl", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "Thermus thermophilus PRODH", "object_type": "GENE"}]}
{"text": "Finally, we demonstrate that T. thermophilus PRODH reacts with O(2) producing superoxide.", "spo_list": [{"subject": "O(2)", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "T. thermophilus PRODH", "object_type": "GENE"}, {"subject": "superoxide", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "T. thermophilus PRODH", "object_type": "GENE"}]}
{"text": "This is significant because superoxide production underlies the role of human PRODH in p53-mediated apoptosis, implying commonalities between eukaryotic and bacterial monofunctional PRODHs.", "spo_list": [{"subject": "superoxide", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "human PRODH", "object_type": "GENE"}]}
{"text": "The scientific basis of this treatment of ED includes relaxation of the corpus cavernosum smooth muscle tissue by inhibition of PDE5 that breaks down cGMP, the key pathway for the production of erectile function in humans.", "spo_list": [{"subject": "cGMP", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "PDE5", "object_type": "GENE"}]}
{"text": "Many clinical studies, both pre- and post-marketing, have demonstrated the clinical efficacy and safety of sildenafil (Viagra, Pfizer) - the first approved selective PDE inhibitor for the treatment of ED.", "spo_list": [{"subject": "sildenafil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE", "object_type": "GENE"}, {"subject": "Viagra", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE", "object_type": "GENE"}]}
{"text": "Sildenafil is inhibitory of PDE5 at a rate tenfold higher than for the next PDE (PDE6), which produces visual changes through the retinal rods.", "spo_list": [{"subject": "Sildenafil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE5", "object_type": "GENE"}, {"subject": "Sildenafil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE", "object_type": "GENE"}, {"subject": "Sildenafil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE6", "object_type": "GENE"}]}
{"text": "With the use of sildenafil, it has been clearly, clinically demonstrated that the selective inhibition of PDE5 is an appropriate, effective, safe method for the treatment of ED of all aetiologies and severities.", "spo_list": [{"subject": "sildenafil", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PDE5", "object_type": "GENE"}]}
{"text": "Minocycline treatment prevents the formation of activated caspase-3, a known effector of apoptosis, as well as the appearance of a calpain cleaved substrate, a marker of excitotoxic/necrotic cell death.", "spo_list": [{"subject": "Minocycline", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "caspase-3", "object_type": "GENE"}]}
{"text": "Omega class GSTs have dehydroascorbate reductase and thioltransferase activities and also catalyze the reduction of monomethylarsonate, an intermediate in the pathway of arsenic biotransformation.", "spo_list": [{"subject": "monomethylarsonate", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Omega class GSTs", "object_type": "GENE"}]}
{"text": "Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs.", "spo_list": [{"subject": "4(3H)-quinazolinone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "dihydrofolate reductase", "object_type": "GENE"}]}
{"text": "In order to produce potent new leads for anticancer drugs, a new series of quinazoline analogs was designed to resemble methotrexate (MTX, 1) structure features and fitted with functional groups believed to enhance inhibition of mammalian DHFR activity.", "spo_list": [{"subject": "quinazoline", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mammalian DHFR", "object_type": "GENE"}, {"subject": "methotrexate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mammalian DHFR", "object_type": "GENE"}, {"subject": "MTX", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "mammalian DHFR", "object_type": "GENE"}]}
{"text": "Synergistic cytotoxicity was demonstrated, and pemetrexed significantly decreased the amount of phosphorylated Akt, enhanced apoptosis, and increased the expression of dCK in A549 and Calu-6 cells, as well as the expression of the human nucleoside equilibrative transporter 1 (hENT1) in all cell lines.", "spo_list": [{"subject": "pemetrexed", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "phosphorylated Akt", "object_type": "GENE"}, {"subject": "pemetrexed", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "dCK", "object_type": "GENE"}, {"subject": "pemetrexed", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "human nucleoside equilibrative transporter 1", "object_type": "GENE"}, {"subject": "pemetrexed", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "hENT1", "object_type": "GENE"}]}
{"text": "These data demonstrated that 1) gemcitabine and pemetrexed synergistically interact against NSCLC cells through the suppression of Akt phosphorylation and induction of apoptosis; 2) the gene expression profile of critical genes may predict for drug chemosensitivity; and 3) pemetrexed enhances dCK and hENT1 expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations.", "spo_list": [{"subject": "gemcitabine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Akt", "object_type": "GENE"}, {"subject": "pemetrexed", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Akt", "object_type": "GENE"}, {"subject": "pemetrexed", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "dCK", "object_type": "GENE"}, {"subject": "pemetrexed", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "hENT1", "object_type": "GENE"}]}
{"text": "Adrenaline inhibits insulin secretion via pertussis toxin-sensitive mechanisms.", "spo_list": [{"subject": "Adrenaline", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "insulin", "object_type": "GENE"}]}
{"text": "Somatostatin which also inhibits insulin secretion was less efficient (inhibition by 20%).", "spo_list": [{"subject": "Somatostatin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "insulin", "object_type": "GENE"}]}
{"text": "In contrast to adrenaline and somatostatin, galanin, another inhibitor of insulin secretion, reduced Ca2+ currents by about 40% in a pertussis toxin-insensitive manner.", "spo_list": [{"subject": "adrenaline", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "insulin", "object_type": "GENE"}, {"subject": "somatostatin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "insulin", "object_type": "GENE"}]}
{"text": "These G-proteins are likely to be involved in the adrenaline-induced inhibition of dihydropyridine-sensitive Ca2+ currents and in other signal transduction pathways contributing to the adrenaline-induced inhibition of insulin secretion.", "spo_list": [{"subject": "adrenaline", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "insulin", "object_type": "GENE"}]}
{"text": "BACKGROUND: This study examines the effects of nicorandil, a K(+) channel opener, on transmural dispersion of repolarization (TDR) and induction of torsade de pointes (TdP) under conditions mimicking the LQT1, LQT2, and LQT3 forms of the congenital long-QT syndrome (LQTS).", "spo_list": [{"subject": "nicorandil", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "K(+) channel", "object_type": "GENE"}]}
{"text": "Isoproterenol (50 to 100 nmol/L) was used to mimic an increase in beta-adrenergic tone, d-sotalol (100 micromol/L) to block I(Kr) (LQT2 model), and ATX-II (20 nmol/L) to augment late I(Na) (LQT3 model).", "spo_list": [{"subject": "Isoproterenol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "I(Kr)", "object_type": "GENE"}, {"subject": "d-sotalol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "I(Kr)", "object_type": "GENE"}, {"subject": "Isoproterenol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ATX-II", "object_type": "GENE"}, {"subject": "d-sotalol", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ATX-II", "object_type": "GENE"}]}
{"text": "Doxorubicin is mainly excreted into the bile via P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.", "spo_list": [{"subject": "Doxorubicin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P-glycoprotein", "object_type": "GENE"}, {"subject": "Doxorubicin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "P-gp", "object_type": "GENE"}, {"subject": "Doxorubicin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "multidrug resistance-associated protein 2", "object_type": "GENE"}, {"subject": "Doxorubicin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Mrp2", "object_type": "GENE"}, {"subject": "Doxorubicin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "cytochrome P450 (CYP) 3A", "object_type": "GENE"}]}
{"text": "The slower CL was due to the reduction of hepatic biliary excretion (67.0% decrease) and hepatic CYP3A subfamily-mediated metabolism (21.9% decrease) of doxorubicin.", "spo_list": [{"subject": "doxorubicin", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CYP3A", "object_type": "GENE"}]}
{"text": "COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.", "spo_list": [{"subject": "phenylbutazone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-1", "object_type": "GENE"}, {"subject": "phenylbutazone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "flunixin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-1", "object_type": "GENE"}, {"subject": "flunixin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "carprofen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-1", "object_type": "GENE"}, {"subject": "carprofen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "meloxicam", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-1", "object_type": "GENE"}, {"subject": "meloxicam", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "We report on the inhibitory activity of the NSAIDs meloxicam, carprofen, phenylbutazone and flunixin, on blood cyclooxygenases in the horse using in vitro enzyme-linked assays.", "spo_list": [{"subject": "meloxicam", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenases", "object_type": "GENE"}, {"subject": "carprofen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenases", "object_type": "GENE"}, {"subject": "phenylbutazone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenases", "object_type": "GENE"}, {"subject": "flunixin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenases", "object_type": "GENE"}]}
{"text": "As expected, comparison of IC50 indicated that meloxicam and carprofen are more selective inhibitors of COX-2 than phenylbutazone and flunixin; meloxicam was the most advantageous for horses of four NSAIDs examined.", "spo_list": [{"subject": "carprofen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "meloxicam", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "phenylbutazone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "flunixin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "However at IC80, phenylbutazone (+134.4%) and flunixin (+29.7%) had greater COX-2 selectivity than at IC50, and meloxicam (-41.2%) and carprofen (-12.9%) had lower COX-2 selectivity than at IC50.", "spo_list": [{"subject": "flunixin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "phenylbutazone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "carprofen", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}, {"subject": "meloxicam", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "COX-2", "object_type": "GENE"}]}
{"text": "RESULT(S): The expression of endometrial ERalpha, PRAB, PRB, and SRC-1 was increased significantly after 1 week of mifepristone, but the increase was no longer seen after 10 weeks.", "spo_list": [{"subject": "mifepristone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ERalpha", "object_type": "GENE"}, {"subject": "mifepristone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PRAB", "object_type": "GENE"}, {"subject": "mifepristone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PRB", "object_type": "GENE"}, {"subject": "mifepristone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "SRC-1", "object_type": "GENE"}]}
{"text": "CONCLUSION(S): Short-term exposure of mifepristone in new starters of DMPA increases the expression of endometrial ERalpha, PRAB, PRB, and SRC-1 and promotes cell proliferation.", "spo_list": [{"subject": "mifepristone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "ERalpha", "object_type": "GENE"}, {"subject": "mifepristone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PRAB", "object_type": "GENE"}, {"subject": "mifepristone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "PRB", "object_type": "GENE"}, {"subject": "mifepristone", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "SRC-1", "object_type": "GENE"}]}
{"text": "Acetyl-coenzyme A carboxylase (ACC) enzymes exist as two isoforms, ACC1 and ACC2, which play critical roles in fatty acid biosynthesis and oxidation.", "spo_list": [{"subject": "fatty acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "Acetyl-coenzyme A carboxylase", "object_type": "GENE"}, {"subject": "fatty acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ACC", "object_type": "GENE"}, {"subject": "fatty acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ACC1", "object_type": "GENE"}, {"subject": "fatty acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ACC2", "object_type": "GENE"}]}
{"text": "The cytosolic ACC1 is expressed primarily in liver and adipose tissue, and uses malonyl-coenzyme A as a key building block in fatty acid biosynthesis.", "spo_list": [{"subject": "fatty acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ACC1", "object_type": "GENE"}]}
{"text": "The mitochondrial ACC2 is primarily expressed in heart and skeletal muscle, where it is involved in the regulation of fatty acid oxidation.", "spo_list": [{"subject": "fatty acid", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "ACC2", "object_type": "GENE"}]}
{"text": "Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1.", "spo_list": [{"subject": "Mesalamine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "p-21 activated kinase-1", "object_type": "GENE"}]}
{"text": "Moreover, 5-ASA treatment restored membranous expression of adhesion molecules E-cadherin and β-catenin.", "spo_list": [{"subject": "5-ASA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "E-cadherin", "object_type": "GENE"}, {"subject": "5-ASA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "β-catenin", "object_type": "GENE"}]}
{"text": "PAK1 expression was elevated in APC(min) polyps and 5-ASA treatment reduced its expression.", "spo_list": [{"subject": "5-ASA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "PAK1", "object_type": "GENE"}]}
{"text": "We propose that inhibition of PAK1 expression by 5-ASA can impede with neoplastic progression in colorectal carcinogenesis.", "spo_list": [{"subject": "5-ASA", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "PAK1", "object_type": "GENE"}]}
{"text": "The mechanism of PAK1 inhibition and induction of membranous translocation of adhesion proteins by 5-ASA might be independent of its known anti-inflammatory action.", "spo_list": [{"subject": "5-ASA", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PAK1", "object_type": "GENE"}]}
{"text": "Transfection of the brain cDNA into COS-1 cells resulted in transporter activity that was blocked by the VMAT inhibitor reserpine and a proton ionophore, but not by tetrabenazine, which has a high affinity for VMAT-2.", "spo_list": [{"subject": "reserpine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "VMAT", "object_type": "GENE"}, {"subject": "tetrabenazine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "VMAT-2", "object_type": "GENE"}]}
{"text": "Antibodies to either the C- or N- terminus of VMAT-1 detected two proteins (73 and 55 kD) in transfected COS-1 cells.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "VMAT-1", "object_type": "GENE"}, {"subject": "N", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "VMAT-1", "object_type": "GENE"}]}
{"text": "The C-terminal antibodies detected both proteins in extracts of mouse medulla/pons, cortex, hypothalamus, and cerebellum but only the 73 kD protein and higher molecular weight immunoreactive proteins in mouse adrenal and rat PC12 cells, which are positive controls for rodent VMAT-1.", "spo_list": [{"subject": "C", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "rodent VMAT-1", "object_type": "GENE"}]}
{"text": "OBJECTIVE: Ziprasidone is an atypical antipsychotic drug that shows a higher affinity for serotonin 5-HT(2) receptors compared with dopamine D(2) receptors in vitro.", "spo_list": [{"subject": "Ziprasidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT(2) receptors", "object_type": "GENE"}, {"subject": "Ziprasidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "dopamine D(2) receptors", "object_type": "GENE"}]}
{"text": "METHOD: The authors conducted a PET study to evaluate D(2) occupancy (using [(11)C]raclopride) and 5-HT(2) occupancy (using [(18)F]setoperone) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40, 80, 120, or 160 mg/day of ziprasidone, which reflected the recommended dose range.", "spo_list": [{"subject": "[(11)C]raclopride", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D(2)", "object_type": "GENE"}, {"subject": "[(18)F]setoperone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT(2)", "object_type": "GENE"}]}
{"text": "The estimated plasma ziprasidone concentration associated with 50% maximal 5-HT(2) receptor occupancy was almost four times lower than that for D(2) receptor occupancy.", "spo_list": [{"subject": "ziprasidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT(2)", "object_type": "GENE"}, {"subject": "ziprasidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D(2) receptor", "object_type": "GENE"}]}
{"text": "CONCLUSIONS: These data affirm that ziprasidone is similar to other novel antipsychotics in having greater 5-HT(2) than D(2) receptor occupancy at therapeutic doses and suggest that the optimal effective dose of ziprasidone is closer to 120 mg/day than to the lower doses suggested by previous PET studies.", "spo_list": [{"subject": "ziprasidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "5-HT(2)", "object_type": "GENE"}, {"subject": "ziprasidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D(2) receptor", "object_type": "GENE"}]}
{"text": "The relatively high D(2) receptor occupancy, even at trough plasma levels, suggests that ziprasidone is more similar to risperidone and olanzapine in receptor occupancy profile than to clozapine and quetiapine.", "spo_list": [{"subject": "ziprasidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D(2) receptor", "object_type": "GENE"}, {"subject": "risperidone", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D(2) receptor", "object_type": "GENE"}, {"subject": "clozapine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D(2) receptor", "object_type": "GENE"}, {"subject": "quetiapine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "D(2) receptor", "object_type": "GENE"}]}
{"text": "Moreover, the effects of the DRD3 agonist 7-hydroxy-N,N-dipropyl-2-aminotetralin (7-OH-DPAT)-induced locomotor hypoactivity were significantly increased when DRD3 proteins were abundant.", "spo_list": [{"subject": "7-hydroxy-N,N-dipropyl-2-aminotetralin", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "DRD3", "object_type": "GENE"}, {"subject": "7-OH-DPAT", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "DRD3", "object_type": "GENE"}, {"subject": "7-hydroxy-N,N-dipropyl-2-aminotetralin", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "DRD3", "object_type": "GENE"}, {"subject": "7-OH-DPAT", "subject_type": "CHEMICAL", "predicate": "AGONIST", "object": "DRD3", "object_type": "GENE"}]}
{"text": "Toosendanin induces apoptosis through suppression of JNK signaling pathway in HL-60 cells.", "spo_list": [{"subject": "Toosendanin", "subject_type": "CHEMICAL", "predicate": "INDIRECT-DOWNREGULATOR", "object": "JNK", "object_type": "GENE"}]}
{"text": "Western blot analysis indicated that TSN inhibits the CDC42/MEKK1/JNK pathway.", "spo_list": [{"subject": "TSN", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "CDC42", "object_type": "GENE"}, {"subject": "TSN", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MEKK1", "object_type": "GENE"}, {"subject": "TSN", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "JNK", "object_type": "GENE"}]}
{"text": "Characteristics of the binding of phenoxybenzamine to calmodulin.", "spo_list": [{"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}]}
{"text": "To determine the factors that influence the interaction between phenoxybenzamine and calmodulin, the binding of phenoxybenzamine to calmodulin was determined by equilibrium dialysis under a variety of experimental conditions.", "spo_list": [{"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}, {"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}]}
{"text": "This interaction was found to be similar in some respects to the interaction between phenothiazines and calmodulin.", "spo_list": [{"subject": "phenothiazines", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}]}
{"text": "The site at which phenoxybenzamine bound to calmodulin appears to be similar to that at which certain antipsychotic agents bind, since several of them, including penfluridol, pimozide and spiroperidol, prevented the binding of phenoxybenzamine to calmodulin.", "spo_list": [{"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}, {"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}, {"subject": "penfluridol", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}, {"subject": "pimozide", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}, {"subject": "spiroperidol", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}]}
{"text": "However, in contrast to the reversible binding of most phenothiazines to calmodulin, phenoxybenzamine bound to calmodulin irreversibly.", "spo_list": [{"subject": "phenothiazines", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}, {"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}]}
{"text": "The binding of phenoxybenzamine to calmodulin was fairly selective in that other alpha-adrenergic agents such as prazosin, yohimbine and clonidine failed to bind to calmodulin when examined under the same experimental conditions.", "spo_list": [{"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}]}
{"text": "In addition, phenoxybenzamine showed little or no calcium-dependent binding to the S-100 protein, bovine serum albumin or cytochrome c. The irreversible complex between phenoxybenzamine and calmodulin may be useful for inhibiting certain calmodulin-dependent reactions and for studying the various biological functions of calmodulin.", "spo_list": [{"subject": "calcium", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cytochrome c", "object_type": "GENE"}, {"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "calmodulin", "object_type": "GENE"}, {"subject": "phenoxybenzamine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "calmodulin", "object_type": "GENE"}]}
{"text": "The protein exhibited modest H(2)O(2)-dependent peroxidase activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS).", "spo_list": [{"subject": "H(2)O(2)", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "peroxidase", "object_type": "GENE"}, {"subject": "guaiacol", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "peroxidase", "object_type": "GENE"}, {"subject": "potassium iodide", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "peroxidase", "object_type": "GENE"}, {"subject": "2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "peroxidase", "object_type": "GENE"}, {"subject": "ABTS", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "peroxidase", "object_type": "GENE"}]}
{"text": "Here, translocation studies using the human androgen receptor (hAR) and the human glucocorticoid receptor (hGR) were performed to aid in identifying the mechanism by which anabolic-androgenic steroids (AAS) were activating hAR and potentially interacting with hGR and how glucocorticoid ligands were interacting with the hGR and hAR.", "spo_list": [{"subject": "steroids", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "hAR", "object_type": "GENE"}]}
{"text": "The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines.", "spo_list": [{"subject": "PJ34", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PARP", "object_type": "GENE"}]}
{"text": "Since PARP-1 is supposed to be part of a multimeric repressor of sodium iodide symporter (NIS) expression, in this study the effect of the PARP inhibitor PJ34 on several properties of thyroid cancer cell lines was investigated.", "spo_list": [{"subject": "PJ34", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PARP", "object_type": "GENE"}]}
{"text": "In TPC1, BCPAP, FRO, WRO cell lines PJ34 induced a strong increase in NIS mRNA levels.", "spo_list": [{"subject": "PJ34", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "NIS", "object_type": "GENE"}]}
{"text": "Accordingly, in transfection experiments performed in TPC1 cells, treatment with PJ34 increased NIS promoter activity without affecting PARP-1 binding to the promoter sequence.", "spo_list": [{"subject": "PJ34", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "NIS promoter", "object_type": "GENE"}, {"subject": "PJ34", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "PARP-1", "object_type": "GENE"}]}
{"text": "We also investigated the epigenetic status of NIS promoter after PJ34 treatment in TPC1 cell line: in addition to an increase of histone modification activation marks (H3K9K14ac, H3K4me3), surprisingly we observed also an increase of H3K27me3, a classical repressive mark.", "spo_list": [{"subject": "PJ34", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "histone modification activation marks", "object_type": "GENE"}, {"subject": "PJ34", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "H3K9K14ac", "object_type": "GENE"}, {"subject": "PJ34", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "H3K4me3", "object_type": "GENE"}]}
{"text": "Folding pathway of guanidine-denatured disulfide-intact wild-type and mutant bovine pancreatic ribonuclease A. The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.", "spo_list": [{"subject": "disulfide", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "bovine pancreatic ribonuclease A", "object_type": "GENE"}, {"subject": "disulfide", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "bovine pancreatic ribonuclease A", "object_type": "GENE"}, {"subject": "disulfide", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "RNase A", "object_type": "GENE"}, {"subject": "proline", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "bovine pancreatic ribonuclease A", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "bovine pancreatic ribonuclease A", "object_type": "GENE"}, {"subject": "proline", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "RNase A", "object_type": "GENE"}, {"subject": "alanine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "RNase A", "object_type": "GENE"}, {"subject": "2'-cytidine monophosphate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "bovine pancreatic ribonuclease A", "object_type": "GENE"}, {"subject": "2'-cytidine monophosphate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "RNase A", "object_type": "GENE"}, {"subject": "2'-cytidine monophosphate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Pro42Ala", "object_type": "GENE"}, {"subject": "2'CMP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "bovine pancreatic ribonuclease A", "object_type": "GENE"}, {"subject": "2'CMP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "RNase A", "object_type": "GENE"}, {"subject": "2'CMP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "Pro42Ala", "object_type": "GENE"}, {"subject": "2'-cytidine monophosphate", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "proline-42-to-alanine", "object_type": "GENE"}, {"subject": "2'CMP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "proline-42-to-alanine", "object_type": "GENE"}]}
{"text": "The folding rate for wild-type RNase A is faster in the presence of the inhibitor 2'CMP than in its absence, indicating that the transition-state structure in the rate-determining step is stabilized by 2'CMP.", "spo_list": [{"subject": "2'CMP", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "RNase A", "object_type": "GENE"}]}
{"text": "The folding rate monitored by 2'CMP binding to the major slow-folding species of Pro42Ala RNase A is faster than the folding rate monitored by tyrosine burial; however, the folding rate monitored by inhibitor binding to the minor slow-folding species is decreased significantly over the folding rate monitored by tyrosine burial, indicating that the major and minor slow-folding species of Pro42Ala fold to the native state with different transition-state conformations in the rate-determining step.", "spo_list": [{"subject": "2'CMP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Pro42Ala", "object_type": "GENE"}, {"subject": "2'CMP", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "RNase A", "object_type": "GENE"}, {"subject": "tyrosine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "Pro42Ala", "object_type": "GENE"}, {"subject": "tyrosine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "RNase A", "object_type": "GENE"}]}
{"text": "Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.", "spo_list": [{"subject": "LY293558", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "GluK1", "object_type": "GENE"}, {"subject": "LY293558", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "AMPA receptor", "object_type": "GENE"}]}
{"text": "To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the GluK1 (GluR5)/α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (LY293558) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.", "spo_list": [{"subject": "(3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "GluK1", "object_type": "GENE"}, {"subject": "(3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "GluR5", "object_type": "GENE"}, {"subject": "(3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor", "object_type": "GENE"}, {"subject": "LY293558", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "GluK1", "object_type": "GENE"}, {"subject": "LY293558", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "GluR5", "object_type": "GENE"}, {"subject": "LY293558", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor", "object_type": "GENE"}]}
{"text": "Advances in antihypertensive combination therapy: benefits of low-dose thiazide diuretics in conjunction with omapatrilat, a vasopeptidase inhibitor.", "spo_list": [{"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "vasopeptidase", "object_type": "GENE"}]}
{"text": "Omapatrilat, the prototypical vasopeptidase inhibitor, inhibits not only ACE but also neutral endopeptidase.", "spo_list": [{"subject": "Omapatrilat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "vasopeptidase", "object_type": "GENE"}, {"subject": "Omapatrilat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}, {"subject": "Omapatrilat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "neutral endopeptidase", "object_type": "GENE"}]}
{"text": "Like conventional ACE inhibitors, omapatrilat causes extracellular volume reduction and vasodilatation; moreover, it increases levels of atrial and brain natriuretic peptides and bradykinin.", "spo_list": [{"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "ACE", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "atrial and brain natriuretic peptides", "object_type": "GENE"}, {"subject": "omapatrilat", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "bradykinin", "object_type": "GENE"}]}
{"text": "No effects were observed when fenclozic acid was assessed for P450-dependent and P450-independent cytotoxicity to THLE cell lines, time-dependent inhibition of five major human cytochrome P450 enzymes, inhibition of the biliary efflux transporters BSEP and MRP2 or mitochondrial toxicity to THLE or HepG2 cells.", "spo_list": [{"subject": "fenclozic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "human cytochrome P450", "object_type": "GENE"}, {"subject": "fenclozic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "efflux transporters", "object_type": "GENE"}, {"subject": "fenclozic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "BSEP", "object_type": "GENE"}, {"subject": "fenclozic acid", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "MRP2", "object_type": "GENE"}]}
{"text": "Among the [Fe-S] cluster biosynthetic proteins are included a pyridoxal phosphate-dependent enzyme (NifS) that is involved in the activation of sulphur from l-cysteine, and a molecular scaffold protein (NifU) upon which [Fe-S] cluster precursors are formed.", "spo_list": [{"subject": "l-cysteine", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "NifS", "object_type": "GENE"}]}
{"text": "Administration of low, but not high, doses of oral nicotine in DSS-treated mice resulted in a significant decrease in disease severity, histologic damage scores, as well as colonic level of tumor necrosis factor-α.", "spo_list": [{"subject": "nicotine", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "tumor necrosis factor-α", "object_type": "GENE"}]}
{"text": "Ka values in nM for rauwolscine (19), WB-4101 (265), SKF-104078 (197), spiroxatrine (128), and prazosin (1531) for blocking relaxation in rat arteries were consistent with their affinities for binding at the alpha-2D adrenoceptor subtype.", "spo_list": [{"subject": "rauwolscine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha-2D adrenoceptor", "object_type": "GENE"}, {"subject": "WB-4101", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha-2D adrenoceptor", "object_type": "GENE"}, {"subject": "SKF-104078", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha-2D adrenoceptor", "object_type": "GENE"}, {"subject": "spiroxatrine", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha-2D adrenoceptor", "object_type": "GENE"}, {"subject": "prazosin", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "alpha-2D adrenoceptor", "object_type": "GENE"}]}
{"text": "Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A.", "spo_list": [{"subject": "SR 141716A", "subject_type": "CHEMICAL", "predicate": "ANTAGONIST", "object": "CB1", "object_type": "GENE"}, {"subject": "SR 141716A", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "CB1", "object_type": "GENE"}]}
{"text": "The antagonist SR 141716A has a high specificity for the central CB1 cannabinoid receptor and negligeable affinity for the peripheral CB2 receptor, making it an excellent tool for probing receptor structure-activity relationships.", "spo_list": [{"subject": "SR 141716A", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "CB1", "object_type": "GENE"}, {"subject": "SR 141716A", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "cannabinoid receptor", "object_type": "GENE"}]}
{"text": "The region delineated by the fourth and fifth transmembrane helices of CB1 proved to be crucial for high affinity binding of SR 141716A.", "spo_list": [{"subject": "SR 141716A", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "CB1", "object_type": "GENE"}]}
{"text": "The CB1 and CB2 second extracellular loops, e2, were exchanged, modifications that had no effect on SR 141716A binding in the CB1 variant but that eliminated CP 55,940 binding in both mutants.", "spo_list": [{"subject": "SR 141716A", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "CB1", "object_type": "GENE"}]}
{"text": "The replacement of the conserved cysteine residues in e2 of CB2 by serine also eliminated CP 55,940 binding, but replacement of those in CB1 resulted in the sequestration of the mutated receptors in the cell cytoplasm.", "spo_list": [{"subject": "cysteine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "CB2", "object_type": "GENE"}, {"subject": "serine", "subject_type": "CHEMICAL", "predicate": "PART-OF", "object": "CB2", "object_type": "GENE"}]}
{"text": "The e2 domain thus plays some role in CP 55,940 binding but none in SR 141716A recognition, binding of the latter clearly implicating residues in the adjoining transmembrane helices.", "spo_list": [{"subject": "CP 55,940", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "e2 domain", "object_type": "GENE"}, {"subject": "SR 141716A", "subject_type": "CHEMICAL", "predicate": "DIRECT-REGULATOR", "object": "e2 domain", "object_type": "GENE"}]}
{"text": "Choline dehydrogenase (CHDH) and betaine-homocysteine methyltransferase (BHMT) are 2 enzymes involved in choline oxidation.", "spo_list": [{"subject": "choline", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "Choline dehydrogenase", "object_type": "GENE"}, {"subject": "choline", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "CHDH", "object_type": "GENE"}, {"subject": "choline", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "betaine-homocysteine methyltransferase", "object_type": "GENE"}, {"subject": "choline", "subject_type": "CHEMICAL", "predicate": "SUBSTRATE", "object": "BHMT", "object_type": "GENE"}]}
{"text": "Liver BHMT activity was 1.3-fold higher in rats fed the Met deficient diet containing choline, which was reflected in corresponding increases in mRNA content and immunodetectable protein.", "spo_list": [{"subject": "choline", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "BHMT", "object_type": "GENE"}, {"subject": "choline", "subject_type": "CHEMICAL", "predicate": "INDIRECT-UPREGULATOR", "object": "BHMT", "object_type": "GENE"}]}
{"text": "Independent of dietary choline, supplemental Met increased hepatic BHMT activity approximately 30%.", "spo_list": [{"subject": "Met", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "BHMT", "object_type": "GENE"}, {"subject": "choline", "subject_type": "CHEMICAL", "predicate": "ACTIVATOR", "object": "BHMT", "object_type": "GENE"}]}
{"text": "BACKGROUND: The active metabolite of the anti-inflammatory drug nabumetone has been characterized as a selective inhibitor of the inducible prostaglandin H synthase (PGHS).", "spo_list": [{"subject": "nabumetone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "prostaglandin H synthase", "object_type": "GENE"}, {"subject": "nabumetone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PGHS", "object_type": "GENE"}]}
{"text": "Moreover, the production of TXB2 during whole blood clotting was assessed as an index of the cyclooxygenase activity of platelet PGHS-1 ex vivo.", "spo_list": [{"subject": "TXB2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "cyclooxygenase", "object_type": "GENE"}, {"subject": "TXB2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PGHS-1", "object_type": "GENE"}]}
{"text": "The daily administration of low-dose aspirin (40 mg), a selective inhibitor of platelet PGHS-1, caused a cumulative inhibition of urinary 11-dehydro-TXB2 and whole blood TXB2 production that recovered with a timecourse consistent with platelet turnover.", "spo_list": [{"subject": "aspirin", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PGHS-1", "object_type": "GENE"}, {"subject": "11-dehydro-TXB2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PGHS-1", "object_type": "GENE"}, {"subject": "TXB2", "subject_type": "CHEMICAL", "predicate": "PRODUCT-OF", "object": "PGHS-1", "object_type": "GENE"}]}
{"text": "CONCLUSIONS: Nabumetone does dose-dependently inhibit the cyclooxygenase activity of platelet PGHS-1 of healthy subjects both in vivo and ex vivo.", "spo_list": [{"subject": "Nabumetone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "cyclooxygenase", "object_type": "GENE"}, {"subject": "Nabumetone", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "PGHS-1", "object_type": "GENE"}]}
{"text": "One group of experimental animals was treated with 5-lipoxygenase (5-LO) inhibitor, diethylcarbamazine (DEC, Sigma, St.", "spo_list": [{"subject": "diethylcarbamazine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-lipoxygenase", "object_type": "GENE"}, {"subject": "diethylcarbamazine", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-LO", "object_type": "GENE"}, {"subject": "DEC", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-lipoxygenase", "object_type": "GENE"}, {"subject": "DEC", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-LO", "object_type": "GENE"}]}
{"text": "Although DEC exerts local antioxidant activity with beneficial effects on lung tissue, this 5-LO inhibitor intensifies the blast overpressure caused hemodynamic insufficiency.", "spo_list": [{"subject": "DEC", "subject_type": "CHEMICAL", "predicate": "INHIBITOR", "object": "5-LO", "object_type": "GENE"}]}
